TABLE OF CONTENTS

FiledAs filed with the Securities and Exchange Commission on August 18, 2008May 11, 2016

Registration No. -                333-208601

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

WASHINGTON, D.C. 20549AMENDMENT NO.

4
TO
FORM S-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

iSign Solutions Inc.
COMMUNICATION INTELLIGENCE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware
3577
942790442
(State or Other Jurisdiction of
Incorporation or Organization)
(Primary Standard Industrial
Classification Code Number)
(I.R.S. Employer
Identification Number)

DELAWARE

7371

94-2790442

(State or other jurisdiction
of incorporation)

(Primary Standard Industrial
Classification Code Number)

(I.R.S. Employer
Identification Number)

275 Shoreline Drive
Suite 500

Redwood Shores, California 94065
94065-1413
(650) 802-7888

(Address, including zip code, and telephone number
including
area code, of Registrant’s principal executive offices)

Andrea Goren
Chief Financial Officer
275 Shoreline Drive
Suite 500
Redwood Shores, California 94065-1413
(650) 802-7888

(Name, address, including zip code, and telephone number
including area code, of registrant’s principal executive offices)agent for service)

With copies to:


Frank Dane
Chief Financial Officer
Communication Intelligence Corporation
275 Shoreline Drive, Suite 500
Redwood Shores, California 94065
(650) 802-7888
Jonathan J. Russo, Esq.

Matthew J. Kane, Esq.
Alexandra F. Calcado, Esq.
Pillsbury Winthrop Shaw Pittman LLP
1540 Broadway
New York, NY 10036-4039
Tel. No.: (212) 858-1000
Fax No.: (212) 858-1500

Richard Friedman, Esq.

Copies to:David Manno, Esq.

Jeff Cahlon, Esq.

Michael C. Phillips, Esq.
Sichenzia Ross Friedman Ference LLP
Davis Wright Tremaine, LLP
1300 SW Fifth Avenue
23rd Floor
Portland, Oregon 97201-5630
Phone: (503) 241-2300
Facsimile: (503) 778-5299

(Name, address, including zip code, and
telephone number,
including area code, of agent for service)

61 Broadway
New York, NY 10006-2504
Tel. No.: (212) 930-9700
Fax No.: (212) 930-9725

Approximate date of commencement of proposed sale to the public: as As soon as practicable after the effective date of this registration statement.Registration Statement is declared effective.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended, check the following box.xo

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act Registrationregistration statement number of the earlier effective registration statement for the same offering.o

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.o

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.o

Indicate by a check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer”, anfiler,” “accelerated filer”, a “non-accelerated filer”, or a and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer Accelerated Filero

Accelerated filer Filero

  Non-accelerated filer

Non-Accelerated Filero

Smaller reporting company x

Reporting Company ☒

TABLE OF CONTENTS

CALCULATION OF REGISTRATION FEE

 

 

 

 

 

 

 

 

 

 

SECURITIES TO BE 
REGISTERED (3)

 

AMOUNT TO BE
REGISTERED (1)(3)

 

PROPOSED
OFFERING PRICE
PER SHARE (2)

 

PROPOSED
AGGREGATE
OFFERING PRICE

 

REGISTRATION
FEE (2)

 

Common stock, $0.01 par value

 

33,410,714

 

$

0.165

 

$

5,512,768

 

$

217

 

(1) All 33,410,714

Title of each class of securities to be registered
Proposed maximum aggregate offering price(1)
Amount of
registration fee(2)
Common stock, par value $0.01 per share(3)
$
2,012,500.00
 
$
202.66
(4)
Warrants to purchase Common Stock(5)
$
 
$
 
Common Stock issuable upon exercise of Warrants(6) (7)
$
1,257,812.50
 
$
126.66
(4)
Representative’s common stock purchase warrants(5)
$
 
$
 
Common stock underlying Representative’s warrants(8)
$
153,125.00
 
$
15.42
(4)
TOTAL
$
3,423,437.50
 
$
344.74
(4)

(1)Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended.
(2)Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.
(3)Includes shares of common stock which may be issued upon exercise of a 45-day option granted to the underwriters to cover over-allotments, if any.
(4)All of the registration fee due hereunder was previously paid.
(5)In accordance with Rule 457(g) under the Securities Act, because the shares of the Registrant’s common stock underlying the warrants are registered hereby, no separate registration fee is required with respect to the warrants registered hereby.
(6)Pursuant to Rule 416 under the Securities, Act the common stock registered hereby also includes an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions.
(7)Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, based on an estimated proposed maximum aggregate offering price of $1,093,750 for the common stock issuable upon exercise of the warrants. Includes $164,062.50 representing the maximum aggregate offering price of the shares of common stock underlying the warrants the underwriters have the option to purchase in this offering to cover over-allotments, if any. The proposed maximum aggregate offering price of the common stock underlying the warrants has been calculated by assuming the warrants are exercisable to purchase shares of common stock at a price per share equal to 125.0% of the public offering price per share.
(8)Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The warrants are exercisable at a per share exercise price equal to 125.0% of the public offering price per share. As estimated solely for the purpose of recalculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the Representative’s warrants is 125% of $122,500.

The registrant hereby amends this registration statement are to be offered by the selling stockholders. In accordance with Rule 416 under the Securities Act of 1933, as amended, the number of shares to be registered includes such indeterminate number of additional shares of common stock as may become issuable as a result of stock splits, stock dividends or similar transactions.

(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, on the basis of the average of the bid and asked prices of the Registrant’s common stock on August 15, 2008, as reported on the Over-The-Counter Bulletin Board.

(3) Includes 25,982,143 shares of common stock issuable upon the exercise of warrants and 7,428,571 shares of common stock issuable upon the conversion of convertible preferred stock held by the selling stockholders.

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrantregistrant shall file a further amendment which specifically states that this Registration Statementregistration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this Registration Statementthe registration statement shall become effective on such date as the Commission, acting pursuant to said Sectionsection 8(a), may determine.

TABLE OF CONTENTS



The information in this prospectus is not complete and may be changed. The selling stockholdersWe may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and neither we nor the selling stockholders areit is not soliciting an offeroffers to buy these securities in any statejurisdiction where the offer or sale is not permitted.

PRELIMINARY PROSPECTUS
SUBJECT TO COMPLETION
DATED MAY 11, 2016

SubjectShares of Common Stock
Warrants to Completion, dated August 18, 2008

Purchase  PROSPECTUS

COMMUNICATION INTELLIGENCE CORPORATION

33,410,714 Shares of Common Stock


GRAPHIC

iSign Solutions Inc.


This prospectus relates to the resaleis a firm commitment public offering of  an aggregate of up to 33,410,714 shares of our common stock issuable to certain of our stockholders who are named in this prospectus. The  shares of common stock being offered by the selling stockholders are either (i) issuable upon the conversionand warrants to purchase  •  shares of preferred stock or (ii) are issuable upon the exercise of certain common stock purchase warrants. Our filing of the registration statement, of which this prospectus is a part, is intended to satisfy our obligations to the selling stockholders to register for resale the shares issuable to them upon exercise of the warrants issued to them or issuable to them upon the conversion of the preferred stock issued to them.iSign Solutions Inc.

The prices at which the selling stockholders may sell these shares will be determined by the prevailing market price for shares of our common stock or in negotiated transactions. We will not receive any of the proceeds from the sale of these shares, although we have paid the expenses of preparing this prospectus and the related registration statement. If the warrants are exercised, we will receive proceeds of certain of the warrants equal to the exercise price of any warrants held by the selling stockholders; the warrants contain net exercise provisions which if exercised would reduce or eliminate the cash proceeds we would receive upon exercise of such warrants but result in our issuing less shares of our common stock. We will not receive any proceeds due to the conversion of our preferred stock.

Our common stock is quoted on the Over-The-Counter Bulletin BoardOTC Markets Group Inc.’s OTCQB quotation system under the trading symbol “CICI.OB.”“ISGN”. On August 15, 2008,May 10, 2016, the closing bidlast reported sale price for a share of our common stock on the OTCQB was $0.165$2.43 per share. Prior to this offering, there has been no public market for our warrants. An application has been filed with the Financial Industry Regulatory Authority (“FINRA”) to have the warrants quoted on the OTCQB quotation system under the trading symbol “ISGNW”.

There can be no assurance that an active trading market for the warrants will develop.

Investing in shares of our common stocksecurities involves a high degree of risk. You should consider carefully the risk factors included in this prospectusSee “Risk Factors” beginning on page 4 before making6 of this prospectus for a decision to purchase discussion of information that should be considered in connection with an investment in our stock.common stock and warrants, including a going concern opinion by the auditors of our financial statements.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacydetermined if this prospectus is truthful or accuracy of this prospectus.complete. Any representation to the contrary is a criminal offense.

Per Share
Per Warrant
Total
Public offering price
$
$
$
Underwriting discounts and commissions(1)
$
$
$
Proceeds to us, before expenses(2)
$
$
$

(1)Does not include a non-accountable expense allowance equal to 1% of the gross proceeds of this offering payable to Axiom Capital Management, Inc., the representative of the underwriters. See “Underwriting” for a description of compensation payable to the underwriters.
(2)Does not include proceeds from the exercise of the warrants, in cash, if any.

We have granted a 45-day option to the representative of the underwriters to purchase up to  •  additional shares of common stock and/or up to  •  warrants solely to cover over-allotments, if any.

The date of this prospectus isunderwriters expect to deliver our shares and warrants to purchasers in the offering on or about May • , 2008.



2016.

Axiom Capital Management, Inc.

TABLE OF CONTENTS

TABLE OF CONTENTS

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

ii

PROSPECTUS SUMMARY

1

RISK FACTORS

4

SELECTED HISTORICAL CONSOLIDATED FINANCIAL DATA

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

7

DESCRIPTION OF CAPITAL STOCK

18

MARKET PRICE INFORMATION

21

DIVIDEND POLICY

22

DESCRIPTION OF INDEBTEDNESS

23

USE OF PROCEEDS

23

SELLING STOCKHOLDERS

23

PLAN OF DISTRIBUTION

27

BUSINESS

29

MANAGEMENT

EXECUTIVE COMPENSATION

37

DIRECTOR COMPENSATION

39

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

40

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

42

SHARES ELIGIBLE FOR FUTURE SALE

44

WHERE YOU CAN FIND MORE INFORMATION

44

LEGAL MATTERS

44

EXPERTS

44

INDEX TO FINANCIAL STATEMENTS

F-1

You should rely only on the information contained or incorporated by reference in this prospectus. We have not, and the underwriters have not, authorized anyone to provide you with additional information or information different from that contained in this prospectus. This prospectus isWe are not making an offer to sell and we are not seeking an offer to buyof these securities in any state or other jurisdiction where thisthe offer or sale is not permitted. You should assume that theThe information appearing in this prospectus ismay only be accurate only as of the date on the front coverof this prospectus regardless of time of delivery of this prospectus or any sale of our securities.

No person is authorized in connection with this prospectus to give any information or to make any representations about us, the common stock and warrants offered hereby or any matter discussed in this prospectus, other than the information and representations contained in this prospectus. If any other information or representation is given or made, such information or representation may not be relied upon as having been authorized by us. This prospectus does not constitute an offer to sell, or a solicitation of an offer to buy our common stock or warrants in any circumstance under which the offer or solicitation is unlawful. Neither the delivery of this prospectus nor any distribution of our common stock or warrants in accordance with this prospectus shall, under any circumstances, imply that there has been no change in our affairs since the date of this prospectus.

i

TABLE OF CONTENTS

PROSPECTUS SUMMARY

This summary highlights selected information appearing elsewhere in this prospectus. While this summary highlights what we consider to be important information about us, you should carefully read this entire prospectus before investing in our common stock and warrants, especially the risks and other information we discuss under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operation” and our consolidated financial statements and related notes beginning on page F-1. Our business, financial condition, results of operationsfiscal year end is December 31 and prospects may have changed since that date.

No action is being taken in any jurisdiction outside the United Statesour fiscal years ended December 31, 2013, December 31 2014 and December 31, 2015 are sometimes referred to permit a public offeringherein as fiscal years 2013, 2014 and 2015, respectively. Some of the common stock or possession or distribution ofstatements made in this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are requireddiscuss future events and developments, including our future strategy and our ability to inform themselves aboutgenerate revenue, income and to observe any restrictions as to this offeringcash flow. These forward-looking statements involve risks and the distribution of this prospectus applicable to those jurisdictions.

i



SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus contains “forward-looking statements” that represent our beliefs, projections and predictions about future events. These statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors thatwhich could cause our actual results, performance or achievements, or industry results to differ materially from any future results, performance,those contemplated in these forward-looking statements. See “Cautionary Note Regarding Forward-Looking Statements”. Unless otherwise indicated or achievement describedthe context requires otherwise, the words “we,” “us,” “our”, the “Company” or implied“our Company” and “iSign” refer to iSign Solutions Inc., a Delaware corporation, and our wholly owned subsidiaries.

Except as otherwise indicated in this prospectus,all common stock share and per share information and all exercise prices with respect to our options and warrants reflect, on a retroactive basis, a 1-for-1,250 reverse stock split of our common stock, which became effective on January 22, 2016. This prospectus assumes the warrants offered by such statements. Forward-looking statements regarding our plans, objectives, expectations, intentions, future financial performance, future financial condition, us and other statementsthe over-allotment option of the underwriters have not been exercised, unless otherwise indicated.

Our Business

We are not historical facts. Whenever you read a statement that is not solelyleading supplier of digital transaction management software enabling the paperless, secure and cost-effective management and authentication of document-based transactions. Our solutions encompass a statementwide array of historical fact (suchfunctionality and services, including electronic signatures, simple-to-complex workflow management and various options for biometric authentication. These solutions function across virtually all enterprise, desktop and mobile environments. Our software can be deployed both on-premise and as when we use wordsa cloud-based (software as a service, or SaaS) service, with the ability to transition between deployment models. We are headquartered in Redwood Shores, California.

Core Technologies

Our core technologies can be referred to as “transaction-enabling,” “digital authentication” and “business process work flow.” These technologies include various forms of electronic signature methods, such as “believe”, “anticipate”, “hope”, “intend”, “expect”, “estimate”, “plan”, “will”, “would”, “could”, “likely”handwritten, biometric, click-to-sign and other similar words, phrasesothers, as well as technologies related to signature verification, authentication, cryptography and statements), you should understandthe logging of audit trails to prove signers’ intent. Our technologies enable the appending of secure, legal and regulatory compliant electronic signatures coupled with an enhanced user experience.

Products

Our enterprise-class SignatureOne® and iSign® suite of electronic signature solutions enables businesses to implement paperless, electronic signature-driven business processes. The aggregate of the software functionality enabling the digitization of end-to-end work flow processes is sometimes referred to as “Digital Transaction Management” (“DTM”). Many applications provide electronic forms and allow users to fill in information, but most of these applications still require users to print out a paper copy for the application of a handwritten, ink signature. Solutions powered by our products allow legally binding electronic signatures to be added to digitized documents, eliminating the need for paper to memorialize the completion, approval or authentication of the transaction. This allows users to reduce transaction times and processing costs.

1

TABLE OF CONTENTS

Competitive Advantage

We are an electronic signature and digital transaction management company that has developed and sold enterprise and application software and professional services for over 15 years. Our current clients include six of the largest U.S. insurance companies and a top-five U.S. bank. We believe that our expectations may not be correct. We do not guarantee thatprimary competitive advantages include the transactionsfollowing:

Customer options and platform flexibility:   Unlike most of our competitors, we offer many flexible configuration options for enterprise clients to address many variants of complex business work flows without the need for costly and time-consuming customization. These solution configurations can be rapidly and seamlessly integrated into a variety of enterprise technology environments.
Software deployment options:   Unlike most of our competitors, our software solutions are available as an on demand, private cloud-based software as a service, and on the customer’s premises, which is an important feature for most of our large enterprise clients for compliance, security and control reasons.
Lower cost structure:   Through our technology, sales and marketing partners, including Cegedim SA, we believe we offer a lower relative cost structure and higher operating margin than most of our larger competitors.

Our Risks and events describedChallenges

An investment in our common stock and warrants involves a high degree of risk including risks related to our business, such as the following:

Our audit report in this prospectus will happen as described orstates that any positive trends noted in this prospectus will continue. The forward-looking information contained in this prospectus is generally located under the headings “Business”our significant recurring losses and “Risk Factors”, but may be found in other locations as well. Some of the risks investors should consider in connection with this offering are:

·                  Our ability to continue as a going concern. Our independent registered public accounting firm has issued a report expressing aaccumulated deficit raise substantial doubt about our ability to continue as a going concern.

·                  Our

We have a history of net losses; we may incur additional losses.
In any given year, three customers could account for approximately 47% of our revenue.
We face competition from companies that have greater resources than we do and we may not be able to effectively compete against these companies.
If we are unable to successfully protect our intellectual property, our competitive position will be harmed.
If others claim we infringe on their intellectual property rights, we may be subject to costly and time consuming litigation.

We are subject to a number of additional risks which you should be aware of before you buy our common stock and warrants. The risks are discussed more fully in the section entitled “Risk Factors” following this prospectus summary.

Our Corporate Information

We were incorporated in Delaware in 1986 as Communication Intelligence Corporation. In December 2015, we changed our name to iSign Solutions Inc. and our common stock trading symbol to “ISGN”. Our executive offices are located at 275 Shoreline Drive, Suite 500 Redwood Shores, California 94065-1413. Our telephone number is (650) 802-7888. Our web site is located at www.isignnow.com. The information contained on our website is not incorporated by reference into this prospectus, Our logo, iSign®, InkTools® SIGVIEW®, Sign-it®, INKshrINK®, Ceremony®, SignatureOne®, Signed, Sealed, Delivered® and The Power To Sign Online® are registered trademarks of the Company. We intend to register our trademarks generally in those jurisdictions where significant marketing of our products will be undertaken in the foreseeable future.

2

TABLE OF CONTENTS

THE OFFERING

Common stock offered by us:
 •  shares
Warrants offered by us:
 •  warrants. Each warrant shall have an exercise price equal to 125% of the public offering price per share of common stock, will be exercisable immediately, and will expire five years from the date of the issuance.
Common stock outstanding before the offering as of May 6, 2016:
187,463 shares
Common stock to be outstanding after the offering:
 •  shares(1)(2)
Offering price per share:
$ •  per share
Offering price per warrant:
$ •  per warrant
Use of proceeds:
We currently intend to use the net proceeds received from this offering to expand our sales and marketing efforts, increase our product offerings, prepay $200,000 in the aggregate principal amount, plus accrued interest, of our unsecured convertible promissory notes due August 25, 2016, pay approximately $285,000 of accrued and unpaid compensation due to officers, employees and/or their affiliated entities, and for working capital and for other general corporate purposes. See “Use of Proceeds” on page 11.
Risk factors:
Investing in our securities involves a high degree of risk. You should carefully consider the information set forth in the “Risk Factors” section beginning on page 6.
Trading Symbols:
Our common stock is currently quoted on the OTCQB under the trading symbol “ISGN”. Prior to this offering, there has been no public market for our warrants. An application has been filed with FINRA to have the warrants quoted on the OTCQB quotation system under the trading symbol “ISGNW”. There can be no assurance that an active trading market for the warrants will develop.
Lock-up:
We and our directors, officers and principal stockholders have agreed with the underwriters not to offer for sale, issue, sell, contract to sell, pledge or otherwise dispose of any of our common stock or securities convertible into common stock for a period of 6 months after the date of this prospectus, in the case of our directors and officers, and 3 months after the date of this prospectus, in the case of us and our principal stockholders. See “Underwriting” section on page 53.
(1)Gives effect to the conversion of (a) all our outstanding shares of preferred stock into 3,639,422 shares of common stock (at the reduced conversion prices that will be effective upon closing of this offering), (b) approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities into 204,845 shares of common stock and warrants to purchase 256,056 shares of common stock (based upon an assumed public offering price of $2.43 per share) and (c) $1,068,000 in the aggregate principal amount, plus accrued interest, of unsecured convertible promissory notes into 485,151 shares of common stock and warrants to purchase 606,439 shares of common stock (based upon an assumed public offering price of $2.43 per share), in each case upon consummation of the offering.
(2)Assumes no exercise by the underwriters of their option to purchase up to  •  shares of common stock, up to • warrants or a combination of shares of common stock and warrants, in each case representing no more than 15% of shares of common stock or warrants sold in this offering, as applicable, to cover over-allotments, if any and excludes (i) 74,652 shares of our common stock issuable upon exercise of outstanding stock options under our stock incentive plans at a weighted average exercise price of $45.84 per share as of May 6, 2016, (ii) 205,158 shares of our common stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $28.70 per share as of May 6, 2016, (iii)  •  shares of common stock issuable upon exercise of the warrants offered hereby, (iv)  •  shares of common stock underlying the warrants to be issued to the underwriters in connection with this offering and (v) • shares of common stock issuable upon the exercise of warrants issued in connection with conversion of unsecured convertible promissory notes and accrued and unpaid compensation.

TABLE OF CONTENTS

SUMMARY CONSOLIDATED FINANCIAL INFORMATION

The following summary consolidated statements of operations data for the years ended December 31, 2015 and 2014 have been derived from our audited consolidated financial statements included elsewhere in this prospectus.The historical financial data presented below is not necessarily indicative of our financial results in future periods. You should read the summary consolidated financial data in conjunction with those financial statements and the accompanying notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Our consolidated financial statements are prepared and presented in accordance with United States generally accepted accounting principles, or U.S. GAAP. Except as otherwise noted, all share and per share data for the periods shown have been adjusted, on a retroactive basis, to reflect a 1-for-1,250 reverse stock split, which became effective on January 22, 2016, but not the automatic conversion of all of our outstanding shares of preferred stock, the conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities and the conversion of $1,068,000 in the aggregate principal amount, plus accrued interest, of unsecured convertible promissory notes, in each case, into common stock (and, in the case of the conversion of accrued and unpaid compensation and unsecured convertible promissory notes, warrants to purchase shares of common stock), which will occur upon consummation of the offering.

 
For the Year
Ended December 31,
 
2015
2014
Consolidated Statements of Operations Data:
 
 
 
 
 
 
Revenue
$
1,620,000
 
$
1,515,000
 
Total operating costs and expenses
 
5,445,000
 
 
5,328,000
 
Loss from operations
 
(3,825,000
)
 
(3,813,000
)
Other income (expense), net
 
(3,000
)
 
50,000
 
Interest expense
 
(54,000
)
 
(259,000
)
Net loss
$
(3,917,000
)
$
(4,015,000
)
Net loss attributable to common stockholders
$
(7,619,000
)
$
(7,379,000
)
Basic and diluted loss per common share
$
(41
)
$
(39
)
Weighted average number of common shares outstanding, basic and fully diluted
 
187,000
 
 
187,000
 

4

TABLE OF CONTENTS

The following table presents consolidated balance sheets data as of December 31, 2015 on:

an actual basis;
on a pro forma basis, giving effect to (a) the automatic conversion of all our outstanding shares of preferred stock into 3,639,422 shares of common stock (at the reduced conversion prices that will be effective upon closing of this offering), (b) the conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities into 204,845 shares of common stock and warrants to purchase 256,056 shares of common stock (based upon an assumed public offering price of $2.43 per share) and (c) the conversion of $1,068,000 in the aggregate principal amount of unsecured convertible promissory notes, plus accrued interest, into 485,151 shares of common stock and warrants to purchase 606,439 shares of common stock (based upon an assumed public offering price of $2.43 per share), in each case, upon consummation of the offering; and
on a pro forma as adjusted basis, giving effect to the pro forma adjustments and the sale by us of 720,164 shares of common stock in this offering at an assumed public offering price of $2.43 per share and 360,082 warrants at an assumed public offering price of $0.01, after deducting underwriting discounts and commissions and estimated offering expenses

The pro forma information set forth below is illustrative only and will be adjusted based on the actual public offering price and other terms of this offering determined at pricing.

 
As of December 31, 2015
 
 
Actual
Pro Forma
Pro Forma
As Adjusted(1)
Consolidated Balance Sheets Data:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
846,000
 
$
846,000
 
$
1,860,000
 
Other current assets
 
466,000
 
 
466,000
 
 
234,000
 
Total assets
 
1,976,000
 
 
1,976,000
 
 
2,757,000
 
Total liabilities
 
(3,846,000
)
 
(2,471,000
)
 
(2,471,000
)
Additional paid-in-capital
 
95,312,000
 
 
128,950,000
 
 
129,950,000
 
Total iSign stockholders’ equity (deficit)
 
(1,334,000
)
 
1,232,000
 
 
2,013,000
 
Non-controlling interest
 
(536,000
)
 
(536,000
)
 
(536,000
)
Total equity (deficit)
 
(1,870,000
)
 
696,000
 
 
1,477,000
 
Total liabilities and equity (deficit)
$
1,976,000
 
$
1,976,000
 
$
2,757,000
 
(1)A $1.00 increase or decrease in the assumed public offering price per share would increase or decrease our pro forma as adjusted cash and cash equivalents, working capital, total assets and total stockholders’ equity by approximately $720,164, assuming the number of shares and warrants offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the underwriting discount and estimated offering expenses payable by us.

5

TABLE OF CONTENTS

RISK FACTORS

Investing in our common stock and warrants involves a great deal of risk. Careful consideration should be made of the following factors as well as other information included in this prospectus before deciding to purchase our common stock and warrants. There are many risks that affect our business and results of operations, some of which are beyond our control. Our business, financial condition or operating results could be materially harmed by any of these risks. This could cause the trading price of our common stock and warrants to decline, and you may lose all or part of your investment. Additional risks that we do not yet know of or that we currently think are immaterial may also affect our business and results of operations.

Risks Related To Our Business

We have a history of net losses and we may incur additional losses.Our audit report in this prospectus states that our significant recurring losses and accumulated deficit raise substantial doubt about our ability to continue as a going concern.

Except for the year ended December 31, 2004, in each year since our inception we have incurred losses. As of June 30, 2008, ourFor the two-year period ended December 31, 2015, net losses attributable to common stockholders aggregated approximately $15.0 million, and, at December 31, 2015, the Company’s accumulated deficit was approximately $93.6 million;$127.1 million. In each of our last three fiscal years, our auditors have raised substantial doubt about our ability to continue as a going concern. Historically, our losses have resulted primarily from expenses incurred in connection with the research and development of our products and from general administrative expenses. We may continue to incur additional operating losses as we continue our research and development efforts, introduce new products and expand our sales and marketing activities. We cannot assure you that our revenue will increase or that we will be profitable in any future period.

Since our revenue is highly dependent on a relatively small number of products, any significant reduction of sales of these products would materially harm our operating results.

·Because our revenue is derived substantially from sales of our SignatureOne® and iSign® suite of products, we are highly dependent upon the continued market acceptance of these products. We cannot assure you that the SignatureOne® and the iSign® suite of products will continue to achieve acceptance in the marketplace. Any significant reduction of sales of either the SignatureOne® and/or the iSign® suite of products would materially harm our operating results.

In fiscal year 2015, approximately 47% of our revenue was derived from three of our customers. If we are unable to replace revenue generated from one of our major customers with revenue from others in future periods, our revenue may materially decline and our growth would be limited.

Historically, the Company’s revenue has been derived from hundreds of customers, but a significant percentage of the revenue has been attributable to a limited number of customers. Three customers accounted for 24%, 13% and 10%, respectively, of total revenue for the year ended December 31, 2015. If we are unable to replace revenue generated from one of our major customers with revenue from others, our revenue may decline and our growth could be limited. In addition, one of our licensees, Cegedim SA, has the right to terminate its license agreement with us for any reason upon 180 days prior notice once the agreement’s initial five year term ends in January 2020. In the event that the license agreement were to be terminated, there may be significant adverse effects on our revenues and prospects.

We face competition from companies that have greater resources than we do and we may not be able to effectively compete against these companies.

We operate in a highly competitive industry. Currently, our primary competition for basic click-to-sign electronic signatures includes Adobe EchoSign, DocuSign and Silanis (which was recently acquired by VASCO Data Security International Inc.). Principal competition for handwritten biometric signatures includes SoftPro, Wondernet and signature pad vendors. Though we believe we have a competitive advantage by offering solutions with a variety of different electronic signature methods that enable users to sign virtually any document format, in any software environment, and on any hardware platform, there can be no assurance that competitors, including some with greater financial or other resources, will not succeed in developing products or technologies that are more effective, easier to use or less expensive than our products or technologies that could render our products or technologies obsolete or non-competitive. If we are unable to successfully compete with our competitors our sales would suffer and as a result our financial condition would be adversely affected.

6

TABLE OF CONTENTS

If we are unable to successfully protect our intellectual property, our competitive position will be harmed.

Our ability to compete is heavily affected by our ability to protect our intellectual property. We rely on a combination of patent applications, trademark laws, trade secrets, confidentiality procedures and contractual provisions to protect our proprietary rights. We have a policy to enter into confidentiality or license agreements with our employees, consultants and other parties with whom we contract, and seek to control access to and distribution of our software, documentation and other proprietary information. The steps we take to protect our intellectual property may be inadequate. Existing trade secret, trademark and copyright laws offer only limited protection. Unauthorized parties may attempt to copy aspects of our products or obtain and use information which we regard as proprietary. Policing unauthorized use of our products is difficult, time consuming and costly, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. We cannot assure you that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar technology, the effect of either of which would harm our competitive position in the market.

Others could claim that we infringe on their intellectual property rights, which may result in costly and time consuming litigation and could delay or otherwise impair the development and commercialization of our products.

In recent years, there has been a significant increase in litigation in the United States involving patents and other intellectual property rights. We do not believe that our products infringe on the proprietary rights of third parties. There can be no assurance, however, that third parties will not claim such infringement by us or our licensees with respect to current or future products. Claims for alleged infringement and any resulting lawsuit, if successful, could subject us to significant liability for damages and invalidation of our intellectual property rights. Any such claims, with or without merit, could be time consuming, expensive to defend, cause product shipment delays or require us to enter into a royalty or licensing agreement, any of which could delay the development and commercialization of our products or reduce our margins. If we are unable to obtain a required license, our ability to sell or use certain products may be impaired. In addition, if we fail to obtain a license, or if the terms of the license are burdensome to us, our operations could be materially harmed.

If we are unable to retain key personnel we may not be able to execute our business strategy.

Our operations are dependent on the abilities, experience and efforts of a number of key personnel, including Philip S. Sassower, the co-chairman of our board of directors and our chief executive officer, William Keiper, our president and chief operating officer, Nhan Nguyen, our chief technology officer, and Andrea Goren, our chief financial officer. Should any of these persons or other key employees be unable or unwilling to continue in our employ, our ability to execute our business strategy may be adversely affected. In addition, our success is highly dependent on our continuing ability to identify, hire, train, motivate and retain highly qualified management, technical and sales and marketing personnel. Competition for such personnel is intense. We may be unable to attract and retain the personnel necessary for the development of our business. Because we have experienced operating losses, we may have a more difficult time in attracting and retaining the employees we need. Our relationships with our key customers;employees are “at will.” Also, we do not have “key person” life insurance policies covering any of our employees. The inability to attract or retain qualified personnel in the future or delays in hiring skilled personnel could harm our relations with our customers and our ability to respond to technological change which would prevent us from executing our business strategy.

·                  Liquidity constraintsWe must respond quickly and effectively to new technological developments, and the availabilityfailure to do so could have a material and adverse effect on our results of future financing if needed;operations.

·                  Economic, business, marketOur failure to maintain our technological, engineering and competitive conditions in the software industry andquality control capabilities or to respond effectively to technological innovations whichchanges could adversely affect our business;business, results of operations or financial condition. Our future success also depends on our ability to enhance existing software and systems and to respond to changing technological developments. If we are unable to successfully develop and bring to market new software and systems in a timely manner, our competitors’ technologies or services may render our products or services noncompetitive or obsolete.

7

TABLE OF CONTENTS

Risks Relating To Ownership Of Our Common Stock And Warrants

A small number of principal stockholders beneficially own approximately 63.2% of our common stock, after giving effect to the consummation of the offering (including the automatic conversion of all outstanding shares of preferred stock, approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entitiesand $1,068,000 in the aggregate principal amount, plus accrued interest, of unsecuredconvertible promissory notes into common stock) and thus have effective control over matters requiring stockholder approval.

·One of our principal stockholders, Phoenix Venture Fund LLC, which we refer to as Phoenix, is co-managed by Philip S. Sassower, our co-chairman and chief executive officer, and Andrea Goren, one of our directors and our chief financial officer. Michael Engmann, who serves with Mr. Sassower as co-chairman of our board of directors, is also one of our principal stockholders. As of the date of this prospectus, Phoenix beneficially owns approximately 49.9% of our common stock, and Mr. Engmann beneficially owns approximately 38.1% of our common stock, in each case after giving effect to the consummation of the offering (including the conversions into common stock referred to above). In addition, Mr. Sassower, personally and through other entities controlled by him other than Phoenix, beneficially owns, in the aggregate, approximately 32.2% of our common stock, after giving effect to the consummation of the offering (including the conversions into common stock referred to above). Thus, Phoenix, Mr. Sassower and Mr. Engmann, together, beneficially own in the aggregate, approximately 63.2% of our common stock, giving effect to the consummation of the offering (including the conversions into common stock referred to above). Accordingly, Phoenix, Mr. Sassower and Mr. Engmann each have the ability to exercise significant influence (and have effective control) over matters generally requiring stockholder approval, including the election of directors and the approval of significant corporate transactions, which could have the effect of delaying or preventing a third party from acquiring control over us.

Our inabilityAmended and Restated Certificate of Incorporation allow for our board of directors to create new series of preferred stock without further approval by our stockholders, which could have an anti-takeover effect and could adversely affect holders of our common stock.

Our authorized capital includes preferred stock issuable in one or more series. Our board of directors has the authority to issue preferred stock and determine the price, designation, rights, preferences, privileges, restrictions and conditions, including voting and dividend rights, of those shares without any further vote or action by stockholders. The rights of the holders of common stock will be subject to, and may be adversely affected by, the rights of holders of any preferred stock that may be issued in the future. The issuance of additional preferred stock, while providing desirable flexibility in connection with possible financings and acquisitions and other corporate purposes, could make it more difficult for a third party to acquire a majority of the voting power of our outstanding voting securities, which could deprive our holders of common stock of a premium that they might otherwise realize in connection with a proposed acquisition of our company.

Our common stock is a “penny stock.Broker-dealers may find it more difficult to trade our common stock and an investor may find it more difficult to acquire or dispose of our common stock in the secondary market.

Our common stock is subject to the so called “penny stock” rules. The Securities and Exchange Commission has adopted regulations that define a “penny stock” to be any equity security that has a market price per share of less than $5.00, subject to certain exceptions, such as any securities listed on a national securities exchange. For any transaction involving a “penny stock,” unless exempt, the rules impose additional sales practice requirements on broker-dealers, subject to certain exceptions. Broker-dealers may find it more difficult to trade our common stock and an investor may find it more difficult to acquire or dispose of our common stock on the secondary market. Investors in penny stocks should be prepared for the possibility that they may lose their whole investment.

The trading liquidity of our common stock may not improve following this offering.

Over the past several years, the trading in our common stock has been limited, and following the consummation of our reverse stock split, the trading in our common stock has been even more limited. The trading liquidity of our common stock may not necessarily improve following the offering.

There has been no public market for our warrants, and an active market may not develop or be sustained, which could limit your ability to sell our warrants.

There currently is no public market for our warrants, and our warrants will not be traded in the open market prior to this offering. An application has been filed with FINRA to have our warrants quoted on the OTCQB. Generally, FINRA must approve the first quotation of a security by a market maker on the OTCQB. An adequate trading market

8

TABLE OF CONTENTS

for the warrants may not develop or be sustained after this offering. The public offering price for our common stock and warrants will be determined by negotiations between the underwriters and our board of directors and may not be representative of the market price at which our shares of common stock and warrants will trade after this offering. In particular, we cannot assure you that you will be able to resell your shares or warrants at or above the public offering price.

Our stock price may be subject to significant volatility.

The public stock markets have experienced significant volatility in stock prices in recent years. The stock prices of technology companies have experienced particularly high volatility, including, at times, severe price changes that are unrelated or disproportionate to the operating performance of such companies. The trading price of the Company’s common stock and warrants could be subject to wide fluctuations in response to, among other factors, quarter-to-quarter variations in operating results, announcements of technological innovations or new products by the Company or its competitors, competitor consolidation in the industry, announcements of new strategic relationships by the Company or its competitors, general conditions in the computer software industry or the global economy generally, or market volatility unrelated to the Company’s business and operating results. The impact and severity of the above factors could be exacerbated by the Company’s small size, public float and a lack of market liquidity.

We do not expect to pay dividends on our common stock.

We have never paid cash dividends on our common stock. Our current policy is to retain any future earnings to finance the future development and expansion of our business. Any future determination about the payment of dividends will be made at the discretion of our board of directors and will depend upon our earnings, capital requirements, operating and financial conditions and on such other factors the board of directors deems relevant.

The warrants are speculative in nature.

The warrants to be issued to investors in this offering do not confer any rights of common stock ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to purchase shares of common stock at a fixed price for a limited period of time. Specifically, commencing on the date of issuance, holders of the warrants may exercise their right to acquire shares of common stock at an exercise price of $   •    per share, prior to five years from the date of issuance after which date any unexercised warrants will expire and have no further value. There can be no assurance that the market price of the common stock will ever equal or exceed the exercise price of the warrants, and consequently, whether it will ever be profitable for holders of the warrants to exercise the warrants.

Risks Related to the Offering

Investors in this offering will experience immediate and substantial dilution in net tangible book value.

The public offering price will be substantially higher than the net tangible book value per share of our outstanding shares of common stock. As a result, investors in this offering will incur immediate dilution of $2.44 per share, based on the assumed public offering price of $2.43 per share. Investors in this offering will pay a price per share that substantially exceeds the book value of our assets after subtracting our liabilities. See “Dilution” for a more complete description of how the value of your investment will be diluted upon the completion of this offering.

We have not determined a specific use for a portion of the net proceeds from this offering, and we may use these proceeds in ways with which you may not agree.

While we currently intend to use the net proceeds received from this offering to expand our sales and marketing efforts, increase our product offerings, prepay $200,000 in the aggregate principal amount, plus accrued interest, of our unsecured convertible promissory notes due August 25, 2016, pay approximately $285,000 of accrued and unpaid compensation due to officers, employees and/or their affiliated entities and for working capital and for other general corporate purposes, our management will have considerable discretion in the application of the proceeds received in connection with this offering. You will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. You must rely on the judgment of our management regarding the application of the net proceeds of this offering. The net proceeds may be used for corporate purposes that do not improve our profitability or increase our share price. The net proceeds from this offering may also be placed in investments that do not produce income or lose value.

9

TABLE OF CONTENTS

We may need additional capital, and the sale of additional shares or equity or debt securities could result in additional dilution to our stockholders.

We believe that our current cash and cash used in operations, together with the net proceeds from this offering, will be sufficient to meet our anticipated cash needs for the next 12 months. We may, however, require additional cash resources due to changed business conditions or other future developments. If these resources are insufficient to satisfy our cash requirements, we may seek to sell additional equity or debt securities or obtain one or more credit facilities. The sale of additional equity securities could result in additional dilution to our stockholders. The incurrence of indebtedness would result in increased debt service obligations and could result in operating and financing covenants that would restrict our operations. It is uncertain whether financing will be available in amounts or on terms acceptable to us, if at all.

Sales of a substantial number of shares of our common stock following this offering may adversely affect the market price of our common stock and the issuance of additional shares will dilute all other stockholders.

Sales of a substantial number of shares of our common stock in the public market or otherwise following this offering, or the perception that such sales could occur, could adversely affect the market price of our common stock. After completion of this offering at an assumed offering price of $2.43 per share (including the automatic conversion of all outstanding shares of preferred stock, the conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities and the conversion of $1,068,000 in the aggregate principal amount, plus accrued interest, of unsecured convertible notes, in each case, into common stock (and, in the case of the conversion of accrued and unpaid compensation and unsecured convertible promissory notes, warrants to purchase shares of common stock) which will occur upon consummation of this offering), our existing stockholders will own approximately 3.57% of our common stock assuming there is no exercise of the underwriters’ over-allotment option.

After completion of this offering at an assumed offering price of $2.43 per share (including the automatic conversion of all outstanding shares of preferred stock, the conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities and the conversion of $1,068,000 in the aggregate principal amount, plus accrued interest, of unsecured convertible notes into common stock, in each case upon consummation of the offering), there will be 5,237,045 shares of our common stock outstanding. In addition, our amended and restated certificate of incorporation, permits the issuance of up to approximately 1,994,762,955 additional shares of common stock after the completion of this offering. Thus, we have the ability to issue substantial amounts of common stock in the future, which would dilute the percentage ownership held by the investors who purchase shares of our common stock in this offering.

We and our officers, directors and certain stockholders have agreed, subject to customary exceptions, not to, without the prior written consent of Axiom Capital Management Inc., the representative of the underwriters, during the period ending 180 days from the date of this offering in the case of our directors and officers and 90 days from the date of this offering in the case of us and our stockholders who beneficially own more than 5% of our common stock, directly or indirectly, offer to sell, sell, pledge or otherwise transfer or dispose of any of shares of our common stock, enter into any swap or other derivatives transaction that transfers to another any of the economic benefits or risks of ownership of shares of our common stock, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company or publicly disclose the intention to do any of the foregoing. In addition, in connection with the recent private placement of unsecured convertible promissory notes due August 25, 2016, purchasers of these notes have agreed to similar “lock-up” provisions for a period of 90 days from the date of this offering.

After the lock-up agreements with our principal stockholders pertaining to this offering expire 90 days from the date of this offering unless waived earlier by the representative, up to 226,390 of the shares that had been locked up will be eligible for future sale in the public market. After the lock-up agreements with our directors and officers pertaining to this offering expire 180 days from the date of this offering unless waived earlier by the managing underwriter, up to 1,911,934 of the shares (net of any shares also restricted by lock-up agreements with our principal stockholders) that had been locked up will be eligible for future sale in the public market. After the lock-up agreements with our noteholders pertaining to this offering expire 90 days from the date of this offering unless waived earlier by the managing underwriter, up to 226,930 of the shares (net of any shares also restricted by lock-up agreements with our directors, officers or principal stockholders) that had been locked up will be eligible for future sale in the public market. Sales of a significant number of these shares of common stock in the public market could reduce the market price of the common stock.

10

TABLE OF CONTENTS

USE OF PROCEEDS

We estimate that the net proceeds from the sale of the  •  shares of common stock and  •  warrants to purchase  •  shares of common stock in the offering at an assumed offering price of $2.43 per share of common stock and $0.01 per warrant will be approximately $ •  million, after deducting the underwriting discounts and commissions and estimated offering expenses, or $ •  million if the underwriters exercise their over-allotment option in full.

We currently intend to use the net proceeds received from this offering to expand our sales and marketing efforts, increase our product offerings, prepay $200,000 in the aggregate principal amount, plus accrued and unpaid interest (which accrues at a rate of 24% per annum), of our unsecured convertible promissory notes due August 25, 2016, pay approximately $285,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities, and for working capital and for other general corporate purposes.

The amount and timing of our actual expenditures will depend on numerous factors, including the status of our development efforts, sales and marketing activities and the amount of cash generated or used by our operations. We may find it necessary or advisable to use portions of the proceeds for other purposes, and we will have broad discretion and flexibility in the application of the net proceeds. Pending these uses, the proceeds will be invested in short-term bank deposits.

11

TABLE OF CONTENTS

MARKET FOR OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS

Market and Other Information

Our common stock is quoted on the OTC Markets Group Inc.’s OTCQB Link quotation platform under the trading symbol “ISGN”. Prior to this offering, there has been no public market for our warrants. An application has been filed with FINRA to have the warrants quoted on the OTCQB quotation system under the trading symbol “ISGNW”. There can be no assurance that an active trading market for the warrants will develop.

On January 22, 2016, we completed a 1-for-1,250 reverse split of our common stock. All share and per share information in the table below gives effect, retroactively, to the reverse stock split but not the automatic conversion of our preferred stock into common stock upon consummation of the offering.

Immediately following the offering, we expect to have one class of common stock, one class of warrants and no classes of preferred stock outstanding. As of May 6, 2016, there were approximately 127 registered holders of record of our common stock, and the last reported sale price of our common stock on the OTCQB was $2.74 per share.

The following table sets forth the high and low sales price of our common stock on the OTCQB for each quarterly period during the fiscal years ended December 31, 2015 and 2014, and for fiscal year ending December 31, 2016 through May 6, 2016, as quoted in U.S. dollars. These prices are based on inter-dealer bid and asked prices, without markup, markdown, commissions, or adjustments and may not represent actual transactions.

 
U.S. $
PERIOD
High
Low
Fiscal Year Ending December 31, 2016:
 
 
 
 
 
 
First Quarter
$
15.00
 
$
2.81
 
Second Quarter (through May 6, 2016)
$
3.55
 
$
2.70
 
Fiscal Year Ended December 31, 2015:
 
 
 
 
 
 
First Quarter
$
35.00
 
$
20.00
 
Second Quarter
$
31.125
 
$
8.75
 
Third Quarter
$
17.75
 
$
5.625
 
Fourth Quarter
$
46.25
 
$
7.625
 
Fiscal Year Ended December 31, 2014:
 
 
 
 
 
 
First Quarter
$
43.00
 
$
28.75
 
Second Quarter
$
38.625
 
$
24.875
 
Third Quarter
$
55.625
 
$
21.875
 
Fourth Quarter
$
43.25
 
$
14.00
 

Dividend Policy

To date, we have not paid any dividends on our common stock and do not anticipate paying any such dividends in the foreseeable future. The declaration and payment of dividends on the common stock is at the discretion of our board of directors and will depend on, among other things, our operating results, financial condition, capital requirements, contractual restrictions or such other factors as our board of directors may deem relevant. We currently expect to use all available funds to finance the future development and expansion of our business and do not anticipate paying dividends on our common stock in the foreseeable future.

12

TABLE OF CONTENTS

Equity Compensation Plan Information

The following table provides information as of December 31, 2015, regarding our compensation plans (including individual compensation arrangements) under which equity securities are authorized for issuance:

 
Number of Securities
To Be Issued
Upon Exercise of
Outstanding Options
and Rights
Weighted-Average
Exercise Price
Of Outstanding
Options and Rights
Number of Securities
Remaining Available
For Future Issuance
Under Equity
Compensation Plans
Equity Compensation Plans Approved by Security Holders
 
 
 
 
 
 
 
 
 
2011 Stock Compensation Plan
 
82,114
 
$
45.24
 
 
37,836
 
Equity Compensation Plans Not Approved by Security Holders
 
 
 
 
 
 
 
 
 
2009 Stock Compensation Plan
 
140
 
 
105.36
 
 
5,402
 
Total:
 
82,254
 
$
45.35
 
 
43,238
 

13

TABLE OF CONTENTS

CAPITALIZATION

The following table sets forth our consolidated cash and cash equivalents and capitalization as of December 31, 2015. Such information is set forth on the following basis:

on an actual basis (giving effect, on a retroactive basis, to a 1-for-1,250 reverse stock split which was consummated on January 22, 2016);
on a pro forma basis, giving effect to (a) the automatic conversion of all our outstanding shares of preferred stock, including accrued and unpaid dividends through May 6, 2016, into 3,639,422 shares of common stock (at the reduced conversion prices that will be effective upon closing of this offering), (b) the conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities into 204,845 shares of common stock and warrants to purchase 256,056 shares of common stock (based upon an assumed public offering price of $2.43 per share) and (c) the conversion of $1,068,000 in the aggregate principal amount of unsecured convertible promissory notes, plus accrued interest, into 485,151 shares of common stock and warrants to purchase 606,439 shares of common stock (based upon an assumed public offering price of $2.43 per share), in each case, upon consummation of this offering; and
on a pro forma as adjusted basis, giving effect to the pro forma adjustments described above, the sale by us of 720,164 shares of common stock in this offering at an assumed public offering price of $2.43 per share and 360,082 warrants at an assumed public offering price of $0.01 per warrant, after deducting underwriting discounts and commissions and estimated offering expenses and the proposed use of net proceeds received from this offering.

The pro forma as adjusted information below is illustrative only and our capitalization following the completion of this offering will be adjusted based on the actual public offering price and other terms of this offering determined at pricing. You should read this table together with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our audited consolidated financial statements and the related notes appearing elsewhere in this prospectus.

 
As of December 31, 2015
 
Actual
Pro forma(1)(2)
Pro Forma as
Adjusted(1)(2)(3)
Cash and cash equivalents
$
846,000
 
$
846,000
 
$
1,352,316
(4)
Total indebtedness
 
1,552,000
 
 
507,283
 
 
 
Stockholders’ equity (deficit):
 
 
 
 
 
 
 
 
 
Series A-1 Cumulative Convertible Preferred Stock, $0.01 par value; 2,000,000 shares authorized; 947,386 shares issued and outstanding actual, 0 shares issued and outstanding pro forma and pro forma as adjusted
 
947,000
 
 
 
 
 
Series B Participating Convertible Preferred Stock, $0.01 par value; 14,000,000 shares authorized; 13,523,449 shares issued and outstanding actual, 0 shares issued and outstanding pro forma and pro forma as adjusted
 
11,653,000
 
 
 
 
 
Series C Participating Convertible Preferred Stock, $0.01 par value; 9,000,000 shares authorized; 5,491,250 shares issued and outstanding actual, 0 shares issued and outstanding pro forma and pro forma as adjusted
 
6,069,000
 
 
 
 
 
Series D-1 Convertible Preferred Stock, $0.01 par value; 10,000,000 shares authorized; 8,076,435 shares issued and outstanding actual, 0 shares issued and outstanding pro forma and pro forma as adjusted
 
6,866,000
 
 
 
 
 
Series D-2 Convertible Preferred Stock, $0.01 par value; 10,000,000 shares authorized; 6,380,386 shares issued and outstanding actual, 0 shares issued and outstanding pro forma and pro forma as adjusted
 
5,272,000
 
 
 
 
 
Common Stock, $0.01 par value; 2,000,000,000 shares authorized; 187,463 shares issued and outstanding actual, 4,516,881 shares issued and outstanding pro forma, 5,237,045 shares issued and outstanding pro forma as adjusted
 
1,872
 
 
45,166
 
 
52,368
 
Treasury Stock
 
(325,000
)
 
(325,000
)
 
(325,000
)
Additional paid-in capital
 
95,312,000
 
 
128,943,416
 
 
129,949,814
 
Accumulated deficit
 
(127,116,000
)
 
(127,418,000
)
 
(127,650,455
)
Accumulated other comprehensive loss
 
(14,000
)
 
(14,000
)
 
(14,000
)
Total iSign stockholders’ equity (deficit)
 
(1,334,128
)
 
1,231,582
 
 
2,012,726
 
Non-controlling interest
 
(536,000
)
 
(536,000
)
 
(536,000
)
Total equity (deficit)
 
(1,870,128
)
 
695,582
 
 
1,476,726
 
Total capitalization
$
(1,024,128
)
$
1,541,582
 
$
2,829,043
 
(1)Includes (i) 3,639,422 shares of our common stock issuable upon conversion of all our outstanding shares of preferred stock, including

14

TABLE OF CONTENTS

accrued and unpaid dividends through May 6, 2016, (ii) 204,845 shares of our common stock issuable upon conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities and (iii) 485,151 shares of our common stock issuable upon conversion of $1,068,000 in the aggregate principal amount of unsecured convertible promissory notes, plus accrued interest.

(2)Excludes (i) 74,652 shares of our common stock issuable upon exercise of outstanding stock options under our stock-based employee compensation plans at a weighted average exercise price of $45.84 per share as of May 6, 2016, (ii) 205,158 shares of our common stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $28.70 per share as of May 6, 2016, (iii) • shares of common stock underlying the warrants to be issued to the underwriters in connection with this offering, (iv) • shares of common stock issuable upon exercise of the warrants offered hereby, (v) up to • shares of common stock, up to • shares of common stock issuable upon exercise of the warrants or a combination of shares of common stock and warrants, in each case representing no more than 15% of shares of common stock or warrants sold in this offering, as applicable, issuable upon the exercise of the underwriters’ over-allotment option and (vi) • shares of common stock issuable upon the exercise of warrants issued in connection with the conversion of unsecured convertible promissory notes and accrued and unpaid compensation.
(3)Includes 720,164 shares of our common stock at an assumed public offering price of $2.43 per share and 360,082 warrants offered hereby at an assumed public offering price of $0.01 per warrant.
(4)A $1.00 increase or decrease in the assumed public offering price per share would increase or decrease our pro forma as adjust cash and cash equivalents, additional paid-in capital, total stockholders’ equity and total capitalization by approximately $720,164 assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the underwriting discount and estimated offering expenses payable by us.

15

TABLE OF CONTENTS

DILUTION

If you invest in our securities, your investment will be diluted immediately to the extent of the difference between the public offering price per share of common stock you pay in this offering, and the pro forma net tangible book value per share of common stock immediately after this offering.

Net tangible book value (deficit) represents the amount of our total tangible assets reduced by our total liabilities. Tangible assets equal our total assets less intangible assets. As of December 31, 2015, our actual net tangible deficit value was $(2,461,000) and our net tangible book deficit per share was $(2.345). The calculation of net tangible book value per share as of December 31, 2015 assumes the conversion of all of our preferred stock into common stock at the conversion rates in effect at December 31, 2015. Pro forma net tangible book value per share represents our pro forma net tangible book value divided by the number of shares of common stock outstanding, after giving effect to (a) the automatic conversion of all our outstanding shares of preferred stock, including accrued and unpaid dividends through May 6, 2016, into 3,639,422 shares of common stock (at the reduced conversion prices that will be in effect upon closing of this offering), (b) the conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities into 204,845 shares of common stock and warrants to purchase 256,056 shares of common stock (based upon an assumed public offering price of $2.43 per share) and (c) the conversion of $1,068,000 in the aggregate principal amount of unsecured convertible promissory notes, plus accrued interest, into 485,151 shares of common stock and warrants to purchase 606,439 shares of common stock (based upon an assumed public offering price of $2.43 per share), in each case, upon consummation of this offering.

After giving effect to the sale of 720,164 shares of common stock at the assumed public offering price of $2.43 per share, and after deducting the underwriting discounts and commissions and estimated offering expenses, our pro forma as adjusted net tangible book value (deficit) as of December 31, 2015 would have been $(53,734), or $(0.010) per share. This represents an immediate increase in pro forma net tangible book value (deficit) of $0.226 per share to existing stockholders and immediate dilution of $2.440 per share to new investors purchasing shares in the offering.

The following table illustrates this per share dilution:

 
As of
December 31, 2015
Pro forma(2)
Pro Forma
as Adjusted
Assumed public offering price per share
 
 
 
 
 
 
$
2.43
 
Net tangible book value (deficit) per share as of December 31, 2015(1)
$
(2.345
)
$
(0.236
)
 
 
 
Increase in pro forma net tangible book value (deficit) per share attributable to new investors
 
 
 
$
0.226
 
 
 
 
Pro forma as adjusted net tangible book value (deficit) per share after giving effect to this offering
 
 
 
 
 
 
$
(0.010
)
Dilution in net tangible book value per share to new investors
 
 
 
 
 
 
$
2.440
 
(1)The calculation of net tangible book value (deficit) as of December 31, 2015 assumes the conversion of all of our outstanding shares of preferred stock into common stock at the conversion rates in effect at December 31, 2015.
(2)Calculated on a pro forma basis, giving effect to the automatic conversion of all our outstanding shares preferred stock into common stock, the conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities into shares of common stock and the conversion of $1,068,000 in aggregate principal amount of unsecured convertible promissory notes, plus accrued interest, in each case, into common stock (and, in the case of the conversion of accrued and unpaid compensation and unsecured convertible promissory notes, warrants to purchase shares of common stock), which will occur upon consummation of this offering at the conversion rates in effect at the consummation of this offering. Excludes the shares of common stock issuable upon exercise of the warrants offered hereby and • shares of common stock issuable upon the exercise of warrants issued in connection with the conversion of unsecured convertible promissory notes and accrued and unpaid compensation.

The information above is as of December 31, 2015 and excludes the following:

205,158 shares of common stock issuable upon the exercise of warrants outstanding at December 31, 2015 with a weighted average exercise price of $28.70 per share; and
82,261 shares of common stock issuable upon the exercise of options outstanding at December 31, 2015 with a weighted average exercise price of $50.00 per share.

If the underwriters’ over-allotment option is exercised in full entirely in shares of common stock, our adjusted pro forma net tangible book value following the offering will be $ • per share, and the dilution to new investors in the offering will be $ • per share.

A $1.00 increase or decrease in the assumed public offering price per share would increase or decrease our pro forma as adjusted net tangible book value per share after this offering by approximately $0.138, and our dilution per share to new investors by approximately $0.138 for an increase or decrease of $1.00, after deducting the underwriting discount and estimated offering expenses payable by us.

16

TABLE OF CONTENTS

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus contains forward-looking statements. Forward looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. They are generally identifiable by use of the words “may,” “will,” “should,” “anticipate,” “estimate,” “plans,” “potential,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend” or the negative of these words or other variations on these words or comparable terminology. These statements may be found under the sections entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business,” as well as in this prospectus generally. In particular, these include statements relating to future actions, prospective products, market acceptance, future performance or results of current and anticipated products, sales efforts, expenses, and the outcome of contingencies such as legal proceedings and financial results.

Examples of forward-looking statements in this prospectus include, but are not limited to, our expectations regarding our business strategy, business prospects, operating results, operating expenses, working capital, liquidity and capital expenditure requirements. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the cost, terms and availability of components, pricing levels, the timing and cost of capital expenditures, competitive conditions and general economic conditions. These statements are based on our management’s expectations, beliefs and assumptions concerning future events affecting us, which in turn are based on currently available information. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect.

Important factors that could cause actual results to differ materially from the results and events anticipated or implied by such forward-looking statements include, but are not limited to:

changes in the market acceptance of our products;
increased levels of competition;
changes in political, economic or regulatory conditions generally and in the markets in which we operate;
our relationships with our key customers;
adverse conditions in the industries in which our customers operate;
our ability to retain and attract senior management and other key employees;
our ability to quickly and effectively respond to new technological developments;
our ability to protect our trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on ourthe proprietary rights;

·                  Technological, engineering, quality control or rights of the Company; and

other circumstances which could delayrisks, including those described in the sale or shipment of products; and

·                  General economic and business conditions.

You should review carefully the section entitled “Risk Factors” beginning on page 4 for a discussion of thesethis prospectus.

We operate in a very competitive and otherrapidly changing environment. New risks that relateemerge from time to time. It is not possible for us to predict all of those risks, nor can we assess the impact of all of those risks on our business or the extent to which any factor may cause actual results to differ materially from those contained in any forward-looking statement. The forward-looking statements in this prospectus are based on assumptions management believes are reasonable. However, due to the uncertainties associated with forward-looking statements, you should not place undue reliance on any forward-looking statements. Further, forward-looking statements speak only as of the date they are made, and investing in shares of our common stock.

Except as otherwiseunless required under applicableby law, we expressly disclaim any obligation or undertaking to revise orpublicly update forward-looking statements to reflectany of them in light of new information, future events, or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

iiotherwise.



17

TABLE OF CONTENTS

PROSPECTUS SUMMARYMANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following summary highlights selected information from this prospectusdiscussion and does not contain allanalysis of the information that you should consider before investing in our common stock. To understand this offering fully, you should carefully read the entire prospectus, including the risk factors and the historical financial statements and related notes, before making an investment.

This prospectus is part of a registration statement (No.       -              ) that we have filed with the Securities and Exchange Commission utilizing a shelf registration process. Under this process, certain stockholders holding shares of our common stock may sell those shares using this prospectus.

This prospectus provides you with a general description of the shares of common stock that may be resold by the selling stockholders. We may update or supplement this prospectus from time to time to add, update or change information contained in this prospectus.

In this prospectus, unless the context requires otherwise, references to “Communication Intelligence Corporation,” “CIC,” “ the “Company,” “we,” “us,” or “our” refer to Communication Intelligence Corporation, a Delaware corporation, and its subsidiaries.

Our Company

We are a leading supplier of electronic signature solutions for business process automation serving primarily the financial services industry and the acknowledged leader in biometric signature verification technology. Our products enable companies to complete secure paperless business transactions with multiple signature technologies across virtually all applications and hardware platforms.

Our products are designed to increase the ease of use, functionality and security of electronic devices and electronic business processes through handwritten data entry and application of electronic signatures. We provide a comprehensive and scalable electronic signature solution suite based on over 20 years of experience and significant input from our valued financial industry client base. We have delivered biometric and electronic signature solutions to over 400 companies worldwide, primarily in the financial services industry, including to AIG/AGLA, Charles Schwab & Co., JP Morgan Chase, Prudential Financial, Inc., Snap-On-Credit, State Farm Insurance Co., Wells Fargo Bank, NA and World Financial Group. We also are a leading supplier of natural input/text entry software for handheld computers and smartphones. Major customers for natural input software are Palm Inc. and Sony Ericsson. We classify these core technologies into two categories, as follows:

·Transaction and Communication Enabling Technologies — Our transaction and communication enabling technologies are designed to provide a cost-effective means for securing electronic transactions, providing network and device access control and enabling workflow automation of traditional paper form processing. We believe that our technologies offer more efficient methods for conducting electronic transactions while providing more functional user authentication and heightened data security. Our transaction and communication enabling technologies have been fundamental to our development of software for multi-modal electronic signatures, handwritten biometric signature verification, and data security.

·Natural Input Technologies — Our natural input technologies are designed to allow users to interact with a computer or handheld device by using an electronic pen or stylus as the primary input device. Our natural input offering includes multilingual handwriting recognition software for such devices as electronic organizers, pagers and smart cellular phones that do not have a keyboard. For such devices, we believe that handwriting recognition offers a viable solution for performing text entry and editing.

We sell our products directly to enterprises and through system integrators, channel partners and original equipment manufacturers.

1



The Transaction

We are registering shares of our common stock for resale by certain holders of warrants to purchase shares of our common stock and by certain holders of our preferred stock convertible into our common stock.

On June 5, 2008, we closed a financing transaction under which the Company raised capital through the issuance of secured indebtedness and equity and also restructured a portion of the Company’s existing debt.

In connection with the transaction, we borrowed an aggregate of $3,000,000 and refinanced $637,500 of existing indebtedness and accrued interest on that indebtedness. The new and refinanced debt bears interest at eight (8%) per annum which, at the option of the Company, may be paid in cash or in-kind, matures two years from issue date and is secured by a first priority security interest in all of our assets.

In partial consideration for the respective loans made as described above, we issued to each creditor a warrant to purchase the number of shares of our common stock obtained by dividing the amount of such creditor’s loan by 0.14.  An aggregate of 25,982,143 shares of our common stock may be issued upon exercise of these warrants.  The warrants are exercisable at the option of the holders, until June 30, 2011, with an exercise price of $0.14 per share. Additional warrants may be issued if we exercise our option to make interest payments on the loans in-kind.

In connection with the closing of the financing transaction, we also entered into a Securities Purchase Agreement and a Registration Rights Agreement, each dated as of June 5, 2008.  Under the Securities Purchase Agreement, in exchange for the cancellation of $995,000 in principal and $45,000 of interest accrued thereon of our existing debt and interest accrued thereon, we issued to the holders of such debt an aggregate of 1,040,000 shares of our Series A Cumulative Convertible Preferred Stock.  The preferred shares carry an 8% annual dividend, payable quarterly in arrears in cash or in additional preferred shares, have a liquidation preference over common stock of $1.00 per share and are convertible into shares of common stock at the conversion price of $0.14 per share.  Thus, at the current applicable conversion rate, one share of Series A Cumulative Convertible Preferred Stock would convert into 7,428,571 shares of our common stock.  The shares of preferred stock are convertible at any time at the option of the holders thereof.

We granted the investors registration rights for the full number of shares represented by the warrants and conversion rights of our preferred stock issued to the investors. This registration statement is intended to satisfy our registration obligations to the holders of the convertible preferred stock and warrants.

Our Corporate Information

We are a Delaware corporation. We were incorporated in October 1986. Our principal executive offices are located at 275 Shoreline Drive, Suite 500, Redwood Shores, California 94065, and the telephone number at our principal executive offices is (650) 802-7888. Our website address is www.cic.com. Except for any documents that are incorporated by reference into this prospectus that may be accessed from our website, the information available on or through our website is not part of this prospectus.

General Information About this Prospectus

CIC® and its logo, Handwriter®, Jot®, iSign®, InkSnap®, InkTools®, RecoEcho®, Sign-On®, QuickNotes®, Sign-it®, WordComplete®, INKshrINK®, SigCheck®, SignatureOne®, Ceremony® and The Power To Sign Online® are registered trademarks of the Company. HRS™, PenX™  and Speller™ are trademarks of the Company.

The Offering

We have prepared this prospectus in connection with the resale of (i) 25,982,143 shares of our common stock issuable upon the exercise of warrants to purchase our common stock issued on June 5, 2008, and (ii) 7,428,571 shares of our common stock issuable upon conversion of our preferred stock we issued on June 5, 2008, to private investors. We will not receive any proceeds from the sale of the shares of common stock being offered pursuant to this prospectus. See “Selling Stockholders” in this prospectus beginning on page 23.

2



Outstanding common stock before offering:

129,057,161 shares as of August 18, 2008.

Number of shares offered for resale:

33,410,714 shares of common stock (includes 25,982,143 shares underlying warrants which have not yet been exercised and 7,428,571 shares issuable upon conversion of our preferred stock).

Offering price:

Determined at the time of sale by the selling stockholder.

Proceeds:

We will not receive any proceeds from the sale of the common stock offered by the selling shareholders pursuant to this prospectus.

Risks:

We face risks in operating our business, including risks that may prevent us from achieving our business objectives or that may materially adversely affect our business, financial condition and operating results. See “Risk Factors” and other information included in this prospectus for a discussion of factors you should consider carefully before deciding to invest in our common stock.

3



RISK FACTORS

(in thousands)

An investment in our common stock involves a high degree of risk. You should consider the risks discussed below, together with the financial and other information contained in this prospectus, before deciding to invest in our common stock. If any of the following risks actually occur, our business, prospects, financial condition and results of operations could be materially adversely affected. In that case, the trading price of our common stock would likely decline and you may lose some or all of your investment.

Our auditors have emphasized in their auditors’ report substantial doubt about our ability to continue as a going concern without additional financing or the achievement of cash flow positive operations.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. Except for 2004, the Company has incurred significant losses since its inception and, at December 31, 2007, the Company’s accumulated deficit was approximately $91,300. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company has primarily funded these losses through the sale of debt and equity securities.

Operating losses may continue, which could adversely affect financial results from operations and stockholder value.

In each year since its inception, except for the year ended December 31, 2004, the Company incurred losses, which were significant in certain periods. For the five-year period ended December 31, 2007, those net losses aggregated approximately $11,441. At December 31, 2007, the accumulated deficit was approximately $91,300. While net income was recorded for the year ended December 31, 2004, there is no guarantee that the Company will be profitable in future years and it may incur substantial losses in the future, which could adversely affect stockholder value.

Our competitors could develop products or technologies that could make our products or technologies non-competitive, which would adversely affect sales, financial results from operations and stockholder value.

Although the Company believes that its patent portfolio provides a barrier to entry to the electronic signature market, and that its established relationships with its OEM customers in the natural input segment are sufficient to maintain that source of revenue, there can be no assurance that it will not face significant competition in this and other aspects of its business.

Some of its competitors, including more established companies or those with greater financial or other resources, could develop products or technologies that are more effective, easier to use or less expensive than the Company’s. This could make the Company’s products and technologies obsolete or non-competitive, which would adversely affect sales, financial results from operations and stockholder value.

If we are unable to adequately protect our intellectual property, third parties may be able to use our technology, which could adversely affect our ability to compete in the market, our financial results from operations and stockholder value.

The Company relies on a combination of patents, copyrights, trademarks, trade secrets and contractual provisions to protect its proprietary rights in its products and technologies. These protections may not adequately protect it for a number of reasons. First, the Company’s competitors may independently develop technologies that are substantially equivalent or superior to ours. Second, the laws of some of the countries in which the Company’s products are licensed do not protect those products and its intellectual property rights to the same extent as do the laws of the United States. Third, because of the rapid evolution of technology and uncertainties in intellectual property law in the United States and internationally, the Company’s current and future products and technologies could be subject to infringement claims by others. Fourth, a substantial portion of its technology and know-how are trade secrets and are not protected by patent, trademark or copyright laws. The Company requires its employees, contractors and customers to execute written agreements that seek to protect its proprietary information. We also have a policy of requiring prospective business partners to enter into non-disclosure agreements before any of our

4



proprietary information is revealed to them. However, the measures taken by the Company to protect its technology, products and other proprietary rights might not adequately protect it against improper use.

The Company may be required to take legal action to protect or defend its proprietary rights. Litigation of third-party claims of intellectual property infringement during 2004 and 2005 required the Company to spend substantial time and financial resources to protect its proprietary rights. If the result of any litigation of this type is adverse to the Company, it may be required to expend significant resources to develop non-infringing technology or obtain licenses from third parties. If the Company is not successful in those efforts, or if it is required to pay any substantial litigation costs, its business would be materially and adversely affected.

A significant portion of our sales are derived from a limited number of customers, and results from operations could be adversely affected and shareholder value harmed if we lost any of these customers.

The Company’s revenues historically have been derived from hundreds of customers, however, a significant percentage of the revenue has been attributable to a limited number of customers. Our top customer accounted for 24% and 27% of revenues in the years ended December 31, 2007 and December 31, 2006, respectively. The loss of any significant customer or other revenue source would have a material adverse effect on the Company’s revenues and profitability.

The market price of our stock can be volatile, which could result in losses for investors.

The Company’s common stock is listed on the Over-the-Counter Bulletin Board (“OTC”). Stock prices of technology companies in recent years have experienced significant volatility, including price fluctuations that are unrelated or not proportional to the operating performance of these companies. Volatility on the OTC is typically higher than the volatility of stocks traded on Nasdaq or other exchanges. The market price of the Company’s common stock has been and could be subject to significant fluctuations as a result of variations in its operating results, announcements of technological innovations or new products by it or our competitors, announcements of new strategic relationships by the Company or our competitors, general conditions in the technology industry or market conditions unrelated to its business and operating results.

Statutory provisions and provisions in our charter may delay or frustrate transactions that may be beneficial to our stockholders.

Certain provisions of the Delaware General Corporation Act and our charter may delay or prevent a merger, tender offer or proxy contest that is not approved by the Company’s Board of Directors, even if such events may be beneficial to the interests of stockholders. For example, the Company’s Board of Directors, without shareholder approval, has the authority and power to issue all authorized and unissued shares of common stock and preferred stock that have not otherwise been reserved for issuance. In addition, the Delaware General Corporation Law contains provisions that may have the effect of making it more difficult or delaying attempts by others to obtain control of the Company.

Resale by the holders of outstanding convertible notes and warrants, or by the holders of shares of our common stock entitled to registration rights applicable to those shares, could adversely affect the market price of our stock.

The holders of the warrants to purchase shares of our common stock may immediately sell the shares issued upon exercise of the warrants. In light of the Company’s historically low trading volume, such sales may adversely affect the price of the shares of the Company’s stock. In addition, certain of our stockholders are entitled to registration rights, and the Company recently filed with the Securities and Exchange Commission resale registration statements on Form S-1, which became effective on December 28, 2007 and August 18, 2008. The resale of the shares registered under the registration statement may be made at any time into the public trading market. In light of the historically low trading volume of our common stock, such sales or the perception that such sales may occur may adversely affect the price of the shares of our common stock.

5



A significant portion of our assets are subject to security interests by our creditors.

The Company’s assets are subject to security interests granted to certain creditors who participated in the June 2008 financing transaction. If we are unable to meet our obligations associated with those security interests the Company may be forced to sell, or the creditors may require us to sell, our assets in order to satisfy those obligations.

6



MANAGEMENT’S DISCUSSION AND ANALYSIS
OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

(dollars in thousands, except share and per share data)

The following discussion and analysis should be read in conjunction with our consolidated financial statements and relatedthe notes to those statements appearing elsewhere in this prospectus. The followingThis discussion relating to projected growth and futureanalysis contains forward-looking statements reflecting our management’s current expectations that involve risks, uncertainties and assumptions. Our actual results and the timing of events constitutes forward-looking statements. Actual results in future periods may differ materially from thethose described in or implied by these forward-looking statements due to a number of risksfactors, including those discussed below and uncertainties, including, but not limited to, our ability to continue as a going concern; our relationships with our customers, including our key customers; our ability to manage our operating costs; and the continued availability of financing and working capital to fund our business operations. Any forward looking statements should be consideredelsewhere in light of these factors. We cannot guarantee future results, levels of activity, performance or achievements. Except as otherwise required under applicable law, we disclaim any obligation to revise or update forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.this prospectus, particularly on page 6 entitled “Risk Factors”.

Overview and Recent Developments

We areThe Company is a leading supplier of digital transaction management software enabling the paperless, secure and cost-effective management and authentication of document-based transactions. Our solutions encompass a wide array of functionality and services, including electronic signaturesignatures, simple-to-complex workflow management and various options for biometric authentication. These solutions for business process automation serving primarilyare available across virtually all enterprise, desktop and mobile environments. The Company’s products and services are used to create legally binding transactions that are compliant with applicable laws and regulations and that can provide a higher level of security than paper-based processes. The Company has been a leading supplier of enterprise software solutions within the financial services industry and insurance industries and has made available to its customers significant expense reduction by enabling a completely electronic document and workflow process, as well as the acknowledged leaderresulting reduction in biometric signature verification technology. Our products enable companiesmailing, scanning, filing and other costs related to achieve secure paperless business transactions with multiple signature technologies across virtually all applicationsthe use of paper.

For information relating to the Company’s expected unaudited financial results for the quarter ended March 31, 2016, see “2016 First Quarter Expected Unaudited Financial Results.”

On December 14, 2015, the Company changed its name to iSign Solutions Inc. and hardware platforms.changed its common stock trading symbol to ISGN.

We were incorporated in Delaware in October 1986. Except for the year ended December 31, 2004, in each year since its inception the Company has incurred losses. For the five-yeartwo-year period ended December 31, 2007,2015, net losses attributable to common stockholders aggregated approximately $11,441$14,998,000, and, at December 31, 2007,2015, the Company’s accumulated deficit was approximately $91,300. At June 30, 2008, our accumulated deficit was approximately $93,600.$127,116,000.

ForDuring the six monthsyear ended June 30, 2008, total revenues were $837, a decrease of $52, or 6%, compared to total revenues of $889 inDecember 31, 2015, the corresponding prior year period. Total revenue for the three months ended June 30, 2008 decreased $148, or 27% to $407, compared to revenues of $555 in the corresponding prior year period.   Orders for the three months ended June 30, 2008, however, were $296 higher than revenue recognizable for that period and such orders are expected to be recognized in the third quarter of 2008.

The Company is experiencing expanding demand and usagecompleted two private placements of its electronic signature technologySeries D-1 Convertible Preferred Stock receiving an aggregate amount of $1,525,000 in its target financial services market. Two recent orders received from top ten US banks are for the Company’s eSignature technologies in new applications and lines of business that expand the use of CIC’s technology beyond the initial deployments with these firms.  In addition, the Company received an order from a top five insurance company for a property and casualty application and orders for additional licenses from one of its key channel partners, a top five supplier of software solutions and platforms to the financial services industry.proceeds. The Company also recently signedissued a demand note for an agreement withaggregate amount of $250,000.

On November 25, 2015, we sold unsecured convertible promissory notes due August 25, 2016 in the aggregate principal amount of $1,000,000 in consideration of gross proceeds of $750,000 plus the exchange of a leading top tier solution provider$250,000 demand note issued in September 2015. On December 15, 2015, we sold additional unsecured convertible promissory notes in the aggregate principal amount of $268,000. Borrowings under these notes bear interest at a rate equal to 24.0% per annum. Subject to the financial services industry, which the Company believes is of strategic significance including the potential for near termterms and future revenue generation.   Recent market surveys by independent technology and market research firms such as Forrester Research conclude that US banks and lenders are challenged with the need to increase revenue while improving the effectiveness and efficiency of their processes in the face of increased regulatory and compliance demands exacerbated by the recent sub prime and credit crises.  The Company believes that electronic signature solutions enhance the customer experience and significantly reduce the time required for account openings and applications, creating more time available for up-cross selling while delivering significant reductions in the life cycle cost of managing mission critical documents, thereby enhancing the need and demand for its product solutions.

The loss from operations for the six months ended June 30, 2008 increased by $247 to $1,393, compared with a loss from operations of $1,146 in the prior year period.  This increase is primarily attributable to a $52 decrease in revenue to $837 in the current period compared to $889 in the prior six month period and to an increase of $195 in operating expenses to $2,230 compared to $2,035 of operating expenses in the comparable prior period. This

7



increase in operating expenses is primarily due to an increase in cost of goods sold related to third party hardware sold with the Company’s software solutions and engineering labor costs associated with nonrecurring engineering project revenue.

In June 2008, the Company closed a financing transaction under which it raised capital through the issuance of secured indebtedness and equity and restructured a portionconditions of the Company’s existing debt.  In connection withnotes, the transaction, the Company borrowed an aggregate of $3,000 and refinanced $638 of existing indebtedness and accrued interest on the Company’s existing indebtedness.  In partial consideration for the respective loans made as described above, the Company issued to each creditor a warrant to purchase up to the number of shares of its common stock obtained by dividing the amount of such creditor’s loan by 0.14.  A total of 25,982,143notes are convertible into shares of our common stock may be issued upon exercise ofat the warrants at an exercise price of $0.14 per share.holder’s option before or after maturity. The issuance of the warrants was exempt from registration under Sections 4(2) and 4(6) of the Securities Act and Rule 506 of Regulation D promulgated thereunder.

In June 2008, in connection with the closing of the financing transaction, the Company also entered into a Securities Purchase Agreement and a Registration Rights Agreement. Under the Securities Purchase Agreement, in exchange for the cancellation of $995 in principal and $45 of interest accrued on our existing debt, the Company issued toexpects that the holders of such debt an aggregate of 1,040,000 shares of Series A Cumulative Convertible Preferred Stock.  The preferred shares carry an 8% annual dividend, payable quarterly in arrears in cash or in additional preferred shares, have a liquidation preference over common stock of $1.00 per share and are convertiblewill convert all indebtedness outstanding under the notes into shares of common stock and warrants to purchase shares of common stock upon the consummation of the offering.

The conversion option included in the unsecured convertible promissory notes was deemed to be an embedded derivative, which required the Company to bifurcate and separately account for the embedded derivative as a separate liability on its consolidated balance sheet at December 31, 2015 at the conversion priceestimated fair value upon issuance. The Company estimated the fair value of fourteen cents $0.14 per share.the derivative liability to be $330,000. The sharesamount of preferred stock are convertible at any time. The issuance and sale of such shares was effected without registration under the Securities Act in relianceshort-term debt recorded on the exemption from registration provided under Rule 506 of Regulation D promulgated under the Securities Act and under Sections 4(2) and 4(6)Company’s consolidated balance sheet at December 31, 2015 is net of the Securities Act.amount of the derivative liability. The Company recorded $53,000 in debt discount amortization expense on its consolidated statement of operations associated with the notes for the year ended December 31, 2015.

The Company is using the funds received from the above financings for working capital and general corporate purposes.

18

TABLE OF CONTENTS

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect the amounts reported in the Company’s consolidated financial statements and the accompanying notes. The amounts of assets and liabilities reported in its balance sheets and the amounts of revenuesrevenue and expenses reported for each period presented are affected by these estimates and assumptions that are used for, but not limited to, revenue recognition, allowance for doubtful accounts, intangible asset impairments, fair value of financial instruments, software development costs, researchstock based compensation and development costs, foreign currency translation and net operating loss carryforwards.valuation allowances on deferred tax assets. Actual results may differ from these estimates. The following critical accounting policies are significantly affected by judgments, assumptions and estimates used by the Company’s management in the preparation of the consolidated financial statements.

Stock based Compensation: Stock-based compensation expense is based on the estimated grant date fair value of the portion of stock-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes-Merton option pricing model. Forfeitures of share-based payment awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated and it is assumed no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized on an accrual basis over the vesting period of the options.

RevenueValuation of equity warrants: The Company values warrants issued using the Black-Scholes-Merton pricing model (a mathematical model used to calculate the theoretical value of a derivative security; in this case warrants).

Derivatives: The Company follows the relevant accounting guidance and records derivative instruments (including certain derivative instruments embedded in other contracts) in its consolidated balance sheet as either an asset or a liability measured at their fair value, with changes in the derivative’s fair value recognized currently in earnings. The Company values these derivative securities under the fair value method at the end of each reporting period (quarter), and their value is marked-to-market at the end of each reporting period with the gain or loss recorded in earnings. The Company continues to revalue these instruments each quarter to reflect their current value in light of the current market price of our common stock. The Company used a simulated probability valuation model to value warrants containing embedded derivative instruments. Determining the appropriate fair-value model and calculating the fair value of such warrants requires considerable judgment. Any change in the estimates (specifically, probabilities) used may cause the value to be higher or lower than that reported. The assumptions used in the model require significant judgment by management and include the following: volatility, expected term, risk-free interest rate, dividends, and warrant holders’ expected rate of return, reset provisions based on expected future financings, projected stock prices, and probability of exercise.

The conversion option included in the Company’s unsecured convertible promissory notes is accounted for as a derivative liability at its estimated fair value. The derivative is subject to re-measurement at the end of each reporting period, with changes in fair value recognized as a component of interest and other income, in the Company’s consolidated statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the conversion or maturity of the unsecured convertible promissory notes.

Revenue: Revenue is recognized when earned in accordance with the applicable accounting standards, including AICPA Statement of Position (“SOP”) No. 97-2, “Software Revenue Recognition”, as amended, Staff Accounting Bulletin 104, “Revenue Recognition” (“SAB 104”), and the interpretive guidance issued by the Securities and Exchange Commission and EITF issue number 00-21, “Accounting for Revenue Arrangements with Multiple Elements”, of the FASB’s Emerging Issues Task Force.guidance. The Company recognizes revenuesrevenue from sales of software products upon shipment, provided that persuasive evidence of an arrangement exists, collection is determined to be probable, all non-recurring engineering work necessary to enable the Company’s product to function within the customer’s application has been completed and the Company’s product has been delivered according to specifications. Revenue from service subscriptions is recognized as costs are incurred or over the service period, which-everwhichever is longer.

Software license agreements may contain multiple elements, including upgrades and enhancements, products deliverable on a when and if available basis and post contractpost-contract support. Revenue from software license agreements is recognized upon delivery of the software, provided that persuasive evidence of an arrangement exists, collection is determined to be probable, all nonrecurring engineering work necessary to enable the Company’s products to function within the customer’s application has been completed and the CompanyCompany’s product has been delivered its product according to specifications.

8For arrangements with multiple deliverables, the Company allocates consideration at the inception of an arrangement to all of its deliverables based on their relative selling prices, which are determined using vendor-specific objective evidence.



19

TABLE OF CONTENTS

Maintenance revenue is recorded for post contractpost-contract support and upgrades or enhancements, which is paid for in addition to license fees, and is recognized as costs are incurred or over the support period, whichever is longer. For undelivered elements where vendor specific objective and reliable evidence of fair value does not exist, revenue is deferred and subsequently recognized when delivery has occurred and when fair valuevendor specific evidence has been determined.

Allowance for Doubtful Accounts:The allowance for doubtful accounts is based on the Company’s assessment of the collectibilitycollectability of specific customer accounts and an assessment of international, political and economic risk as well as the aging of the accounts receivable. If there is a change in actual defaults from the Company’s historical experience, the Company’s estimates of recoverability of amounts due could be affected and the Company would adjust the allowance accordingly.

Long-lived assetsassets:. The Company performs intangible asset impairment analyses on an annual basis in accordance withevaluates the guidance in Statement of Financial Accounting Standard No. 142, “Goodwill and Other Intangible Assets” (“SFAS No. 142”) and Financial Accounting Standard No. 144, “Accounting for the Impairment or Disposal of Long Lived Assets” (“SFAS No. 144”). The Company uses SFAS 144 in response to changes in industry and market conditions that affect its patents, the Company then determines if an impairmentrecoverability of its long-lived assets, has occurred. The Company reassesses the lives of its patents and tests for impairmentincluding intangible assets at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in order to determine whether the event the net book value exceedsof such assets exceeded the fair value for each patent. Fair value is determined by estimatingfuture undiscounted cash flows attributable to such assets. Estimation of future cash flows from the products that are and will be protected by the patents and consideringconsiders the following additional factors:

·             whether there are

legal, regulatory or contractual provisions known to the Company that limit the useful life of any patentproduct technology to less than the assigned useful life;

·

whether the Company needs to incur material costs or make modifications in order for it to continue to be able to realize the protectionbenefits afforded by the patents;

·             whether any product technologies;

effects of obsolescence or significant competitive pressure on the Company’s current or future products that are expected to reduce the anticipated cash flow from the products covered by the patents;

·             whether products;

demand for products utilizing the patentedCompany’s technology will diminish, remain stable or increase; and

·

whether the current markets for the products based on the patentedCompany’s technology will remain constant or will change over the useful lives assigned to the patents.

The Company obtained an independent valuation from Strategic Equity Group of the carrying value of its patents as of December 31, 2005. The Company believes that the biometric market potential identified in current year market research has improved over the data used to validate the carrying value of the Company’s patents at the end of 2005. Management updated this analysis at December 31, 2007 and believes that that no impairment of the carrying value of the patents existed at December 31, 2007.

technologies.

Customer BaseBase:. To date, the Company’s eSignature revenues haveelectronic signature revenue has been derived primarily from financial service industry end-users and from resellers and channel partners serving the financial service industry primarily in North America, the ASEAN Region including China (PRC) and Europe. Natural Input (text entry) revenues have been derived primarily from hand held computer and smart phone manufacturers (OEMs) primarily in North America, Europe and the Pacific Rim. The Company performs periodic credit evaluations of its customers and does not require collateral. The Company maintains reserves for potential credit losses. Historically, such losses have been within the range of management’s expectations.

Cost of sales: Cost of sales includes direct engineering labor and overhead for specific revenue based projects initiated by customers and maintenance projects specific to customer needs, along with third party services related to the Company’s transactional based revenues.

Software Development Costs. Software development costs are accounted for in accordance with Statement of Financial Accounting Standards No. 86, “Accounting for the Costs of Computer Software to be Sold, Leased or Otherwise Marketed” (“SFAS 86”). Under SFAS 86, capitalization of software development costs begins upon the establishment of technological feasibility, subject to net realizable value considerations. The costs capitalized

9



include the coding and testing of the product after technological feasibility has been established and ends upon the release of the product. The annual amortization is the greater of (a) the straight-line amortization over the estimated useful life not to exceed three years or (b) the amount based on the ratio of current revenues to anticipated future revenues. The Company capitalized software development costs of $788, and $510, for the years ended December 31, 2007, and 2006.

Research and Development CostsCosts:. Research and development costs are charged toas expense as incurred.

Share-based Compensation. Share-based compensation expense is based on the estimated grant date fair value of the portion of share-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes option pricing model. SFAS No. 123(R) requires forfeitures of share-based payment awards to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The estimated average forfeiture rates for the years ended December 31, 2006 and 2007, were approximately 27.90% and 25.01%, respectively. For the years ended December 31, 2006 and 2007, stock-based compensation expense includes compensation expense for share-based payment awards granted prior to, but not yet vested as of December 31, 2005.

Foreign Currency Translation. The Company considers the functional currency of the Company’s Chinese based Joint Venture to be the respective local currency and, accordingly, gains and losses from the translation of the local foreign currency financial statements are included as a component of “accumulated other comprehensive loss” in the Company’s consolidated balance sheets. Foreign currency assets and liabilities are translated into U.S. dollars at exchange rates prevailing at the end of the period, except for long-term assets and liabilities that are translated at historical exchange rates. Revenue and expense accounts are translated at the average exchange rates in effect during each period. Net foreign currency transaction gains and losses are included as components of “interest income and other income (expense), net” in the Company’s consolidated statements of operations. Due to the stability of the currency in China, and limited transactions in the respective periods, net foreign currency transaction gains and losses were not material for the year ended December 31, 2007, and 2006 respectively.

Net Operating Loss CarryforwardsCarry-forwards:. Utilization of the Company’s net operating losses may be subject to an annual limitation due to the ownership change limitations provided byunder Section 382 of the Internal Revenue Code of 1986 and similar state provisions. As a result, a portion of the Company’s net operating loss carryforwardscarry-forwards may not be available to offset future taxable income. The Company has provided a full valuation allowance for deferred tax assets at December 31, 20072015, of approximately $30 million$26,000,000 based upon the Company’s history of losses.

Segments: The Company reports its financial results in one segment.

Warrant valuation.  Warrants2016 First Quarter Expected Unaudited Financial Results

The Company’s unaudited consolidated financial statements as of and for the quarter ended March 31, 2016 are not yet available. However, based on preliminary numbers, the Company expects to purchase shares ofreport the following unaudited consolidated financial results for the quarter ended March 31, 2016. These expected results are subject to change and the Company’s common stock were issued as partactual unaudited consolidated financial results for the quarter ended March 31, 2016 may differ from these expected numbers.

The Company expects to report total revenue of $276,000 for the Company’s 2008 financing transaction.quarter ended March 31, 2016, a decrease of $170,000, or 38%, compared to total revenue of $446,000 for the quarter ended March 31, 2015. For the quarter ended March 31, 2016, the Company expects to report product revenue of $59,000, a decrease of $171,000, or 74%, compared to product revenue of $230,000 for the quarter ended March 31, 2015. The fair value of the warrantsdecrease in revenue was calculated using the Black-Scholes pricing model at the date of issuance. The relative fair value

20

TABLE OF CONTENTS

primarily attributable to the warrants is recorded as a debt discount in the Company’s balance sheet. The debt discount is amortized to interest expense over the lifetiming of the debt, using the straight-line interest method, which approximates the effective interest method, assuming the debt will be held to maturity.  The use of the Black-Scholes model requires that we estimate the fair value of the underlying equity instruments issuable upon the exercise of options and warrants. In determining the fair value of our warrants, the Company utilizes the market price for our shares, the contractual life, and volatility.

10



Recent Pronouncements

certain sales opportunities. The Company adopted the provisions of Financial Standards Accounting Board Interpretation No. 48, “Accounting for Uncertainty in Income Taxes - an Interpretation of FASB Statement No. 109” (“FIN 48”), on January 1, 2007. There were no unrecognized tax benefits and, accordingly, there has been no effect on the Company’s financial condition or results of operations as a result of implementing FIN 48.

The Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company is no longer subjectexpects to U.S. federal tax examinations for years before 2003, and state tax examinations for years before 2002. Management does not believe there will be any material changes in our unrecognized tax positions over the next 12 months.

The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of the date of adoption of FIN 48, there was no accrued interest or penalties associated with any unrecognized tax benefits, nor was any interest expense recognized during the six month period ended June 30, 2008.

Results Of Operations

Six Months Ended June 30, 2008, Compared to the Six Months Ended June 30, 2007

Revenues

Totalreport maintenance revenue for the three months ended June 30, 2008 decreased $148,first quarter of 2016 of $217,000, an increase of $1,000, or 27%0.5%, to $407, compared to $555 inmaintenance revenue of $216,000 for the prior year period.  Product revenue reflects a 7% decrease in eSignature and a 84% decrease in natural input revenuesfirst quarter of 2015.

For the first quarter of 2016, the Company expects to report cost of sales of $170,000, an increase of $47,000, or 38%, compared to the prior year period.  Orderscost of sales of $123,000 for the three month periodquarter ended June 30, 2008 were $296 higher than revenue recognizable for that period and is expected to be recognized as revenue in the third quarter of 2008.  Maintenance revenue increased 11%, or $19, for the three months ended June 30, 2008 compared to the prior year period.March 31, 2015. The increase was primarily due to the renewal of existing maintenance contracts from ongoing customers and new maintenance contracts associated with new product orders.

For the six months ended June 30, 2008, total revenues were $837, a decrease of $52, or 6%, comparedrequirements for updates to $889 in the prior year period. Product revenues decreased 15%, or $83, while maintenance revenues increased 9%, or $31, comparedour delivered software. The Company expects to the prior year period.  The reduction in revenue primarily reflects lower reported royalties from a major natural input/Jot customer. The increase in maintenance revenue was primarily due to the renewal of existing maintenance contracts from ongoing customers and new maintenance contracts associated with new product orders.

Cost of Sales

Cost of sales primarily includes amortization of new and previously capitalized software development costs associated with the Company’s product and maintenance revenues, engineering labor and third party hardware costs associated with certain product sales.  Cost of sales for the three months ended June 30, 2008 increased $38, or 23%, to $200, compared to $162 in the prior year period. The increase is due in part to engineering labor for product development work completed in the second quarter. In addition, amortization of previously capitalized software development costs increased $23, or 24%, to $117, compared to $94 in the prior year period.

For the six months ended June 30, 2008, cost of sales increased $180, or 82%, to $400 compared to $220 in the prior year period.  The increase is due primarily to the sale of third party hardware, engineering labor associated with nonrecurring engineering revenues and amortization of previously capitalized engineering software development costs.  Amortization of capitalized software development cost to cost of sales will increase in the future as new products and enhancements are completed.

11



Operating expenses

Research and Development Expenses

Research and development expenses consist primarily of salaries and related costs, outside engineering, maintenance, and allocated facilities expenses, net of software development costs capitalized.  Research and development expenses decreased approximately 67%, or $88, for the three months ended June 30, 2008 compared to the prior year period.  The decrease was due primarily to engineering labor cost associated with nonrecurring engineering revenues transferred to cost of sales and an increase in the amount of software development costs capitalized compared to the prior year period.  Total costs, before capitalization of software development and other allocations, were $394 for the three months ended June 30, 2008 compared to $367 in the prior year period.

For the six months ended June 30, 2008,report research and development expenses decreased $164,of $318,000 for the quarter ended March 31, 2016, a decrease of $204,000, or 63%39%, compared to research and development expenses of $522,000 for the prior year period.  The decrease is primarily duefirst quarter of 2015. For the quarter ended March 31, 2016, the Company expects to the amount of engineering labor transferred to cost ofreport sales and the amount software development costs capitalized compared to the prior year period.

Sales and Marketing Expenses

Sales and marketing expenses increased 20%, or $58, for the three months ended June 30, 2008 compared to the prior year period.of $202,000, The increasedecrease in research and development expense was primarily attributable to increasesreductions in salary and related expenses due to the additionnumber of one sales person compared to the prior year, increases in advertising and marketing programs and engineering sales support efforts.

For the six months ended June 30, 2008, sales and marketing expense increased $158,offshore resources, a decrease of $96,000, or 28%32%, compared to the prior year period.  The increase is primarily due to the reasons discussed above for the change in the three month period.

The Company expects sales and marketing expenses will continue atof $298,000 for the current higher levelsquarter ended March 31, 2015. The decrease was primarily attributable to reductions in head count and related expenses in connection with a shift in the near term dueCompany’s go to planned increases marketing programs.

General and Administrative Expenses

Generalmarket strategy to focus primarily on integrations with document management software solutions. The Company expects to report general and administrative expenses increased 6%, or $29,of $730,000 for the three monthsquarter ended June 30, 2008, compared toMarch 31, 2016, an increase of $209,000, or 40%, from general and administrative expenses of $521,000 for the prior year period.first quarter of 2015. The increase was due to increases in professional services expense, amortization of annual maintenance subscriptions and the provision for uncollectible accounts comparedexpensing certain costs related to the prior year period. These increases were partially offset by an decrease in insurance premiums and stock option expense compared to the prior year period.

Company’s public offering of common stock.

For the six monthsquarter ended June 30, 2008, general and administrative expenses increased $21,March 31, 2016, based on these preliminary numbers, the Company expects to report a loss from operations of $1,144,000, an increase of $126,000, or 2%12%, compared to the prior period. The increase is attributable to the reasons discussed above for the change in the three month period.quarter ended March 31, 2015.

The Company anticipates that general and administrative expense will remain above the prior year amounts for the foreseeable future due to the increases in the expenses discussed above.

Interest income and other income, net

Interest income and other income (expense), net, for the three months ended June 30, 2008 decreased $2 from income of $4 in the prior year period.  The decrease is due to the reduced cash balance during the current period compared to the prior year period.  For the six months ended June 30, 2008, interest income and other income (expense), net, increased $1, or 25%,  to $5, compared to $4 in the prior year period.  The increase was primarily due to the interest earned on the cash received in the June 2008 financing transaction.

Interest expense

Interest expense decreased 13%, or $10, to $66 for the three months ended June 30, 2008, compared to $76 in the prior year period. The decrease was primarily due to the reduction in the rate of interest accrued on the Company’s debt from 15% to 8% brought about by debt and equity financing completed in June 2008. See Notes 5 and 6 in the Notes to Unaudited Condensed Consolidated Financial Statements included with this registration statement on Form S-1.

12



For the six months ended June 30, 2008, interest expense increased 8%, or $10, to $133, compared to $123 in the prior year period.  The increase is primarily due to the increase in debt financing consummated in June 2007, which was accrued during the full six months ended June 30, 2008.

Amortization of loan discount, which includes warrant and beneficial conversion feature costs associated with the Company’s debt, deferred financing costs, associated with the convertible notes and note and warrant purchase agreements increased 30%, or $65, to $280 for the three months ended June 30, 2008 compared to $215 in the prior year period.  The increase was primarily due to acceleration of the write off to expense of the warrant and beneficial conversion feature costs of a portion of short-term debt due to the conversion in June 2008 to new long-term debt and equity.

For the six months ended June 30, 2008, amortization of loan discount and related costs discussed above increased 7%, or $26, to $416 compared to $390 in the prior year period. The increase was due to the factors discussed above.  The Company will amortize an additional $9 to interest expense over the remaining life of the unconverted notes and $1,180 assigned to the new long term debt or sooner if the notes are paid off before the due date.

Results of Operations Years Ended December 31, 20072015 and December 31, 20062014

Revenue

Revenues

TotalFor the year ended December 31, 2015, total revenue was $1,620,000, an increase of $105,000, or 7%, compared to total revenue of $1,515,000 in the prior year. For the year ended December 31, 2015, software product revenue was $738,000, a decrease of $28,000, or 4%, compared to product revenue of $766,000 in the prior year. Maintenance revenue for the year ended December 31, 2007 decreased $197,2015 was $882,000, an increase of $133,000, or 8%18%, compared to revenuesmaintenance revenue of $2,342$749,000 in the prior year. Product revenue reflects a 23% or $170 increase in eSignature and a 22% or $149The decrease in natural input revenues comparedsoftware product revenue was primarily attributable to the priortiming of introducing new products during the year. The increase is primarilyin maintenance revenue was due to the relative sizesale of orders betweennew enterprise licenses during 2014 and 2015 and a new maintenance contract entered into with Cegedim SA.

Cost of Sales

For the comparable years offset by lower reported royalties from a major natural input/Jot customer. Maintenance revenue decreased 24%, or $218, for year ended December 31, 20072015, cost of sales was $519,000, an increase of $129,000, or 33%, compared to the prior year period. The decrease was primarily due to the non-renewal of a maintenance contract from an ongoing customer due to financial constraints driven by a severe natural disaster occurring in 2006.

In addition, the Company has experienced the need to extend and enhance its product offerings to serve various eSignature applications as the market matures. This included multi-model signings, web based offerings, call centers, server side and hosted solutions. Although this product evolution is consistent with the transition from a developing market to market take-off, 2006 and 2007 revenue was negatively impacted by the delay in large follow-on rollout-type deployments from our installed base of initial deployments especially with top-tier early adopter financial institutions. The Company believes it has maintained and enhanced its product and competitive leadership. Although 2007 revenue was essentially the same as 2006, fourth quarter revenue of $800 was up 75 % over the prior quarter and up 63% over the corresponding prior year period. eSignature sales activity in the last half of 2007, as measured by the revenue potential reflected in the formal proposal and quotation requests, was at the highest level in the Company’s history. The Company experienced delays in closing several material orders in the last half of 2007, with negotiations still ongoing, and believes that the current pipeline and it’s growth rate has the sales potential for achieving and sustaining quarterly profitability.

Cost of Sales

Costcost of sales increased 110% or $275, for the twelve months ended December 31, 2007, compared to $250of $390,000 in the prior year. The increase iswas due primarily due to the third party hardwarehigher engineering direct labor costs for hardware sold as part of our eSignature solution software andresulting from increased amortization of new and previously capitalized software development costs associated with the Company’s productnon-recurring engineering orders and maintenance revenues. Direct engineering costs associated with development contracts and proof of concept orders decreased approximately $38 to $56, compared to $94 in the prior year. Cost of sales is expected to increase near term as capitalized engineering software development for new and existing products is completed and products are released.

13



Operating Expenses

Research and Development Expenses

Research and development expenses decreased approximately 42%, or $341, forduring the year ended December 31, 20072015 compared to the prior year.

Operating Expenses

Research and Development Expenses

For the year ended December 31, 2015, research and development expenses were $1,771,000, a decrease of $160,000, or 8%, compared to research and development expenses of $1,931,000 in the prior year. Research and development expenses consist primarily of salaries and related costs, outside contract engineering, as required, maintenance items, and allocated facilitiesfacility expenses. The most significant factorfactors contributing to the $341 decrease wasin research and development expenses were decreases in salaries and wages due to the attrition of two full time positions in the second half of 2014 and a decrease in the number of outside engineering personnel. In addition, transfers to cost of sales increased due to the increase in non-recurring engineering orders and maintenance. The decrease in engineering cost was partially offset by an increase in third party software services associated with the Company’s development costs capitalized during 2007 compared to the prior year.  In addition salariesactivities and related expenses decreased 11% compared to the prior year due to the elimination of two engineering personnel latean increase in 2006 and early in 2007. The expense of the estimated fair value of stock options that vested in 2007 required under SFAS 123(R), (see Critical Accounting Policies “Share-Based Compensation”) decreased 67% or $36, forstock-based compensation expense. For the year ended December 31, 2007. The2015, total research and development expenses before IT and cost of sales allocations were $2,350,000, a decrease was dueof $4,000, or 0.2%, compared to fewer options vesting$2,354,000 of total research and development expenses before allocations in the current year period. Total expenses, before capitalization of software development costsprior year.

Sales and other allocations was $1,057 forMarketing Expenses

For the year ended December 31, 2007 compared to $1,619 in the prior year.  Research and development expenses before capitalization of software development costs, as well as the amounts to be capitalized on future product development are expected to remain consistent with the 2007 amount in the near term.

Sales and Marketing Expenses

Sales2015, sales and marketing expenses decreased 23%were $980,000, a decrease of $284,000, or $382, for the twelve months ended December 31, 2007,22%, compared to sales and marketing expenses of $1,264,000 in the prior year. The decrease was primarily

21

TABLE OF CONTENTS

attributable to a decrease in salarysalaries and related expense, including stock based compensation, resulting fromwages due to the reductionattrition of two marketing personnel. In addition advertisingfull time positions, and marketing programs and participation at trade shows decreaseddecreases in other sales related overhead costs compared to the prior year. Engineering allocated expenseyear partially offset by an increase in support of sales related communications and customer demonstration activities including the trade shows and exhibits was also reduced. The Company expects sales and marketing expenses to remain consistent in the near term.

stock-based compensation expense.

General and Administrative Expenses

General and administrative expenses for the twelve months ended December 31, 2007 decreased 5% or $113, compared to the prior year. Salaries and related expense including stock based compensation were consistent with the prior year. Professional services, insurance and allocated expenses were reduced due completion of our web-site in 2006, renegotiation of the Company’s office lease and reductions in annual insurance premiums.  These favorable trends were offset by increases in the Company’s allowance for doubtful accounts. The Company anticipates that general and administrative expense will remain consistent over the near term.

Interest Income and Other Income (Expense), Net

Interest income and other income (expense), net, decreased $69 to an expense of $26, compared to the prior year. The decrease is due to the reduced cash balances during the most of the current year, disposal of fixed assets and inventory by the joint venture and the affect of exchange rate changes on cash compared to the prior year.

Interest Expense

Interest expense related party increased $124 to $135 forFor the year ended December 31, 2007, compared to $112015, general and administrative expenses were $2,175,000, an increase of $432,000, or 25%, from general and administrative expenses of $1,743,000 in the prior year. The increase was attributable to an increase in salaries and related costs, including stock option compensation and hiring expense, due to two additional financingthe addition of one accounting position compared to the prior year, and professional service fees associated with the Company’s public offering of common stock.

Other Income (Expense), Net

Other income/expense, net, was an expense of $3,000, a decrease of $53,000, or 106%, compared to income of $50,000 in March/April 2007 and Junethe prior year. The decrease was primarily due to the sale of 2007. one of the Company’s unused trademarks to a third party in the third quarter of 2014.

Interest expense-other forExpense

For the year ended December 31, 2007 increased 42%, or $44, to $149,2015, related party interest expense was $31,000, an increase of $31,000 compared to $105related party interest expense of $0 in the prior year. The increase was primarily due to short-term borrowings in November and December of 2015. For the year ended December 31, 2015, other party interest expense was $23,000, a decrease of $236,000, or 91%, compared to other party interest expense of $259,000 in the prior year. The decrease in other party interest expense resulted from expensing the valuation of the warrants issued to third parties in connection with the closing of a $2,000,000 credit facility in May 2014.

For the year ended December 31, 2015, the Company recorded $53,000 in debt discount amortization associated with short-term borrowings, $11,000 of which was attributable to a related party and $42,000 was attributable to other investors. There was no debt discount amortization in the prior year.

For the year ended December 31, 2015, the change in fair value of derivative liabilities resulted in a non-cash gain of $18,000, an increase of $11,000, or 157%, compared to a gain of $7,000 in the prior year. The change in fair value was primarily due to the expiration of the related derivatives in November of 2015.

For the year ended December 31, 2015, accretion of the beneficial conversion feature on the Company’s Preferred Stock with an exercise price less than the closing market price on December 31, 2015 (Series C Participating Convertible Preferred Stock and Series D-1 Convertible Preferred Stock) was $526,000, a decrease of $126,000, or 19%, compared to $652,000 in the prior year period. The decrease was due to the decrease in the closing price of the Company’s common stock on the date of issue compared to the prior year.

The Company recorded dividends in kind on shares of its Series A-1 Cumulative Convertible Preferred Stock, Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and Series D Preferred Stock. For the year ended December 31, 2015, dividends on shares of Preferred Stock were $3,176,000, an increase of $464,000, or 17%, compared to $2,712,000 in the prior year period. The increase was primarily due to March/April 2007 financings mentioned above.  See Notes 4the issuances of shares of Series D Preferred Stock in 2015 and 52014.

Liquidity and Capital Resources

Our principal needs for liquidity have been to fund operating losses, working capital requirements and research and development. For the year ended December 31, 2015, we funded our operations with $1,268,000 from the issuance of short-term debt and $1,525,000 in net proceeds from the issuance of Series D-1 Convertible Preferred Stock. Our principal source of liquidity as of December 31, 2015 consisted of cash and cash equivalents of approximately $846,000. As of May 6, 2016, we had cash and cash equivalents of $35,886.

In November and December 2015, we consummated a debt financing and sold unsecured convertible promissory notes due August 25, 2016 in the Notes to the December 31, 2007 Consolidated Financial Statements included with this registration statement on Form S-1.aggregate principal amount of $1,268,000.

Amortization of loan discount and deferred financing expense-related party increased $235We have incurred net losses in each fiscal year since our inception except for the year ended December 31, 2007.2004. From inception, we have financed our operations and met our capital expenditure requirements primarily from the net proceeds of private and public sales of debt and equity securities. For the year ended December 31, 2015, the net proceeds of such financings totaling $2,793,000. For the year ended December 31, 2014, the net proceeds of such financings totaling $2,259,000.

22

TABLE OF CONTENTS

In each of the last three fiscal years, our auditors have raised substantial doubt about our ability to continue as a going concern. We believe that our current cash and cash flow from operations, together with the proceeds from this offering, will be sufficient to fund our anticipated operations, working capital and capital spending for the next 12 months. We may, however, require additional cash resources due to changing business conditions or other future developments. Our ability to maintain sufficient liquidity depends partially on our ability to achieve anticipated levels of revenue, while continuing to control costs. If we do not have sufficient available cash, we would have to seek debt or equity financing through other external sources, which may not be available on acceptable terms, or at all. Due to often volatile nature of the financial markets, equity and debt financing may be difficult to obtain. In addition, any unfavorable development or delay in the progress for our products or services could have a material adverse impact on our ability to raise additional capital.

We may seek to raise any necessary additional capital through a combination of private or public equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements. If we raise additional capital through private or public equity offerings, the ownership interest of our existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our stockholders’ rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.

Cash Flow Results

The table set forth below provides a summary statement of cash flows for the periods indicated:

 
Year Ended
December 31,
 
2015
2014
Net cash used in operating activities
$
(2,674,000
)
$
(2,425,000
)
Net cash used in investing activities
 
(48,000
)
 
(4,000
)
Net cash provided by financing activities
 
2,793,000
 
 
2,259,000
 
Cash and cash equivalents at end of period
 
846,000
 
 
775,000
 

At December 31, 2015, cash and cash equivalents totaled $846,000, compared to $775,000 at December 31, 2014. The increase was primarily dueattributable to amortization$2,793,000 of the additional warrant costs issued with the new debt mentioned above.funds provided by financing activities, partially offset by $2,674,000 of funds used in operating activities, and $48,000 of funds used in investing activities.

14



Amortization of loan discount and deferred financing-other, which includes warrant, beneficial conversion feature and deferred financing costs, associated with the convertible notes and the note and warrant purchase agreements, increased 12%, or $73,The cash used in operations for the year ended December 31, 2007 compared to $591 in the prior year period. The increase2015 was due to the increase in borrowings in 2007 and $202 of additional beneficial conversion feature costs due to a reduction in the conversion price of the convertible debt. See Note 3 and 4 in the Notes to the December 31, 2007 Consolidated Financial Statements included with this registration statement on Form S-1.

The Company will amortize an additional $371 of warrant cost related to the note and warrant purchase agreements entered into between November 2006 and October 2007 to interest expense through October 2009.

Liquidity and Capital Resources – Years Ended December 31, 2007 and December 31, 2006

Cash and cash equivalents at December 31, 2007 totaled $1,144, compared to cash and cash equivalents of $727 at December 31, 2006. This increase is primarily attributable to $2,452 provided by financing activitiesthe net loss of $3,917,000 and $40 as a result of exchange rate changes.an $18,000 gain on derivative liability. These amounts were partially offset by $1,261 used by operations and $814 used in investing activities.

The cash used by operations was primarily due to a net loss of $3,399. Other net changes in operating assets and liabilities amounted to proceeds of $252.  The cash used in operations was offset bynon-cash depreciation and amortization charges of $857,$357,000, amortization of the loandebt discount deferred financingof $53,000 and warrant costs of $969, and stock basedstock-based employee compensation of $130.$575,000.

TheFor the year ended December 31, 2015, the cash used in investing activities of $814 was primarily due to the capitalized software development costs of $788 and$48,000 resulted from the acquisition of leasehold improvements associated with the sub-lease of approximately 3,000 square feet of unutilized office and computer equipmentspace.

At December 31, 2015, accounts receivable were $94,000, a decrease of $26.

Proceeds from financing activities consisted primarily$28,000, or 23%, compared to accounts receivable of $2,602 in net proceeds from the sale of common stock through a private placement and $1,120 in proceeds from short term debt with a related party (see “Financing” below). The proceeds from the sale of common stock and short-term notes were offset by the payment of convertible notes amounting to $1,265 and $5 in payments on capital lease obligations.

Accounts receivable decreased 7%, or $35, to $452$122,000 at December 31, 2007, compared to $487 at December 31, 2006.2014. Accounts receivable at December 31, 20072015 and 2006 are2014, were net of $117$22,000 and $397,$22,000, respectively, in reservesof allowances provided for potentially uncollectible accounts. Sales in the Company’s fourth quarter of 20072015 were 63% higher than 2006 due to recognitiongenerated early in the quarter increasing fourth quarter collection of deferred revenues. The Company expects that there will be fluctuations in accounts receivable in the foreseeable future duecompared to volumes and timing of revenues from quarter to quarter.

The deferred financing costs were completely written off during 2007. The deferred financing costs are associated with the November 2004 financing (see “Financing” below).

2014.

Prepaid expenses and other current assets increased 29%, or $30, to $135were $372,000 at December 31, 20072015, an increase of $292,000, or 365%, compared to $105 at December 31, 2006.  The increase is primarily due the timing of the billings of annual maintenance and other prepaid contracts. Prepaid expenses generally fluctuate due to the timing of annual insurance premiums and maintenance and support fees, which are prepaid in December and June of each year.

Accounts payable increased 87%, or $63, primarily due to expenses associated with the preparation and filing of a Registration Statement on Form S-1 required by the sale of common stock in a private placement effected in fiscal 2007.

Other current liabilities, which include deferred revenue of $431 and the related party notes of $1,370, becoming due in May, September and December of 2008, were $2,463 at December 31, 2007, compared to $2,063 at December 31, 2006, a net increase of $400. Deferred revenue increased $27, to $431, at December 31, 2007, compared to $404 at December 31, 2006.  The increase in current liabilities is due to primarily to the reclassification of the related party notes from long-term to short-term at December 31, 2007.

Liquidity and Capital Resources – Six Months Ended June 30, 2008, Compared to Year Ended December 31, 2007

At June 30, 2008, cash and cash equivalents totaled $2,387 compared to cash and cash equivalents of $1,144 at December 31, 2007. The increase in cash was primarily due to proceeds from the 2008 financing transaction offset by cash used in operations of $771 and $499 used in investing activities, including $492 in capitalization of software development costs and the acquisition of property and equipment amounting to $7. Total current assets were $2,715 at June 30, 2008, compared to $1,731 at December 31, 2007. As of June 30, 2008, the Company’s principal sources of funds included its cash and cash equivalents aggregating $2,387.

Accounts receivable net, decreased $208 for the six months ended June 30, 2008, compared to the December 31, 2007 balance, due primarily to the decrease in sales in the second quarter of 2008 compared to the fourth quarter of 2007.  The Company expects the development of the eSignature market ultimately will result in more consistent revenue on a quarter to quarter basis and, therefore, less fluctuation in accounts receivable from quarter to quarter.

The deferred financing costs of $433 at June 30, 2008 are associated with the debt and equity financing consummated in June 2008.  These costs represent consulting and legal fees associated with the Financing transaction. These costs will be amortized to interest expense over the life of the debt or sooner if the debt is paid off early.

Prepaid expenses and other current assets decreasedof $80,000 at December 31, 2014. The increase was primarily due to certain professional fees related to the Company’s public offering of its common stock.

At December 31, 2015, short-term debt was $991,000 compared to $0 at December 31, 2014. The increase in short-term debt was due to borrowings by $51the Company in November and December 2015 for working capital.

At December 31, 2015, accounts payable were $787,000, an increase of $459,000, or 140%, compared to $328,000 at December 31, 2014. The increase was due to liabilities incurred in connection with the Company’s proposed public offering.

23

TABLE OF CONTENTS

At December 31, 2015, other current liabilities, which include accrued compensation of $263,000, were $878,000 at December 31, 2015, an increase of $247,000, or 39%, compared to other current liabilities of $631,000 at December 31, 2014. The increase was primarily due to the accrual of professional services compared to the prior year.

At December 31, 2015, deferred revenue was $839,000, a decrease of $118,000, or 12%, compared to deferred revenue of $957,000 at December 31, 2014. The decrease was primarily due to the recognition of revenue from the renewal of a five-year maintenance contract with one of the Company’s customers in December 2014.

Contractual Obligations

The Company had the following material commitments as of June 30, 2008, compared to December 31, 2007, due primarily2015:

Contractual obligations
Total
2016
Thereafter
Operating lease commitments(1)(2)
$
161,000
 
$
161,000
 
 
 
(1)The Company extended the lease on its offices in April 2010. The base rent decreased by approximately 6% in November 2011 and increases by approximately 3% per annum over the term of the new lease, which expires on October 31, 2016.
(2)The Company sublet approximately 3,000 square feet of unutilized office space in August 2015. The sub-lease will expire on October 31, 2016. The operating lease commitments are net of the sub lease amounts of $97,000 through 2016.

As of December 31, 2015, the Company leases facilities in the United States totaling approximately 9,600 square feet. The Company’s rental expense was $271,000 and $289,000 for the years ended December 31, 2015 and 2014, respectively. In addition to expensingbase rent, the prepaid fees forCompany pays a marketing program heldpercentage of the increase, if any, in May 2008. Annual fees on maintenance and supportoperating costs added to prepaidsincurred by its landlord in such year, over the three months ended June, 2008 were approximately equaloperating expenses incurred by its landlord in the base year.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.

24

TABLE OF CONTENTS

BUSINESS

Company Overview

We are a leading supplier of digital transaction management software enabling the paperless, secure and cost-effective management and authentication of document-based transactions. Our solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and various options for biometric authentication. These solutions function across virtually all enterprise, desktop and mobile environments. Our software can be deployed both on-premise and as a cloud-based (SaaS) service, with the ability to the quarterly amortization amounts.easily transition between deployment models.

The Company was incorporated in Delaware in October 1986 as Communication Intelligence Corporation. In December 2015, we changed our name to iSign Solutions Inc. and our common stock trading symbol to “ISGN”. We are headquartered in Redwood Shores, California.

Accounts payable decreased $11Core Technologies

The Company’s core technologies can be referred to as “transaction-enabling,” “digital authentication” and “business process work flow.” These technologies include various forms of June 30, 2008, compared to December 31, 2007, due primarily to third party hardware costselectronic signature methods, such as handwritten, biometric, click-to-sign and others, as well as technologies related to orders shipped insignature verification, authentication, cryptography and the three months ended March 31, 2008. Accounts payable balances typically increase inlogging of audit trails to prove signers’ intent. Our technologies enable the secondappending of secure, legal and fourth quarters whenregulatory compliant electronic signatures coupled with an enhanced user experience at a fraction of the insurancetime and annual maintenancecost required by traditional, paper-based processes for signature capture.

Products

The Company’s enterprise-class SignatureOne® and support fees are incurred.  Materials used in costiSign® suite of sales may impact accounts payable depending on the amount of third party hardware sold as partelectronic signature solutions enable businesses to implement paperless, electronic signature-driven business processes. The aggregate of the software functionality enabling the digitization of end-to-end work flow processes is sometimes referred to as “Digital Transaction Management” (“DTM”). Many applications provide electronic forms and allow users to fill-in information, but most of these applications still require users to print out a paper copy for the application of a handwritten, ink signature. Solutions powered by our products allow legally binding electronic signatures to be added to digitized documents, eliminating the need for paper to memorialize the completion, approval or authentication of the transaction. This allows users to reduce transaction times and processing costs.

The SignatureOne® and iSign® suite of products includes the following:

SignatureOne®
Ceremony® Server
The SignatureOne® Ceremony® Server (“Ceremony Server”) provides a highly secure, scalable and streamlined electronic signature solution. Accrued compensation decreased $67, comparedIts flexible, configurable and customizable workflow options can be rapidly integrated via standard Web services. This enables the Ceremony Server DTM to become a commercial grade and cost efficient transaction management engine driving true straight-through processing (the complete removal of paper from business processes) and to facilitate end-to-end management of multi-party approvals for PDF and XHTML documents.

The Ceremony Server contains iSign’s core esignature engine and signature ceremony management tools, and can be seamlessly integrated with numerous ancillary products. Its key features include:

Consent/disclosure management – integral part of audit record; easily reproducible in the event of a dispute;
Configurable document presentment – signatory receipt, access and viewing of document tracked in audit trail;
Multi-party ceremonies – complex processes, simplified; allows for dynamic, multi-channel workflow changes, including remote, face-to-face and mobile scenarios;
Support for complex business rules and dynamic user behaviors;

25

TABLE OF CONTENTS

Configurable branding and workflow;
Flexible tracking and reporting – including event notification service
Extensive audit trail – embedded in individual document in a tamper evident digital seal; and
Support for multiple signature methods – electronic, click-to-sign; biometric; and others.
iSign® Console™
The iSign® Console™ (“Console”) leverages the Ceremony Server’s core signature engine and is ideal for organizations looking for a standalone electronic signature solution coupled with significant workflow management features. Through its intuitive graphical interface, Console allows users to upload documents for signature, select signers and signature methods, and manage and enforce document workflow for routing, reviewing, signing and notifications. Console offers a secure and intuitive solution that requires no integration and is available on-premise or in the cloud.
iSign® Enterprise
iSign® Enterprise incorporates the features and function of the Ceremony Server and Console.
iSign® Family
The growing suite of iSign® products and services include iSign® Mobile (for signing on iOS and Android mobile devices), iSign® Forms (for integrated use of templates and forms), and iSign® Live (iSign’s patent-pending co-browsing solution for guided, simultaneous signature ceremonies).
Sign-it®
Sign-it® is a family of desktop software products that enable the real-time capture of electronic and digital signatures, as well as their verification and binding within a standard set of applications, including Adobe Acrobat and Microsoft Word, web-based applications using HTML, XML and XHTML, and custom applications for .NET, C# and similar development environments for the enterprise market. These signatures have the same legal standing as a traditional so-called wet signature on paper and are created pursuant to the U.S. Electronic Signature in National and Global Commerce Act, as well as other related legislation and regulations. With Sign-it® products, organizations wishing to process electronic forms, requiring varying levels of security, can reduce the cost and other inefficiencies inherent with paper documents by adding electronic signature technologies to their workflow solutions.
iSign® Toolkits
The iSign® suite of application development tools for electronic signature capture, encryption and verification in custom applications and web-based processes captures and analyzes the image, speed, stroke sequence and acceleration of a person’s handwritten electronic signature. This capability offers an effective and inexpensive solution for immediate authentication of handwritten signatures. iSign® toolkits also store certain forensic elements of an electronic signature for use in determining whether a person’s electronic signature is legally valid. They also include software libraries for industry standard encryption and hashing to protect a user’s signature, as well as the data captured in the Ceremony® process.

Products and upgrades that we introduced and first deployed in 2015 include the following:

iSign® Enterprise
5.1.2.1
iSign® Enterprise
5.1.3
iSign® Enterprise
5.1.4
iSign® Enterprise
5.2.6
iSign® Enterprise
5.2.7
iSign® Enterprise
5.2.9
iSign® Enterprise
5.4
iSign® Enterprise
5.4.1
iSign® Enterprise
5.4.2

26

TABLE OF CONTENTS

iSign® Enterprise
5.4.3
iSign® Enterprise
5.4.4
iSign® Enterprise
5.4.5
iSign® Enterprise
5.4.6
iSign® Enterprise
5.4.6.1
iSign® Enterprise
5.4.7
iSign® Enterprise
5.4.8
iSign® Enterprise
5.4.9
iSign® Enterprise
5.4.10
iSign® Enterprise
5.4.11
iSign® Enterprise
5.4.12
iSign® Enterprise
5.5
iSign® Enterprise
6.0
Sign-it® for Acrobat®
7.6
Sign-it® for Acrobat®
9.4

Intellectual Property

The Company relies on a combination of patent applications, trademarks, trade secrets and contractual provisions to protect its software offerings and technologies. The Company has a policy of requiring its employees and contractors to commit to the protection of proprietary information through written agreements. The Company also has a policy of requiring prospective business partners to enter into non-disclosure agreements before disclosure of any of its proprietary information.

Over the years, the Company has developed and patented major elements of its software offerings and technologies. The Company currently has the following patent applications pending:

Patent App. No.
Filing Date
14/650,271
June 5, 2015
14/455,425
August 8, 2014
14/538,744
November 11, 2014

The Company’s technologies go beyond simple electronic signature and include biometric signatures, verification solutions, authentication and validation methods, that result in signed documents that are secure, legal and tamper-resistant.

The Company has over 20 registered and unregistered trademarks in the United States and other countries. The Company intends to register its trademarks in those jurisdictions where significant marketing of its products will be undertaken in the foreseeable future.

Research & Development

Our research and development effort is focused on the development, advancement and refinement of our core products and the development of new products. In addition, our research and development team is responsible for the continuous quality measurement and assurance of both existing and new products. We conduct research on software technology, related computer hardware, competitive offerings and alternative solution approaches to develop appropriate product and service offerings for our target markets. Our research and development efforts are often aimed at assisting clients and licensees in further streamlining new and existing workflow processes that our software solutions support and at ensuring that we meet or exceed industry standards and competitive offerings. We provide certain customization and integration services to our clients, including software integration partners and enterprise customers. These efforts are conducted by our team in Redwood Shores, California, supported by contracted staff, including offshore engineers.

We believe that our software technologies, platforms and products are now competitive and, while research and development activities will remain at the core of our operations, we intend, going forward, to invest an increasing amount of our resources in sales and marketing activities.

27

TABLE OF CONTENTS

Our research and development expense was $1,771,000 for the year ended December 31, 2007 balance due2015, $1,931,000 for the year ended December 31, 2014 and $2,073,000 for the year ended December 31, 2013.

Material Customers

Historically, the Company’s revenue has been derived from many customers, but a significant percentage of our revenue over recent years has been attributable to a limited number of customers. Three customers accounted for 24%, 13% and 10%, respectively, of total revenue for the year ended December 31, 2015.

Our customers include direct end user clients like Prudential, State Farm, Wells Fargo, Allstate and Travelers, as well as integration partner clients such as Ebix, Oracle, Striata and Cegedim SA.

Cegedim License Agreement

In January 2015, the Company entered into an amended and restated license agreement with Cegedim SA, a company organized under the laws of France (the “Cegedim License Agreement”). Cegedim is listed on Euronext, has annual revenue of approximately €500 million and is a leading European provider of software and IT services, primarily in the healthcare and insurance sectors.

Subject to the terms and conditions of the Cegedim License Agreement, the Company granted Cegedim a non-exclusive, non-transferable, limited license to integrate the Company’s SignatureOne® Ceremony® server software into Cegedim’s platforms to provide integrated services to its subscribers and other end-users. Our software is currently in production and integrated with Cegedim’s MA€A platform, which manages Single Euro Payments Area payment mandates, and CG Pay, a single, fully-integrated electronic service managing the purchase-order-to-payment-fulfillment cycle in a completely paperless fashion. Cegedim has also deployed our software on a standalone basis for clients including Pfizer and Sanofi.

The Company receives a share of salariesrevenue generated from each electronic signature used and each payment transaction processed by Cegedim platforms incorporating Company software, as well as maintenance and other fees. The Cegedim License Agreement has an initial term of five years and may be terminated prior to that date by mutual agreement of the parties or by either party after the initial five year term ends in January 2020 for any reason upon at least 180 days prior notice.

Seasonality of Business

The Company believes that the sale of its products is not subject to seasonal fluctuations.

Backlog

Backlog was approximately $839,000 and $957,000 at December 31, 2015 and 2014, respectively, representing advanced payments on product and service maintenance agreements. In 2014, the Company negotiated a long term maintenance agreement with one of its customers, the balance of which is $455,000, which will be recognized over four years. The remaining backlog is expected to be recognized over the next twelve months.

Competition

We believe that our primary competitive advantages include the following:

Customer options and platform flexibility:   Unlike most of our competitors, we offer many flexible configuration options for enterprise clients to address many variants of complex business work flows without the need for costly and time-consuming customization. These solution configurations can be rapidly and seamlessly integrated into a variety of enterprise technology environments.
Software deployment options:   Unlike most of our competitors, our software solutions are available as an on demand, private cloud-based software as a service, and on the customer’s premises, which is an important feature for most of our large enterprise clients for compliance, security and control reasons.
Lower cost structure:   Through our technology, sales and marketing partners, including Cegedim SA, we believe we offer a lower relative cost structure and higher operating margin than most of our larger competitors.

28

TABLE OF CONTENTS

Currently, our primary competition for basic click-to-sign electronic signatures includes Adobe EchoSign, DocuSign and Silanis (being recently acquired by VASCO Data Security International Inc.). We view the balance of the U.S. market as fragmented with a variety of smaller competitors focused on the consumer and small business markets rather than enterprise organizations.

Employees

As of May 6, 2016, the Company employed fifteen full-time employees and seven independent contractors. The Company has established strategic, software engineering relationships (both domestic and offshore) that allow it to rapidly access product development and deployment capabilities that could be required to address most customer requirements. None of the Company’s employees are party to any collective bargaining agreements. We believe our employee relations are good.

Geographic Areas

For the years ended December 31, 2015 and 2014, sales in the United States as a percentage of total sales were deferred93% and 99%, respectively. At December 31, 2015 and 2014, long-lived assets located in the United States were $664,000 and $973,000, respectively. There were no long-lived assets located elsewhere as of December 31, 2015 and 2014.

Segments

The Company reports its financial results in one segment.

Properties

The Company leases its principal facilities, and currently occupies approximately 6,600 square feet, in Redwood Shores, California, pursuant to a lease that expires on October 31, 2016. We believe that we can find suitable space following the expiration of our lease on comparable or more favorable terms.

Legal Proceedings

The Company is not subject to any material pending legal proceedings.

Available Information

Our web site is located at www.isignnow.com, and we are in the process of developing our new website at www.isignnow.com. The information on or accessible through our web site is not part of this registration statement on Form S-1. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to such reports are available, free of charge, on our web site as soon as reasonably practicable after we electronically file with or furnish such material to the Securities and Exchange Commission (“SEC”). Furthermore, a copy of this registration statement on Form S-1 and other reports filed by us with the SEC may be read and copied by the public at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549 on official business days during 2007.the hours of 10 a.m. and 3 p.m. Information on the operation of the Public Reference Room can be obtained by calling the SEC at 1-800-SEC-0330. The balance may fluctuate due to increasesSEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers, including our Company, that file electronically with the SEC at www.sec.gov.

29

TABLE OF CONTENTS

DIRECTORS AND EXECUTIVE OFFICERS

As of the date of this prospectus, our directors, executive officers and significant employees are as follows:

Name
Age
Positions with the Company
Philip S. Sassower
76
Co-Chairman and Chief Executive Officer
Michael Engmann
67
Co-Chairman
Andrea Goren
48
Director and Chief Financial Officer
William Keiper
65
President and Chief Operating Officer
Francis J. Elenio
50
Director
Stanley Gilbert
76
Director
Jeffrey Holtmeier
58
Director
David E. Welch
69
Director

Each director serves for a one year term, or decreasesuntil his successor is duly elected and qualified or his earlier resignation, removal or disqualification. On October 27, 2015, the Board of Directors of the Company (the “Board”) approved an increase in the number of personnelauthorized directors from five to seven directors. In order to fill the two vacancies created by the increase in the number of authorized directors, in accordance with the applicable provisions of the Company’s Amended and utilizationRestated Certificate of or increasesIncorporation, as amended (the “Charter”) and Bylaws, the Board appointed Michael Engmann and Francis J. Elenio to the accrued vacation balance.Board on October 27, 2015 on November 11, 2015, respectively. The business experience of each of our directors and executive officers for at least the past five years includes the following:

Philip S. Sassower has served as the Company’s Chairman and Chief Executive Officer since August 2010 and as Co-Chairman since October 2015. Mr. Sassower is a Managing Director of SG Phoenix LLC, a private equity firm, and has served in that capacity since May 2003. Mr. Sassower has also been Chief Executive Officer of Phoenix Enterprises LLC, a private equity firm, and has served in that capacity since 1996. In addition, Mr. Sassower has served as Chief Executive Officer of Xplore Technologies Corp. (NASDAQ: XPLR) since February 2006 and has been a director of Xplore Technologies Corp. and served as Chairman of its board of directors since December 2004. On May 13, 2008, Mr. Sassower was named Chairman of the Board of The Fairchild Corporation (NYSE: FA), a motorcycle accessories and aerospace parts and services company. On March 18, 2009, The Fairchild Corporation and 61 subsidiaries filed a petition for bankruptcy under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court, District of Delaware. On January 7, 2010, The Fairchild Corporation’s plan of liquidation was declared effective and the company’s board of directors was relieved of its duties. Mr. Sassower also served as Chairman of the Board of the Company from 1998 to 2002 and as Co-Chief Executive Officer of the Company from 1997 to 1998. Mr. Sassower is co-manager of the managing member of Phoenix Venture Fund LLC. Mr. Sassower’s qualifications to serve on the Board include more than 40 years of business and investment experience. Mr. Sassower has developed extensive experience working with management teams and boards of directors, and in acquiring, investing in and building companies and implementing changes.

Total current liabilities were $1,363Michael Engmannhas served as the Company’s Co-Chairman since October 2015. Mr. Engmann is Chairman of Engmann Options, a family trading and investment holding company and has served in that capacity since 1978. Mr. Engmann has approximately 40 years of experience in building successful financial service companies. He began his career as a trader and was one of the early market-makers in the Pacific Stock Exchange’s options program. He (i) founded, in 1980, Sage Clearing Corporation, a stock and options clearing company for professional traders, which was sold to ABN Amro Inc. in 1988, (ii) founded, in 1982, Preferred Trade, Inc., a broker-dealer providing research and trade execution services, which was sold to Fimat in May 2005, and (iii) acquired in 2001 Revere Data LLC, a global financial and market data company, which was sold to Factset in 2013. Mr. Engmann’s qualifications to serve on the Board of Directors include more than 40 years of business and investment experience.

Andrea Gorenhas served as a director since August 2010. Mr. Goren was appointed the Company’s Chief Financial Officer in December 2010. Mr. Goren is a Managing Director of SG Phoenix LLC, a private equity firm, and has served in that capacity since May 2003. Mr. Goren is co-manager of the managing member of Phoenix Venture Fund LLC, the Company’s largest stockholder. Prior to that, Mr. Goren served as Vice President of Shamrock International, Ltd., a private equity firm. Mr. Goren has been a director of Xplore Technologies Corp. (NASDAQ:

30

TABLE OF CONTENTS

XPLR) since December 2004 and serves on its Executive Committee, and a director of The Fairchild Corporation (NYSE: FA) from May 2008 to January 2010. Mr. Goren’s qualifications to serve on the Board include his experience and knowledge acquired in approximately 16 years of private equity investing and his extensive experience working with management teams and boards of directors.

William Keiperwas appointed the Company’s President and Chief Operating Officer in December 2010. Mr. Keiper is Managing Partner of FirstGlobal Partners LLC where he specializes in working with investors and Boards of Directors in resolving issues related to business continuity, performance and sustainable value creation. Mr. Keiper has over 30 years of business experience, more than 18 of which have been in the management of software, technology and IT product distribution and services organizations. He was President and Chief Executive Officer of Hypercom Corporation (NYSE: HYC) from 2005 to 2007 and served as a member of its Board of Directors from 2000 to 2007. He was Chairman and Chief Executive Officer of Arrange Technology LLC, a software development services outsourcing company, from 2002 to 2005. From 1997 to 2002, he served as a principal in mergers and acquisitions firms serving middle market software and IT services companies. He was Chief Executive Officer of Artisoft, Inc., a public networking and communications software company, from 1993 to 1997, and its Chairman from 1995 to 1997. He held several executive positions, including President and Chief Operating Officer, of MicroAge, Inc., an indirect sales-based IT products distribution and services company, from 1986 to 1993, where he was a key executive in helping to profitably drive more than a billion dollar revenue increase over the course of his tenure with the company.

Francis J. Elenio has served as a director since November 2015, after having served as a director of the Company from August 2010 to October 2011. Since November 2005, Mr. Elenio has served as Managing Director of Reeff Consulting LLC, a financial and business advisory firm providing outsourced accounting and consulting services for start-up to midsized companies. Mr. Elenio also served as Chief Financial Officer of Signal Point Communications Corp. from February 2011 to October 2013. Mr. Elenio has over 25 years of experience working with corporations as a strategic, solution-driven professional focused on finance and accounting, operations and turn-around management. Mr. Elenio has served at June 30, 2008, comparedthe CFO level at numerous public and private companies, including Wilshire Enterprises, Inc., a real estate investment and management company, WebCollage, Inc., an internet content integrator for manufacturers, GoAmerica, Inc., a wireless internet service provider and Roomlinx, Inc., a provider of wireless high speed internet access to $2,598hotels and conference centers. Mr. Elenio is a CPA and received an MBA. Since September 2007, Mr. Elenio has also been an Adjunct Professor of Finance at Seton Hall University. Mr. Elenio serves on the Company’s audit committee. Mr. Elenio’s qualifications to serve on the Board of Directors and Audit Committee include his experience as a CFO working with technology companies like iSign.

Stanley L. Gilberthas served as a director since October 2011. Mr. Gilbert has more than 45 years of experience as a lawyer with primary specialties in wills, trusts, estate planning and administration, as well as tax planning. Mr. Gilbert is Founder, and, has been President of Stanley L. Gilbert PC since 1982. Mr. Gilbert has also been a partner of a number of law firms, including Nager Korobow, Bell Kalnick Klee and Green, and Migdal Pollack Rosenkrantz and Sherman. Mr. Gilbert has served as a Director of Planned Giving at Columbia University Medical Center’s Nathaniel Wharton Fund, which supports a broad variety of projects in basic research, clinical care and teaching since 2001. Mr. Gilbert was elected by a majority of the Company’s Series C and Series B Participating Convertible Preferred stockholders voting together as a separate class on an as converted basis, and serves on our compensation committee. Mr. Gilbert’s qualifications to serve on the Board include his significant tax and accounting expertise acquired through his years of practicing law.

Jeffrey Holtmeier has served as a director since August 2011. Mr. Holtmeier has more than 25 years of successful entrepreneurship in the technology and communications fields. As CEO of GENext from 2001 to present, and through its subsidiary China US Business Development, LLC, Mr. Holtmeier has assisted many U.S. companies in establishing relationships in China, where he also co-founded Koncept International, Inc., a Chinese-based VoIP and digital media technology company. Prior to his involvement in the Chinese market, Mr. Holtmeier founded, built over seventeen years and successfully sold InfiNET in 2001 to Teligent, a NASDAQ listed company. Mr. Holtmeier was a recipient of the prestigious Ernst & Young, NASDAQ/USA Today “Entrepreneur of the Year” award in 1999, and has served on the boards of numerous corporations and non-profit organizations. He serves on our audit and compensation committees. Mr. Holtmeier’s qualifications to serve on the Board include his experience as a successful entrepreneur and his experience in establishing business relationships in China.

David E. Welch has served as a director since March 2004. From July 2002 to present, Mr. Welch has been the principal of David E. Welch Consulting, a financial consulting firm. Mr. Welch has also been Vice President and

31

TABLE OF CONTENTS

Chief Financial Officer of American Millennium Corporation, Inc., a provider of satellite-based asset tracking and reporting equipment, from April 2004 to present. Mr. Welch was Vice President and Chief Financial Officer of Active Link Communications, a manufacturer of telecommunications equipment, from 1999 to 2002. Mr. Welch has held positions as Director of Management Information Systems and Chief Information Officer with Micromedex, Inc. and Language Management International from 1995 through 1998. Mr. Welch’s other directorships have been or are with AspenBio Pharma, Inc., from 2004 to present, PepperBall Technologies, Inc. from January 2007 to January 2009 and Advanced Nutraceuticals, Inc., from 2003 to 2006. Mr. Welch is a Certified Public Accountant licensed in the state of Colorado. He serves on our audit and compensation committees. Mr. Welch’s qualifications to serve on the Board include his significant accounting and financial expertise.

Director Independence

The Board has determined that Messrs. Elenio, Gilbert, Holtmeier and Welch are “independent,” as defined under the rules of the NASDAQ Capital Market relating to director independence, and Messrs. Sassower, Goren and Engmann are not independent under such rules. Messrs. Gilbert, Holtmeier and Welch serve on the Compensation Committee of the Board. Each of the members of the Compensation Committee is independent under the rules of the NASDAQ Capital Market relating to director independence. Messrs. Elenio, Holtmeier and Welch serve on the Audit Committee of the Board. Under the applicable rules of the NASDAQ Capital Market and the SEC relating to independence of Audit Committee members, the Board has determined that Messrs. Elenio, Holtmeier and Welch are independent.

Audit Committee Financial Expert

Mr. Welch serves as the Audit Committee’s financial expert. Each member of the Audit Committee is independent as defined under the applicable rules and regulations of the SEC and the director independence standards of NASDAQ, as currently in effect.

32

TABLE OF CONTENTS

EXECUTIVE COMPENSATION

Compensation of Named Executive Officers

The following table sets forth the compensation for our fiscal years ended December 31, 2007. Deferred revenue, totaling $384 at June 30, 2008, compared2015 and 2014 earned by or awarded to, $431 atas applicable, our principal executive officer, principal financial officer and our other most highly compensated executive officers as of December 31, 2007, primarily reflects advance payments for maintenance fees from the Company’s licensees that are generally recognized2015. In this prospectus, we refer to such officers as revenueour “named executive officers.”

Name and Principal Position
Year
Salary ($)
Bonus ($)
Stock
Awards ($)
Option
Awards ($)
All Other
Compensation ($)
Total ($)
Philip S. Sassower, Co-Chairman and CEO
 
2015
 
 
(1)
 
 
 
 
$
59,100
 
 
 
$
59,100
 
 
2014
 
 
(1)
 
 
 
 
$
 
 
 
$
 
William Keiper, President
 
2015
 
 
(2)
 
 
 
 
$
94,560
 
 
 
$
94,560
 
 
2014
 
 
(2)
 
 
 
 
$
 
 
 
$
 
Andrea Goren, CFO
 
2015
 
 
(3)
 
 
 
 
$
70,902
 
 
 
$
70,902
 
 
2014
 
 
(3)
 
 
 
 
$
 
 
 
$
 
1.Mr. Sassower was appointed Chairman of the Board and Chief Executive Officer on August 5, 2010 and has served as Co-Chairman since October 2015, and during the last two fiscal years received no salary or other compensation from the Company in either capacity.
2.Mr. Keiper was appointed President and Chief Operating Officer on December 7, 2010. As described below, Mr. Keiper provides services to the Company and is compensated through an affiliated entity and, as a result, received no salary from the Company during the last two fiscal years.
3.Mr. Goren was appointed Chief Financial Officer on December 7, 2010. As described below, Mr. Goren provides services to the Company and is compensated through an advisory services agreement with an affiliated entity and, as a result, received no compensation from the Company during the last two fiscal years. Mr. Goren serves as a Director of the Board and received no compensation from the Company in that capacity during the last two fiscal years.

Mr. Keiper is retained by the Company when all obligations are metthrough an Advisory Services Agreement (the “FGP Agreement”) with First Global Partners, LLC (“FGP’) dated August 12, 2011. Mr. Keiper is Managing Partner of FGP. The initial term of the FGP Agreement was two years and automatically renewed for additional one year periods upon the same terms and conditions unless either party notifies the other in writing of its intent to terminate at least 90 days prior to the then-current term. Pursuant to the terms of the FGP Agreement, FGP is entitled to receive a cash sum payment of $20,000 per month. In addition, FGP is eligible to receive an annual cash performance fee of up to 35% of the cash sum payment during a given year or overprorated portion thereof. Such performance fee, if any, would be awarded based upon the sole discretion of our Board. No performance fee was paid to FGP in 2014 or 2015. The Company has agreed to pay FGP for reasonable and documented out of pocket expenses incurred for services rendered during the term of the maintenance agreement, whichever is longer.  Deferred revenue is recorded whenFGP Agreement, as long as FGP obtains written approval of the Company receivesprior to incurring any significant expense. Pursuant to a letter agreement between the Company and FGP, FGP and the Company agreed to defer all unpaid compensation due to FGP until the consummation of the offering. As of May 6, 2016, the aggregate amount of deferred compensation due to FGP was $186,000. The FGP deferred compensation started to bear interest at a rate equal to 24.0% per annum in October 2015. Subject to the terms and conditions of a letter agreement between the Company and FGP, FGP agreed to convert approximately $93,000 of the accrued and unpaid deferred compensation due to it into shares of common stock at the per share offering price and warrants to purchase 125% of the shares received in connection with such conversion at an exercise price of 125% of the per share offering price, and FGP will be paid $93,000 in cash, in each case, upon consummation of the offering.

Mr. Goren is retained by the Company through an Advisory Services Agreement (the “SGP Agreement”) with SG Phoenix LLC (“SGP”) dated August 12, 2011. Mr. Goren and Mr. Sassower are managing members of SGP. The term of the SGP Agreement is two years unless terminated earlier and will automatically renew for additional one year periods upon the same terms and conditions unless either party notifies the other in writing of its intent to terminate at least 90 days prior to the then-current term. Pursuant to the terms of the SGP Agreement, SGP is entitled to receive a cash sum payment from its customers.of $15,000 per month. In addition, SGP is eligible to receive an annual cash performance fee of up to 35% of the cash sum payment during a given year or prorated portion thereof. Such performance fee, if any, would be awarded based upon the sole discretion of our Board. No performance fee was paid to SGP in 2014 or 2015. The Company has agreed to pay SGP for reasonable and documented out of pocket expenses incurred for services rendered by SGP during the term of the SGP Agreement, as long as SGP obtains written approval of the Company prior to incurring any significant expense. Pursuant to a letter agreement between the Company and SGP, SGP and the Company agreed to defer all of the unpaid compensation due to SGP until the consummation of

33

TABLE OF CONTENTS

the offering. As of May 6, 2016, the aggregate amount of deferred compensation due to SGP was $539,700. The SGP deferred compensation started to bear interest at a rate equal to 24.0% per annum in October 2015. Subject to the terms and conditions of a letter agreement between the Company and SGP, SGP agreed to convert $404,775 of the accrued and unpaid deferred compensation due to it into shares of common stock at the per share offering price and warrants to purchase 125% of the shares received in connection with such conversion, at an exercise price of 125% of the per share offering price, and SGP will be paid $134,925 in cash, in each case, upon consummation of the offering.

Outstanding Equity Awards at December 31, 2015

The following table summarizes the outstanding equity award holdings held by our named executive officers at December 31, 2015.

Name and Principal Position
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
Option
Exercise
Price ($)
Option
Expiration
Date
Philip S. Sassower, Co-Chairman and CEO
 
800
(1)
 
(1)
$
81.13
 
01/28/2018
 
4,766
(2)
 
434
(2)
$
56.25
 
01/03/2020
 
600
(3)
 
1,800
(3)
 
29.00
 
01/05/2022
William Keiper, President and COO
 
6,400
(4)
 
(4)
$
31.25
 
08/11/2018
 
2,933
(5)
 
267
(5)
$
56.25
 
01/03/2020
 
961
(6)
 
2,879
(6)
 
29.00
 
01/05/2022
Andrea Goren, Chief Financial Officer
 
800
(7)
 
(7)
$
81.13
 
01/28/2018
 
4,000
(8)
 
(8)
$
31.25
 
08/11/2018
 
2,200
(9)
 
200
(9)
$
56.25
 
01/03/2020
 
720
(10)
 
2,160
(10)
 
29.00
 
01/05/2022
(1)Mr. Sassower’s 800 options were granted on January 28, 2011, vest pro rata quarterly over three years, and expire on January 28, 2018.
(2)Mr. Sassower’s 5,200 options were granted on January 3, 2013, vest pro rata quarterly over three years, and expire on January 3, 2020.
(3)Mr. Sassower’s 2,400 options were granted on January 5, 2015, vest pro rata quarterly over three years, and expire on January 5, 2022.
(4)Mr. Keiper’s 6,400 options were granted on August 11, 2011, vest pro rata monthly over two years, and expire on August 11, 2018.
(5)Mr. Keiper’s 3,200 options were granted on January 3, 2013, vest pro rata quarterly over three years, and expire on January 3, 2020.
(6)Mr. Keiper’s 3,840 options were granted on January 5, 2015, vest pro rata quarterly over three years, and expire on January 5, 2022.
(7)Mr. Goren’s 800 options were granted on January 28, 2011, vest pro rata quarterly over three years, and expire on January 28, 2018.
(8)Mr. Goren’s 4,000 options were granted on August 11, 2011, vest pro rata quarterly over three years, and expire on August 11, 2018.
(9)Mr. Goren’s 2,400 options were granted on January 3, 2013, vest pro rata quarterly over three years, and expire on January 3, 2020.
(10)Mr. Goren’s 2,880 options were granted on January 5, 2015, vest pro rata quarterly over three years, and expire on January 5, 2022.

Option Exercises and Stock Vested

There were no stock options exercised during the year ended December 31, 2015 and 2014.

Director Compensation

The following table provides information regarding the compensation of the Company’s non-employee directors for the year ended December 31, 2015:

Name Current Directors
Fees Earned
or Paid in
Cash(1)
Stock
Awards
Option
Awards
Non-Equity
Incentive Plan
Compensation
Non-qualified
Deferred
Compensation
Earnings
All Other
Compensation
Total
Francis Elenio
$
 
$
 
$
7,500
 
$
 
$
 
$
 
$
7,500
 
Michael Engmann
$
 
$
 
$
7,500
 
$
 
$
 
$
 
$
7,500
 
Stanley Gilbert
$
 
$
 
$
19,700
 
$
 
$
 
$
 
$
19,700
 
Jeffrey Holtmeier
$
 
$
 
$
19,700
 
$
 
$
 
$
 
$
19,700
 
David Welch
$
 
$
 
$
20,094
 
$
 
$
 
$
 
$
20,094
 
(1)All Board of Directors Meetings in 2015 were telephonic and no attendance fees were paid.

34

TABLE OF CONTENTS

Michael Engmann and Francis Elenio were each granted an option to purchase 800 shares of the Company’s common stock under the Company’s 2011 Stock Compensation Plan at a per share exercise price equal to the closing per share market price of the Company’s common stock on November 16, 2015. The options will vest quarterly over three years, and will have a seven-year term. In addition, in accordance with the Company’s current director compensation policy, Mr. Engmann and Mr. Elenio, as non-employee directors, will each receive $1,000 for each Board meeting attended and will be reimbursed for reasonable out-of-pocket expenses incurred in connection with attending such meetings.

35

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information as of May 6, 2016, with respect to the beneficial ownership of (i) any person known to be the beneficial owner of more than 5% of any class of voting securities of the Company, (ii) each director and director nominee of the Company, (iii) each of the current executive officers of the Company named in the Summary Compensation Table under the heading “Executive Compensation” and (iv) all directors and executive officers of the Company as a group. Except as indicated in the footnotes to this table (i) each person has sole voting and investment power with respect to all shares attributable to such person and (ii) each person’s address is c/o iSign Solutions Inc., 275 Shoreline Drive, Suite 500, Redwood Shores, California 94065-1413.

 
Common Stock
Series A-1
Cumulative
Convertible
Preferred
Stock
Series B
Participating
Convertible
Preferred
Stock
Series C
Participating
Convertible
Preferred
Stock
Series D-1
Convertible
Preferred
Stock
Series D-2
Convertible
Preferred
Stock
Name of
Beneficial
Owner
Number
of
Shares(1)
Percent
of
Class(1)
Number
of
Shares(2)
Percent
of
Class (2)
Number
of
Shares(3)
Percent
of
Class(3)
Number
of
Shares(4)
Percent
of
Class(4)
Number
of
Shares(5)
Percent
of
Class(5)
Number
of
Shares(6)
Percent
of
Class(6)
Philip S. Sassower(9)
 
267,906
 
 
65.7
%
 
 
 
 
 
8,068,410
 
 
57.7
%
 
2,441,470
 
 
43.0
%
 
1,556,081
 
 
10.4
%
 
210,590
 
 
2.5
%
Andrea Goren(10)
 
241,224
 
 
63.0
%
 
 
 
 
 
8,103,894
 
 
57.9
%
 
2,402,371
 
 
42.3
%
 
1,103,060
 
 
7.4
%
 
118,461
 
 
1.8
%
Stanley Gilbert(11)
 
45,248
 
 
20.1
%
 
 
 
 
 
177,416
 
 
1.3
%
 
503,408
 
 
8.9
%
 
153,296
 
 
1.8
%
 
162,930
 
 
2.5
%
Jeffrey Holtmeier(12)
 
2,101
 
 
1.1
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31,294
 
 
*
David E. Welch(13)
 
1,648
 
 
*
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Michael W. Engmann(14)
 
188,627
 
 
51.0
%
 
580,074
 
 
59.6
%
 
669,900
 
 
4.8
%
 
173,189
 
 
3.0
%
 
2,431,305
 
 
16.3
%
 
322,629
 
 
4.9
%
Francis Elenio(15)
 
133
 
 
*
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
William Keiper(16)
 
25,771
 
 
12.1
%
 
 
 
 
 
 
 
 
 
400,845
 
 
7.1
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All directors and executive officers as a group (8 persons)(17)
 
648,779
 
 
83.8
%
 
580,074
 
 
59.6
%
 
8,951,210
 
 
64.0
%
 
3,537,730
 
 
62.3
%
 
4,235,045
 
 
28.3
%
 
736,520
 
 
11.2
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5% Shareholders
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phoenix Venture Fund LLC (18)
 
227,296
 
 
61.5
%
 
 
 
 
 
8,068,410
 
 
57.7
%
 
2,383,553
 
 
41.9
%
 
 
 
 
 
 
 
 
 
Pro Forma
Common Stock Beneficially Owned
Pro Forma as Adjusted
Common Stock Beneficially Owned
Name of Beneficial Owner
Number of Shares(7)
Percent of Class
Number of Shares(8)
Percent of Class
Philip S. Sassower(9)
 
1,402,063
 
 
60.1
%
 
1,402,063
 
 
51.8
%
Andrea Goren(10)
 
1,348,199
 
 
59.1
%
 
1,348,199
 
 
50.7
%
Stanley Gilbert(11)
 
121,713
 
 
11.1
%
 
121,713
 
 
8.3
%
Jeffrey Holtmeier(12)
 
5,249
 
 
*
 
5,249
 
 
*
David E. Welch(13)
 
1,648
 
 
*
 
1,648
 
 
*
Michael W. Engmann(14)
 
829,561
 
 
46.0
%
 
829,561
 
 
38.1
%
Francis Elenio(15)
 
133
 
 
*
 
133
 
 
*
William Keiper(16)
 
138,900
 
 
12.4
%
 
138,900
 
 
6.1
%
 
 
 
 
 
 
 
 
 
 
 
 
 
All directors and executive officers as a group (8 persons)(17)
 
2,467,251
 
 
72.9
%
 
2,467,251
 
 
65.6
%
 
 
 
 
 
 
 
 
 
 
 
 
 
5% Shareholders
 
 
 
 
 
 
 
 
 
 
 
 
Phoenix Venture Fund LLC(18)
 
1,302,305
 
 
58.2
%
 
1,302,305
 
 
49.9
%
*Less than 1%.
1.Shares of common stock beneficially owned and the respective percentages of beneficial ownership of common stock assumes the exercise or conversion, at the rates in effect as of May 6, 2016, of all options, warrants and other securities convertible into common stock, including shares of Series A-1 Cumulative Convertible Preferred Stock, Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and Series D Preferred Stock beneficially owned by such person or entity currently exercisable or exercisable within 60 days of May 6, 2016. Shares issuable pursuant to the exercise of stock options and warrants exercisable within 60 days of May 6, 2016 or securities convertible into common stock within 60 days of May 6, 2016 are deemed outstanding and held by the holder of such shares of common stock, options, warrants, or the other convertible securities listed above for purposes of computing the percentage of outstanding common stock beneficially owned by such person, but are not deemed outstanding for computing the percentage of outstanding common stock beneficially owned by any other person. The shares of common stock beneficially owned and the respective percentages of

36

TABLE OF CONTENTS

beneficial ownership of common stock beneficially owned stated in these columns are based on 187,463 shares of common stock, 973,756 shares of Series A-1 Cumulative Convertible Preferred Stock, 13,993,989 shares of Series B Participating Convertible Preferred Stock, 5,682,326 shares of Series C Participating Convertible Preferred Stock, 8,357,448 shares of Series D-1 Convertible Preferred Stock and 6,602,390 shares of Series D-2 Convertible Preferred Stock outstanding as of May 6, 2016 and assume conversion of shares of Series A-1 Cumulative Convertible Preferred Stock, Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock, Series D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock at current conversion rates. The conversion prices of each such series of preferred stock will be reduced upon closing of this offering. See “Description of Capital Stock”.

2.Each outstanding share of Series A-1 Cumulative Convertible Preferred Stock is presently convertible into 7.1429 shares of common stock. The shares of Series A-1 Cumulative Convertible Preferred Stock beneficially owned and the respective percentages of beneficial ownership of Series A-1 Cumulative Convertible Preferred Stock stated in these columns reflect ownership of shares of Series A-1 Cumulative Convertible Preferred Stock, and not shares of common stock issuable upon conversion of shares of Series A-1 Cumulative Convertible Preferred Stock at this ratio. The percentage of beneficial ownership of Series A-1 Cumulative Convertible Preferred Stock beneficially owned is based on 973,756 shares of Series A-1 Cumulative Convertible Preferred Stock outstanding as of May 6, 2016.
3.Each outstanding share of Series B Participating Convertible Preferred Stock is presently convertible into 23.0947 shares of common stock. The shares of Series B Participating Convertible Preferred Stock beneficially owned and the respective percentages of beneficial ownership of Series B Participating Convertible Preferred Stock stated in these columns reflect ownership of shares of Series B Participating Convertible Preferred Stock, and not shares of common stock issuable upon conversion of shares of Series B Participating Convertible Preferred Stock at this ratio. The percentage of beneficial ownership of Series B Participating Convertible Preferred Stock beneficially owned is based on 13,993,989 shares of Series B Participating Convertible Preferred Stock outstanding as of May 6, 2016.
4.Each outstanding share of Series C Participating Convertible Preferred Stock is presently convertible into 44.4444 shares of common stock. The shares of Series C Participating Convertible Preferred Stock beneficially owned and the respective percentages of beneficial ownership of Series C Participating Convertible Preferred Stock stated in these columns reflect ownership of shares of Series C Participating Convertible Preferred Stock, and not shares of common stock issuable upon conversion of shares of Series C Participating Convertible Preferred Stock at this ratio. The percentage of beneficial ownership of Series C Participating Convertible Preferred Stock beneficially owned is based on 5,682,326 shares of Series C Participating Convertible Preferred Stock outstanding as of May 6, 2016.
5.Each share of Series D-1 Convertible Preferred Stock is presently convertible into 44.4444 shares of common stock. The shares of Series D-1 Convertible Preferred Stock beneficially owned and the respective percentages of beneficial ownership of Series D-1 Convertible Preferred Stock stated in these columns reflect ownership of shares of Series D-1 Convertible Preferred Stock, and not shares of common stock issuable upon conversion of shares of Series D-1 Convertible Preferred Stock at this ratio. The percentage of beneficial ownership of Series D-1 Convertible Preferred Stock beneficially owned is based on 8,357,448 shares of Series D-1 Convertible Preferred Stock outstanding as of May 6, 2016.
6.Each share of Series D-2 Convertible Preferred Stock is presently convertible into 20.000 shares of common stock. The shares of Series D-2 Convertible Preferred Stock beneficially owned and the respective percentages of beneficial ownership of Series D-2 Convertible Preferred Stock stated in these columns reflect ownership of shares of Series D-2 Convertible Preferred Stock, and not shares of common stock issuable upon conversion of shares of Series D-2 Convertible Preferred Stock at this ratio. The percentage of beneficial ownership of Series D-2 Convertible Preferred Stock beneficially owned is based on 6,602,390 shares of Series D-2 Convertible Preferred Stock outstanding as of May 6, 2016.
7.Gives effect to (a) the automatic conversion of all our outstanding shares of preferred stock into 3,639,422 shares of common stock (at the reduced conversion prices that will be effective upon closing of this offering), (b) the conversion of approximately $498,000 in accrued and unpaid compensation due to officers, employees and/or their affiliated entities into 204,845 shares of common stock and warrants to purchase 256,056 shares of common stock (based upon on an assumed public offering price of $2.43 per share) and (c) the conversion of $1,068,000 in the aggregate principal amount of unsecured convertible promissory notes, plus accrued interest, into 485,151 shares of common stock and warrants to purchase 606,439 shares of common stock (based upon the assumed public offering price of $2.43 per share), in each case, upon consummation of the offering. See “Description of Capital Stock”.
8.Gives effect to the pro forma adjustments and the sale of 720,164 shares of common stock at an assumed public offering price of $2.43 per share and 360,082 warrants at an assumed public offering price of $0.01 per warrant in the offering.
9.Represents (a) 47,566 shares of common stock, (b) 7,199 shares issuable to Mr. Sassower upon the exercise of options exercisable within 60 days of May 6, 2016, (c) 46,105 shares of common stock issuable upon the conversion of 8,068,410 shares of Series B Participating Convertible Preferred Stock, (d) 86,807 share of common stock issuable upon the conversion of 2,441,470 shares of Series C Participating Convertible Preferred Stock, (e) 55,329 shares of common stock issuable upon the conversion of 1,556,081 shares of Series D-1 Convertible Preferred Stock (f) 3,370 shares of common stock issuable upon the conversion of 210,590 shares of Series D-2 Convertible Preferred Stock and (g) 21,530 shares of common stock issuable upon the exercise of warrants (see table below for details), including securities beneficially owned by Phoenix, SG Phoenix Ventures LLC, SG Phoenix LLC, Phoenix Banner Holdings LLC and Phoenix Enterprises Family Fund. Please see footnote 18 below for information concerning shares of common stock beneficially owned by Phoenix. Along with Mr. Goren, Mr. Sassower is the co-manager of SG Phoenix Ventures LLC, which has the shared power to vote and dispose of the shares of common stock held by Phoenix and Phoenix Banner Holdings LLC, and, accordingly, Mr. Sassower may be deemed to be the beneficial owner of the shares owned by Phoenix and Phoenix Banner Holdings LLC. SG Phoenix Ventures LLC,

37

TABLE OF CONTENTS

 
Philip
Sassower
SG
Phoenix
Ventures
LLC
SG Phoenix
LLC
Phoenix
Venture
Fund LLC
Phoenix
Enterprises
Family Fund
LLC
Phoenix
Banner
Holdings
Total
Common Stock
 
2,044
 
 
 
 
 
2,234
 
 
43,288
 
 
 
 
 
 
 
 
47,566
 
Stock Options
 
7,199
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7,199
 
Series B Participating Convertible Preferred Stock As If Converted to Common Stock
 
 
 
 
 
 
 
 
 
 
46,105
 
 
 
 
 
 
 
 
46,105
 
Series C Participating Convertible Preferred Stock As If Converted to Common Stock
 
 
 
 
 
 
 
 
 
 
84,748
 
 
2,059
 
 
 
 
 
86,807
 
Series D-1 Preferred Stock As If Converted to Common Stock
 
19,464
 
 
 
 
 
 
 
 
 
 
 
 
 
 
35,865
 
 
55,329
 
Series D-2 Convertible Preferred Stock As If Converted to Common Stock
 
1,620
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,750
 
 
3,370
 
Warrants
 
8,225
 
 
10,905
 
 
2,400
 
 
 
 
 
 
 
 
 
 
 
21,530
 
Total
 
38,552
 
 
10,905
 
 
4,634
 
 
174,141
 
 
2,059
 
 
37,615
 
 
267,906
 
10.Represents (a) 45,537 shares of common stock, (b) 8,639 shares issuable upon the exercise of options exercisable within 60 days of May 6, 2016, (c) 46,308 shares of common stock issuable upon the conversion of 8,068,410 shares of Series B Participating Convertible Preferred Stock, (d) 85,417 shares of common stock issuable upon the conversion of 2,402,371 shares of Series C Participating Convertible Preferred Stock, (e) 39,220 shares of common stock issuable upon the conversion of 1,103,060 shares of Series D-1 Convertible Preferred Stock (f) 1,896 shares of common stock issuable upon the conversion of 118,461 shares of Series D-2 Convertible Preferred Stock and (g) 14,207 shares of common stock issuable upon the exercise of warrants (see table below for details), including securities beneficially owned by Phoenix, SG Phoenix Ventures LLC, SG Phoenix LLC, Phoenix Banner Holdings LLC, Andax LLC and Mr. Goren. Please see footnote 18 below for information concerning Phoenix’s beneficial ownership. Mr. Goren is managing member Andax LLC and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Along with Mr. Sassower, Mr. Goren is the co-manager of SG Phoenix Ventures LLC, which has the power to vote and dispose of the shares held by Phoenix and by Phoenix Banner Holdings LLC, and accordingly, Mr. Goren may be deemed to be the beneficial owner of the shares owned by Phoenix and Phoenix Banner Holdings LLC.
 
Andrea
Goren
Andax,
LLC
SG Phoenix
LLC
Phoenix
Venture
Fund LLC
Phoenix
Banner
Holdings
Total
Common Stock
 
15
 
 
 
 
 
2,234
 
 
43,288
 
 
 
 
 
45,537
 
Stock Options
 
8,639
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8,639
 
Series B Participating Convertible Preferred Stock As If Converted to Common Stock
 
 
 
 
202
 
 
 
 
 
46,105
 
 
 
 
 
46,308
 
Series C Participating Convertible Preferred Stock As If Converted to Common Stock
 
 
 
 
669
 
 
 
 
 
84,748
 
 
 
 
 
85,417
 
Series D-1 Convertible Preferred Stock As If Converted to Common Stock
 
 
 
 
3,355
 
 
 
 
 
 
 
 
35,865
 
 
39,220
 
Series D-2 Convertible Preferred Stock As If Converted to Common Stock
 
 
 
 
146
 
 
1,750
 
 
 
 
 
 
 
 
1,896
 
Warrants
 
 
 
 
902
 
 
2,400
 
 
 
 
10,905
 
 
14,207
 
Total
 
8,654
 
 
5,275
 
 
4,634
 
 
174,141
 
 
48,520
 
 
241,224
 
11.Represents (a) 7,981 shares of common stock, (b) 1,600 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 6, 2016, (c) 3,278 shares of common stock issuable upon the conversion of 177,416 shares of Series B Participating Convertible Preferred Stock, and (d) 17,899 shares of common stock issuable upon the conversion of 503,408 shares of Series C Participating Convertible Preferred Stock, (e) 5,451 shares of common stock issuable upon the conversion of 153,296 shares of Series D-1 Convertible Preferred Stock, and (f) 2,607 shares of common stock issuable upon the conversion of 162,930 shares of Series D-2 Convertible Preferred Stock, and (g) 6,432 shares of common stock issuable upon the exercise of warrants, (see table below for details). As manager of Galaxy LLC, Mr. Gilbert has the power to vote and dispose of the shares of common stock held by Galaxy LLC, and, accordingly, Mr. Gilbert may be deemed to be the beneficial owner of the shares owned by Galaxy LLC.
 
Stanley
Gilbert
Stanley
Gilbert PC
Galaxy LLC
Mrs. Gilbert
Total
Common Stock
 
4,815
 
 
23
 
 
1,426
 
 
1,717
 
 
7,981
 
Stock Options
 
1,600
 
 
 
 
 
 
 
 
 
 
 
1,600
 
Series B Participating Convertible Preferred Stock As If Converted to Common Stock
 
3,278
 
 
 
 
 
 
 
 
 
 
 
3,278
 
Series C Participating Convertible Preferred Stock As If Converted to Common Stock
 
17,899
 
 
 
 
 
 
 
 
 
 
 
17,899
 
Series D-1 Convertible Preferred Stock As If Converted to Common Stock
 
5,451
 
 
 
 
 
 
 
 
 
 
 
5,451
 
Series D-2 Convertible Preferred Stock As If Converted to Common Stock
 
2,607
 
 
 
 
 
 
 
 
 
 
 
2,607
 
Warrants
 
6,432
 
 
 
 
 
 
 
 
 
 
 
6,432
 
Total
 
42,082
 
 
23
 
 
1,426
 
 
1,717
 
 
45,248
 

38

TABLE OF CONTENTS

12.Represents (a) 1,600 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 6, 2016, (b) 501 shares of common stock issuable upon the conversion of 31,294 shares of Series D-2 Convertible Preferred Stock owned by Genext, LLC (“Genext”). As manager of Genext, Mr. Holtmeier has the power to vote and dispose of the shares of common stock held by Genext, and, accordingly, Mr. Holtmeier may be deemed to be the beneficial owner of the shares owned by CUBD and Genext.
13.Represents 1,648 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 6, 2016.
14.Represents (a) 6,197 shares of common stock beneficially owned by Mr. Engmann, (b) 133 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 6, 2016, (c) 3,315 shares of common stock issuable upon the conversion of 580,074 shares of Series A-1 Cumulative Convertible Preferred Stock beneficially owned by Mr. Engmann, (d) 12,377 shares of common stock issuable upon the conversion of 669,900 shares of Series B Participating Convertible Preferred Stock beneficially owned by Mr. Engmann (e) 6,158 shares of common stock issuable upon the conversion of 173,189 shares of Series C Participating Convertible Preferred Stock beneficially owned by Mr. Engmann (f) 86,446 shares of common stock issuable upon the conversion of 2,431,305 shares of Series D-1 Convertible Preferred Stock beneficially owned by Mr. Engmann (g) 5,162 shares of common stock issuable upon the conversion of 322,629 shares of Series D-2 Convertible Preferred Stock beneficially owned by Mr. Engmann and (h) an aggregate of 68,839 shares of common stock issuable upon exercise of warrants exercisable within 60 days of May 6, 2016 beneficially owned by Mr. Engmann. See the following table for more detail.
 
Michael
Engmann
MDNH
Partners, LP
KENDU
Partners
Company
Total
Common Shares
 
1,969
 
 
3,233
 
 
995
 
 
6,197
 
Stock Options
 
133
 
 
 
 
 
 
 
 
133
 
Series A-1 Cumulative Convertible Preferred Stock As If Converted to Common Stock
 
1,781
 
 
1,534
 
 
 
 
3,315
 
Series B Participating Convertible Preferred Stock As If Converted to Common Stock
 
2,390
 
 
9,987
 
 
 
 
12,377
 
Series C Participating Convertible Preferred Stock As If Converted to Common Stock
 
129
 
 
6,029
 
 
 
 
6,158
 
Series D-1 Convertible Preferred Stock As If Converted to Common Stock
 
86,446
 
 
 
 
 
 
86,446
 
Series D-2 Convertible Preferred Stock As If Converted to Common Stock
 
5,162
 
 
 
 
 
 
5,162
 
Warrants
 
68,839
 
 
 
 
 
 
68,839
 
Total
 
166,849
 
 
20,783
 
 
995
 
 
188,627
 
15.Represents 133 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 6, 2016.
16.Represents (a) 11,519 shares of common stock issuable upon the exercise of options exercisable within 60 days of May 6, 2016, (b) 14,252 shares issuable upon the conversion of 400,845 shares of Series C Participating Convertible Preferred Stock beneficially owned by FirstGlobal Partners LLC (“FirstGlobal”). As manager of FirstGlobal, Mr. Keiper has the power to vote and dispose of the shares of common stock held by FirstGlobal and, accordingly, Mr. Keiper may be deemed to be the beneficial owner of the shares owned by FirstGlobal.
17.Includes shares of common stock beneficially owned by Phoenix. Please see footnote 18 below for information concerning shares of common stock beneficially owned by Phoenix. Mr. Sassower and Mr. Goren are the co-managers of SG Phoenix Ventures LLC, which has the shared power to vote and dispose of the shares of common stock held by Phoenix and, accordingly, Mr. Sassower and Mr. Goren may be deemed to be the beneficial owner of the shares owned by Phoenix. The amount stated above includes an aggregate of 32,471 shares issuable upon the exercise of options within 60 days of May 6, 2016.
18.SG Phoenix Ventures LLC is the Managing Member of Phoenix, with the power to vote and dispose of the shares of common stock held by Phoenix. Accordingly, SG Phoenix Ventures LLC may be deemed to be the beneficial owner of such shares. Andrea Goren is the co-manager of SG Phoenix Ventures LLC, has the shared power to vote and dispose of the shares of common stock held by Phoenix and, as such, may be deemed to be the beneficial owner of the common shares owned by Phoenix and by SG Phoenix LLC, of which he is a member. Philip Sassower is the co-manager of SG Phoenix Ventures LLC, has the shared power to vote and dispose of the shares of common stock held by Phoenix and, as such, may be deemed to be the beneficial owner of the common shares owned by Phoenix and by SG Phoenix LLC, of which he is a member.
 
Phoenix
Venture
Fund LLC
SG Phoenix
Ventures LLC
Phoenix
Banner
Holdings
Total
Common Shares
 
43,288
 
 
2,234
 
 
 
 
 
45,522
 
Stock Options
 
 
 
 
 
 
 
 
 
 
 
Series B Participating Convertible Preferred Stock As If Converted to Common Stock
 
46,105
 
 
 
 
 
 
 
 
46,105
 
Series C Participating Convertible Preferred Stock As If Converted to Common Stock
 
84,748
 
 
 
 
 
 
 
 
84,748
 
Series D-1 Convertible Preferred Stock As If Converted to Common Stock
 
 
 
 
 
 
 
35,865
 
 
35,865
 
Series D-2 Convertible Preferred Stock As If Converted to Common Stock
 
 
 
 
 
 
 
1,750
 
 
1,750
 
Warrants
 
 
 
2,400
 
 
10,905
 
 
13,305
 
Total
 
174,141
 
 
4,634
 
 
48,520
 
 
227,295
 

39

TABLE OF CONTENTS

TRANSACTIONS WITH RELATED PERSONS

Procedures for Approval of Related Person Transactions

In 2006accordance with our Code of Business Conduct and 2007,Ethics, we submit to our Board, a committee of independent directors of our Board or the Audit Committee for approval all proposed transactions involving our officers and directors and related parties, and other transactions involving conflicts of interest. Each of the related party transactions listed below that were approved by a disinterested majority of our Board or a committee of independent directors of our Board.

Related Party Transactions

As of May 6, 2016, Phoenix is the beneficial owner of approximately 61.5% of the common stock of the Company, and Michael W. Engmann, together with two affiliated entities, is the beneficial owner of approximately 51.0% of the common stock of the Company, in each case when calculated in accordance with Rule 13d-3, which calculation includes the conversion or exercise of derivative securities owned by such beneficial owner (but not the conversion or exercise of derivative securities owned by any other person) that may be converted or exercised within 60 days of such date. For further information with regard to the beneficial ownership of our directors, officers and 5% stockholders, please see “Security Ownership of Certain Beneficial Owners and Management”. Messers Sassower and Goren are co-managers of the managing member of Phoenix and are directors and executive officers of the company. Mr. Engmann is the Co-Chairman of the Board.

2015

On March 24, 2015, the Company issued 1,000,000 shares of Series D-1 Convertible Preferred Stock to Mr. Engmann for $1,000,000 in cash. In addition, the Company issued Mr. Engmann warrants to purchase 17,778 shares of common stock, immediately exercisable into common stock of the Company at $28.125 per share. The warrants expire March 23, 2018. The warrants are exercisable in whole or in part and contain a cashless exercise provision.

On July 23, 2015, the Company issued 200,000 shares of Series D-1 Convertible Preferred Stock to Mr. Engmann for $200,000 in cash. In addition, the Company issued Mr. Engmann warrants to purchase 6,400 shares of common stock, immediately exercisable into common stock of the Company at $15.625 per share. The warrants expire March 23, 2018. The warrants are exercisable in whole or in part and contain a cashless exercise provision.

On September 29, 2015, the Company received a loan from Mr. Engmann pursuant to a demand note in the principal amount of $250,000. This note bore interest at the rate of 10% per year and both the principal and interest accrued were payable on demand. On November 25, 2015, Mr. Engmann exchanged the demand note for an unsecured convertible promissory note due August 25, 2016 (as described below) in the same principal amount and paid Mr. Engmann all accrued and unpaid interest owed under the demand note.

On November 25, 2015, the Company entered into long-term financing agreements aggregating $1,670a note purchase agreement with investors. Under the terms of the note purchase agreement, on November 25, 2015, the Company issued to Michael Engmann an unsecured convertible promissory note in the principal amount of $250,000, to Mitch Sassower, a stockholder of the Company owning approximately 7%brother of the Company’s thenCo-Chairman of the Board and Chief Executive Officer, an unsecured convertible promissory note in the principal amount of $20,000 and to Goren Brothers LP, an entity controlled by immediate family members of the Company’s Chief Financial Officer, an unsecured convertible promissory note in the principal amount of $70,000, and, on December 15, 2015, the Company issued to Michael Engmann an unsecured convertible promissory notice in the principal amount of $100,000 and to Andax LLC, an entity controlled by Andrea Goren, the Company’s Chief Financial Officer, an unsecured convertible promissory note in the principal amount of $18,000.

The principal amount of the unsecured convertible promissory notes issued in connection with the Company’s unsecured debt financing in November and December 2015 bear interest at a rate of 24% per year, are due on August 25, 2016 and are convertible into shares of our common stock at the holder’s option (i) prior to maturity, in the event the Company consummates an SEC registered public offering of shares of common stock, at a conversion price that is 30% less than the price to the public of the common stock in the public offering, or (ii) up to 60 days after maturity, at a conversion price based upon a Company pre-money valuation of $5,000,000, as determined by taking into account the outstanding shares of common stock and preferred stock, on an as-converted basis, on the maturity date of the note; provided, that following such conversion after the maturity date, each holder that converted

40

TABLE OF CONTENTS

such note will also receive cash payments, payable from unrelated third parties. Each financing included1.5% for each $100,000 of notes converted of the revenue received by the Company from Cegedim to be paid quarterly on a Notepro rata basis, with any and Warrant Purchase Agreement

15



and a Registration Rights Agreement.  Theall other holders who converted their notes; provided, further, however, that the total amount of cash payments that the holder will be entitled to receive will not exceed three times the aggregate principal amount of each holder’s note. In April 2016, each holder of unsecured convertible promissory notes bore interestagreed with the Company to convert its note into shares of common stock at a rate of 15%the per annum, payable quarterly in cash.  The Company issuedshare offering price and warrants to acquire an aggregatepurchase shares of 9,753,000common stock, in each case, upon consummation of this offering.

During the year ended December 31, 2015, the Company paid dividends on its outstanding preferred stock in kind. For the year ended December 31, 2015, the Company paid dividends in shares as follows, 72,000 shares of Series A-1 Cumulative Convertible Preferred Stock, of which 43,000 shares were to related parties, 1,272,000 shares of Series B Participating Convertible Preferred Stock, of which 834,000 shares were to related parties, 516,000 shares of Series C Participating Convertible Preferred Stock, of which 274,000 shares were to related parties, 714,000 shares of Series D-1 Convertible Preferred Stock, of which 350,000 shares were to related parties, and 602,000 shares of Series D-2 Convertible Preferred Stock, of which 74,000 shares were to related parties.

2014

In connection with a February 2014 private placement of units consisting of two shares of Series D-1 Convertible Preferred Stock and one share of Series D-2 Convertible Preferred Stock, the Company received $9,000 and $50,000 from Andax LLC (an entity controlled by Mr. Goren, our chief financial officer) and Mr. Gilbert (a director of the Company), respectively, and issued 9,000 and 50,000 shares of Series D Preferred Stock to the related parties, respectively. The purchase price for each unit was $3.00. In addition, Andax LLC and Mr. Gilbert received 66 and 364 warrants to purchase shares of the Company’s common stock associated with the notes withat an exercise price range of $0.25$34.375 at closing. Pursuant to $0.51 per share. These warrants are exercisable until June 30, 2010. Allthe terms of the shares underlying thefinancing, Andax LLC and Mr. Gilbert received an additional 66 and 364 warrants, discussed above were registered withrespectively, in May, August and November of 2014, based on the Company’s Form S-1/A, which was declared effective December 28, 2007.achievement of certain revenue targets. The fair value ascribedCompany paid a $35,000 administrative fee in cash to the warrants issuedSG Phoenix LLC, a Phoenix affiliate (“SG Phoenix”) in connection with the financings is carried as a discount to the related debt in the balance sheetprivate placement.

In connection with December 2013, February 2014, and is written off to interest expense over the life of the respective loans. The proceeds from these financings were used for working capital purposes.  At June 30, 2008, there is $125 of the above referenced debt remaining, which is due August 30, 2008.  The balance of the debt, including accrued and unpaid interest through May 31, 2008, was restructured into long term debt or exchanged for Preferred Shares as more fully described below.

On June 5, 2008,March 2014 private placements, the Company closed a financing transaction which raised capital through the issuanceissued to SG Phoenix warrants to purchase 2,400 shares of new secured indebtedness and equity, and restructured a portioncommon stock at an exercise price of the Company’s existing short-term debt (collectively, the “Financing Transaction”).  Certain parties to the Financing Transactions (Phoenix Venture Fund LLC and Michael Engmann) have a pre-existing relationship$34.375 per share.

In connection with an August 2014 private placement, the Company and, with respectissued 400,000 shares of Series D-1 Preferred to such parties, the Financing Transactions may be considered a related party transaction.

Under the Financing Transaction, the Company entered into a Credit Agreement (the “Credit Agreement”) and a Pledge and Security Agreement (the “Pledge Agreement”), each dated as of June 5, 2008, with Phoenix Venture Fund LLC (“Phoenix”), Michael Engmann and Ronald Goodman (collectivelyreceived $400,000. The Company paid $50,000 in cash to SG Phoenix as an administrative fee in connection with Phoenix,this private placement.

The following table summarizes the “Creditors,” and each individually a “Creditor”).  Under the terms of the Credit Agreement, the Companycontingent warrants (described above) received an aggregate of $3,000 and refinanced $638 of existing indebtedness and accrued interest on that indebtedness (individually, a “Loan” and collectively, the “Loans”).  The Loans, which are represented by secured promissory notes (each a “Note” and collectively, the “Notes”), bear interest at eight percent (8%) per annum which, at the optionrelated persons of the Company may be paid in cash or in kind and mature two (2) years from issue date.  The Company may use the proceeds from the Loans to pay the Company’s existing indebtedness and accrued interest on that indebtedness that was not exchanged for Preferred Shares as described below, for working capital and general corporate purposes, in each case in the ordinary course of business; and to pay fees and expenses in connection with the Financing Transaction, which were approximately $475.  Additionally, a portion of the proceeds of the Loans were used to repay a short term loan from a Company employee in the amount of $125, plus accrued interest, that was made prior to and in anticipation of the closing of the Financing Transaction.  Under the terms of the Pledge Agreement, the Company and its subsidiary, CIC Acquisition Corp., granted the Creditors a first priority security interest in and lien upon all of the respective assets of the Company and CIC Acquisition Corp.

Under the terms of the Credit Agreement and in partial consideration for the Creditors’ respective Loans madeduring 2014 pursuant to the terms of the Credit Agreement as described above,December 2013, February 2014, and March 2014 private placements.

Date of Issue
Expiration
Date
Exercise
Price
Andax LLC
Michael
Engmann
Philip
Sassower
Phoenix
Banner
Holdings
Stanley
Leon
Gilbert
5/15/2014
 
12/31/2016
 
$
34.38
 
 
146
 
 
4,421
 
 
1,640
 
 
1,893
 
 
364
 
8/14/2014
 
12/31/2016
 
$
34.38
 
 
146
 
 
4,421
 
 
1,640
 
 
1,893
 
 
364
 
11/14/2014
 
12/31/2016
 
$
34.37
 
 
145
 
 
4,421
 
 
1,639
 
 
1,893
 
 
363
 
Total
 
 
 
 
 
 
 
437
 
 
13,263
 
 
4,919
 
 
5,679
 
 
1,091
 

During the year ended December 31, 2014, the Company paid dividends on its outstanding preferred stock in kind. For the year ended December 31, 2014, the Company paid dividends in shares as follows: 82,000 shares of Series A-1 Cumulative Convertible Preferred Stock, of which 55,000 shares were to related parties, 1,149,000 shares of Series B Participating Convertible Preferred Stock, of which 776,000 shares were to related parties, 468,000 shares of Series C Participating Convertible Preferred Stock, of which 249,000 shares were to related parties, 472,000 shares of Series D-1 Convertible Preferred Stock, of which 213,000 shares were to related parties, and 541,000 shares of Series D-2 Convertible Preferred Stock, of which 70,000 shares were to related parties.

41

TABLE OF CONTENTS

2013

In April 2013, the Company borrowed $250,000 in the form of a demand note from Phoenix Banner Holdings LLC, an entity affiliated with Messrs. Sassower and Goren, with an interest rate of 10% per annum. This amount plus $2,000 in accrued interest was repaid out of proceeds from a May 2013 private placement of Series D Preferred Stock.

In connection with a May 2013 private placement of Series D Preferred Stock, the Company received $100,000 and $11,000 from Mr. Sassower and Andax LLC, respectively, and issued to20,000 and 2,200 units consisting of one share of Series D-1 Convertible Preferred Stock and four shares of Series D-2 Convertible Preferred Stock, respectively. The purchase price for each Creditorunit was $5.00. The shares of Series D Preferred Stock received by Mr. Sassower and Andax LLC in this private placement were subsequently exchanged in connection with a warrantDecember 31, 2013 financing consummated by the Company for shares of Series D Preferred Stock, warrants to purchase up to the number of shares of the Company’s common stock (“Common Stock”) obtained by dividingand the amount of such Creditor’s Loan by 0.14 (each a “Warrant” and collectively, the ‘Warrants”).  A total of 25,982,143ability to receive additional warrants to purchase shares of common stock promptly after each of the quarters ended March 31, 2014, June 30, 2014 and September 30, 2014, to the extent that the Company’s Common Stock may be issued upon exercise of the Warrants.  The Warrants are exercisable beginning June 30, 2008 until their expiration on June 30, 2011. The Warrants have an exercise price of fourteen cents ($0.14) per share. Additional Warrants may be issued ifrevenue for any such quarter did not exceed $750,000, $1,000,000 and $1,250,000, respectively.

On August 2, 2013, the Company exercises its option to make interest payments on the Loans in kind.  The Company ascribed a relative fair value of $1,231 to the Warrants, which is recorded as a discount to “Long-term debt”borrowed $250,000 from Phoenix Banner Holdings LLC, an entity affiliated with Messrs. Sassower and Goren, in the balance sheet.  The fair valueform of an unsecured demand note. Under the Warrants ($1,861) was estimated on the commitment date using the Black-Scholes pricing model with the following assumptions: risk-freeterms of this unsecured demand note, unpaid principal bore an interest rate of 2.73%; expected life10% per year. The demand notes and accrued interest were converted into units of Series D Preferred Stock, consisting of one share of Series D-1 Convertible Preferred Stock and two shares of Series D-2 Convertible Preferred Stock, in December 2013 as discussed further below.

On September 3, years; expected volatility2013, the Company borrowed $250,000 from Kendu Partners in the form of 82.3%;an unsecured demand note. Mr. Engmann is a managing member of Kendu Partners. On September 27, 2013, the Company borrowed $250,000 from Michael Engmann in the form of an unsecured demand note. On December 3, 2013, the Company borrowed an additional $150,000 from Mr. Engmann in the form of an unsecured demand note. Under the terms of these unsecured demand notes, unpaid principal bore an interest rate of 10% per year. The demand notes and expected dividend yieldaccrued interest were converted into units of 0%.Series D Preferred Stock, consisting of one share of Series D-1 Convertible Preferred Stock and two shares of Series D-2 Convertible Preferred Stock, in December 2013 as discussed further below.

In November 2013, the Board approved the issuance of warrants in connection with the issuances of demand notes and as a result, the Company issued a total of 15,667 warrants to related parties.

On November 26, 2013, the Company borrowed $125,000 from Michael Engmann in the form of an unsecured demand note. On December 3, 2013 Mr. Engmann transferred the demand note to Philip Sassower. Under the terms of this unsecured demand note, unpaid principal bore an interest rate of 10% per year. The demand notes and accrued interest were converted into units of Series D Preferred Stock, consisting of one share of Series D-1 Convertible Preferred Stock and two shares of Series D-2 Convertible Preferred Stock, in December 2013 as discussed further below.

Additional details on the demand note and warrant issuances to related parties from August to December 2013 are as follows:

Date
Phoenix Banner
Holdings LLC
Michael W. Engmann
Kendu Partners
Company
Philip Sassower
Note
Amount
Warrants
Note
Amount
Warrants
Note
Amount
Warrants
Note
Amount
Warrants
8/2/2013
$
250,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9/3/2013
 
 
 
 
 
 
 
 
 
 
 
 
$
250,000
 
 
 
 
 
 
 
 
 
 
9/27/2013
 
 
 
 
 
 
$
250,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11/6/2013
 
 
 
 
3,334
 
 
 
 
 
3,334
 
 
 
 
 
3,334
 
 
 
 
 
 
 
12/3/2013
 
 
 
 
 
 
$
150,000
 
 
4,000
 
 
 
 
 
 
 
 
 
 
 
 
 
12/17/2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
125,000
 
 
1,666
 
Total
$
250,000
 
 
3,334
 
$
400,000
 
 
7,334
 
$
250,000
 
 
3,334
 
$
125,000
 
 
1,666
 

42

TABLE OF CONTENTS

In November 2013, the Company borrowed an additional $60,000 in demand notes from an employee of the Company. The notes plus accrued interest of $1,000 were repaid at December 31, 2013 from financing proceeds.

In connection with a December 2013 private placement of Series D Preferred Stock, the closingrelated parties listed in the above table converted their demand notes and most of the Financing Transaction, the Company also enteredaccrued interest into units of Series D Preferred Stock consisting of one share of Series D-1 Convertible Preferred Stock and two shares of Series D-2 Convertible Preferred Stock. As a Securities Purchase Agreement (the “Purchase Agreement”) and a Registration Rights Agreement (the “Registration Rights Agreement”), each dated as of June 5, 2008.  Under the Purchase Agreement, in exchange for the cancellation of $995 in principal amount and $45 of interest accrued thereon of the Company’s aggregate outstanding $2,071 in existing debt and interest accrued thereon through May 31, 2008,result, the Company issued to the holders of such debt an aggregate of 1,040,000260,000, 258,000, 407,000 and 125,000 shares of Series D Preferred Stock, as well as 1,893, 1,877, 2,966 and 912 warrants to purchase Company common stock, to Phoenix Banner Holdings LLC, Kendu Partners Company, Michael W. Engmann and Philip Sassower, respectively.

During the Company’syear ended December 31, 2013, the Company paid dividends on its outstanding preferred stock in kind. For the year ended December 31, 2013, the Company paid dividends in shares as follows: 79,000 shares of Series AA-1 Cumulative Convertible Preferred Stock, (the “Preferred Shares”).  Theof which 56,000 shares were to related parties, 1,044,000 shares of Series B Participating Convertible Preferred Shares carry an eight percent (8%) annual dividend, payable quarterly in arrears in cash or in additional Preferred Shares, have a liquidation preference over Common Stock, of one dollar ($1.00) per share and are convertible intowhich 711,000 shares were to related parties, 433,000 shares of CommonSeries C Participating Convertible Preferred Stock, at the conversion price of fourteen cents ($0.14) per share.  If the

16



“Preferred Shares” are converted in their entirety, the Company would issue 7,428,571which 225,000 shares were to related parties, 131,000 shares of common stock. TheSeries D-1 Convertible Preferred Stock, of which 113,000 shares were to related parties, and 402,000 shares of Series D-2 Convertible Preferred Stock, are convertible any time after June 30, 2008.

Under the terms of the Registration Rights Agreement, the Company is obligatedwhich 35,000 shares were to prepare and file with the Securities and Exchange Commission (the “Commission”) a registration statement under the Securities Act of 1933, as amended (the “Securities Act”) covering the resale of the shares of Common Stock issued upon conversion of the shares of Preferred Stock and exercise of the Warrants as described above.  The Company must also use its reasonable best efforts to keep the registration statement continuously effective under the Securities Act until the earlier of the date that is two years after its Effective Date or until the date that all shares purchased under the Purchase Agreement have been sold or can be sold publicly under Rule 144.  The Company is obligated to pay the costs and expenses of such registration.

The offer and sale of the Notes, Warrants and Preferred Shares as detailed above, including the Common Stock issuable upon exercise or conversion thereof, was made in reliance upon exemptions from registration afforded by Section 4(2) of the Securities Act and Rule 506 of Regulation D, as promulgated by the Commission under the Securities Act and under exemptions from registration available under applicable state securities laws.

related parties.

Interest expense associated with the Company’s debtoutstanding indebtedness for the three monthsyear ended June 30, 2008 and 2007December 31, 2013 was $346 and $291, respectively,$436,000, of which $265 and $107$436,000 was related party and $81 and $184 was related to other creditors.expense. Amortization of debt discount included in interest expenseand deferred financing costs and the loss on extinguishment of debt for the three monthsyear ended June 30, 2008 and 2007December 31, 2013 was $280 and $215, respectively,$111,000, of which $217 and $74$111,000 was related party expense and $63 and $141 was related to the other creditors.

Interest expense associated with the Company’s debt for the six months ended June 30, 2008 and 2007 was $549 and $513, respectively, of which $400 and $196 was related party and $149 and $317 was related to the other creditors. Amortization of debt discount included in interest expense for the six months ended June 30, 2008 and 2007 was $416 and $390, respectively, of which $308 and $147 was related party and $108 and $243 was related to the other creditors.

The warrants to purchase 4,850,000 shares of the Company’s common stock issued under the 2004 Purchase Agreement expire on October 28, 2009. The Company may call the warrants if the Company’s common stock trades at $1.00 or above for 20 consecutive trading days after the date that is 20 days The placement agent in connection with this financing will be paid approximately $28 in the aggregate if all of the investor warrants are exercised.  The Company will receive additional proceeds of approximately $1,845 if all of the investor warrants are exercised.

The Company has the following material commitments as of June, 2008:

 

 

Payments due by period

 

Contractual obligations

 

Total

 

2008

 

2009

 

2010

 

2011

 

2012

 

Thereafter

 

Short-term debt (1)

 

$

125

 

$

125

 

$

 

$

 

$

 

$

 

$

 

Long-term debt related party (2)

 

3,638

 

 

 

 

3,638

 

 

 

 

Long-term debt (3)

 

117

 

 

 

117

 

 

 

 

 

 

 

 

 

Operating lease commitments (4)

 

924

 

132

 

272

 

280

 

240

 

 

 

Total contractual cash obligations

 

$

4,804

 

$

257

 

$

389

 

$

3,918

 

$

240

 

$

 

$

 

expense.


(1)Short-term debt reported on the balance sheet is net of approximately $9 in discounts representing the fair value of warrants issued to the investors.

43

(2)Long-term debt related party reported on the balance sheet is net of approximately $1,180 in discounts representing the fair value of warrants issued to the investors.

(3)Long-term debt reported on the balance sheet is net of approximately $16 in discounts representing the fair value of warrants issued to the investor.

17TABLE OF CONTENTS



(4)The operating lease commenced on November 1, 2002. The lease was renegotiated in December 2005 and extended for an additional 60 months. The base rent increases approximately 3% per annum over the term of the lease, which expires on October 31, 2011.

The Company has suffered recurring losses from operations that raise a substantial doubt about its ability to continue as a going concern. There can be no assurance that the debt and equity transactions described above (or “entered into in June 2008”) will provide the Company with adequate capital resources to fund planned operations or that any additional funds will be available to it when needed, or if available, will be available on favorable terms or in amounts required by it. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on its business, results of operations and ability to operate as a going concern. In addition, under the terms of the June debt financing the Company granted the holders of the debt a security interest in all of the Companies assets. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

DESCRIPTION OF CAPITALSTOCK

The following summaryAs of certain provisions of our capital stock does not purport to be complete and is subject to our Amended and Restated Certificate of Incorporation, our Bylaws, and the provisions of applicable law. Copies of our Amended and Restated Certificate of Incorporation and our Bylaws are filed as exhibits to the registration statement, of which this prospectus is a part.

Authorized Capital Stock

Our authorized capital stock consists of 225,000,000May 6, 2016, there were 187,463 shares of common stock, $0.01 par value, and 10,000,000971,888 shares of preferred stock, $0.01 par value. As of August 14, 2008, we had 961 stockholders of record, 6 of which ownedSeries A-1 Cumulative Convertible Preferred Stock, 13,960,647 shares of our preferred stock.

CommonSeries B Participating Convertible Preferred Stock,

Authorized Common Stock. This prospectus covers the resale by certain of our stockholders of 5,668,785 shares of our common stock, $0.01 par value, which are either to beSeries C Participating Convertible Preferred Stock, 8,337,534 shares of Series D-1 Convertible Preferred Stock and 6,586,655 shares of Series D-2 Convertible Preferred Stock issued uponand outstanding. Immediately following the exerciseconsummation of warrants to purchase our common stock or uponthe offering and the automatic conversion of our preferred stock pursuant tointo common stock, and the June 2008 financing transaction.  Assale by us of  August 18, 2008 we had 129,057,161  shares of common stock in this offering, we expect to have  •  shares of common stock outstanding, no shares of preferred stock outstanding and warrants to purchase an aggregate of • shares of common stock outstanding. Immediately following the offering, we will have 2,000,000,000 shares of common stock authorized and  •  shares issued and outstanding 41,131,478and 45,000,000 shares reserved for issuance upon the exercise of warrants to purchase our common stock, 7,428,571 shares reserved for issuance upon the conversion of preferred stock 7,616,161authorized and none outstanding. See “Market for Our Common Stock and Related Stockholder Matters” for more information about the market for our common stock.

Common Stock

Authorized Common Stock.   We are authorized to issue 2,000,000,000 shares, reserved for issuance upon exercisepar value $0.01 per share, of 7,616,161common stock (of which 187,463 shares are outstanding options and upon exerciseas of 267,137 options that may be granted in the future under our stock option plans.

May 6, 2016).

Voting RightsRights..   The holders of shares of our common stock are entitled to one vote for each share held of record on all matters on which stockholders are entitled or permitted to vote. Stockholders may vote in person or by proxy. Our bylaws provide that except as otherwise required by law, our certificate of incorporation or our bylaws, the presence of holders of shares representingnot less than a majority of the combined voting power of our outstanding capital stockshares entitled to vote at a stockholders’any meeting constitutes a quorum. Whenof the stockholders, present in person or by proxy, shall constitute a quorum is present,and the affirmative vote of a majority of such quorum shall be deemed the votes cast is required to take action, unless otherwise specified by law or our certificateact of incorporation.the stockholders. There are no cumulative voting rights.

Dividends and LiquidationLiquidation.. After recognition   Subject to all of the rights of any applicable preferences to any outstanding shares of preferred stock, holders of common stock are entitled to share pro rata in accordance with their respective rights and interests in any liquidation proceeds and receive dividends as the Board of Directors may lawfully declare out of funds legally available, and share pro rata in any other distribution to the holders of common stock.available. We have never paid any dividends on our common stock and we do not anticipate doing so in the future.

Warrants

Other RightsThe following summary of certain terms and provisions of the warrants offered hereby is not complete and is subject to, and qualified in its entirety by the provisions of the form of warrant, which is filed as an exhibit to the registration statement of which this prospectus is a part. Prospective investors should carefully review the terms and provisions set forth in the form of warrant.

Exercisability.   The warrants are exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance. The warrants will be exercisable, at the option of each holder, in whole or in part (but not as to fractional shares) by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares of our common stock to be purchased upon such exercise (except in the case of a cashless exercise, as discussed below). HoldersUnless otherwise specified in the warrant, the holder will not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the warrants.

Cashless Exercise.   In the event that a registration statement covering shares of common stock have no preemptiveunderlying the warrants is not effective or subscription rights. There are no conversion rights, redemption rights, sinking fund provisions, fixed dividend rights, liabilitiesavailable for the resale of such shares of common stock underlying the warrants, the holder may, in its sole discretion, exercise the warrant in whole or in part and, in lieu of making the cash payment otherwise required to further calls, assessment for liabilities under state statute, or any discriminating provision against existing or prospectivebe made to us upon such exercise in payment of the aggregate exercise price, elect instead to receive upon such exercise the net number of shares of common stock with respectdetermined according to the formula set forth in the warrant. In no event shall we be required to make any cash payments or net cash settlement to the registered holder in lieu of issuance of common stock.stock underlying the warrants.

Exercise Price.   The initial exercise price per share of common stock purchasable upon exercise of the warrants is $ •  per share (125% of the public offering price of the common stock). The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, recapitalization, reclassifications or similar events affecting our common stock and also upon any distributions of assets, including cash, stock or other property to our stockholders.

44

TABLE OF CONTENTS

Transferability.   Subject to applicable laws, the warrants may be transferred at the option of the holders upon surrender of the warrants to us together with the appropriate instruments of transfer.

18



Redemption.   From and after one year following issuance of the warrants, the Company may redeem the then outstanding warrants, in whole and not in part, upon not less than 30 days prior written notice of redemption at a price of $0.001 per warrant, provided that, at the time of such notice, (i) there is an effective registration statement covering the common stock issuable upon exercise of the warrants that has been effective and current for the thirty consecutive trading day period prior to the date of the notice of redemption and (ii) the last reported sales price of the shares of common stock of the Company equals or exceeds 200% of the exercise price of the warrants (subject to adjustment for splits, dividends, recapitalizations and other similar events) for the ten consecutive trading day period ending three business days prior to the date of the notice of redemption.

Fundamental Transaction.   If, at any time while the warrants are outstanding, we, directly or indirectly, (1) consolidate or merge with or into another entity, (2) sell, assign, transfer, convey or otherwise dispose of all or substantially all of our property or assets, (3) allow another person to make a purchase, tender or exchange offer that is accepted by the holders of more than 50% of our outstanding shares of common stock (not including any shares of common stock held by the person or persons making or party to, or associated or affiliated with the persons making or party to, such purchase, tender or exchange offer), (4) consummate a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another person or entity whereby such other person or entity acquires more than 50% of our outstanding shares of common stock (not including any shares of common stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making or party to, such stock purchase agreement or other business combination) or (5) reorganize, recapitalize or reclassify our common stock, each a “Fundamental Transaction”, then upon any subsequent exercise of the warrants, the holders thereof will have the right to receive the same amount and kind of securities, cash or property as they would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of shares then issuable upon exercise of the warrant, and any additional consideration payable as part of the Fundamental Transaction.

Rights as a Stockholder.   The holder of a warrant does not have the rights or privileges of a holder of our common stock, including any voting rights, until the holder exercises the warrant.

Preferred Stock

Our Board of Directors is authorized to establish by resolution different classes or series of preferred stock and to fix the rights, preferences, and privileges, including, but not limited to, dividend rights, dividend rates, conversion rights, terms of redemption, redemption prices, liquidation preferences, and the number of shares constituting any class or series or the designation of such class or series without any further shareholder vote or action. The issuance of a class or series of preferred stock with special rights or privileges could have the effect of delaying, deferring, or preventing a change in our control, which may adversely affect the voting and other rights of the holders of our common stock. See “Description of Capital Stock—Delaware Anti-Takeover Law and Certain Charter and Bylaw Provisions” below. We currently have 1,040,000are authorized to issue 45,000,000 shares of preferred stock, outstanding.

Election and Removal of Directors

Our bylaws require a minimum of three directors, with the number fixed from time to time by our Board of Directors. We currently have five directors. Directors are elected by a pluralitypar value $0.01 per share. Upon consummation of the votes presentoffering no shares of preferred stock will be outstanding.

Series A-1 Cumulative Convertible Preferred Stock

Authorized Shares and Liquidation Preference.   The number of authorized shares of Series A-1 Cumulative Convertible Preferred Stock is 2,000,000 (of which 973,756 shares are outstanding as of May 6, 2016). The shares of Series A-1 Cumulative Convertible Preferred Stock have a liquidation preference of $1.00 plus any accrued and unpaid dividends.

Ranking.   Shares of Series A-1 Cumulative Convertible Preferred Stock rank junior to our outstanding Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and Series D Preferred Stock and senior to all shares of common stock with respect to dividend rights and rights on liquidation, winding-up and dissolution.

Dividends.   Shares of Series A-1 Cumulative Convertible Preferred Stock accrue dividends at each annual meetingthe rate of our stockholders. Any director may be removed from office without cause, but only8% per annum, payable quarterly, in cash or additional shares of Series A-1 Cumulative Convertible Preferred Stock valued at $1.00 per share. The holders of shares of Series A-1 Cumulative Convertible Preferred Stock are entitled to receive such dividends immediately after the payment of any dividends to senior securities required by the affirmative voteCharter.

45

TABLE OF CONTENTS

Liquidation.   In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of Series A-1 Cumulative Convertible Preferred Stock are entitled to receive, immediately after all distribution to holders of Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and Series D Preferred Stock required by the Charter, and prior and in preference to all shares of the Company’s common stock, unless they elect to receive distributions on an as-converted to common stock basis, liquidating distributions in the amount of $1.00 per share plus any accrued but unpaid dividends. Upon completion of the liquidating distributions to holders of Series A-1 Cumulative Convertible Preferred Stock who do not less thanelect to receive distributions on an as-converted to common stock basis, any remaining assets of the Company will be distributed pro rata, on an as-converted basis, to the holders of the shares of Series A-1 Cumulative Convertible Preferred Stock who have elected to receive distributions on an as-converted to common stock basis, Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and common stock. A sale, lease, conveyance or disposition of all or substantially all of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other transaction or series of related transactions in which the Company’s stockholders immediately prior to such transaction do not retain a majority of our outstanding capital stock entitled to vote in the electionvoting power of directors, votingthe surviving entity will be treated as a single class.liquidation event.

Voting Rights.   Holders of Series A-1 Cumulative Convertible Preferred Stock vote together with holders of common stock and holders of Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and Series D Preferred Stock on an as-converted basis on all matters brought before the stockholders. Each share of Series A-1 Cumulative Convertible Preferred Stock is convertible into common stock at a conversion price of $0.14 per share, which means that holders of Series A-1 Cumulative Convertible Preferred Stock have approximately 7.143 votes for each share of Series A-1 Cumulative Convertible Preferred Stock held by them when voting on an as-converted basis.

Board Meetings

Our bylaws provide that regular meetingsConversion Rights.   Each share of Series A-1 Cumulative Convertible Preferred Stock is convertible into common stock at the conversion price of $0.14 per share, at any time at the option of the Boardholder, subject to adjustments for stock dividends, splits, combinations and similar events (including our recent reverse stock split).

In April 2016, the requisite holders of Directors will be held at such timespreferred stock (voting together as a class and separately as a series) consented to an amendment to the board determines by resolution, immediately prior to any special meetingThird Amended and Restated Certificate of Designation of the stockholders, and immediately followingSeries A-1 Cumulative Convertible Preferred Stock which provides for the adjournment of any annual or special meetingautomatic conversion of the stockholders. The chairmanSeries A-1 Cumulative Convertible Preferred Stock into shares of common stock at a conversion price of $19.4375 per share upon the Boardclosing by no later than July 31, 2016 of Directors, the president, any two directors, or any officer authorized by our Boarda firm-commitment underwritten public offering of Directors, may call special meetings of the Board of Directors.

Under the August 2007  Purchase Agreement, so long as the purchaser of the shares sold under the agreement holds shares of our common stock.

Series B Participating Convertible Preferred Stock

Authorized Shares and Liquidation Preference.   The number of authorized shares of Series B Participating Convertible Preferred Stock is 14,000,000 (of which 13,993,989 shares are outstanding as of May 6, 2016). The shares of Series B Participating Convertible Preferred Stock have a liquidation preference of $1.50 plus any accrued and unpaid dividends.

Ranking.   Shares of Series B Participating Convertible Preferred Stock rank junior to our outstanding Series C Participating Convertible Preferred Stock and Series D Preferred Stock and senior to our outstanding Series A-1 Cumulative Convertible Preferred Stock and all shares of common stock representingwith respect to dividend rights and rights on liquidation, winding-up and dissolution.

Dividends.   Shares of Series B Participating Convertible Preferred Stock accrue dividends at least fifty-percentthe rate of 10% per annum, payable quarterly, in cash or additional shares of Series B Participating Convertible Preferred Stock valued at $1.00 per share. The holders of shares of Series B Participating Convertible Preferred Stock are entitled, in preference to all other holders of capital stock of the Company other than Series D Preferred Stock and Series C Participating Convertible Preferred Stock, to receive such dividends immediately after the payment of any dividends to Series D Preferred Stock and Series C Participating Convertible Preferred Stock required by the Charter. Additionally, all dividends other than required dividends are subject to the protective provisions set forth below.

Liquidation.   In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of Series B Participating Convertible Preferred Stock are entitled to receive, immediately after all distributions to holders of Series C Participating Convertible Preferred Stock and Series D Preferred Stock required by the Charter, and on a preferred basis prior and in preference to any distribution to any holders of

46

TABLE OF CONTENTS

Series A-1 Cumulative Convertible Preferred Stock and common stock, liquidating distributions in the amount of $1.50 per share plus any accrued but unpaid dividends. After the payment of all preferential amounts required to be paid pursuant to the Charter, any remaining assets of the Company will be distributed pro rata, on an as-converted basis, to the holders of the shares of Series A-1 Cumulative Convertible Preferred Stock who have elected to receive distributions on an as-converted common stock purchasedbasis, Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and common stock. A sale, lease, conveyance or disposition of all or substantially all of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other transaction or series of related transactions in which the Company’s stockholders immediately prior to such transaction do not retain a majority of the voting power of the surviving entity will be treated as a liquidation event.

Board of Directors:   So long as 20% of the originally issued shares of Series B Participating Convertible Preferred Stock remain outstanding, Phoenix is entitled to nominate two preferred directors to our Board (the “Preferred Stock Directors”).

Protective Provisions.   So long as 20% of the originally issued shares of Series B Participating Convertible Preferred Stock remain outstanding, in addition to any other vote or approval required under the Company’s Charter and by-laws or by applicable law, the Company will not, without the written consent or affirmative vote of holders of at least a majority of the then outstanding shares of Series B Participating Convertible Preferred Stock, either directly or indirectly by amendment, merger, consolidation, or otherwise:

(i)liquidate, dissolve or wind-up the business and affairs of the Company or any subsidiary, or effect any sale or disposition of all or a significant portion of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other similar transaction or consent to any of the foregoing;
(ii)amend, alter or repeal any provision of the Charter or Bylaws of the Company;
(iii)authorize, create, designate or issue any equity securities or securities convertible into equity securities with equal or superior rights, preferences or privileges to those of the Series B Participating Convertible Preferred Stock (including, debt that is convertible into capital stock and redeemable preferred stock that is not treated as common stock for tax purposes) or, other than the issuance of shares of common stock on exercise or conversion of securities outstanding on the closing date of the transactions, issue any shares of common stock or securities convertible into or exercisable (directly or indirectly) for common stock if at such time (or after giving effect to such issuance) the Company does not have sufficient shares of common stock available out of its authorized but unissued stock for the purpose of effecting the conversion of the Series B Participating Convertible Preferred Stock into common stock and the exercise and conversion of all other securities convertible or exercisable (directly or indirectly) for common stock;
(iv)increase or decrease the number of authorized shares of Series B Participating Convertible Preferred Stock or of any additional class or series of capital stock;
(v)reclassify, alter or amend any existing security that is junior to or on parity with the Series B Participating Convertible Preferred Stock;
(vi)purchase or redeem, or declare or pay any dividends on, any capital stock or securities convertible or exchangeable into shares of capital stock, other than dividends required to be paid on shares of Series D Preferred Stock, Series C Participating Convertible Preferred Stock, Series B Participating Convertible Preferred Stock and Series A-1 Cumulative Convertible Preferred Stock under the terms of the certificates of designation for such stock;
(vii)incur any indebtedness, including capital leases, other than trade payables incurred in the ordinary course of business;
(viii)create or hold capital stock in any subsidiary that is not a wholly-owned subsidiary of the Company or dispose of any subsidiary stock or all or a significant portion of any subsidiary assets;
(ix)increase or decrease the size of the Board of Directors of the Company;
(x)hire, terminate or change the compensation of the Company’s executive officers, including approving any option grants, other than changes which have been approved by the Board of Directors, including a majority of the Preferred Stock Directors;

47

TABLE OF CONTENTS

(xi)make any material alteration to the Company’s business plan; or
(xii)except as otherwise approved by the Board of Directors, including a majority of the Preferred Stock Directors, authorize or adopt any stock option plan, restricted stock plan, stock incentive plan or other employee benefit plan or increase the number of shares of common stock issuable under any such plan.

Voting Rights.   Holders of Series B Participating Convertible Preferred Stock vote together with the holders of common stock and holders of Series A-1 Cumulative Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and Series D Preferred Stock on an as-converted basis on all matters brought before the stockholders. Each share of Series B Participating Convertible Preferred Stock is convertible into common stock at a conversion price of $0.0433 per share, which means that holders of Series B Participating Convertible Preferred Stock have approximately 23.095 votes for each share of Series B Participating Convertible Preferred Stock held by them when voting on an as-converted basis. In addition, holders of Series B Participating Convertible Preferred Stock are entitled to vote separately as a class in connection with the protective provisions described above and as otherwise required by law or the Company’s Charter.

Conversion Rights.   Each share of Series B Participating Convertible Preferred Stock is convertible into common stock at the conversion price of $0.0433 per share, at any time at the option of the holder, subject to adjustments for stock dividends, splits, combinations and similar events (including our recent reverse stock split).

In April 2016, the requisite holders of preferred stock (voting together as a class and separately as a series) consented to an amendment to the Second Amended and Restated Certificate of Designation of the Series B Participating Convertible Preferred Stock which provides for the automatic conversion of the Series B Participating Convertible Preferred Stock into shares of common stock at a conversion price of $12.9625 per share upon the closing by no later than July 31, 2016 of a firm-commitment underwritten public offering of shares of our common stock.

Mandatory Conversion.   Each share of Series B Participating Convertible Preferred Stock will automatically be converted into common stock at the then applicable conversion price upon the written consent or agreement of holders representing a majority of the shares of Series B Participating Convertible Preferred Stock then outstanding.

Series C Participating Convertible Preferred Stock

Authorized Shares and Liquidation Preference.   The number of authorized shares of Series C Participating Convertible Preferred Stock is 9,000,000 (of which 5,682,326 shares are outstanding as of May 6, 2016). The shares of Series C Participating Convertible Preferred Stock have a liquidation preference of $1.50 plus any accrued and unpaid dividends.

Ranking.   Shares of Series C Participating Convertible Preferred Stock rank junior to our outstanding Series D Preferred Stock and senior to our outstanding Series A-1 Cumulative Convertible Preferred Stock, Series B Participating Convertible Preferred Stock and all shares of common stock with respect to dividend rights and rights on liquidation, winding-up and dissolution.

Dividends.   Shares of Series C Participating Convertible Preferred Stock accrue dividends at the rate of 10% per annum, payable quarterly, in cash or additional shares of Series C Participating Convertible Preferred Stock valued at $1.00 per share. The holders of shares of Series C Participating Convertible Preferred Stock are entitled, in preference to all other holders of capital stock of the Company other than Series D Preferred Stock, to receive such dividends immediately after the payment of any dividends to Series D Preferred Stock required by the Charter. Additionally, all dividends other than required dividends are subject to the protective provisions set forth below.

Liquidation.   In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of Series C Participating Convertible Preferred Stock are entitled to receive, immediately after all distributions to holders of Series D Preferred Stock required by the Charter, and on a preferred basis prior and in preference to any distribution to any holders of Series B Participating Convertible Preferred Stock, Series A-1 Cumulative Convertible Preferred Stock and common stock, liquidating distributions in the amount of $1.50 per share plus any accrued but unpaid dividends. After the payment of all preferential amounts required to be paid pursuant to the Charter, any remaining assets of the Company will be distributed pro rata, on an as-converted basis, to the holders of the shares of Series A-1 Cumulative Convertible Preferred Stock who have elected to receive distributions on an as-converted common stock basis, Series B Participating Convertible Preferred Stock, Series C Participating Convertible Preferred Stock and common stock. A sale, lease, conveyance or disposition of all or substantially all of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other

48

TABLE OF CONTENTS

transaction or series of related transactions in which the Company’s stockholders immediately prior to such transaction do not retain a majority of the voting power of the surviving entity will be treated as a liquidation event.

Protective Provisions.   So long as 20% of the originally issued shares of Series C Participating Convertible Preferred Stock remain outstanding, in addition to any other vote or approval required under the Company’s Charter or by applicable law, the Company will not, without the written consent or affirmative vote of holders of at least a majority of the then outstanding shares of Series C Participating Convertible Preferred Stock, either directly or indirectly by amendment, merger, consolidation, or otherwise:

(i)liquidate, dissolve or wind-up the business and affairs of the Company or any subsidiary, or effect any sale or disposition of all or a significant portion of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other similar transaction or consent to any of the foregoing;
(ii)amend, alter or repeal any provision of the Charter or Bylaws of the Company;
(iii)authorize, create, designate or issue any equity securities or securities convertible into equity securities with equal or superior rights, preferences or privileges to those of the Series C Participating Convertible Preferred Stock (including, debt that is convertible into capital stock and redeemable preferred stock that is not treated as common stock for tax purposes) or, other than the issuance of shares of common stock on exercise or conversion of securities outstanding on the closing date of the transactions, issue any shares of common stock or securities convertible into or exercisable (directly or indirectly) for common stock if at such time (or after giving effect to such issuance) the Company does not have sufficient shares of common stock available out of its authorized but unissued stock for the purpose of effecting the conversion of the Series C Participating Convertible Preferred Stock into common stock and the exercise and conversion of all other securities convertible or exercisable (directly or indirectly) for common stock;
(iv)increase or decrease the number of authorized shares of Series C Participating Convertible Preferred Stock or of any additional class or series of capital stock;
(v)reclassify, alter or amend any existing security that is junior to or on parity with the Series C Participating Convertible Preferred Stock;
(vi)purchase or redeem, or declare or pay any dividends on, any capital stock or securities convertible or exchangeable into shares of capital stock, other than dividends required to be paid on shares of Series D Preferred Stock, Series C Participating Convertible Preferred Stock, Series B Participating Convertible Preferred Stock and Series A-1 Cumulative Convertible Preferred Stock under the terms of the certificates of designation for such stock;
(vii)incur any indebtedness, including capital leases, other than trade payables incurred in the ordinary course of business;
(viii)create or hold capital stock in any subsidiary that is not a wholly-owned subsidiary of the Company or dispose of any subsidiary stock or all or a significant portion of any subsidiary assets;
(ix)increase or decrease the size of the Board of Directors of the Company;
(x)make any material alteration to the Company’s business plan; or
(xi)except as otherwise approved by the Board of Directors, including a majority of the Preferred Stock Directors, authorize or adopt any stock option plan, restricted stock plan, stock incentive plan or other employee benefit plan or increase the number of shares of common stock issuable under any such plan.

Voting Rights.   Holders of Series C Participating Convertible Preferred Stock vote together with the holders of common stock and holders of Series A-1 Cumulative Convertible Preferred Stock, Series B Participating Convertible Preferred Stock and Series D Preferred Stock on an as-converted basis on all matters brought before the stockholders. Each share of Series B Participating Convertible Preferred Stock is convertible into common stock at a conversion price of $0.0225 per share, which means that holders of Series C Participating Convertible Preferred Stock have approximately 44.444 votes for each share of Series C Participating Convertible Preferred Stock held by them when voting on an as-converted basis. In addition, holders of Series C Participating Convertible Preferred Stock are entitled to vote separately as a class in connection with the protective provisions described below and as otherwise required by law or the Company’s Amended and Restated Certificate of Incorporation.

49

TABLE OF CONTENTS

Conversion Rights.   Each share of Series C Participating Convertible Preferred Stock is convertible into common stock at a conversion price of $0.0225 per share, at any time at the option of the holder, subject to adjustments for stock dividends, splits, combinations and similar events (including our recent reverse stock split).

In April 2016, the requisite holders of preferred stock (voting together as a class and separately as a series) consented to an amendment to the Amended and Restated Certificate of Designation of the Series C Participating Convertible Preferred Stock which provides for the automatic conversion of the Series C Participating Convertible Preferred Stock into shares of common stock at a conversion price of $9.7125 per share upon the closing by no later than July 31, 2016 of a firm-commitment underwritten public offering of shares of our common stock.

Mandatory Conversion.   Each share of Series C Participating Convertible Preferred Stock will automatically be converted into common stock at the then applicable conversion price upon the written consent or agreement of holders representing a majority of the shares of Series C Participating Convertible Preferred Stock then outstanding.

Series D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock

The rights, preferences, powers and restrictions of the Series D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock are summarized below. In instances where the rights of the Series D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock are identical and pari passu, the Series D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock are referred to collectively as the “Series D Preferred Stock.”

Authorized Shares and Liquidation Preference.   The number of authorized shares of Series D-1 Convertible Preferred Stock is 10,000,000 (of which 8,357,448 shares are outstanding as of May 6, 2016), and the number of authorized shares of Series D-2 Convertible Preferred Stock is 10,000,000 (of which 6,602,390 shares are outstanding as of May 6, 2016). The shares of Series D Preferred Stock have a liquidation preference of $1.00 plus any accrued and unpaid dividends.

Ranking.   Shares of Series D Preferred Stock rank senior to our outstanding Series A-1 Cumulative Convertible Preferred Stock, Series B Participating Convertible Preferred Stock and Series C Participating Convertible Preferred Stock and all shares of common stock with respect to dividend rights and rights on liquidation, winding-up and dissolution.

Dividends.   Shares of Series D Preferred Stock accrue dividends at the rate of 10% per annum, payable quarterly, in cash or additional shares of Series D Preferred Stock valued at $1.00 per share. The holders of shares of Series D Preferred Stock are entitled, in preference to all other holders of capital stock of the Company, to receive such dividends immediately after the payment of any dividends to Series D Preferred Stock required by the Charter. Additionally, all dividends other than required dividends are subject to the protective provisions set forth below.

Liquidation.   In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of Series D Preferred Stock are entitled to receive, on a preferred basis prior and in preference to any distribution to any holders of Series C Participating Convertible Preferred Stock, Series B Participating Convertible Preferred Stock, Series A-1 Cumulative Convertible Preferred Stock and common stock, liquidating distributions in the amount of $1.00 per share plus any accrued but unpaid dividends. A sale, lease, conveyance or disposition of all or substantially all of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other transaction or series of related transactions in which the Company’s stockholders immediately prior to such transaction do not retain a majority of the voting power of the surviving entity will be treated as a liquidation event.

Protective Provisions.   So long as 20% of the originally issued shares of Series D Preferred Stock are outstanding, in addition to any other vote or approval required under the Company’s Charter or by applicable law, the Company will not, without the written consent or affirmative vote of holders of at least a majority of the then outstanding shares of Series D-1 Convertible Preferred Stock and at least five-percent of our outstanding capital stock, the managing membera majority of the purchaser is permitted to designate up to two non-voting observers to attend meetingsthen outstanding shares of ourSeries D-2 Convertible Preferred Stock, either directly or indirectly by amendment, merger, consolidation, or otherwise:

(i)liquidate, dissolve or wind-up the business and affairs of the Company or any subsidiary, or effect any sale or disposition of all or a significant portion of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other similar transaction or consent to any of the foregoing;

50

TABLE OF CONTENTS

(ii)amend, alter or repeal any provision of the Charter or Bylaws of the Company;
(iii)authorize, create, designate or issue any equity securities or securities convertible into equity securities with equal or superior rights, preferences or privileges to those of Series D Preferred Stock (including, debt that is convertible into capital stock and redeemable preferred stock that is not treated as common stock for tax purposes) or, other than the issuance of shares of common stock on exercise or conversion of securities outstanding on the closing date of the transactions, issue any shares of common stock or securities convertible into or exercisable (directly or indirectly) for common stock if at such time (or after giving effect to such issuance) the Company does not have sufficient shares of common stock available out of its authorized but unissued stock for the purpose of effecting the conversion of Series D Preferred Stock into common stock and the exercise and conversion of all other securities convertible or exercisable (directly or indirectly) for common stock;
(iv)increase or decrease the number of authorized shares of Series D Preferred Stock or of any additional class or series of capital stock;
(v)reclassify, alter or amend any existing security that is junior to or on parity with Series D Preferred Stock;
(vi)purchase or redeem, or declare or pay any dividends on, any capital stock or securities convertible or exchangeable into shares of capital stock, other than dividends required to be paid on shares of Series D Preferred Stock, Series C Participating Convertible Preferred Stock, Series B Participating Convertible Preferred Stock and Series A-1 Cumulative Convertible Preferred Stock under the terms of the certificates of designation for such stock;
(vii)incur any indebtedness, including capital leases, other than trade payables incurred in the ordinary course of business;
(viii)create or hold capital stock in any subsidiary that is not a wholly-owned subsidiary of the Company or dispose of any subsidiary stock or all or a significant portion of any subsidiary assets;
(ix)increase or decrease the size of the Board of Directors of the Company;
(x)make any material alteration to the Company’s business plan; or
(xi)except as otherwise approved by the Board of Directors, including a majority of the Preferred Stock Directors, authorize or adopt any stock option plan, restricted stock plan, stock incentive plan or other employee benefit plan or increase the number of shares of common stock issuable under any such plan.

Voting Rights.   Holders of Directors.

Annual MeetingsSeries D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock vote together with holders of Stockholders

Our bylaws provide that our Boardcommon stock and holders of Directors may designate the date of the annual meeting ofSeries A-1 Cumulative Convertible Preferred Stock, Series B Participating Convertible Preferred Stock and Series C Participating Convertible Preferred Stock on an as-converted basis on all matters brought before the stockholders. For business to be properly brought before an annual meetingEach share of stockholders bySeries D-1 Convertible Preferred Stock is convertible into common stock at a stockholder, the stockholder must have given timely noticeconversion price of the matter in writing to our Secretary. In order to be timely, the notice must be delivered to or mailed and received at our principal executive offices not less than 45 and not more than 90 days prior to the annual meeting of the stockholders, provided$0.0225 per share, which means that if the Board of Directors provides less than 60 days’ prior notice of the annual meeting of the stockholders, the notice from the stockholder must be received by the Secretary not later than the close of business on the fifteenth day following the date on which we mailed notice of the date of the annual meeting.

Special Meetings of Stockholders

Our bylaws provide that special meetings of our stockholders may be called by the chairman of our Board of Directors, by our president, or by holders of not less than 10%Series D-1 Convertible Preferred Stock have approximately 44.444 votes for each share of our outstanding capitalSeries D-1 Convertible Preferred Stock held by them when voting on an as-converted basis. Each share of Series D-2 Convertible Preferred Stock is convertible into common stock at a conversion price of $0.05 per share, when means that holders of Series D-2 Convertible Preferred Stock have 20 votes for each share of Series D-2 Preferred held by them when voting on an as-converted basis. In addition, holders of Series D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock are entitled to vote separately as a class in connection with the electionprotective provisions described below and as otherwise required by law or the Company’s Amended and Restated Certificate of directors. Business transactedIncorporation.

Conversion Rights.   Each share of Series D-1 Convertible Preferred Stock and each share of Series D-2 Convertible Preferred Stock converts into common stock at a conversion price of $0.0225 per share and a conversion price of $0.05 per share, respectively, at any time at the meeting is limitedoption of the holder, subject to adjustments for stock dividends, splits, combinations and similar events (including our recent reverse stock split).

In April 2016, the requisite holders of preferred stock (voting together as a class and separately as a series) consented to an amendment to the purposes stated in the noticeCertificate of Designation of the meeting.Series D Convertible Preferred Stock which provides for the automatic conversion of the Series D-1 Convertible Preferred Stock into shares of common stock at a conversion price of $7.2375 and Series D-2 Convertible Preferred Stock into shares of common stock at a conversion price of $8.5750 per share upon the closing by no later than July 31, 2016 of a firm-commitment underwritten public offering of shares of our common stock.

51

TABLE OF CONTENTS

Mandatory Conversion.   Each share of Series D-1 Convertible Preferred Stock will automatically be converted into common stock at the then applicable conversion price upon the written consent or agreement of holders representing a majority of the shares of Series D-1 Convertible Preferred Stock then outstanding. Each share of Series D-2 Convertible Preferred Stock will automatically be converted into common stock at the then applicable conversion price upon the written consent or agreement of holders representing a majority of the shares of Series D-2 Convertible Preferred Stock then outstanding. Each share of Series D-1 and D-2 Preferred Stock will automatically be converted into common stock at the then applicable conversion price upon the date specified by the written consent or agreement of holders representing a majority of the shares of Series B Participating Convertible Preferred Stock then outstanding with respect to the automatic conversion of Series B Participating Convertible Preferred Stock.

Delaware Anti-Takeover Law and Certain Charter and Bylaw Provisions

Certain provisions of Delaware law and our certificate of incorporationCharter and bylaws could make it more difficult to acquire us by means of a tender offer, a proxy contest or otherwise, or to remove incumbent officers and directors. These provisions, summarized below, may discourage certain types of takeover practices and takeover bids, and encourage persons seeking to acquire control of our company to first negotiate with us. We believe that the potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh

19



the disadvantages of discouraging such proposals because, among other things, negotiation of such proposals could result in an improvement of their terms.

Delaware Anti-Takeover Statute

We are subject to Section 203 of the Delaware General Corporation law, or DGCL, an anti-takeover statute. In general, Section 203 prohibits a publicly-held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years following the date the person became an interested stockholder, unless (with certain exceptions):

·      prior to such date, our Board of Directors approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;

·      upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned by persons who are directors and also officers and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer;

·      on or before such date, the business combination is approved by the Board of Directors and authorized at an annual or special meeting of stockholders and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder.

Generally, a “business combination” includes:

·      a merger or consolidation involving us and the interested stockholder;

·      a sale of 10% or more of our assets;

·      a stock sale, subject to certain exceptions, resulting in the transfer of our stock to the interested stockholder;

·      any transaction involving us that has the effect of increasing the proportionate share of the stock of any class or series beneficially owned by the interested stockholders; or

·      other transactions resulting in a financial benefit to the interested stockholder.

Generally, an “interested stockholder” is a person who, together with affiliates and associates, owns (or within three years prior to the determination of interested stockholder status, did own) 15% or more of a corporation’s voting stock. The fact we are subject to Section 203 would be expected to have an anti-takeover effect with respect to transactions not approved in advance by the Board of Directors, including discouraging attempts that might result in a premium over the market price for the shares of common stock held by stockholders.

Rights and Preferences of Preferred Stock

Our Board of Directors is authorized to create a new series of preferred stock and to determine the rights and limitations of this preferred stock. Stockholder approval will not be required for the issuance of such shares. Such shares of preferred stock could have rights that are senior to the rights of the holders of shares of common stock, e.g., preferred liquidation rights, cumulative dividends, or voting and conversion rights that could adversely affect the voting power or dividend rights of the holders of common stock and delay, defer, or prevent a change in control of us. Our certificate of incorporation authorizes the issuances of 10,000,000 shares of preferred stock.

20



We currently have 1,040,000 shares of our Series A Cumulative Convertible Preferred Stock outstanding.  The Series A Cumulative Convertible Preferred Stock carry an 8% annual dividend, payable quarterly in arrears in cash or in additional preferred shares, have a liquidation preference over common stock of $1.00 per share and are convertible into shares of common stock at the conversion price of $0.14 per share.  Thus, at the current applicable conversion rate, one share of Series A Cumulative Convertible Preferred Stock would convert into 7,428,571 shares of our common stock.  The shares of preferred stock are convertible at any time.

Authorized but Unissued Shares

Our authorized but unissued shares of common stock and preferred stock will be available for future issuance without your approval.shareholder approval, except as may be required under the listing rules of any stock exchange on which our common stock is then listed. We may use additional shares for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

Limitations on Liability and Indemnification of Directors and Officers

Pursuant to the terms of our bylaws, we have agreed to indemnify, to the full extent permitted by the laws of the State of Delaware, any current or former directors and officers who are made, or threatened to be made, a party to an action or proceedings, whether criminal, civil, administrative or investigative, by reason of the fact that such person or such persons is or was a director or officer of the Company, or served any other enterprise as a director or officer at the request of the Company. In addition, we may enter into agreements with our directors providing contractually for indemnification consistent with our certificate of incorporation and bylaws. Currently, we have no such agreements.

Pursuant to our certificate of incorporation, to the fullest extent permitted by the DGCL,General Corporation Law of the State of Delaware (“DGCL”), our directors will not be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director.

The DGCL also authorizes us to purchase insurance for our directors and officers insuring them against risks as to which we may be unable lawfully to indemnify them. We have obtained limited insurance coverage for our officers and directors as well as insurance coverage to reimburse us for potential costs of our corporate indemnification of officers and directors.

Insofar as indemnification for liabilities arising under the Securities Act or 1933, as amended, may be permitted to directors, officers or persons controlling the registrant pursuant to the foregoing provisions, the registrant has been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act, of 1933, as amended, and is therefore unenforceable.

52

TABLE OF CONTENTS

Trading and ListingUNDERWRITING

Our sharesAxiom Capital Management, Inc. is acting as representative of common stock are tradedthe underwriters (the “Representative”). We have entered into an underwriting agreement dated  • , 2016 with the Representative. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to each underwriter named below, and each underwriter named below has severally agreed to purchase, at the public offering price less the underwriting discounts set forth on the Over-The-Counter Bulletin Board, or the “OTC Bulletin Board,” under the trading symbol “CICI.OB.”

Transfer Agent and Registrar

Our stock transfer agent is American Stock Transfer & Trust Company, 59 Maiden Lane, New York, New York 10038.

MARKET PRICE INFORMATION

Our sharescover page of common stock are traded on the OTC Bulletin Board under the trading symbol “CICI.OB.”  The market for our common stock is highly volatile. Set forth below are the high and low bid prices for our stock on the OTC Bulletin Board for each quarter during fiscal years 2006 and 2007, and for the first two quarters of fiscal year 2008. The bid prices below reflect inter-dealer prices, without retail mark-up, mark-down, or commission and may

21



not represent actual transactions. We have not declared any cash dividends on our common stock for the periods indicated.

 

 

Bid Price 
Per Share

 

 

 

High

 

Low

 

2006

Quarter Ended March 31, 2006

 

$

0.53

 

$

0.40

 

 

Quarter Ended June 30, 2006

 

$

0.50

 

$

0.39

 

 

Quarter Ended September 30, 2006

 

$

0.41

 

$

0.24

 

 

Quarter Ended December 30, 2006

 

$

0.30

 

$

0.18

 

2007

Quarter Ended March 31, 2007

 

$

0.20

 

$

0.32

 

 

Quarter Ended June 30, 2007

 

$

0.27

 

$

0.13

 

 

Quarter Ended September 30, 2007

 

$

0.28

 

$

0.15

 

2008

Quarter Ended March 31, 2008

 

$

0.27

 

$

0.14

 

 

Quarter Ended June 30, 2008

 

$

0.27

 

$

0.14

 

As of August 14, 2008, there were approximately 961 holders of record of our common stock. As of such date, there were 1,040,000 shares of our preferred stock outstanding. The high and low bid price for our common stock on the OTC Bulletin Board on August 15, 2008 were $0.17 and $0.16, respectively.

Equity Compensation Plan Information

       The following table provides information as of December 31, 2007, regarding our compensation plans (including individual compensation arrangements) under which equity securities are authorized for issuance:

 

 

Number of
Securities To Be
Issued Upon
Exercise of
Outstanding
Options,
Warrants and
Rights

 

Weighted-
Average Exercise
Price Of
Outstanding
Options,
Warrants and
Rights

 

Number of
Securities
Remaining
Available For
Future Issuance
Under Equity
Compensation
Plans

 

Equity Compensation Plans Approved by Security Holders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1999 Stock Option Plan

 

3,747

 

$

0.55

 

72

 

 

 

 

 

 

 

 

 

Equity Compensation Plans Not Approved by Security Holders

 

2,289

 

$

0.63

 

72

 

 

 

 

 

 

 

 

 

Total:

 

6,036

 

$

0.59

 

72

 

DIVIDEND POLICY

Stockholders holding common stock are entitled to dividends only if declared by our Board of Directors. To date, we have neither declared nor paid any dividends on shares of our common stock and we do not anticipate doing so in the foreseeable future.

22



DESCRIPTION OF INDEBTEDNESS

June 2008 Financing Transaction

On June 5, 2008, we executed documents and closed a financing transaction under which the Company raised capital through the issuance of secured indebtedness and equity and also restructured a portion of the Company’s existing debt.

In connection with the transaction, we borrowed an aggregate of $3,000,000 and refinanced $637,500 of existing indebtedness and accrued interest on that indebtedness. The new and refinanced debt bears interest at 8% per annum which, at the option of the Company, may be paid in cash or in kind and matures two years from issue date and is secured by a first priority security interest in all of our assets.

In partial consideration for the respective loans made as described above, we issued to each creditor a warrant to purchase the number of shares of our common stock obtained by dividing the amount of such creditor’s loan by 0.14.  An aggregate of 25,982,143 shares of our common stock may be issued upon exercise of these warrants.  The warrants are exercisable at the option of the holders, until June 30, 2011, with an exercise price of $0.14 per share. Additional warrants may be issued if we exercise our option to make interest payments on the loans in-kind.

In connection with the closing of the financing transaction, we also entered into a Securities Purchase Agreement and a Registration Rights Agreement, each dated as of June 5, 2008.  Under the Securities Purchase Agreement, in exchange for the cancellation of $995,000 in principal and $45,000 of interest accrued thereon of our existing debt and interest accrued thereon, we issued to the holders of such debt an aggregate of 1,040,000 shares of our Series A Cumulative Convertible Preferred Stock.  The preferred shares carry an 8% annual dividend, payable quarterly in arrears in cash or in additional preferred shares, have a liquidation preference over common stock of $1.00 per share and are convertible into shares of common stock at the conversion price of $0.14 per share.  This, at the current applicable conversion rate, one share of Series A Cumulative Conversion Preferred Stock would convert into 7,428,571 shares of our common stock.  The shares of preferred stock are convertible at any time at the option of the holders thereof.

We granted the investors registration rights for the full number of shares represented by the warrants and conversion rights of our preferred stock issued to the investors. This registration statement is intended to satisfy our registration obligations to the holders of the convertible preferred stock and warrants.

USE OF PROCEEDS

Thisthis prospectus, relates to 33,410,714 shares of our common stock, including 25,982,143 shares of common stock issuable upon the exercise of warrants and 7,428,571 shares of common stock issuable upon the conversion of convertible preferred stock, which may be sold from time to time by the selling stockholders. We will not receive any proceeds from the sale of the shares of common stock covered by this prospectus. We will not receive any proceeds due to the conversion of our preferred stock issued pursuant to the Purchase Agreement. We will receive proceeds from the issuance of the shares of common stock upon exercise of warrants issued under the June 2008 financing transaction. Assuming all warrants are exercised for cash, we will receive gross proceeds of $3,637,500and issue an additional 25,982,143 shares of our common stock. Readers should be aware that all of the warrants include net issue exercise provisions that may reduce or eliminate the cash proceeds we receive upon exercise of such warrants; however, any such reduction also will have the effect of reducing the number of shares of common stock issuedand warrants listed next to its name in net issue exercise transactions.the following table:

SELLING STOCKHOLDERS

Name of Underwriter
Number of
Shares
Number of
Warrants
Axiom Capital Management, Inc.
          • 
          • 
Total
 • 
          • 

The selling security holders identified below, or their respective pledges, donees, assignees, transferees or their successors in interest,underwriters are selling all of the common shares being offered under this prospectus. The shares of common stock registered for sale under this prospectus are comprised of an aggregate of 33,410,714 shares of common stock. These shares, if issued, would represent approximately 31.58% of our issued and outstanding common stock as of August 18, 2008. The common stock being registered hereby and the underlying warrants, notes and convertible preferred stock were acquired from us in transactions which were exempt from the registration requirements of the Securities Act of 1933, as amended, or the “Securities Act,” provided by Section 4(2) thereof and the Rules promulgated thereunder.

23



On June 5, 2008, we executed documents and closed a financing transaction with several private investors, under which we issued to the investors warrantscommitted to purchase an aggregate of 25,982,143 shares of our common stock at a price per share of $0.14, for an aggregate purchase price of $3,637,500. In addition to the warrants we issued 1,040,000 shares of our preferred stock in exchange for cancellation of $995,000 of existing indebtedness and $45,000 of interest accrued on such indebtedness. These shares of preferred stock are presently convertible into an aggregate of 7,428,571 shares of our common stock. Under the transaction documents covering the resale by the purchaser of the full number of shares of common stock sold pursuant to the Financing Transaction and Purchase Agreement. Further, we are obligated to use our best efforts to keep the registration statement continuously effective under the Securities Act until the earlier of the date that all shares issued pursuant to exercise of the Warrants and conversion of the Convertible Preferred Stock issued under the Financing Transaction and Purchase Agreement have been sold or can be sold publicly pursuant to Paragraph (k) of Rule 144.  This registration statement is intended to satisfy our registration obligations to the holder of the Convertible Preferred Stock and Warrants issued under the Financing Transaction and Purchase Agreement, representing 33,410,714 shares of common stock if all of the Convertible Preferred Stock is converted and all of the Warrants are exercised.

The following list provides, as of August 18, 2008:

·      the names of the selling security holders;

·      the number of shares beneficially owned by each selling security holders prior to the offering (assuming exercise of the warrants held by each selling stockholder that are currently exercisable or exercisable within 60 days of the date of this prospectus); and

·      the total number of shares being offered under this offering for each selling security holder’s account.

Except as otherwise indicated in the selling security holders table below or in a footnote to the table, or in the section entitled “Certain Relationships and Related Transactions” beginning on page 42, none of the selling security holders has had any material relationship with us within the past three years. To our knowledge, each of the selling security holders listed below has sole voting and investment power with respect to all of the shares of common stock beneficially ownedand warrants offered by it, except asus other than those covered by the option to purchase additional shares and warrants described below, if they purchase any shares. The obligations of the underwriters may be listedterminated upon the occurrence of certain events specified in the footnotesunderwriting agreement. Furthermore, pursuant to the selling security holders table.

For purposes ofunderwriting agreement, the table of selling security holders, beneficial ownership is determinedunderwriters’ obligations are subject to customary conditions, representations and warranties contained in accordance with Rule 13d-3 promulgatedthe underwriting agreement, such as receipt by the Securitiesunderwriters of officers’ certificates and Exchange Commission, and generally includes voting or investment power with respect to securities. In computing the number of shares beneficially owned by the holder and the percentage ownership of the holder, shares of common stock issuable upon conversion of the Preferred Convertible Stock and upon exercise of the warrants held by the holder that are currently convertible or exercisable, or are convertible or exercisable within 60 days after the date of the table, are deemed outstanding. The percentage ownership data is based on 129,057,161 shares of our common stock outstanding as of August 18, 2008.legal opinions.

24



 

 

Shares of Common
Stock Beneficially
Owned Prior to the
Offering(1)

 

Number of
Shares Being
Offered

 

Shares of
Common Stock
Beneficially
Owned After the
Offering(1)(2)

 

Name of Selling Shareholder

 

Number

 

%

 

Number

 

Number

 

%

 

MDNH Partners L.P. (3)

 

2,326,355

 

1.8

%

1,138,393

 

1,187,962

 

 

*

KENDU Partners Company (4)

 

4,087,771

 

3.2

%

2,428,571

 

1,659,200

 

1.3

%

Michael W. Engmann (5)

 

9,643,436

 

7.5

%

5,312,500

 

4,330,936

 

3.4

%

AFS Investments, Inc. (6)

 

4,232,918

 

3.3

%

1,071,429

 

3,161,489

 

2.4

%

Rubicon Global Value Fund, L.P. (7)

 

924,589

 

 

*

535,714

 

388,875

 

 

*

Frederick Farrar (8)

 

1,155,746

 

 

*

357,143

 

798,603

 

 

*

Ronald Goodman (9)

 

1,916,143

 

1.5

%

1,138,393

 

777,750

 

 

*

Phoenix Venture Fund LLC (10)

 

41,714,285

 

32.3

%

20,214,285

 

21,500,000

 

16.7

%

Donna Halpern

 

1,565,111

 

1.2

%

357,143

 

1,207,968

 

 

*

Frederick Halpern

 

1,993,682

 

1.5

%

785,714

 

1,207,968

 

 

*

Holly Metzger

 

71,429

 

 

*

71,429

 

0

 

 

*

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

69,631,465

 

54.0

%

33,410,714

 

36,220,751

 

28.1

%


* Less than one percent.

(1)

The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of the Exchange Act, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and also any shares which the individual has the right to acquire within 60 days of the date of this prospectus through the exercise of any warrant or other right or upon conversion of a convertible note. Unless otherwise indicated below or in the table entitled “Security Ownership of Certain Beneficial Owners and Management,” each person has sole voting and investment power with respect to the shares shown as beneficially owned. Percentage of beneficial ownership is based on 129,057,161 shares of common stock outstanding as of August 18, 2008.

(2)

To our knowledge, there are no agreements, arrangements or understandings with respect to the sale of any of our common stock, and each selling stockholder may decide not to sell its shares that are registered under this registration statement.

(3)

Michael Engmann is a partner of MDNH Partners, L.P. and, as such, may be deemed to be the beneficial owner of such shares. Mr. Engmann disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

(4)

Michael Engmann is a partner of Kendu Partners and, as such, may be deemed to be the beneficial owner of such shares. Mr. Engmann disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

(5)

Shares of common stock beneficially owned prior to the offering includes warrants to purchase 1,187,962 shares of common stock, which warrants are owned by MDNH Partners, L.P. (“MDNH”), of which Michael Engmann is a partner. Shares of common stock beneficially owned prior to the offering also includes 1,659,200 warrants to purchase common stock owned by Kendu Partners (“Kendu”), of which Mr. Engmann is a partner. Mr. Engmann disclaims beneficial ownership of the shares owned by MDNH and Kendu, except to the extent of his pecuniary interest therein.

(6)

Shares of common stock beneficially owned prior to the offering includes warrants to purchase 777,750 shares of common stock. Fred J. Merritt is the President of AFS Investments, Inc., and has sole voting and investment power with respect to the shares owned by AFS Investments, Inc. Accordingly, he may be deemed to be the beneficial owner of such shares. Mr. Merritt disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

(7)

Steven Shum is the director of Rubicon Global Value Fund, L.P., and has voting and investment power with respect to the shares held by Rubicon Global Value Fund, L.P. Mr. Shum disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

25



(8)

Shares of common stock beneficially owned prior to the offering includes warrants to purchase 259,250 shares of common stock.

(9)

Shares of common stock beneficially owned prior to the offering includes warrants to purchase 777,750 shares of common stock.

(10)

SG Phoenix Ventures LLC is the Managing Member of Phoenix Venture Fund LLC (the “Phoenix Fund”), with the power to vote and dispose of the shares of common stock held by the Phoenix Fund. Accordingly, SG Phoenix Ventures LLC may be deemed to be the beneficial owner of such shares. Andrea Goren is the co-manager of SG Phoenix Ventures LLC, has the shared power to vote and dispose of the shares of common stock held by the Phoenix Fund and, as such, may be deemed to be the beneficial owner of the common shares owned by the Phoenix Fund. Philip Sassower is the co-manager of SG Phoenix Ventures LLC, has the shared power to vote and dispose of the shares of common stock held by the Phoenix Fund and, as such, may be deemed to be the beneficial owner of the common shares owned by the Phoenix Fund. SG Phoenix Ventures LLC, Mr. Goren and Mr. Sassower each disclaim beneficial ownership of the shares owned by the Phoenix Fund, except to the extent of their respective pecuniary interests therein.

26



PLAN OF DISTRIBUTION

We are registering the shares of common stock issuable upon exercise of the warrants or conversion of the preferred stock to permit the resale of these shares of common stock by the holders of the common stock from time to time after the date of this prospectus.  We will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock.

The selling stockholders may, from time to time, sell any or all of the shares of common stock beneficially owned by them and offered hereby directly or through one or more underwriters, broker-dealers or agent. The shares of common stock may be sold in one or more transactions on any stock exchange, quotation service, market or trading facility on which the shares are traded or in private transactions.  These sales may be at fixed or negotiated prices.  The selling stockholders may use any one or more of the following methods when selling shares:

·                  ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

·                  block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

·                  purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

·                  an exchange distribution in accordance with the rules of the applicable exchange;

·                  privately negotiated transactions;

·                  short sales;

·                  broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;

·                  through the writing of options, whether such options are listed on an options exchange or otherwise;

·                  a combination of any such methods of sale; and

·                  any other method permitted pursuant to applicable law.

The selling stockholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus.

If the selling stockholders effect such transactions by selling shares of common stock to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the selling stockholders or commissions from purchasers of the shares of common stock for whom they may act as agent or to whom they may sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved).  In connection with sales of the shares of common stock or otherwise, the selling stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of common stock in the course of hedging in positions they assume.  The selling stockholders may also sell shares of common stock short and deliver shares of common stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales.  The selling stockholders may also loan or pledge shares of common stock to broker-dealers that in turn may sell such shares.

Broker-dealers engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales.  Broker-dealers may receive commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated.  Any profits on the resale of shares of common stock by a broker-dealer acting as principal might be deemed to be underwriting discounts or commissions under the Securities Act.  Discounts, concessions, commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by a selling stockholder.  The selling stockholders may agree to indemnify any agent, dealer or broker-dealer that participates in transactions involving sales of the shares if liabilities are imposed on that person under the Securities Act.

The selling stockholders may from time to time pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the

27



pledgees or secured parties may offer and sell the shares of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 supplementing or amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.

The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 supplementing or amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.

The selling stockholders and any broker-dealers or agents that are involved in selling the shares of common stock may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales.  In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares of common stock purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.

We are required to pay all fees and expenses incident to the registration of the shares of common stock; provided, however, that a selling stockholder will pay all underwriting discounts and selling commissions, if any.  We have agreed to indemnify the selling stockholdersunderwriters against certain losses, claims, damages andspecified liabilities, including liabilities under the Securities Act, orand to contribute to payments the selling stockholders willunderwriters may be entitledrequired to contribution.

make in respect thereof.

The selling stockholdersunderwriters are offering the shares and warrants, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel and other conditions specified in the underwriting agreement. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.

We have advised us that they have not entered into any agreements, understandings or arrangements with anygranted the underwriters or broker-dealers regardingan over-allotment option. This option, which is exercisable for up to 45 days after the saledate of theirthis prospectus, permits the underwriters to purchase up to • shares of common stock, nor is there an underwriterup to • warrants or coordinating broker acting in connection with a proposed salecombination of shares of common stock and warrants, in each case representing no more than 15% of shares of common stock or warrants sold in this offering, as applicable, from us to cover over-allotments, if any. If the underwriters exercise all or part of this option, they will purchase such shares and warrants covered by the option at the public offering price that appears on the cover page of this prospectus, less the underwriting discount. If this option is exercised in full entirely in shares of common stock, the total price to the public will be $ •  and the total net proceeds, before expenses, to us will be $ • .

Discounts

The following table shows the public offering price, underwriting discount and proceeds, before expenses, to us. The information assumes either no exercise or full exercise by the underwriters of their over-allotment option.

Per Share
Per Warrant
Total Without
Over-Allotment
Option
Total With Full
Over-Allotment
Option
Public offering price
$
          • 
$
          • 
$
          • 
$
          • 
Underwriting discount (7%)
$
 • 
$
          • 
$
 • 
$
 • 
Non-accountable expense allowance (1%)
$
 • 
$
          • 
$
 • 
$
 • 
Proceeds, before expenses, to us
$
 • 
$
          • 
$
 • 
$
 • 

The underwriters propose to offer the shares and warrants offered by us to the public at the public offering price set forth on the cover of this prospectus. In addition, the underwriters may offer some of the shares and warrants to other securities dealers at such price less a concession of $ •  per share. If all of the shares and warrants offered by us are not sold at the public offering price, the Representative may change the offering price and other selling terms by means of a supplement to this prospectus.

We have agreed to pay the Representative a non-accountable expense allowance of 1% of the public offering price at the closing, excluding the over-allotment option. We have paid an expense deposit of $25,000 to the Representative, which will be applied against such non-accountable expense allowance.

53

TABLE OF CONTENTS

We have also agreed to pay the following expenses of the Representative relating to the offering: (a) all filing fees and communication expenses associated with the review of this offering by FINRA; (b) all fees, expenses and disbursements relating to the registration, qualification or exemption of securities offered under the securities laws of foreign jurisdictions designated by the Representative; (c) $29,500 for the underwriters’ use of Ipreo’s book-building, prospectus tracking and compliance software for this offering; (d) up to $10,000 of the Representative’s actual accountable road show expenses for the offering; (e) up to $7,500 for settlement services incurred by the Representative with National Financial Services in connection with this offering and (f) the costs associated with receiving commemorative mementos and lucite tombstones, up to $2,500. We have also agreed to pay up to $30,000 in reasonable attorney's fees and expenses for the Representative in connection with this offering.

We estimate that the total expenses of the offering payable by us, excluding the total underwriting discount, will be approximately $600,000.

Discretionary Accounts

The underwriters do not intend to confirm sales of the securities offered hereby to any accounts over which they have discretionary authority.

Lock-Up Agreements

Pursuant to “lock-up” agreements, we, our executive officers and directors, and certain of our stockholders, have agreed, subject to limited exceptions, without the prior written consent of the Representative not to directly or indirectly, offer to sell, sell, pledge or otherwise transfer or dispose of any of shares of (or enter into any transaction or device that is designed to, or could be expected to, result in the transfer or disposition by any selling stockholder.  Atperson at any time in the timefuture of) our common stock, enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of our common stock, make any demand for or exercise any right or cause to be filed a particular offeringregistration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company or publicly disclose the intention to do any of the foregoing, subject to customary exceptions, for a period of 180 days from the date of this prospectus, in the case of our directors and officers, and 90 days from the date of this prospectus, in the case of us and our principal stockholders. In addition, in connection with the recent private placement of unsecured convertible promissory notes due August 25, 2016, purchasers of these notes have agreed to similar “lock-up” agreements for a period of 90 days from the date of this offering.

Representative’s Warrants

We have agreed to issue to the Representative warrants to purchase up to a total of  •  shares of common stock (7% of the shares of common stock is made, a prospectus supplement, if required,sold in this offering, excluding the over-allotment option). The warrants will be distributedexercisable at any time, and from time to time, in whole or in part, during the four-year period commencing one year from the effective date of the offering, which period shall not extend further than five years from the effective date of the offering in compliance with FINRA Rule 5110(f)(2)(G). The warrants are exercisable at a per share price equal to 125% of the public offering price per share in the offering. The warrants have been deemed compensation by FINRA and are therefore subject to a 180 day lock-up pursuant to Rule 5110(g)(1) of FINRA. The underwriters (or permitted assignees under Rule 5110(g)(1)) will set forthnot sell, transfer, assign, pledge, or hypothecate these warrants or the aggregate amountsecurities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the date of this prospectus.

The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary cash dividend or recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock being offered andat a price below the termswarrant exercise price.

Right of First Refusal

Until twelve months after the closing date of the offering, includingprovided that we receive gross proceeds of at least $3.0 million in this offering, the nameRepresentative will have a right of first refusal to act as lead underwriter for any future public or names of any broker-dealers or agents, any discounts, commissionsprivate equity (a “Subject Transaction”) offering during such twelve month period, subject to the

54

TABLE OF CONTENTS

terms and other terms constituting compensation fromconditions contained in the selling stockholders and any discounts, commissions or concessions allowed or reallowed or paid to broker-dealers.underwriting agreement. If the Representative fails to diligently pursue in good faith the consummation of the Subject Transaction, or if it fails to consummate the Subject Transaction, its right of first refusal shall expire.

Electronic Offer, Sale and Distribution of Shares

A prospectus in electronic format may be made available on the websites maintained by one or more of the underwriters or selling stockholders usegroup members. The Representative may agree to allocate a number of shares to underwriters and selling group members for sale to its online brokerage account holders. Internet distributions will be allocated by the underwriters and selling group members that will make internet distributions on the same basis as other allocations. Other than the prospectus in electronic format, the information on these websites is not part of, nor incorporated by reference into, this prospectus for any sale ofor the shares of common stock, they will be subject to the prospectus delivery requirements of the Securities Act.

Under the securities laws of some states, the shares of common stock may be sold in such states only through registered or licensed brokers or dealers.  In addition, in some states the shares of common stock may not be sold unless such shares have been registered or qualified for sale in such state or an exemption from registration or qualification is available and is complied with.

There can be no assurance that any selling stockholder will sell any or all of the shares of common stock registered pursuant to the shelf registration statement, of which this prospectus forms a part.

The selling stockholders and any other person participating in such distribution will be subject to applicable provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, including, without limitation, the anti-manipulation rules of Regulation M under the Securities Exchange Act, which may limit the timing of purchases and sales of any of the shares of common stock by the selling stockholders and any other participating person.  Regulation M may also restrict the ability of any person engaged in the distribution of the shares of common stock to engage in market-making activities with respect to the shares of common stock.  All of the foregoing may affect the marketability of the shares of common stock and the ability of any person or entity to engage in market-making activities with respect to the shares of common stock.

Once sold under the shelf registration statement of which this prospectus forms a part, has not been approved or endorsed by us, and should not be relied upon by investors.

Stabilization

In connection with this offering, the underwriters may engage in stabilizing transactions, over-allotment transactions, syndicate-covering transactions, penalty bids and purchases to cover positions created by short sales.

Stabilizing transactions permit bids to purchase shares so long as the stabilizing bids do not exceed a specified maximum, and are engaged in for the purpose of preventing or retarding a decline in the market price of the shares while the offering is in progress.
Over-allotment transactions involve sales by the underwriters of shares in excess of the number of shares the underwriters are obligated to purchase. This creates a syndicate short position which may be either a covered short position or a naked short position. In a covered short position, the number of shares over-allotted by the underwriters is not greater than the number of shares that they may purchase in the over-allotment option. In a naked short position, the number of shares involved is greater than the number of shares in the over-allotment option. The underwriters may close out any short position by exercising their over-allotment option and/or purchasing shares in the open market.
Syndicate covering transactions involve purchases of shares in the open market after the distribution has been completed in order to cover syndicate short positions. In determining the source of shares to close out the short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared with the price at which they may purchase shares through exercise of the over-allotment option. If the underwriters sell more shares than could be covered by exercise of the over-allotment option and, therefore, have a naked short position, the position can be closed out only by buying shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that after pricing there could be downward pressure on the price of the shares in the open market that could adversely affect investors who purchase in the offering.
Penalty bids permit the Representative to reclaim a selling concession from a syndicate member when the shares originally sold by that syndicate member are purchased in stabilizing or syndicate covering transactions to cover syndicate short positions.

These stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price of our shares of common stock will be freely tradableor preventing or retarding a decline in the handsmarket price of persons other than our affiliates.

28



DESCRIPTION OF BUSINESS
(dollars in thousands, except per share data)

General

Communication Intelligence Corporation was incorporated in Delaware in October 1986. Communication Intelligence Corporation and its joint venture (the “Company” or “CIC”) isshares of common stock. As a leading supplierresult, the price of electronic signature solutions for business process automationour common stock in the financial industry as well as the recognized leader in biometric signature verification. CIC’s products enable companies to achieve truly paperless business transactions with multiple signature technologies across virtually all applications and hardware platforms. To date, the Company has delivered biometric and electronic signature solutions to over 400 channel partners and end-user customers worldwide representing hundreds of millions of electronic documents and well over 500 million electronic signatures. These deployments are primarilyopen market may be higher than it would otherwise be in the financial industryabsence of these transactions. Neither we nor the underwriters make any representation or prediction as to the effect that the transactions described above may have on the price of our common stock. These transactions may be effected on the NASDAQ Capital Market, in the over-the-counter market or otherwise and, include AIG/AGLA, Charles Schwab & Co., JP Morgan Chase, Prudential Financial, Inc., Snap-On-Credit, State Farm Insurance Co., Wells Fargo Bank, NAif commenced, may be discontinued at any time.

Passive market making

In connection with this offering, underwriters and World Financial Group.selling group members may engage in passive market making transactions in our common stock on The Company providesNASDAQ Capital Market or on the most comprehensive and scaleable electronic signature solutions based on over 20 years of experience and significant input from CIC’s valued financial industry client base. The Company is also a leading supplier of natural input/text entry software for handheld computers and smartphones. Major customers for natural input software are Palm Inc. and Sony Ericsson. CIC sells directly to enterprises and through system integrators, channel partners and OEMs. The Company is headquartered in Redwood Shores, California and has a joint venture, CICC, in Nanjing, China.

Core Technologies

The Company’s core technologies are classified into two broad categories: “transaction and communication enabling technologies” and “natural input technologies”. These technologies include multi-modal electronic signature, handwritten biometric signature verification, cryptography (Sign-it, iSign, and SignatureOne) and multilingual handwriting recognition software (Jot).

Transaction and Communication Enabling Technologies. The Company’s transaction and communication enabling technologies are designed to provide a cost-effective means for securing electronic transactions, providing network and device access control and enabling workflow automation of traditional paper form processing. The Company believes that these technologies offer more efficient methods for conducting electronic transactions while providing more functional user authentication and heightened data security. The Company’s transaction and communication enabling technologies have been fundamental to its development of software for multi-modal electronic signatures, handwritten biometric signature verification, and data security.

Natural Input Technologies. CIC’s natural input technologies are designed to allow users to interact with a computer or handheld device by using an electronic pen or stylus as the primary input device. CIC’s natural input offering includes multilingual handwriting recognition software for such devices as electronic organizers, pagers and smart cellular phones that do not have a keyboard. For such devices, handwriting recognition offers the most viable solutions for performing text entry and editing.

Products

Key products include the following:

SignatureOne

SignatureOne Ceremony Server is a complete electronic signature workflow process server that facilitates the straight through processing of electronic documents during the signature phase for enabling a truly paperless workflow.

SignatureOne Profile Server is the server compliment to CIC’s Sign-it software, which enables the real-time capture of electronic and digital signatures in various

29



application environments. All user enrollment, authentication and transaction tracking in SignatureOne are based on data from the Sign-it client software.

iSign

A suite of application development tools for electronic signatures, biometric signature verification and cryptography for custom developed applications and web based development.

Sign-it

Multi-modal electronic signature software for common applications including; Microsoft Word, Adobe Acrobat, AutoDesk AutoCAD, web based applications using HTML, XML, & XHTML, and custom applications for .NET, C# and similar development environments for the enterprise market.

Jot

Multi-lingual handwriting recognition software.

Products and upgrades that were introduced and first shipped in 2007 and 2008 include the following:

SignatureOne™ Sign-it® v6.2 for Acrobat®

SignatureOne™ Sign-it® v6.2 for Acrobat® (Viewer)

SignatureOne™ Sign-it® v6.04 for Word

SignatureOne™ Sign-it® Tools v3.03 for Word

SignatureOne™ Sign-it® v3.1.0.1 for AutoCAD®

SignatureOne™ Sign-it® v3.1.0.2 for AutoCAD®

SignatureOne™ Sign-it® v4.0 for AutoCAD®

SignatureOne™ Sign-it® Tools v 4.0 for AutoCAD®

SignatureOne™ iSign® v4.3

SignatureOne™ Sign-it® XF v1.2

SignatureOne™ Sign-it® XF v1.3

SignatureOne™ Profile Server v2.01. SQL (WebSphere)

SignatureOne™ Sign-it® XF Runtime License

The SignatureOne® Ceremony® Server is a J2EE server product that provides the capability to define and manage an electronic signature process within a Service Oriented Architecture (SOA) to be implemented in an On-Premise Deployed Model or through a Software as a Service (SaaS) environment. This product enables the use of web services to pass documents and/or packages of documents and related XML data to a server that facilitates end to end management of often complex, multi-party approvals of documents.

The SignatureOne Profile Server provides server based enterprise administration and authentication of user eSignatures and maintenance of signature transaction logs for eSigned documents. The SignatureOne architecture implements a common process and methodology that provides a uniform program interface for multiple signature methods and multiple capture devices, simplifying enterprise wide integration of business process automation tasks requiring eSignature.

iSign is an electronic signature and handwritten signature verification software developer’s kit for custom applications or Web based processes. It captures and analyzes the image, speed, stroke sequence and acceleration of a person’s handwritten electronic signature. iSign provides an effective and inexpensive handwriting security check for immediate authentication. It also stores certain forensic elements of a signature for use in determining whether a person actually electronically signed a document. The iSign kit includes software libraries for industry standard encryption and hashing to protect the sensitive nature of a user signature and the data captured in association with that signature. This software toolkit is used internally by the Company as the underlying technology in its SignatureOne and Sign-it products.

Sign-it is a family of electronic signature products for recording multi-modal electronic signatures as they are being captured as well as binding and verifying electronic signatures within standard consumer applications. These products combine the strengths of biometrics, and electronic signatures and cryptography with a patented process to

30



insure legally compliant electronic signatures to process, transact and create electronic documents that have the same legal standing as a traditional wet signature on paperOTCQB in accordance with Rule 103 of Regulation M under the Electronic SignatureExchange Act, during a period before the commencement of offers or sales of the shares and extending through the completion of the distribution. A passive market maker must display its bid at a price not in National and Global Commerce Act, and other related legislation and regulations. Organizations wishing to process electronic forms, requiring varying levelsexcess of security, can reduce the need for paper forms by adding electronic signature technologies to their workflow solution. Currently, Sign-it is available for MS Word, AutoCAD, Adobe Acrobat, Web based transactions using common formats like XML, HTML, or XHTML, and custom application development with .NET, C# or similar development environments.

Jot software analyzeshighest independent bid of that security. However, if all independent bids are lowered below the individual strokes of characters written with a pen/stylus and converts these strokes into machine-readable text characters. Jot recognizes handwritten input and is specifically designed for small devices. Unlike many recognizerspassive market maker’s bid, then that compete in the market for handheld data input solutions, Jot offers a user interface that allows for the input of natural upper and lowercase letters, standard punctuation and European languages without requiring the user to learn and memorize unique characters or symbols. Jot has been ported to numerous operating systems, including Palm OS, Windows, Windows CE, VT-OS, EPOC, QNX, Linux and OS/9. The standard version of Jot, which is available through OEM customers, recognizes and supports input of Roman-based Western European languages.bid must then be lowered when specified purchase limits are exceeded.

Copyrights, Patents and Trademarks55

TABLE OF CONTENTS

Restriction on Continuous Offerings

The Company, relies on a combination of patents, copyrights, trademarks, trade secrets and contractual provisions to protect its software offerings and technologies. The Company has a policy of requiring its employees and contractors to respect proprietary information throughwithout the prior written agreements. The Company also has a policy of requiring prospective business partners to enter into non-disclosure agreements before disclosure of any of its proprietary information.

Over the years, the Company has developed and patented major elements of its software offerings and technologies. In addition, in October 2000 the Company acquired, from PenOp, Inc. and its subsidiary, a significant patent portfolio relevant to the markets in which the Company sells its products. The Company’s patents and the years in which they each expire are as follows:

Patent No.

 

Expiration

5049862

 

2008

5544255

 

2013

5647017

 

2014

5818955

 

2015

5933514

 

2016

6064751

 

2017

6091835

 

2017

6212295

 

2018

6381344

 

2019

6487310

 

2019

The Company believes that these patents provide a competitive advantage in the electronic signature and biometric signature verification markets. The Company believes the technologies covered by the patents are unique and allow it to produce superior products. The Company also believes these patents are very broad in their coverage. The technologies go beyond the simple handwritten signature and include measuring electronically the manner in which a person signs to ensure tamper resistance and securityconsent of the resultant documents and the useRepresentative will not, for a period of other systems for identifying an individual and using that information to close a transaction. The Company believes that the patents are sufficiently broad in coverage that products with substantially similar functionality would infringe its patents. Moreover, because the majority of these patents do not expire for the next 5 to 11 years from12 months after the date of this registration statement on Form S-1, the Company believes that it has sufficient timeunderwriting agreement, directly or indirectly, consummate or enter into any agreement for any “at-the-market” or continuous equity transaction.

Other Relationships

Certain of the underwriters and their affiliates may in the future provide various investment banking, commercial banking and other financial services for us and our affiliates for which they may in the future receive customary fees.

Suitability Standards

Several states have established suitability requirements and shares of our common stock and warrants will be sold to develop new related technologies, which may be patentable, and to establish CIC as market leaderinvestors in these product areas. Accordingly,states only if they meet the Company believesspecial suitability standards set forth below. In each case, these special suitability standards exclude from the calculation of net worth the value of the investor’s home, home furnishings and automobiles. Below please find the suitability standards set forth by the state of California.

California

Investors’ maximum investment in our common stock and warrants will be limited to 10% of the investor’s liquid net worth. In addition, California investors must have (a) a minimum net worth of up to $250,000 and (b) had during the last tax year, or estimates that forthe investor will have during the current tax year, gross income of $65,000 or, (c) in the alternative, an investor must have a significant periodminimum net worth of time its patents will deter competitors from introducing competing products without creating substantially different technology or licensing or infringing its technology.up to $500,000.

Offer restrictions outside the United States

31



The Company has an extensive list of registered and unregistered trademarks and applicationsOther than in the United States, and other countries. The Company intends to register its trademarks generally in those jurisdictions where significant marketing of its products will be undertaken inno action has been taken by us or the foreseeable future.

Material Customers

Historically, the Company’s revenues have been derived from hundreds of customers, however,underwriters that would permit a significant percentagepublic offering of the revenue has been attributable to a limited number of customers.  For instance, four customers accountedsecurities offered by this prospectus in any jurisdiction where action for 57% of total revenuesthat purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in 2007. Access Systems Americas, Inc. (formerly PalmSource, Inc.) accounted for 24%, Tennessee Valley Authority accounted for 10%, World Financial Group accounted for 13% and Wells Fargo Bank, NA accounted for 10%. One customer, Palm, Inc., accounted for 27% of total revenues in 2006.

Competition

The Company faces competition at different levels. The technology-neutral nature of the laws and regulations related to what constitutes an “electronic signature” and CIC’s multi-modal enterprise-wide suite of products causes the Company to compete with different companies depending upon the specific type of electronic signature sought by a prospective customer. Our principal competition for handwritten biometric signatures includes SoftPro, Wondernet, and low-end tablet vendors. CIC faces additional competition from primarily Silanis and DocuSign when the application is click-wrap, voice, fingerprint, password, and basic click sign technology.

Certain of the Company’s significant competitors in the natural input market segment include PenPower Group, Advanced Research Technology, Inc., and Zi Corporation.

The Company believes that it has a competitive advantage, in part, due to CIC’s range of product offerings and patent portfolio. There can be no assurance, however, that competitors, including some with greater financial or other resources, will not succeed in developing products or technologies that are more effective, easier to use or less expensive than our products or technologies, which could render our products or technologies obsolete or non-competitive.

Employees

As of July 31, 2008, the Company employed an aggregate of 24 full-time employees, 22 of which are in the United States and 2 of which are in China. The Company, as a strategy, has been focused for years on being at its core “lean and agile” while establishing long standing strategic relationships that allow the Company to rapidly access product development and deployment capabilities required to address virtually any business requirement. The company believes it has scalability to virtually any business requirement through existing agreements with specialized development teams (well versed in the area of signature technology and processes), mid-size vertical market IT services groups (with explicit knowledge of the intricacies of the financial services industry) and with tier one IT Services firms with virtually limitless resources available.  None of the Company’s employees are a party to a collective bargaining agreement.  We believe our employee relations are good.

DESCRIPTION OF PROPERTY

We lease our principal facilities, consisting of approximately 9,600 square feet, in Redwood Shores, California, pursuant to a sub-lease that expires in 2011.

32



DIRECTORS AND EXECUTIVE OFFICERS

Directors

Our affairs are managed under the direction of our Board of Directors. Members of the Board of Directors receive information concerning our affairs through oral and written reports by management, Board of Director and committee meetings, and through other means. Our directors generally attend Board of Directors meetings, committee meetings and informal meetings with management and others, participate in telephone conversations and have other communications with management and others regarding our affairs. Directors serve until their successors are duly elected and qualified or until their earlier resignation, removal or disqualification. The following table sets forth certain information concerning our directors as of the date of this prospectus:

Name

 

Age

 

Year First Elected
or Appointed

 

 

 

 

 

Guido D. DiGregorio (5)

 

69

 

1997

Garry S. Meyer (5)

 

58

 

2007

Louis P. Panetta (1), (2), (3), (4), (5)

 

59

 

2000

Chien-Bor Sung (1), (2), (3), (4)

 

83

 

1986

David E. Welch (1), (3)

 

61

 

2004


(1)          Member of the Audit Committee (Chairman David E. Welch)

(2)          Member of the Finance Committee (Chairman Chien-Bor Sung)

(3)          Member of the Compensation Committee (Chairman Louis P. Panetta)

(4)          Member of the Nominating Committee (Chairman Chien-Bor Sung)

(5)          Member of the Best Practices Committee (Chairman Garry Meyer)

The business experience of each of the directors for at least the past five years includes the following:

Guido D. DiGregorio was elected Chairman of the Board in February 2002, Chief Executive Officer in June 1999 and President & Chief Operating Officer in November 1997. Mr. DiGregorio began his career with General Electric where, from 1966 to 1986, after successive promotions in product development, sales, strategic marketing and venture management assignments, he rose to the position of General Manager of an industrial automation business. Prior to joining CIC, Mr. DiGregorio was recruited as CEO of several companies to position those businesses for sustained sales and earnings growth. Those companies include Exide Electronics, Maxitron Corp., Proxim and Display Technologies Inc.

Louis P. Panetta was elected a director of the Company in October 2000. Mr. Panetta is currently the principal of Louis Panetta Consulting, a management consulting firm, a position he has held since August, 2005.  He also teaches at the school of business at California State University, Monterey Bay where he has been a member of the faculty since January, 2005.  He served as Vice President-Client Services for Valley Oak Systems from September 2003 to December 2003. From November 2001 to September 2003, Mr. Panetta was a member of the Board of Directors of Active Link. He was Vice President of Marketing and Investor Relations with Mobility Concepts, Inc. (a wireless Systems Integrator), a subsidiary of Active Link Communications from February 2001 to April 2003. He was President and Chief Operating Officer of PortableLife.com (eCommerce products provider) from September 1999 to October 2000 and President and Chief Executive Officer of Fujitsu Personal Systems (a computer manufacturer) from December 1992 to September 1999. From 1995 to 1999, Mr. Panetta served on the Board of Directors of Fujitsu Personal Systems. Mr. Panetta’s prior positions include Vice President-Sales for Novell, Inc. (the leading supplier of LAN network software) and Director-Product Marketing for Grid Systems (a leading supplier of Laptop & Pen Based Computers).

33



C.B. Sung was elected a director of the Company in 1986.  Mr. Sung has been the Chairman and Chief Executive Officer of Unison Group, Inc. (a multi-national corporation involved in manufacturing, computer systems, international investment and trade) since 1986 and Unison Pacific Corporation since 1979. Unison Group manages investment funds specializing in China-related businesses and is a pioneer in investing in China. Mr. Sung’s background includes over twenty years in various US high technology operating assignments during which time he rose to the position of Corporate Vice President-Engineering & Development for the Bendix Corporation. Mr. Sung was recently acknowledged and honored for his contributions by his native China (PRC) with a documentary produced by China’s National TV focusing on his life and career as an entrepreneurial scholar, successful US high technology executive and for his pioneering and continuing work in fostering capital investment and economic growth between the US and China.  He has been a member of the Board of Directors of Capital Investment of Hawaii, Inc., since 1985, and serves on the Board of Directors of several private companies and non-profit organizations.

David E. Welch was elected a director in March 2004 and serves as the financial expert on the Audit Committee. From July 2002 to present, Mr. Welch has been the principal of David E. Welch Consulting, a financial consulting firm, Mr. Welch has also been Vice President and Chief Financial Officer of American Millennium Corporation, Inc., a provider of satellite-based asset tracking and reporting equipment, from April 2004 to present. Mr. Welch was Vice President and Chief Financial Officer of Active Link Communications, a manufacturer of telecommunications equipment, from 1999 to 2002.  Mr. Welch has held positions as Director of Management Information Systems and Chief Information Officer with Micromedex, Inc. and Language Management International from 1995 through 1998.  Mr. Welch is a member of the Board of Directors of Security with Advanced Technology, Inc. and AspenBio Pharma, Inc.  Mr. Welch is a Certified Public Accountant licensed in the state of Colorado.

Garry S. Meyer was appointed as a director in November 2007. Dr. Meyer has more than 25 years of experience in the financial services industry, and is currently a Principal of GSMeyer & Associates LLC, a private equity and technology consulting firm. From 2006 to 2007, he was the Chief Information Officer of Agency and Personal Markets at Liberty Mutual Insurance. From 1998 to 2006, Dr. Meyer was Senior Vice President & Global IT Quality Leader for General Electric. At General Electric, he developed and implemented a strategy of core technology platforms and methods to enable leverage in multiple businesses and was a key contributor to LEAN Six Sigma new product introductions and best practice processes. Previously, Dr. Meyer was Managing Director, Trusted Services at SafeNet, Vice President at Marsh & McLennan, Principal & CIO at Smart Card International, Inc., Director, Information Technology at Citicorp POS Information Services, Inc., and Vice President, Management Information System at Standard & Poor’s. Dr. Meyer holds a M.S. in electrical engineering and computer science from the Massachusetts Institute of Technology (M.I.T.), a B.S. and Ph.D. from the State University of New York, and is certified in Six Sigma.

There are five committees of our Board of Directors, as set forth below. The members of each committee are appointed by the Board of Directors.

·Audit Committee. The Audit Committee oversees our financial reporting process on behalf of the Board of Directors and reports to the Board of Directors the results of these activities, including the systems of internal controls that management and the Board of Directors have established, our audit and compliance process and financial reporting. The Audit Committee, among other duties, engages the independent public accountants retained as the registered public accounting firm, pre-approves all audit and non-audit services provided by the independent public accountants, reviewsconnection with the independent public accountants the plansoffer and results of the audit engagement, considers the compatibilitysale of any non-audit services provided by the independent public accountants with the independence of such auditors and reviews the independence of the independent public accountants. The members of the Audit Committee are Louis P. Panetta, C. B. Sung and David E. Welch.  Mr. Welch serves as the Audit Committee’s financial expert.  Each member of the Audit Committee is independent as definedsecurities be distributed or published in any jurisdiction, except under applicable rules and regulations.  The Audit Committee conducted four meetingscircumstances that will result in the year ended December 31, 2007 and all members attended all of the meetings.  A copy of the Audit Committee charter can be found at our website, www.cic.com.

34



·Finance Committee. The Finance Committee develops strategies for the financing and development of the Company and monitors and evaluates progress toward established objectives. The members of the Finance Committee are Louis P. Panetta and C. B. Sung. During the year the Finance Committee discussions were held concurrently with the three meetings of the Board of Directors.

·Compensation Committee. The Compensation Committee generally reviews compensation matters with respect to executive and senior management arrangements and administer the Company’s stock option plans. The members of the Compensation Committee are Louis P. Panetta, C. B. Sung, and David Welch. The Compensation Committee held no formal meetings but acted by unanimous written consent eleven times. The Board has adopted a Compensation Committee Charter, a copy of which can be found on our website, www.cic.com.

·Nominating Committee. The Nominating Committee is responsible for considering and making recommendations to the Board concerning the appropriate size, functions and needs of the Board.  The Nominating Committee reviews the appropriate skills and characteristics required of directors in the context of prevailing business conditions. The objective of the Nominating Committee is to create and sustain a Board that brings to the Company a variety of perspectives and skills derived from high-quality business and professional experience. Directors should possess the highest personal and professional ethics, integrity, and values, and be committed to representing the long-term interests of the stockholders. They must also have an inquisitive and objective perspective, practical wisdom, and mature judgment. We endeavor to have a Board representing diverse experience at policy-making levels in business, government, education, and technology, and in areas that are relevant to the Company’s business activities. Directors must be willing to devote sufficient time to carrying out their duties and responsibilities effectively, and should be committed to serving on the Board for an extended period of time.

During 2007, Nominating Committee discussions were held concurrently with the meetings of the Board of Directors.  The Nominating Committee determined in 2007 that one additional board seat be authorized in order to add an individual with financial services industry experience.  The Board filled this new seat by appointing Garry Meyer as a director in November 2007.  The members of the Nominating Committee are Louis P. Panetta, and C. B. Sung.  The Board has adopted a Nominating Committee Charter, a copy of which can be found on our website, www.cic.com.

·Best Practices Committee.  The Board concluded in October, 2007 that the interests of the Company would be best served by the creation of a Best Practices Committee.  The purpose of the Best Practices Committee is to enhance both the sales and product development processes by developing a standardized set of practices to maintain and improve the Company’s market leadership position.  The Board has designated Garry Meyer as the chairman of the Best Practices Committee and appointed Guido DiGregorio and Louis Panetta as members. The Best Practices Committee was formed in November 2007and held no formal meetings in 2007.

Code of Business Conduct and Ethics

We have adopted a written code of business conduct and ethics, referred to as our Code of Business Conduct and Ethics, which applies to all of our directors, officers, and employees, including our principal executive officer, our principal financial and accounting officer, and our chief product officer. The code addresses, among other things, conflicts of interest, compliance with disclosure controls and procedures and internal control over financial reporting, corporate opportunities and confidentiality requirements. Pursuant to the Code of Business Conduct and Ethics, authorization from the Audit Committee is required for a director or officer to enter into a related party transaction or a similar transaction which could result in a conflict of interest. Conflicts of interest are prohibited unless specifically authorized in accordance with the Code of Ethics. A copy of the Code of Business Conduct and Ethics is posted on the Company’s web site, at www.cic.com. The Company intends, when applicable, to post amendments to or waivers from the Code of Conduct and Ethics (to the extent applicable to its senior executive and financial officers) on its website and in any manner otherwise required by the applicable standards or best practices.

35



Compensation Committee Interlocks and Insider Participation in Compensation Decisions

Our Compensation Committee is currently comprised of Messrs. Panetta,  Sung, and Welch all of whom are independent directors.

Director Independence

The Board has determined that each of our directors, except Mr. DiGregorio, is independent within the meaning of the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.

Australia

This prospectus is not a disclosure document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian Securities and Investments Commission and does not purport to include the information required of a disclosure document under Chapter 6D of the Australian Corporations Act. Accordingly, (i) the offer of the securities under this prospectus is only made to persons to whom it is lawful to offer the securities without disclosure under Chapter 6D of the Australian Corporations Act under one or more exemptions set out in section 708 of the Australian Corporations Act, (ii) this prospectus is made available in Australia only to those persons as set forth in clause (i) above, and (iii) the offeree must be sent a notice stating in substance that by accepting this offer, the offeree represents that the offeree is such a person as set forth in clause (i) above, and, unless permitted under the Australian Corporations Act, agrees not to sell or offer for sale within Australia any of the securities sold to the offeree within 12 months after its transfer to the offeree under this prospectus.

China

The information in this document does not constitute a public offer of the securities, whether by way of sale or subscription, in the People’s Republic of China (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan). The securities may not be offered or sold directly or indirectly in the PRC to legal or natural persons other than directly to “qualified domestic institutional investors.”

56

TABLE OF CONTENTS

European Economic Area—Belgium, Germany, Luxembourg and Netherlands

The information in this document has been prepared on the basis that all offers of securities will be made pursuant to an exemption under the Directive 2003/71/EC (“Prospectus Directive”), as implemented in Member States of the European Economic Area (each, a “Relevant Member State”), from the requirement to produce a prospectus for offers of securities.

An offer to the public of securities has not been made, and may not be made, in a Relevant Member State except pursuant to one of the following exemptions under the Prospectus Directive as implemented in that Relevant Member State:

(a)to legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities;
(b)to any legal entity that has two or more of (i) an average of at least 250 employees during its last fiscal year; (ii) a total balance sheet of more than €43,000,000 (as shown on its last annual unconsolidated or consolidated financial statements) and (iii) an annual net turnover of more than €50,000,000 (as shown on its last annual unconsolidated or consolidated financial statements);
(c)to fewer than 100 natural or legal persons (other than qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive) subject to obtaining the prior consent of the Company or any underwriter for any such offer; or
(d)in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of securities shall result in a requirement for the publication by the Company of a prospectus pursuant to Article 3 of the Prospectus Directive.

France

This document is not being distributed in the context of a public offering of financial securities (offre au public de titres financiers) in France within the meaning of Article L.411-1 of the French Monetary and Financial Code (Code monétaire et financier) and Articles 211-1 et seq. of the General Regulation of the French Autorité des marchés financiers (“AMF”). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France.

This document and any other offering material relating to the securities have not been, and will not be, submitted to the AMF for approval in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France.

Such offers, sales and distributions have been and shall only be made in France to (i) qualified investors (investisseurs qualifiés) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2° and D.411-1 to D.411-3, D. 744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation and/or (ii) a restricted number of non-qualified investors (cercle restreint d’investisseurs) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2° and D.411-4, D.744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation.

Pursuant to Article 211-3 of the General Regulation of the AMF, investors in France are informed that the securities cannot be distributed (directly or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 to L.621-8-3 of the French Monetary and Financial Code.

Hong Kong

The securities may not be offered or sold in Hong Kong by means of any document other than (1) in circumstances which do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), (2) to “professional investors” within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder, or (3) in other circumstances which do not result in the document being a “prospectus” within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating to the securities may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to securities which are or are intended to be disposed

57

TABLE OF CONTENTS

of only to persons outside Hong Kong or only to “professional investors” within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder.

Ireland

The information in this document does not constitute a prospectus under any Irish laws or regulations and this document has not been filed with or approved by any Irish regulatory authority as the information has not been prepared in the context of a public offering of securities in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations 2005 (the “Prospectus Regulations”). The securities have not been offered or sold, and will not be offered, sold or delivered directly or indirectly in Ireland by way of a public offering, except to (i) qualified investors as defined in Regulation 2(l) of the Prospectus Regulations and (ii) fewer than 100 natural or legal persons who are not qualified investors.

Israel

The securities offered by this prospectus have not been approved or disapproved by the Israeli Securities Authority (the ISA), or ISA, nor have such securities been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public in Israel, absent the publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection with the offering or publishing the prospectus; nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered an opinion as to the quality of the securities being offered. Any resale in Israel, directly or indirectly, to the public of the securities offered by this prospectus is subject to restrictions on transferability and must be effected only in compliance with the Israeli securities laws and regulations.

Italy

The offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission (Commissione Nazionale per le Societ—$$—Aga e la Borsa, “CONSOB” pursuant to the Italian securities legislation and, accordingly, no offering material relating to the securities may be distributed in Italy and such securities may not be offered or sold in Italy in a public offer within the meaning of Article 1.1(t) of Legislative Decree No. 58 of 24 February 1998 (“SEC”Decree No. 58”), other than:

to Italian qualified investors, as defined in Article 100 of Decree no.58 by reference to Article 34-ter of CONSOB Regulation no. 11971 of 14 May 1999 (“Regulation no. 1197l”) as amended (“Qualified Investors”); and
in other circumstances that are exempt from the rules on public offer pursuant to Article 100 of Decree No. 58 and Article 34-ter of Regulation No. 11971 as amended.

Any offer, sale or delivery of the securities or distribution of any offer document relating to the securities in Italy (excluding placements where a Qualified Investor solicits an offer from the issuer) under the paragraphs above must be:

made by investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with Legislative Decree No. 385 of 1 September 1993 (as amended), Decree No. 58, CONSOB Regulation No. 16190 of 29 October 2007 and any other applicable laws; and
in compliance with all relevant Italian securities, tax and exchange controls and any other applicable laws.

Any subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement rules provided under Decree No. 58 and the director independence standardsRegulation No. 11971 as amended, unless an exception from those rules applies. Failure to comply with such rules may result in the sale of such securities being declared null and void and in the liability of the entity transferring the securities for any damages suffered by the investors.

Japan

The NASDAQ Stock Market, Inc. (“NASDAQ’)securities have not been and will not be registered under Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948), as currentlyamended (the “FIEL”) pursuant to an exemption from the registration requirements applicable to a private placement of securities to Qualified Institutional Investors (as defined in effect.  Furthermore, the board has determined that eachand in accordance with Article 2, paragraph 3 of the membersFIEL and the regulations promulgated thereunder).

58

TABLE OF CONTENTS

Accordingly, the securities may not be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, eachany resident of Japan other than Qualified Institutional Investors. Any Qualified Institutional Investor who acquires securities may not resell them to any person in Japan that is not a Qualified Institutional Investor, and acquisition by any such person of securities is conditional upon the execution of an agreement to that effect.

Portugal

This document is not being distributed in the context of a public offer of financial securities (oferta pública de valores mobiliários) in Portugal, within the meaning of Article 109 of the committeesPortuguese Securities Code (Código dos Valores Mobiliários). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal. This document and any other offering material relating to the securities have not been, and will not be, submitted to the Portuguese Securities Market Commission (Comissão do Mercado de Valores Mobiliários) for approval in Portugal and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in Portugal, other than under circumstances that are deemed not to qualify as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of securities in Portugal are limited to persons who are “qualified investors” (as defined in the Portuguese Securities Code). Only such investors may receive this document and they may not distribute it or the information contained in it to any other person.

Sweden

This document has not been, and will not be, registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority). Accordingly, this document may not be made available, nor may the securities be offered for sale in Sweden, other than under circumstances that are deemed not to require a prospectus under the Swedish Financial Instruments Trading Act (1991:980) (Sw. lag (1991:980) om handel med finansiella instrument). Any offering of securities in Sweden is limited to persons who are “qualified investors” (as defined in the Financial Instruments Trading Act). Only such investors may receive this document and they may not distribute it or the information contained in it to any other person.

Switzerland

The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (“SIX”) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the board is “independent”Swiss Code of Obligations or the disclosure standards for listing prospectuses under the applicable rules and regulationsart. 27 ff. of the SECSIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering material relating to the securities may be publicly distributed or otherwise made publicly available in Switzerland.

Neither this document nor any other offering material relating to the securities have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the director independence standardsoffer of NASDAQ, as currentlysecurities will not be supervised by, the Swiss Financial Market Supervisory Authority (FINMA).

This document is personal to the recipient only and not for general circulation in effect.Switzerland.

United Arab Emirates

Executive Officers

The following table sets forth, asNeither this document nor the securities have been approved, disapproved or passed on in any way by the Central Bank of the date of this prospectus, the name and age of each executive officer of the Company, and all positions and offices of the Company presently held by each of them.

Name

Age

Positions Currently Held

Guido D. DiGregorio

69

Chairman of the Board,
Chief Executive Officer and President

Francis V. Dane

56

Chief Legal Officer,
Secretary and Chief Financial Officer

Russel L. Davis

44

Chief Technology Officer &
Vice President, Product Development

Guido D. DiGregorio–See the discussion above under “Directors.”

Francis V. Dane was appointed the Company’s Secretary in February of 2002, its Chief Financial Officer in October 2001, its Human Resources Executive in September 1998 and he assumed the position of Chief Legal Officer in December of 1997.  From 1991 to 1997 he served as a Vice President and Secretary of the Company, and from 1988 to 1992 as its Chief Financial Officer and Treasurer.  Since July of 2000, Mr. Dane has also been the Secretary and Treasurer of Genyous Biomed International Inc. (including its predecessors and affiliates) a company in the biopharmaceutical field focused on the development of medical products and services for the prevention, detection and treatment of chronic illnesses such as cancer.  From October 2000 to April 2004, Mr. Dane served as a director of Perceptronix Medical, Inc. and SpectraVu Medical Inc., two companies focused on developing improved methods for the early detection of cancer. From October 2000 to June 2003 Mr. Dane was a director of CPC Cancer Prevention Centers Inc., a company focused on developing a comprehensive cancer prevention program based upon the detection of early stage, non-invasive cancer.  Prior to this Mr. Dane spent over a decade with PricewaterhouseCoopers, his last position was that of Senior Manager, Entrepreneurial Services Division.  Mr. Dane is a member of the State Bar of California and has earned a CPA certificate from the states of Connecticut and California.

Russel L. Davisrejoined the Company as Chief Product Officer in August of 2005 and now serves as its Chief Technology Officer and Vice President of Product Development.  He served as CTO of SiVault Systems, from November of 2004 to August of 2005.  Mr. Davis originally joined CIC in May of 1997 and was appointed Vice President of Product Development & Support in October of 1998. Prior to this, Mr. Davis served in a number of technical management roles including; Director of Service for Everex Systems, Inc., a Silicon Valley based PC manufacturer and member of the Formosa Plastics Group, managing regional field engineering operations for Centel Information Systems, which was acquired by Sprint. He also servedUnited Arab Emirates or any other governmental authority in the United States Navy supervising shipboard Electronic Warfare operations.

36



EXECUTIVE COMPENSATION

Summary Compensation Table

The following table sets forth compensation awardedArab Emirates, nor has the Company received authorization or licensing from the Central Bank of the United Arab Emirates or any other governmental authority in the United Arab Emirates to earned bymarket or paidsell the securities within the United Arab Emirates. This document does not constitute and may not be used for the purpose of an offer or invitation. No services relating to the Company’s Presidentsecurities, including the receipt of applications and/or the allotment or redemption of such shares, may be rendered within the United Arab Emirates by the Company.

No offer or invitation to subscribe for securities is valid or permitted in the Dubai International Financial Centre.

United Kingdom

Neither the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Services Authority in the United Kingdom and Chief Financial Officer, regardlessno prospectus (within the meaning of section 85 of the amount of compensation,Financial Services and each executive officerMarkets Act 2000, as amended (“FSMA”)) has been published or is intended to be

59

TABLE OF CONTENTS

published in respect of the Company assecurities. This document is issued on a confidential basis to “qualified investors” (within the meaning of December 31, 2007 whose total annual salary, bonus and option awards for 2007 exceeded $100,000 which we refer to as our “named executive officers.”

Name and Principal Position

 

Year

 

Salary
($)

 

Bonus
($)

 

Stock
Awards
($)

 

Option
Awards
($) (2)

 

Non-Equity
Incentive Plan
Compensation ($)

 

Change in
Pension
Value
And
Nonqualified
Deferred
Compensation
Earnings
($)

 

All Other
Compensation
($)

 

Total
($)

 

Guido DiGregorio

 

2007

 

200,000

 

 

 

 

 

 

9486

 

209,486

 

President & CEO

 

2006

 

285,000

(1)

 

 

 

 

 

9,072

 

294,072

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Frank Dane

 

2007

 

160,000

 

 

 

1,875

 

 

 

 

161,875

 

CLO & CFO

 

2006

 

160,000

 

 

 

7,400

 

 

 

 

167,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Russel Davis

 

2007

 

165,000

 

 

 

 

 

 

 

165,000

 

CTO

 

2006

 

165,000

 

 

 

 

 

 

 

165,000

 


(1)   Mr. DiGregorio’s salary was increased in February 2002 to $250,000.  In 2003 and 2004, Mr. DiGregorio voluntarily deferred approximately $70,000 in salary payments to ease cash flow requirements.  Mr. DiGregorio was paid his deferred salary from 2003 and 2004section 86(7) of approximately $70,000 and $70,000in January 2004 and 2005, respectively. In September of 2005, Mr. DiGregorio’s salary was increased to $285,000. As of December 2007, $85,000 of his 2007 salary has been deferred in order to ease cash constraints on the Company.

(2)   On January 1, 2006, the Company adopted SFAS No. 123(R), “Share-Based Payment Share-based compensation expense is based on the estimated grant date fair value of the portion of share-based payment awards that are ultimately expected to vest during the period.  The grant date fair value of stock-based awards to officers, employees and directors is calculated using the Black-Scholes option pricing model. Mr. DiGregorio has 1,950,000 options that are vested and exercisable within sixty days of December 31, 2007.  Mr. Dane has 443,943 options that are vested and exercisable within sixty days of December 31, 2007. Mr. Davis has 500,000 options that are vested and exercisable within sixty days of December 31, 2007. In accordance with applicable regulations, the value of such options does not reflect an estimate for features related to service-based vesting used by the Company for financial statement purposes. See footnote 6FSMA) in the Notes toUnited Kingdom, and the December 31, 2007 Consolidated Financial Statements included withsecurities may not be offered or sold in the United Kingdom by means of this registration statement on Form S-1.

There are no written employment agreements withdocument, any named executive officers, and employment of all named executive officers is at-will.

Grants of Plan-Based Awards

The board of directors approves awards under the Company’s 1999 Stock Option Plan and awards that are outside of the 1999 Stock Option Plan (“Individual Plans’). There were no awards made to our named executive officers under our 1999 Stock Option Plan or otherwise during fiscal years 2007 and 2006 as the boards review indicated that the number of options held by each named executive officer at that time were adequate to satisfy the long term goal underlying the granting of options in prior years. In July 2008, the Compensation Committee of the

37



Board of Directors approved stock option grants to Mr. DiGregorio, Mr. Davis and Mr. Dane of 600, 450, and 300 stock options, respectively, under Individual Plans.

The 1999 Option Plan is administered by the board of directors or a stock option committee of the board.  The boardaccompanying letter or any such committee hasother document, except in circumstances which do not require the authoritypublication of a prospectus pursuant to determine the terms of the options granted, including the exercise price, number of shares subject to each option, vesting provisions, if any, and the form of consideration payable upon exercise.  The exercise price of incentive options mustsection 86(1) FSMA. This document should not be less than the fair market value of the common stock valued at the date of grant and the exercise price for non-qualified options must be at least 85% of the fair market value of the common stock valued at the date of grant.  The expiration date of options is determined by the boarddistributed, published or committee, but options cannot expire later than ten years from the date of grant, and in the case of incentive options granted to stockholders owning at least 10% of the Company’s stock, cannot expire later than five years from the date of grant.  Options have typically been granted with an expiration date seven years after the date of grant.

If an employee to whom an award has been granted under the 1999 Option Plan dies while providing services to the Company, retires from employment with the Company after attaining his retirement date, or terminates employment with the Company as a result of permanent and total disability, the restrictions then applicable to such award shall continue as if the employee had not terminated employment and such award shall thereafter be exercisable,reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other person in the personUnited Kingdom.

Any invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) received in connection with the issue or sale of the securities has only been communicated or caused to be communicated and will only be communicated or caused to be communicated in the United Kingdom in circumstances in which section 21(1) of FSMA does not apply to the Company.

In the United Kingdom, this document is being distributed only to, and is directed at, persons (i) who have professional experience in matters relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (“FPO”), (ii) who fall within the categories of persons referred to in Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the FPO or (iii) to whom it was granted (or by his duly appointed, qualified,may otherwise be lawfully communicated (together “relevant persons”). The investments to which this document relates are available only to, and acting personal representative, his estate,any invitation, offer or by aagreement to purchase will be engaged in only with, relevant persons. Any person who acquiredis not a relevant person should not act or rely on this document or any of its contents.

60

TABLE OF CONTENTS

TRANSFER AGENT AND REGISTRAR

The transfer agent and registrar for our common stock and warrants is American Stock Transfer & Trust Company, LLC, 6201 15th Avenue, Brooklyn, NY 11219, telephone number 718-921-8200.

LEGAL MATTERS

The validity of the right to exercise such option by bequest or inheritance from the grantee), in the manner set forth in the award, at any time within the remaining term of such award. Options not vested at the time of death, retirement, termination or disability cease to vest.  Except as provided in the preceding paragraph, generally if a person to whom an optionsecurities offered hereby has been granted underpassed upon for us by Pillsbury Winthrop Shaw Pittman LLP, New York, New York. Certain legal matters in connection with this offering have been passed upon for the 1999 Option Plan ceases to be an employee of the Company, such options vested at the date of termination shall continue to be exercisable to the same extent that it was exercisable on the last day on which such person was an employee for a period of 90 days thereafter, or for such longer period as may be determinedunderwriters by the Committee, whereupon such option shall terminate and shall not thereafter be exercisable.Sichenzia Ross Friedman Ference LLP, New York, New York.

The board has the authority to amend or terminate the 1999 Option Plan, provided that such action does not impair the rights of any optionee under any option previously granted under the 1999 Option Plan, without the consent of such optionee.

Incentive and non-qualified options under the 1999 Option Plan may be granted to employees, officers, and consultants of the Company.  There are 4,000,000 shares of common stock authorized for issuance under the 1999 Option Plan. The options generally have a seven year life and vest quarterly over three years. As of July 31, 2008, options to acquire 3,551,718 shares of common stock were outstanding under the 1999 Option Plan and options to acquire 3,269,957 shares of common stock were exercisable with a weighted average exercise price of $0.57 per share. At July 31,2008, there were 267,137 shares available for future grants under the 1999 Option Plan.

Individual Plan OptionsEXPERTS

The Company also grants options to employees, directors and consultants outside of the 1999 Stock Option Plan pursuant to Individual Plans. These options are granted with the same terms as those granted under the 1999 Stock Option Plan, except all such options Non-Qualified Stock Options. The Company has issued non-plan options to its employees and directors pursuant to Individual Plans.  As of July 31, 2008, options to acquire 4,064,443 shares under such Individual Plans were outstanding and 2,643,643 were exercisable with a weighted average exercise price of $0.27 per share.

Option Exercises and Stock Vested

In fiscal 2007, no stock options were exercised and 33,320 options to purchase stock granted to Mr. Dane vested during the period.  The Company does not grant or issue restricted stock or other equity-based incentives.

38



Outstanding Equity Awards at Fiscal 2007 Year End

The following table summarizes the outstanding equity award holdings held by our named executive officersOur consolidated balance sheet as of December 31, 2007. The Company does not grant performance based options under its equity incentive plans,2015 and the Company does not grant or issue restricted stock awards.

Name and Principal Position

 

Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)

 

Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)

 

Option
Exercise
Price ($)(4)

 

Option
Expiration
Date (5)

 

Guido DiGregorio, President & CEO (1)

 

250,000

 

 

$

0.79

 

2009

 

 

 

425,000

 

 

$

0.39

 

2012

 

 

 

1,275,000

 

 

$

0.75

 

2012

 

 

 

 

 

 

 

 

 

 

 

Frank Dane, CLO & CFO (2)

 

100,000

 

 

$

0.79

 

2009

 

 

 

100,000

 

 

$

0.33

 

2010

 

 

 

100,000

 

 

$

0.55

 

2011

 

 

 

35,985

 

 

$

0.39

 

2012

 

 

 

107,958

 

 

$

0.75

 

2012

 

 

 

 

 

 

 

 

 

 

 

Russel Davis, CIO (3)

 

125,000

 

 

$

0.57

 

2012

 

 

 

375,000

 

 

$

0.75

 

2012

 


(1)         Mr. DiGregorio options vested as follows: 250,000 options vested prorata quarterly over three years; 425,000 options vested on the date of grant; and 1,275,000 options vested on the date of grant.

(2)         Mr. Dane’s options vested as follows: 100,000 options vested prorata quarterly over three years; 100,000 options vested prorata quarterly over three years; 100,000 options vested prorata quarterly over three years; 35,985 options vested on the date of grant; and 107,958 options vested on the date of grant.

(3)          Mr. Davis’s options vested as follows: 125,000 options vested on the date of grant; and 375,000 options vested on the date of grant.

(4)         Mr. DiGregorio holds options to acquire 250,000 shares granted under the 1999 Option Plan and options to acquire 1,700,000 shares under Individual Plans. Mr. Dane holds 300,000 options to acquire shares granted under the 1999 Option Plan and options to acquire 143,943 shares granted under Individual Plans. Mr. Davis holds options to acquire 500,000 shares granted under the 1999 Option Plan.

(5)         All options granted will expire seven years from the date of grant, subject to continuous employment with the Company.

Nonqualified Deferred Compensation

None of the named executives participate in or have account balances in non-qualified defined contribution plans or other deferred compensation plans maintained by the Company, except the Chief Executive Officer who, as stated above, began deferring a portion of his salary in January of 2007 in order to ease cash constraints on the Company. The compensation committee, which is comprised solely of “outside directors” as defined for purposes of Section 162(m) of the Internal Revenue Code, may elect to provide our officers and other employees with non-qualified defined contribution or deferred compensation benefits if the compensation committee determines that doing so is in our best interests.

DIRECTOR COMPENSATION

For their services as directors of the Company, all non-employee directors receive a fee of $1,000 for each board of directors meeting attended and all directors are reimbursed for all reasonable out-of-pocket expenses incurred in connection with attending such meetings. First time directors receive options to acquire 50,000 shares of the Company’s common stock upon joining the board and options to acquire 25,000 shares each time they are elected to the board thereafter.  The exercise prices of all options granted to directors are equal to the market closing price on the date of grant, vest immediately and have a seven year life.

39



In June 2007, Louis Panetta, C. B. Sung and David Welch were each granted immediately exercisable non-qualified options to purchase 25,000 shares of common stock at an exercise price of $0.18 per share (the then current market price of the Company’s stock), which options expire on June 25, 2014.

In September 2007 Mr. Panetta was granted immediately exercisable non-qualified options to purchase 50,000 shares of common stock at an exercise price of $0.22 per share (the then current market price of the Company’s stock), which options expire on September 25, 2014.

In December Garry Meyer was appointed to the Company’s Board of Directors.  Upon his appointment, Mr. Meyer was granted immediately exercisable non-qualified options to purchase 50,000 shares of common stock at an exercise price of $0.25 per share (the then current market price of the Company’s stock), which options expire on December 11, 2014.

The following table sets forth a summary of the compensation paid to our directors during 2007.

Name

 

Fees Earned
Or Paid in
Cash
($)

 

Stock
Awards
($)

 

Option
Awards
($)

 

Non-Equity
Incentive
Plan
Compensation
($)

 

Deferred
Compensation
Earnings
($)

 

All Other
Compensation
($)

 

Total
($)

 

Louis P. Panetta (1)

 

$

3,000

 

$

 

$

10,173

 

$

 

$

 

$

 

$

13,173

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

C. B. Sung (2)

 

$

3,000

 

$

 

$

7,072

 

$

 

$

 

$

 

$

10,072

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

David E. Welch (3)

 

$

3,000

 

$

 

$

2,898

 

$

 

$

 

$

 

$

5,898

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Garry Meyer (4)

 

$

1,000

 

 

$

2,898

 

$

 

$

 

$

 

$

5,898

 


(1) Mr. Panetta holds options to acquire 253,125 shares of stock at December 31, 2007, all of which were vested.

(2) Mr. Sung holds options to acquire 226,190 shares of stock at December 31, 2007, all of which were vested.

(3) Mr. Welch holds options to acquire 125,000 shares of stock at December 31, 2007, all of which were vested.

(4) Mr. Meyer holds options to acquire 50,000 shares of stock at December 31, 2007, all of which were vested.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

As of August 18, 2008, a total of 129,057,161 shares of our common stock were outstanding. The following table shows information regarding the beneficial ownership of shares of our common stock as of August 18, 2008 and shows the number of and percentage owned by:

·   each person who is known by us to own beneficially more than 5% of our common stock;

·   each member of our Board of Directors;

·   each of our named executive officers; and

·   all members of our Board of Directors and our executive officers as a group.

Except as indicated in the footnotes to this table (i) each person has sole voting and investment power with respect to all shares attributable to such person and (ii) each person’s address is c/o Communication Intelligence Corporation, 275 Shoreline Drive, Suite 500, Redwood Shores, California 94065-1413.

40



 

 

Common Stock

 

Name of Beneficial Owner

 

Number
of Shares(1)

 

Percent
of Class(1)

 

5% Stockholders:

 

 

 

 

 

Phoenix Venture Fund LLC (2)

 

41,714,285

 

32.3

%

Michael W. Engmann (3)

 

16,057,562

 

14.8

%

 

 

 

 

 

 

Named Executive Officers and Directors:

 

 

 

 

 

Guido DiGregorio (4)

 

2,243,900

 

1.7

%

C. B. Sung (5)

 

1,844,420

 

1.4

%

Louis P. Panetta (6)

 

225,000

 

 

*

Welch, David E. (7)

 

175,000

 

 

*

Francis V. Dane (8)

 

519,155

 

 

*

Russel L. Davis (9)

 

612,500

 

 

*

Garry S. Meyer (10)

 

75,000

 

 

*

All directors and executive officers as a group (6 persons)

 

5,550,863

 

4.31

%


* Less than 1%.

(1)

Shares of common stock beneficially owned and the respective percentages of beneficial ownership of common stock assumes the exercise or conversion of all options, warrants and other securities convertible into common stock beneficially owned by such person or entity currently exercisable or exercisable within 60 days of the date hereof. Shares issuable pursuant to the exercise of stock options and warrants exercisable within 60 days, or securities convertible into common stock within 60 days are deemed outstanding and held by the holder of such shares of common stock, options, warrants, or other convertible securities for computing the percentage of outstanding common stock beneficially owned by such person, but are not deemed outstanding for computing the percentage of outstanding common stock beneficially owned by any other person. The percentage of beneficial ownership of common stock beneficially owned is based on 129,057,161 shares of common stock outstanding as of August 18, 2008.

(2)

Represents (a) 21,500,000 shares owned by SG Phoenix Ventures LLC, and (b) 20,214,285 warrants owned by  SG Phoenix Ventures LLC . SG Phoenix Ventures LLC is the Managing Member of Phoenix Venture Fund LLC (the “Phoenix Fund”), with the power to vote and dispose of the shares of common stock held by the Phoenix Fund. Accordingly, SG Phoenix Ventures LLC may be deemed to be the beneficial owner of such shares. Andrea Goren is the co-manager of SG Phoenix Ventures LLC, has the shared power to vote and dispose of the shares of common stock held by the Phoenix Fund and, as such, may be deemed to be the beneficial owner of the common shares owned by the Phoenix Fund. Philip Sassower is the co-manager of SG Phoenix Ventures LLC, has the shared power to vote and dispose of the shares of common stock held by the Phoenix Fund and, as such, may be deemed to be the beneficial owner of the common shares owned by the Phoenix Fund. SG Phoenix Ventures LLC, Mr. Goren and Mr. Sassower each disclaim beneficial ownership of the shares owned by the Phoenix Fund, except to the extent of their respective pecuniary interests therein. The address of such stockholder is 110 East 59th Street, Suite 1901, New York, NY 10022.

(3)

Represents (a) 17,750 shares held by Mr. Engmann and (b) 10,575,527 warrants beneficially owned by Mr. Engmann, of which 1,187,962 are held by MDNH Partners, L.P. and 1,659,200 are held by KENDU Partners Company of which Mr. Engmann is a partner and (c) 5,464,285 shares upon the conversion of 765,000 Series A Convertible preferred Shares at $0.14per share, of which 159,375 are convertible into 1,138,393 shares of common stock by MDNH Partners, L.P. and 340,000 Preferred Shares are convertible into 2,428,571 shares of common stock by KENDU Partners Company. Mr. Engmann was issued warrants to purchase 2,333,250 shares of the Company’s common stock at $0.51 per share, warrants to purchase 1,979,936 shares of the Company’s common stock at $0.25 per share and warrants to purchase 3,415,179 shares of the Company’s common stock at $0.14 per share. MDNH Partners, L.P. was issued warrants to purchase 1,659,200 shares of the Company’s common stock at $0.51 per share, and MDNH Partners, L.P. was issued warrants to purchase 1,187,962 shares of the Company’s common stock at $0.25 per share. Such warrants were issued in connection with notes issued in 2006 and 2007.

(4)

Represents (a) 143,900 shares of common stock held by Mr. DiGregorio and (b) 2,100,000 shares of common    stock, issuable upon the exercise of stock options exercisable within 60 days hereof.

(5)

Includes (a) 1,631,051 shares of common stock held by the Sung Family Trust, of which Mr. Sung is a trustee, (b) 3,369 shares of common stock held by the Sung-Kwok Foundation, of which Mr. Sung is the Chairman, and

41



(c) 210,000 shares of common stock issuable upon the exercise of stock options. Mr. Sung may be deemed to beneficially own the shares held by the Sung Family Trust and the Sung-Kwok Foundation. The business address of Mr. Sung is, UNISON Group, 1001 Bayhill Dr., 2nd Floor, San Bruno, California 94066.

(6)

Represents 225,000 shares issuable upon the exercise of options exercisable within 60 days hereof.  Mr. Panetta’s business address is 827 Via Mirada, Monterey, California 93940.

(7)

Represents 175,000 shares issuable upon the exercise of stock options exercisable within 60 days hereof.  The business address of Mr. Welch is 1729 East Otero Avenue, Littleton, CO 80122.

(8)

Represents (a) 212 shares held by Mr. Dane and (b) 518,943 shares issuable upon the exercise of stock options exercisable within 60 days hereof.

(9)

Represents 612,500 shares issuable upon the exercise of stock options within 60 days hereof.

(10)

Represents 75,000 shares issuable upon the exercise of stock options exercisable within 60 days hereof. The business address of Mr. Meyer is 4 Nersesian Way, Hampton, NH 03842.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

In February 2007, the Company entered into a Note and Warrant Purchase Agreement (the “February 2007 Purchase Agreement”) and a Registration Rights Agreement (the “February 2007 Registration Rights Agreement”), each dated as of February 5, 2007, with the Affiliated Stockholder.  The Company secured the right to borrow up to $600,000. On March 15, 2007 the Company and the Affiliated Stockholder amended the February 2007 Purchase Agreement to increase the maximum amount of borrowing from $600,000, to $1,000,000. The terms of the February 2007 Purchase Agreement and 2006 Purchase Agreement are identical with the exception that the maximum number of warrants that may be issued under the February 2007 Purchase Agreement is 5,185,000  rather than 3,111,000. On March 30, 2007, and April 1, 2007 the Company borrowed $670,000 and $50,000 under the February 2007 Purchase Agreement of which $320,000 pertains to Mr. Engmann and the remaining $400,000 from unrelated third parties.  The proceeds were used for working capital purposes. The warrants have a three year life, became exercisable on June 30, 2007, and have an exercise price of $0.51.  The warrants included piggyback registration rights for the underlying shares to participate in any future registrations of the Company’s common stock.  The shares were registered with the Company’s Form S-1/A which was declared effective December 28, 2007.

On June 15, 2007, the Company entered into a Note and Warrant Purchase Agreement (the “June 2007 Purchase Agreement”) and a Registration Rights Agreement (the “June 2007 Registration Rights Agreement”), each dated as of June 15, 2007. The Company secured the right to borrow up to $1,000,000.  The June 2007 Purchase Agreement required the Company to draw $400,000 of the funds upon signing.  As of December 31, 2007, the Company had borrowed $400,000 under this facility, all pertaining to Mr. Engmann, and the option to borrow the remaining $600,000 lapsed as of that date. The Company used the proceeds of the financing for working capital purposes.  The note bears interest at the rate of 15% per annum payable quarterly in cash. The Company issued 3,168,000 warrants to purchase shares of its common stock at an exercise price of $0.25. The warrants have a three year life and include piggyback registration rights for the underlying shares to participate in any future registrations of the Company’s common stock.  The shares were registered with the Company’s Form S-1/A which was declared effective December 28, 2007.

The Company paid approximately $102,000 in interest to Mr. Engmann as of December 31, 2007 related to the above Notes. (See Note 4 of Notes to Consolidated Financial Statements on page F-34 for additional details.)

On January 9, 2008, the Company entered into the Company’s standard form of Consulting Agreement (the “Consulting Agreement”) with GSMeyer & Associates LLC (the “Consultant Entity”), an entity of which Garry Meyer, a director of the Company, is a principal.  Mr. Meyer owns 50% of the Consultant Entity’s outstanding equity, and Mr. Meyer’s spouse owns the other 50% of the Consultant Entity’s outstanding equity.  Mr. Meyer and

42



his spouse share in the profits of the Consultant Entity in accordance with their ownership percentages.  Under the terms of the Consulting Agreement, the Consultant Entity is authorized to market the Company’s products as an independent contractor of the Company. The Consultant Entity is paid commissions equal to 7% of the license fees, professional service fees and of first year maintenance fees on sales closed with StateStreet Bank and  ING (of Eastern Europe) , subject to the Company having received payment of such fees from such customers prior to the payment of the above described commissions.  The Consultant Entity is also entitled to reimbursement of reasonable travel and other out-of-pocket expenses incurred in the performance of its obligations under the Consulting Agreement, provided that the Consultant Entity provides receipts and obtains prior approval from the Company’s Chief Executive Officer for such expenses. Either the Company or the Consultant Entity may terminate the Consulting Agreement at any time upon thirty days’ written notice to the other party and the accounts covered by the Consulting Agreement my be changed from time to time by mutual agreement

On June 5, 2008, we executed documents and closed a financing transaction under which the Company raised capital through the issuance of secured indebtedness and equity and also restructured a portion of the Company’s existing debt.  In connection with the transaction, we borrowed an aggregate of $3,000,000 and refinanced $637,500 of existing indebtedness and accrued interest on that indebtedness.  The new and refinanced debt bears interest at 8% per annum which, at the option of the Company, may be paid in cash or in kind and matures two years from issue date and is secured by a first priority security interest in all of our assets.  In partial consideration for the respective loans made as described above, we issued to each creditor a warrant to purchase the number of shares of our common stock obtained by dividing the amount of such creditor’s loan by 0.14.  An aggregate of 25,982,143 shares of our common stock may be issued upon exercise of these warrants.  The warrants are exercisable at the option of the holders, until June 30, 2011, with an exercise price of $0.14 per share.  Additional warrants may be issued if we exercise our option to make interest payments on the loans in-kind.

In connection with the closing of the financing transaction, we also entered into a Securities Purchase Agreement and a Registration Rights Agreement, each dated as of June 5, 2008.  Under the Securities Purchase Agreement, in exchange for the cancellation of $995,000 in principal and $45,000 of interest accrued thereon of our existing debt and interest accrued thereon, we issued to the holders of such debt an aggregate of 1,040,000 shares of our Series A Cumulative Convertible Preferred Stock.  The preferred shares carry an 8% annual dividend, payable quarterly in arrears in cash or in additional preferred shares, have a liquidation preference over common stock of $1.00 per share and are convertible into shares of common stock at the conversion price of $0.14 per share.  Thus, at the current applicable conversion rate, one share of Series A Cumulative Convertible Preferred Stock would convert into 7,428,571 shares of our common stock.  The shares of preferred stock are convertible at any time at the option of the holders thereof.

Certain parties to the financing transactions have a pre-existing relationship with the Company and, with respect to such parties, the financing transactions may be considered related party transactions.  In August 2007, the Company entered into a Securities Purchase and Registration Rights Agreement (the “2007 Purchase Agreement”) and related agreements and documents with Phoenix Venture Fund LLC (“Purchaser”), one of the Creditors.  Under the terms of that transaction, the Company issued 21,500,000 shares of the Company’s common stock at a price per share of approximately $0.14, for an aggregate purchase price of $3,000,000. An advisory fee of $250,000 was paid to the managing member of the Purchaser for services rendered in connection with the transaction. The Company was permitted under the terms of the 2007 Purchase Agreement to use up to $1,400,000 of the net proceeds to repay outstanding indebtedness.  As of the date hereof, the Purchaser, directly or through one or more affiliate, owns 21,500,000 shares of Common Stock.  Pursuant to the terms of the 2007 Purchase Agreement, the Purchaser has the right to appoint two Board observers.  Philip Sassower, a principal of the Purchaser, has been appointed by the Purchaser as an observer.  The Company is prohibited from selling or otherwise disposing of material properties, assets or rights of the Company without the consent of the Creditors holding a majority of the aggregate principal amount of the Loans, and the Purchaser by itself holds such an amount.  In addition to the securities noted above, in connection with the financing transactions, the Purchaser received a fee of $100,000 and the Company paid approximately $225,000 in legal fees to Phoenix’s law firm.

Michael Engmann, and certain of his affiliates, and Ronald Goodman each are holders of the Company’s debt. A portion of the debt held by Mr. Engmann, and all of the debt held by Mr. Engmann’s affiliates, including accrued and unpaid interest through May 31, 2008, was exchanged for Preferred Shares. The remainder of the debt held by Mr. Engmann, and all of the debt held by Mr. Goodman, including accrued and unpaid interest through May 31,

43



2008, was refinanced pursuant to the Credit Agreement, as described above.  The debt being so exchanged or refinanced was originally issued in four transactions between August 2006 and June 2007 pursuant to certain Note and Warrant Purchase Agreements. The debt being so exchanged,2014, and the related Noteconsolidated statements of operations, comprehensive loss, statements of stockholders’ equity (deficit), and Warrant Purchase Agreements, will be terminated in connection with the financing transactions.  In addition to the debt held by Messrs. Engmann and Goodman, they hold warrants to acquire up to 7,938,098 shares in the aggregate.  These warrants are exercisable until June 30, 2010 and include piggyback registration rightsstatements of cash flows for the underlying shares to participateperiod ended December 31, 2015 and 2014 have been audited by Armanino LLP, an independent registered public accounting firm, as set forth in certain future registrationsits report appearing herein and are included in reliance upon such report given on the authority of the Company’s common stock. In connection with the financing transactions, Mr. Engmannsuch firm as experts in accounting and Mr. Goodman each received Warrants as described above.auditing.

We granted the investors registration rights for the full number of shares represented by the warrants and conversion rights of our preferred stock issued to the investors on June 5, 2008. This registration statement is intended to satisfy our registration obligations to the holders of the convertible preferred stock and warrants.

Indemnification Agreements

We have agreed to indemnify, to the full extent permitted by the laws of the State of Delaware, any current or former directors and officers who are made, or threatened to be made, a party to an action or proceedings, whether criminal, civil, administrative or investigative, by reason of the fact that such person or such persons is or was a director or officer of the Company, or served any other enterprise as a director or officer at the request of the Company. The DGCL also authorizes us to purchase insurance for our directors and officers insuring them against risks as to which we may be unable lawfully to indemnify them. We have obtained limited insurance coverage for our officers and directors as well as insurance coverage to reimburse us for potential costs of our corporate indemnification of officers and directors.

SHARES ELIGIBLE FOR FUTURE SALE

Sales of substantial amounts of common stock in the public market following the offering could adversely affect the market price of the common stock and adversely affect our ability to raise capital at a time and on terms favorable to us. As of August 18, 2008, we had 129,057,161 shares of common stock issued and outstanding, 41,131,478 shares of common stock reserved for issuance under outstanding warrants, 7,616,161 shares of common stock reserved for issuance upon exercise of options at a weighted average purchase price of $0.48 per share and 267,131 for options which may be granted in the future. See “Description of Securities.” As of August 18, 2008, 5,855,250 options to purchase our common stock are vested and exercisable.

WHERE YOU CAN FIND MORE INFORMATION

We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares and warrants offered hereby. This prospectus, which constitutes a part of the registration statement, does not contain all of the information in the registration statement and the exhibits of the registration statement. For further information with respect to us and the securities being offered under this prospectus, we refer you to the registration statement, including the exhibits and schedules thereto.

You may read and copy the registration statement of which this prospectus is a part at the SEC’s Public Reference Room, which is located at 100 F Street, N.E., Washington, D.C. 20549. You can request copies of the registration statement by writing to the SEC and related exhibitspaying a fee for the copying cost. Please call the SEC at 1-800-SEC-0330 for more information about the operation of the SEC’s Public Reference Room. In addition, the SEC maintains an Internet web site, which is located at www.sec.gov, which contains reports, proxy and information statements and other information regarding issuers that file electronically with the United States Securities and Exchange Commission underSEC. You may access the Securities Act of 1933, as amended. The registration statement contains additionalof which this prospectus is a part at the SEC’s Internet web site. We are subject to the information about us. Wereporting requirements of the Exchange Act, and we will file annual, quarterly and special reports, proxy statements and other information with the United States Securities and Exchange Commission. You may read and copy any document we file at the Securities and Exchange Commission’s public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Our SEC fillings are also availableSEC.

61

TABLE OF CONTENTS

iSign Solutions Inc.
Index to the public from the SEC’s website at http://www.sec.gov.

LEGAL MATTERSConsolidated Financial Statements

Certain legal matters in connection with the resale of the securities held by the selling stockholders will be passed upon for us by Davis Wright Tremaine LLP, Portland, Oregon.

EXPERTS

GHP Horwath, P.C., independent registered public accounting firm, has audited our consolidated financial statements and schedule for the periods and to the extent set forth in their report dated March 10, 2008 appearing in this prospectus, which report expresses an unqualified opinion and includes an explanatory paragraph relating to the entity’s ability to continue as a going concern described in note 1 to the consolidated financial statements. We have included our audited financial statements and schedule in this prospectus in reliance on the report of such firm, given upon the firm’s authority as experts in accounting and auditing.

44



INDEX TO FINANCIAL STATEMENTS

Financial StatementsTABLE OF CONTENTS

PAGE NO.

Page

Unaudited Interim Condensed Consolidated Financial Statements of iSign Solutions Inc.

Condensed

Audited Consolidated Balance Sheets at June 30, 2008 (unaudited) and December 31, 2007

Financial Statements:

F-2

Condensed Consolidated Statements of Operations for the Three and Six-Month Periods Ended June 30, 2008 and 2007 (unaudited)

F-3

Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three and Six-Month Periods Ended June 30, 2008 (unaudited)

F-4

Condensed Consolidated Statements of Cash Flows for the Six-Month Periods Ended June 30, 2008 and 2007 (unaudited)

F-5

Notes to Unaudited Condensed Consolidated Financial Statements

F-7

Audited Annual Consolidated Financial Statements

F-16

F-17

F-18

F-19

F-20

F-22

Financial Statement Schedule

Schedule II Valuation and Qualifying Accounts and Reserves

F-42

F-1



Communication Intelligence Corporation

and Subsidiary

Condensed Consolidated Balance Sheets

(In thousands)

 

 

June 30

 

December 31

 

 

 

2008

 

2007

 

 

 

Unaudited

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

2,387

 

$

1,144

 

Accounts receivable, net of allowances of $136 and $117 at June 30, 2008 and December 31, 2007 respectively

 

244

 

452

 

Prepaid expenses and other current assets

 

84

 

135

 

Total current assets

 

2,715

 

1,731

 

Property and equipment, net

 

52

 

77

 

Patents

 

3,338

 

3,528

 

Capitalized software development costs

 

1,389

 

1,109

 

Deferred financing costs

 

433

 

 

Other assets

 

30

 

30

 

Total assets

 

$

7,957

 

$

6,475

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Short-term debt – net of unamortized fair value assigned to warrants of $9 and $350 at June 30, 2008 and December 31, 2007, including related party debt of $1,170 at December 31, 2007, net of unamortized fair value assigned to warrants

 

116

 

1,370

 

Accounts payable

 

124

 

135

 

Accrued compensation

 

297

 

364

 

Other accrued liabilities

 

442

 

298

 

Deferred revenue

 

384

 

431

 

Total current liabilities

 

1,363

 

2,598

 

 

 

 

 

 

 

Long-term debt –net of unamortized fair value assigned to warrants of $1,196 and $21 at June 30, 2008 and December 31, 2007, including related party debt of $2,458 at June 30, 2008, net of unamortized fair value assigned to warrants

 

2,559

 

96

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $.01 par value; $1,046 liquidation preference; 10,000 shares authorized; 1,040 outstanding at June 30, 2008 and 0 at December 31, 2007, respectively

 

1,046

 

 

Common stock, $.01 par value; 225,000 shares authorized; 129,057 shares issued and outstanding at June 30, 2008 and December 31, 2007

 

1,291

 

1,291

 

Additional paid-in capital

 

95,294

 

93,785

 

Accumulated deficit

 

(93,574

)

(91,260

)

Accumulated other comprehensive loss

 

(22

)

(35

)

Total stockholders’ equity

 

4,035

 

3,781

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

7,957

 

$

6,475

 

The accompanying notes form an integral part of these Condensed Consolidated Financial Statements.

F-2TABLE OF CONTENTS



Communication Intelligence Corporation

and Subsidiary

Condensed Consolidated Statements of Operations

Unaudited

(In thousands, except per share amounts)

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

 

 

Product

 

$

218

 

$

385

 

$

460

 

$

543

 

Maintenance

 

189

 

170

 

377

 

346

 

Total Revenues

 

407

 

555

 

837

 

889

 

 

 

 

 

 

 

 

 

 

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

 

 

 

 

 

 

 

Product

 

157

 

132

 

327

 

162

 

Maintenance

 

43

 

30

 

73

 

58

 

Research and development

 

43

 

131

 

96

 

260

 

Sales and marketing

 

355

 

297

 

715

 

557

 

General and administrative

 

552

 

523

 

1,019

 

998

 

Total operating costs and expenses

 

1,150

 

1,113

 

2,230

 

2,035

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(743

)

(558

)

(1,393

)

(1,146

)

 

 

 

 

 

 

 

 

 

 

Interest and other income (expense), net

 

2

 

4

 

5

 

4

 

Interest expense:

 

 

 

 

 

 

 

 

 

Related party (Note 5)

 

(48

)

(33

)

(92

)

(49

)

Other (Notes 4 and 5)

 

(18

)

(43

)

(41

)

(74

)

Amortization of loan discount and deferred financing:

 

 

 

 

 

 

 

 

 

Related party (Note 5)

 

(217

)

(74

)

(308

)

(147

)

Other (Notes 4 and 5)

 

(63

)

(141

)

(108

)

(243

)

 

 

 

 

 

 

 

 

 

 

Minority interest

 

 

2

 

 

5

 

Net loss

 

(1,087

)

(843

)

(1,937

)

(1,650

)

 

 

 

 

 

 

 

 

 

 

Accretion of beneficial conversion feature,
Preferred shares (Note 7):

 

 

 

 

 

 

 

 

 

Related party

 

(273

)

 

(273

)

 

Other

 

(98

)

 

(98

)

 

Preferred stock dividends:

 

 

 

 

 

 

 

 

 

Related party

 

(4

)

 

(4

)

 

Other

 

(2

)

 

(2

)

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$

(1,464

)

$

(843

)

$

(2,314

)

$

(1,650

)

Basic and diluted loss per common share

 

$

(0.01

)

$

(0.01

)

$

(0.02

)

$

(0.02

)

Weighted average common shares outstanding, basic and diluted

 

129,057

 

107,557

 

129,057

 

107,557

 

The accompanying notes form an integral part of these Condensed Consolidated Financial Statements.

F-3



Communication Intelligence Corporation

and Subsidiary

Consolidated Statements of Changes in Stockholders’ Equity

Three and Six Months Ended June 30, 2008

Unaudited

(In thousands, except share amounts)

 

 

Preferred
Shares
Outstanding

 

Preferred
Shares
Amount

 

Common
Shares
Outstanding

 

Common
Stock

 

Additional 
Paid-In
Capital

 

Accumulated
Deficit

 

Accumulated 
Other
Comprehensive
Loss

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances as of December 31, 2007

 

 

$

 

129,057

 

$

1,291

 

$

93,785

 

$

(91,260

)

$

(35

)

$

3,781

 

Stock based employee compensation

 

 

 

 

 

 

 

 

 

14

 

 

 

 

 

14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(850

)

 

 

(850

)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

(2

)

(2

)

Total comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(852

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2008

 

 

 

129,057

 

1,291

 

93,799

 

(92,110

)

(37

)

2,943

 

Stock based employee compensation

 

 

 

 

 

 

 

 

 

26

 

 

 

 

 

26

 

Fair value of warrants issued in connection with Long-term debt

 

 

 

 

 

 

 

 

 

1,231

 

 

 

 

 

1,231

 

Conversion of Short-term notes into Preferred Shares, net of expenses of $127

 

1,040

 

1,040

 

 

 

 

 

(127

)

 

 

 

 

913

 

Beneficial Conversion Feature associated with the Preferred Shares

 

 

 

 

 

 

 

 

 

371

 

 

 

 

 

371

 

Preferred share dividends

 

 

 

6

 

 

 

 

 

(6

)

 

 

 

 

 

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(1,087

)

 

 

(1,087

)

Accretion of beneficial conversion feature on preferred stock

 

 

 

 

 

 

 

 

 

 

 

(371

)

 

 

(371

)

Preferred stock dividend

 

 

 

 

 

 

 

 

 

 

 

(6

)

 

 

(6

)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

15

 

15

 

Total comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,449

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of June 30, 2008

 

1,040

 

$

1,046

 

129,057

 

$

1,291

 

$

95,294

 

$

(93,574

)

$

(22

)

$

4,035

 

The accompanying notes form an integral part of these Condensed Consolidated Financial Statements.

F-4



Communication Intelligence Corporation

and Subsidiary

Condensed Consolidated Statements of Cash Flows

Unaudited

(In thousands)

 

 

Six Months Ended
June 30,

 

 

 

2008

 

2007

 

Cash flows from operating activities:

 

 

 

 

 

Net loss

 

$

(1,937

)

$

(1,650

)

Adjustments to reconcile net loss to net cash used for operating activities:

 

 

 

 

 

Depreciation and amortization

 

438

 

391

 

Amortization of discount on convertible notes

 

 

149

 

Amortization of discount and deferred financing costs related party debt

 

308

 

197

 

Amortization of discount and deferred financing costs on other debt

 

108

 

45

 

Stock based employee compensation

 

40

 

60

 

Minority interest

 

 

(5

)

Provision for doubtful accounts

 

19

 

16

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable, net

 

189

 

14

 

Prepaid expenses and other current assets

 

51

 

29

 

Accounts payable

 

(11

)

13

 

Accrued compensation

 

(67

)

38

 

Other accrued liabilities

 

138

 

 

Deferred revenue

 

(47

)

103

 

Net cash used for operating activities

 

(771

)

(600

)

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Acquisition of property and equipment

 

(7

)

(3

)

Capitalized software development costs

 

(492

)

(373

)

Net cash used for investing activities

 

(499

)

(376

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Deferred financing costs

 

(452

)

 

Proceeds from issuance of short-term debt

 

125

 

 

Proceeds from issuance of long-term debt

 

3,000

 

1,120

 

Principal payments on short-term debt

 

(125

)

 

Principal payments on capital lease obligations

 

 

(4

)

Net cash provided by (used) for financing activities

 

2,548

 

1,116

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

(35

)

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

1,243

 

140

 

Cash and cash equivalents at beginning of period

 

1,144

 

727

 

Cash and cash equivalents at end of period

 

$

2,387

 

$

867

 

The accompanying notes form an integral part of these Condensed Consolidated Financial Statements.

F-5



Communication Intelligence Corporation

and Subsidiary

Condensed Consolidated Statements of Cash Flows (continued)

Unaudited

(In thousands)

Supplemental Disclosure of Non Cash Financing Activities

Short-term notes and accrued interest exchanged for convertible preferred stock

 

$

1,040

 

$

 

Preferred stock dividend

 

$

6

 

$

 

Short term notes and accrued interest exchanged for long term notes

 

$

638

 

$

 

Accretion of beneficial conversion feature on convertible preferred shares

 

$

371

 

$

 

Fair value of beneficial conversion feature and warrants

 

$

 

$

546

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information

 

 

 

 

 

Interest paid

 

$

95

 

$

82

 

The accompanying notes form an integral part of these Condensed Consolidated Financial Statements.

F-6



Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except per share amounts)

1.Nature of business

The financial information contained herein should be read in conjunction with the Company’s consolidated audited financial statements and notes thereto included in its Annual Report for the year ended December 31, 2007.

The accompanying unaudited condensed consolidated financial statements of Communication Intelligence Corporation and its subsidiary (the “Company” or “CIC”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company’s results of operations and cash flows for the periods presented.  The Company’s interim results are not necessarily indicative of the results to be expected for the entire year.

The Company’s core technologies are classified into two broad categories: “transaction and communication enabling technologies” and “natural input technologies”. These technologies include multi-modal electronic signature, handwritten biometric signature verification, cryptography (Sign-it, iSign, and SignatureOne) and multilingual handwriting recognition software (Jot).  The Company reports results in one segment, handwriting recognition.

The Company’s transaction and communication enabling technologies are designed to provide a cost-effective means for securing electronic transactions, providing network and device access control and enabling workflow automation of traditional paper form processing. The Company believes that these technologies offer more efficient methods for conducting electronic transactions while providing more functional user authentication and heightened data security. The Company’s transaction and communication enabling technologies have been fundamental to its development of software for multi-modal electronic signatures, handwritten biometric signature verification, and data security.

The Company’s natural input technologies are designed to allow users to interact with a computer or handheld device by using an electronic pen or stylus as the primary input device. CIC’s natural input offering includes multilingual handwriting recognition software for such devices as electronic organizers, pagers and smart cellular phones that do not have a keyboard. For such devices, handwriting recognition offers the most viable solutions for performing text entry and editing.

Going Concern

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. Except for 2004, the Company has incurred significant losses since its inception and, at June 30, 2008, the Company’s accumulated deficit was approximately $93,600. At June 30, 2008, the Company had working capital of $1,352, including cash and cash equivalents of $2,387.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.  The Company has primarily funded losses through the sale of debt and equity securities.

In June 2008, the Company raised additional funds through a debt and equity financing and also converted short-term notes payable to equity (see notes 4 and 5).  Management believes these transactions along with planed operations, will provide adequate capital recourses for at least the next twelve months.  However, there can be no assurance that these transactions will provide the Company with adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed or if

F-7



Notes to Unaudited Condensed Consolidated Financial Statements (continued)

1.Nature of business (continued)

available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company’s business, results of operations and ability to operate as a going concern.  The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Fair value of financial instruments

The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, short-term debt and long-term debt approximate fair value due to their relatively short maturities.

2.Accounts receivable and revenue concentration

As of June 30, 2008 three customers in the aggregate accounted for 68% of net accounts receivable: eCom Asia Pacific, Ltd. (26%), Travelers Insurance Company (25%), and Palm, Inc. (17%).  As of December 31, 2007 four customers in the aggregate accounted for 92% of accounts receivable: Access Systems Americas, Inc, (28%), eCom Asia Pacific, Ltd (22%), Tennessee Valley Authority (32%) and Sony Ericsson (10%).

Three customers in the aggregate accounted for 49% of total revenues for the three months ended June 30, 2008: Fiserv (12%), Wells Fargo Bank, NA (13%), and Travelers Insurance Company (24%).  For the three months ended June 30, 2007, two customers in the aggregate accounted for 43% of total revenues: Wells Fargo Bank, NA (10%), and Access Americas, Inc. (33%).

Three customers in the aggregate accounted for 43% of total revenue for the six months ended June 30, 2008: Travelers Insurance Company (11%), Wells Fargo Bank, NA (13%) and Access Systems Americas, Inc. (19%). Two customers in the aggregate accounted for 48% of total revenue for the six months ended June 30, 2007: Wells Fargo Bank, NA (12%), and Access Systems Americas, Inc. (36%).

3.Patents

The Company performs intangible asset impairment analyses at least annually in accordance with the guidance in Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets” (“SFAS 142”) and Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long Lived Assets” (“SFAS 144”). The Company follows the guidance of SFAS 144 in response to changes in industry and market conditions that affect its patents. The Company then determines if an impairment of its assets has occurred. The Company periodically reassesses the lives of its patents and tests for impairment in order to determine whether the book value of each patent exceeds the fair value of each patent. Fair value is determined by estimating future cash flows from the products that are and will be protected by the patents and considering the additional factors listed in Critical Accounting Policies in the Company’s Annual Report.

Management completed an analysis of its patents as of December 31, 2007.  Based on that analysis, the Company concluded that no impairment of the carrying value of the patents existed. The Company believes that no events or circumstances occurred or changed during the six months ended June 30, 2008, and therefore concluded that no impairment in the carrying values of the patents existed at June 30, 2008.

F-8



Notes to Unaudited Condensed Consolidated Financial Statements (continued)

3.Patents (continued)

Amortization of patent costs was $95 and 190, respectively, for each of the three and six month periods ended June 30, 2008 and 2007.

4.Short-term debt

In 2006 and 2007, the Company entered into long-term financing agreements with Michael Engmann, a stockholder of the Company owning approximately 7% of the Company’s then outstanding shares of common stock, and with unrelated third parties. Each financing included a Note and Warrant Purchase Agreement and a Registration Rights Agreement.  The notes bear interest at a rate of 15% per annum, payable quarterly in cash.  The fair value ascribed to the warrants issued in connection with the financings creates a debt discount that is amortized to interest expense over the life of the respective loans. The proceeds from these financings, as more fully described below, were used for working capital purposes.

In November 2006, the Company borrowed $600, of which $450 was borrowed from Michael Engmann and the remaining $150 from an unrelated third party.  The notes were due May 17, 2008.  In connection with the notes, the lenders were granted warrants to purchase 3,111 shares of common stock. The warrants are exercisable for three years commencing June 30, 2007, and have an exercise price of $0.51. The Company ascribed a fair value of $336 to the warrants, which was recorded as a discount to “debt” in the balance sheet.  The fair value ascribed to the warrants was estimated on the commitment date using the Black-Scholes pricing model with the following assumptions: risk-free interest rate of 4.68%; expected life of 3 years; expected volatility of 54%; and expected dividend yield of 0%.

In March 2007 the Company borrowed $670, of which $350 was borrowed from Michael Engmann and the remaining $320 from unrelated third parties.  The notes are due August 30, 2008. In connection with the notes, the lenders were granted warrants to purchase 3,474 shares of common stock.  The warrants are exercisable for three years commencing June 30, 2007, and have an exercise price of $0.51.  The Company ascribed a fair value of $359 to the warrants, which was recorded as a discount to “debt” in the balance sheet.  The fair value ascribed to the warrants was estimated on the commitment date using the Black-Scholes pricing model with the following assumptions: risk-free interest rate of 4.68%; life of 3 years; expected volatility of 45%; and expected dividend yield of 0%.

In June 2007, the Company borrowed $400 under a financing agreement from Michael Engmann.  The notes are due December 30, 2008.  In connection with the notes, the lenders were granted warrants to purchase 3,168 shares of common stock.  The warrants are exercisable for three years commencing June 30, 2007, and have an exercise price of $0.25.  The Company has ascribed a fair value of $187 to the warrants, which is recorded as a discount to “debt” in the balance.  The relative fair value ascribed to the warrants was estimated on the commitment date using the Black-Scholes pricing model with the following assumptions: risk-free interest rate of 4.90%; life of 3 years; expected volatility of 69%; and expected dividend yield of 0%.

All of the shares underlying the warrants discussed above were registered with the Company’s Form S-1/A, which was declared effective December 28, 2007.

A portion of the above referenced debt held by Michael Engmann, including accrued and unpaid interest through May 31, 2008, was exchanged for Preferred Shares (See Note 7). The remainder of the debt held by Michael Engmann, and the debt held by certain third parties, including accrued and unpaid interest through May 31, 2008, was refinanced pursuant to the Credit Agreement (See Note 5).  The debt being so

F-9



Notes to Unaudited Condensed Consolidated Financial Statements (continued)

4.Short-term debt (continued)

exchanged or refinanced was originally issued in the transactions between August 2006 and June 2007 discussed above, and the related Note and Warrant Purchase Agreements, were terminated in connection with the Financing Transactions.  The warrants to acquire 9,653 shares of the Company’s common stock issued as part of the above reference financings remain outstanding.  These warrants are exercisable until June 30, 2010.

5.Long-term debt

On June 5, 2008, the Company effected a financing transaction under which the Company raised capital through the issuance of new secured indebtedness and equity, and restructured a portion of the Company’s existing short-term debt (collectively, the “Financing Transaction”).  Certain parties to the Financing Transactions (Phoenix Venture Fund LLC and Michael Engmann) have a pre-existing relationship with the Company and, with respect to such parties, the Financing Transaction may be considered a related party transaction.

Under the Financing Transaction, the Company entered into a Credit Agreement (the “Credit Agreement”) and a Pledge and Security Agreement (the “Pledge Agreement”), each dated as of June 5, 2008, with Phoenix Venture Fund LLC (“Phoenix”), Michael Engmann and Ronald Goodman (collectively with Phoenix, the “Creditors,” and each individually a “Creditor”).  Under the terms of the Credit Agreement, the Company received an aggregate of $3,000 and refinanced $638 of existing indebtedness and accrued interest on that indebtedness (individually, a “Loan” and collectively, the “Loans”).  The Loans, which are represented by secured promissory notes (each a “Note” and collectively, the “Notes”), bear interest at eight percent (8%) per annum which, at the option of the Company, may be paid in cash or in kind and mature two (2) years from issue date.  The Company may use the proceeds from the Loans to pay the Company’s existing indebtedness and accrued interest on that indebtedness that was not exchanged for preferred stock as described below, for working capital and general corporate purposes, in each case in the ordinary course of business; and to pay fees and expenses in connection with the Financing Transaction, which were approximately $475.  Additionally, a portion of the proceeds of the Loans were used to repay a short term loan from a Company employee in the amount of $125, plus accrued interest, that was made prior to and in anticipation of the closing of the Financing Transaction.  Under the terms of the Pledge Agreement, the Company and its subsidiary, CIC Acquisition Corp., granted the Creditors a first priority security interest in and lien upon all of the assets of the Company and CIC Acquisition Corp.

Under the terms of the Credit Agreement and in partial consideration for the Creditors’ respective Loans made pursuant to the terms of the Credit Agreement as described above, the Company issued to each Creditor a warrant to purchase up to the number of shares of the Company’s common stock obtained by dividing the amount of such Creditor’s Loan by 0.14 (each a “Warrant” and collectively, the ‘Warrants”).  A total of 25,982 shares of the Company’s Common Stock may be issued upon exercise of the Warrants.  The Warrants are exercisable beginning June 30, 2008 until their expiration on June 30, 2011. The Warrants have an exercise price of fourteen cents ($0.14) per share. Additional Warrants may be issued if the Company exercises its option to make interest payments on the Loans in kind.  The Company ascribed the relative fair value of $1,231 to the warrants, which is recorded as a discount to “Long-term debt” in the balance sheet.  The fair value of the warrants was estimated on the commitment date using the Black-Scholes pricing model with the following assumptions: risk-free interest rate of 2.73%; expected life of 3 years; expected volatility of 82.3%; and expected dividend yield of 0%.

F-10



Notes to Unaudited Condensed Consolidated Financial Statements (continued)

5.Long-term debt (continued)

In connection with the closing of the Financing Transaction, the Company also entered into a Securities Purchase Agreement (the “Purchase Agreement”) and a Registration Rights Agreement (the “Registration Rights Agreement”) each dated as of June 5, 2008, (See Note 7).

The offer and sale of the Notes, Warrants and Preferred Shares as detailed above, including the Common Stock issuable upon exercise or conversion thereof, was made in reliance upon exemptions from registration afforded by Section 4(2) of the Securities Act and Rule 506 of Regulation D, as promulgated by the Securities and Exchange Commission under the Securities Act and under exemptions from registration available under applicable state securities laws.

Interest expense associated with the Company’s debt for the three months ended June 30, 2008 and 2007 was $346 and $291, respectively, of which $265 and $107 was related party and $81 and $184 was related to other creditors. Amortization of debt discount included in interest expense for the three months ended June 30, 2008 and 2007 was $280 and $215, respectively, of which $217 and $74 was related party expense and $63 and $141 was related to the other creditors.

Interest expense associated with the Company’s debt for the six months ended June 30, 2008 and 2007 was $549 and $513, respectively, of which $400 and $196 was related party and $149 and $317 was related to the other creditors. Amortization of debt discount included in interest expense for the six months ended June 30, 2008 and 2007 was $416 and $390, respectively, of which $308 and $147 was related party and $108 and $243 was related to the other creditors.

6.Net (loss) per share

The Company calculates net loss per share under the provisions of Statement of Financial Accounting Standards No. 128, “Earnings Per Share” (“SFAS 128”). SFAS 128 requires the disclosure of both basic net loss per share, which is based on the weighted average number of shares outstanding, and when applicable, diluted income per share, which is based on the weighted average number of shares and dilutive potential shares outstanding.

For the three and six month periods ended June 30, 2008, 6,002 and 41,131 shares of common stock subject to outstanding options and warrants, respectively, and 7,429 shares of common stock issuable upon the conversion of the convertible preferred stock were excluded from the calculation of dilutive earnings per share because the exercise of such options and warrants and the conversion of the preferred stock would be anti-dilutive. For the three and six month periods ended June 30, 2007, 5,641 and 14,862 shares of common stock subject to outstanding options, and warrants, respectively, and 3,013 shares issuable upon the conversion of the convertible notes were excluded from the calculation of dilutive earnings per share because the exercise or conversion of such options and warrants would be anti-dilutive.

7.Equity

Common Stock Options

The Company has one stock-based employee compensation plan, (the “1999 Option Plan”) and also grants options to employees, directors and consultants pursuant to individual agreements (collectively, the

F-11



Notes to Unaudited Condensed Consolidated Financial Statements (continued)

7.Equity (continued)

Common Stock Options (continued)

“Individual Plans”). Share-based compensation expense is based on the estimated grant date fair value of the portion of share-based payment awards that are ultimately expected to vest during the period.  The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes option pricing model. Statement of Financial Accounting Standards (“SFAS”) No. 123(R), “Share-Based Payment” requires forfeitures of share-based payment awards to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.  The estimated average forfeiture rates for both the six months ended June 30, 2008 and 2007 was approximately 27%, based on historical data.

SFAS No. 123(R) requires the cash flows from tax benefits for deductions in excess of the compensation costs recognized for share-based payment awards to be classified as financing cash flows.  Due to the Company’s loss position, there were no such tax benefits during the three and six month periods ending June 30, 2008 and 2007.

Valuation and Expense Information under SFAS No. 123(R):

The weighted-average fair value of stock-based compensation is based on the single option valuation approach.  Forfeitures are estimated and it is assumed no dividends will be declared.  The estimated fair value of stock-based compensation awards to employees is amortized using the accrual method over the vesting period of the options. The fair value calculations are based on the following assumptions:

Three and Six
Months Ended
June 30, 2008

Three and Six
Months Ended
June 30, 2007

Risk free interest rate

3.32% - 5.11%

3.65% - 5.11%

Expected life (years)

3.21 – 6.86

3.19 -7.00

Expected volatility

80.96% – 104.57%

51.68% – 104.57%

Expected dividends

None

None

The following table summarizes the allocation of stock-based compensation expense related to stock option grants under SFAS 123(R) included in operating expenses for the three and six months ended June 30, 2008 and 2007. There were 100 stock options granted during the three and six months ended June 30, 2008 and no options were exercised. There were 325 stock options granted during the three and six months ended June 30, 2007, and no options were exercised.

 

 

Three Months Ended June 30,

 

Six months Ended June 30,

 

 

 

2008

 

2007

 

2008

 

2007

 

Research and development

 

$

1

 

$

3

 

$

2

 

$

6

 

Sales and marketing

 

8

 

19

 

20

 

37

 

General and administrative

 

1

 

5

 

2

 

8

 

Director options

 

15

 

9

 

16

 

9

 

Stock-based compensation expense

 

$

25

 

$

36

 

$

40

 

$

60

 

F-12



Notes to Unaudited Condensed Consolidated Financial Statements (continued)

7.Equity (continued)

Common Stock Options (continued)

A summary of option activity under the Company’s plans as of June 30, 2008 and 2007 is as follows:

 

 

As of June 30,

 

 

 

2008

 

2007

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted 

 

 

 

 

 

 

 

Weighted

 

average

 

 

 

 

 

Weighted

 

average

 

 

 

 

 

 

 

Average

 

Remaining

 

Aggregate

 

 

 

Average

 

Remaining

 

Aggregate

 

 

 

Shares

 

Exercise

 

Contractual

 

Intrinsic

 

Shares

 

Exercise

 

Contractual

 

Intrinsic

 

Options

 

(000)

 

Price

 

Term

 

Value

 

(000)

 

Price

 

Term

 

Value

 

Outstanding at January 1,

 

6,036

 

$

0.59

 

 

 

 

 

5,893

 

$

0.69

 

 

 

 

 

Granted

 

100

 

$

0.20

 

 

 

 

 

325

 

$

0.22

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

(134

)

$

0.25

 

 

 

 

 

(577

)

$

0.95

 

 

 

 

 

Outstanding at June 30

 

6,002

 

$

0.58

 

4.16

 

$

 

5,641

 

$

0.63

 

4.79

 

$

 

Vested and expected to vest at June 30

 

6,002

 

$

0.58

 

4.16

 

$

 

5,641

 

$

0.63

 

4.94

 

$

 

Exercisable at June 30

 

5,550

 

$

0.61

 

4.04

 

$

 

4,978

 

$

0.68

 

4.78

 

$

 

The following tables summarize significant ranges of outstanding and exercisable options as of June 30, 2008:

 

 

As of June 30, 2008

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of Exercise Prices

 

Number
Outstanding

 

Weighted
Average
Remaining
Contractual
Life(in
years)

 

Weighted
Average
Exercise
Price

 

Number
Outstanding

 

Weighted
Average
Exercise
Price

 

$0.14 – $0.50

 

2,479

 

4.80

 

$

0.32

 

2,027

 

$

0.33

 

  0.51 –   1.00

 

3,341

 

3.84

 

$

0.73

 

3,341

 

$

0.73

 

  1.01 –   2.00

 

167

 

1.62

 

$

1.32

 

167

 

$

1.32

 

  2.01 –   3.00

 

 

 

$

 

 

$

 

  3.01 –   7.50

 

15

 

1.97

 

$

3.56

 

15

 

$

3.56

 

 

 

6,002

 

4.16

 

$

.58

 

5,550

 

$

 

F-13



Notes to Unaudited Condensed Consolidated Financial Statements (continued)

7.Equity (continued)

Common Stock Options (continued)

The following tables summarize significant ranges of outstanding and exercisable options as of June 30, 2007:

 

 

As of June 30, 2007

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of Exercise Prices

 

Number
Outstanding

 

Weighted
Average
Remaining
Contractual
Life(in
years)

 

Weighted
Average
Exercise
Price

 

Number
Outstanding

 

Weighted
Average
Exercise
Price

 

$0.14 – $0.50

 

2,059

 

5.5

 

$

0.34

 

1,442

 

$

0.36

 

  0.51 –   1.00

 

3,341

 

4.8

 

$

0.73

 

3,295

 

$

0.73

 

  1.01 –   2.00

 

176

 

2.5

 

$

1.31

 

176

 

$

1.31

 

  2.01 –   3.00

 

50

 

0.3

 

$

3.00

 

50

 

$

3.00

 

  3.01 –   7.50

 

15

 

2.9

 

$

3.56

 

15

 

$

3.56

 

 

 

5,641

 

4.8

 

$

0.63

 

4,978

 

$

0.68

 

There were 100 options granted to four directors with an exercise price of $0.20 during the three and six months ended June 30, 2008.

A summary of the status of the Company’s non-vested shares as of June 30, 2008 is as follows:

Nonvested Shares

 

Shares

 

Weighted
Average
Grant-Date
Fair Value

 

Nonvested at January 1, 2008

 

672

 

$

0.32

 

Granted

 

100

 

$

0.16

 

Forfeited

 

(134

)

$

0.17

 

Vested

 

(186

)

$

0.33

 

Nonvested at June 30, 2008

 

452

 

$

0.17

 

As of June 30, 2008, there was $25 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans.  The unrecognized compensation cost is expected to be realized over a weighted average period of 1.9 years.

Preferred Shares

In connection with the closing of the June 2008 Financing Transaction (see Note 6, Long-term debt), the Company also entered into a Securities Purchase Agreement (the “Purchase Agreement”) and a Registration Rights Agreement (the “Registration Rights Agreement”) each dated as of June 5, 2008.  Under the Purchase Agreement, in exchange for the cancellation of $995 in principal amount and $45 of interest accrued thereon of the Company’s aggregate outstanding $2,071 in existing debt and interest accrued thereon through May 31, 2008, the Company issued to the holders of such debt an aggregate of1,040 shares of the Company’s Series A Cumulative Convertible Preferred Stock (the “Preferred Shares”).  The Preferred Shares carry an eight percent (8%) annual dividend, payable quarterly in arrears in cash or in additional Preferred Shares, have a liquidation preference over Common Stock of one dollar ($1.00) per share and are convertible into

F-14



Notes to Unaudited Condensed Consolidated Financial Statements (continued)

7.Equity (continued)

Preferred Shares (continued)

shares of Common Stock at the conversion price of fourteen cents ($0.14) per share.  If the “Preferred Shares” are converted in their entirety, the Company would issue 7,429 shares of common stock. The shares of Preferred Stock are convertible any time after June 30, 2008. The preferred stock transaction resulted in a beneficial conversion feature of $371, of which $273 is attributable to Michael Engmann and $98 to the other creditors.  The beneficial conversion feature was recorded as a charge to loss applicable to common stockholders for the quarter ended June 30, 2008. In addition, the Company accrued a dividend on the preferred shares of $6.

Under the terms of the Registration Rights Agreement, the Company is obligated to prepare and file with the Securities and Exchange Commission (the “Commission”) a registration statement under the Securities Act of 1933, as amended (the Securities Act”) covering the resale of the shares of Common Stock issued upon conversion of the shares of Preferred Stock and exercise of the Warrants as described above.  The Company must also use its reasonable best efforts to keep the registration statement continuously effective under the Securities Act until the earlier of the date that is two years after its Effective Date or until the date that all shares purchased under the Purchase Agreement have been sold or can be sold publicly under Rule 144.  The Registration Rights Agreement provides for certain registration rights whereby the Company could incur penalties if a registration statement is not filed or declared effective by the SEC on a timely basis. Under the Registration Rights Agreement, the Company must file a registration statement registering for resale the shares within 2 days following the filing of its Quarterly Report on Form 10-Q for the three and six months ending June 30, 2008. Furthermore, the Company is to use commercially reasonable efforts to cause such registration statement to become effective within 180 calendar days after the closing of the June 2008 Financing Transaction. If the registration statement is not filed on a timely basis or is not declared effective by the SEC for any reason on a timely basis, the Company will be required to make a payment to the holders of the registrable securities an amount in cash equal to 1.5% of the aggregate conversion, or exercise price applicable to such holder’s registrable securities for certain defined failures every thirtieth day until such failure is cured. The Company is obligated to pay the costs and expenses of such registration.

The Company believes that it is not probable that an event can occur which will trigger a penalty payment under the agreement. Therefore, the Purchase Agreement was recorded as an equity transaction with no recorded asset or liability associated with the defined failure features included in the Registration Rights Agreement.

F-15



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders

Communication Intelligence Corporation


iSign Solutions Inc.
Redwood Shores, CA

We have audited the accompanying consolidated balance sheets of iSign Solutions Inc., formerly known as Communication Intelligence Corporation, and its subsidiary (“the Company”(the “Company”) as of December 31, 20072015 and 2006,2014, and the related consolidated statements of operations, comprehensive loss, changes in stockholders’ equity,deficit, and cash flows and financial statement schedule for each of the two years in the two-year period ended December 31, 2007.  These2015. The Company's management is responsible for these consolidated financial statements and financial statement schedule are the responsibility of the Company’s management.statements. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the auditsaudit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were engaged to perform, an audit of the Company's internal controls over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements.  An audit also includesstatements, assessing the accounting principles used and significant estimates made by the management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Communication Intelligence Corporation and its subsidiaryiSign Solutions Inc. as of December 31, 20072015 and 2006,2014, and the consolidated results of their operations and their cash flows for each of the two years in the two-year period ended December 31, 2007,2015, in conformity with accounting principles generally accepted in the United States of America.  Also in our opinion, the related financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company’sCompany's significant recurring operating losses and accumulated deficit raise substantial doubt about its ability to continue as a going concern. Management’sManagement's plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/S/ GHP Horwath, P.C.

Denver, Colorado

March 10, 2008

F-16ArmaninoLLP
San Ramon, California
April 6, 2016



F-2

TABLE OF CONTENTS

Communication Intelligence CorporationiSign Solutions Inc.

Consolidated Balance Sheets

(In thousands, except par value amounts)

 
December 31,
 
2015
2014
Assets
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
Cash and cash equivalents
$
846
 
$
775
 
Accounts receivable, net of allowance of $22 at December 31, 2015 and 2014, respectively
 
94
 
 
122
 
Prepaid expenses and other current assets
 
372
 
 
80
 
Total current assets
 
1,312
 
 
977
 
Property and equipment, net
 
44
 
 
11
 
Intangible assets, net
 
591
 
 
933
 
Other assets
 
29
 
 
29
 
Total assets
$
1,976
 
$
1,950
 
Liabilities and Deficit
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
Accounts payable
$
787
 
$
328
 
Short – term debt, net
 
991
 
 
 
Accrued compensation
 
263
 
 
293
 
Other accrued liabilities
 
615
 
 
338
 
Deferred revenue
 
384
 
 
257
 
Derivative liability
 
330
 
 
 
Total current liabilities
 
3,370
 
 
1,216
 
Deferred revenue long-term
 
455
 
 
700
 
Deferred rent
 
 
 
41
 
Derivative liability
 
 
 
18
 
Other long-term liabilities
 
21
 
 
28
 
Total liabilities
 
3,846
 
 
2,003
 
Commitments and contingencies (Note 10)
 
 
 
 
 
 
Equity (deficit):
 
 
 
 
 
 
Series A-1 Preferred Stock, $0.01 par value; 2,000 shares authorized; 947 and 875 shares issued and outstanding at December 31, 2015 and 2014, respectively ($947 liquidation preference at December 31, 2015)
 
947
 
 
875
 
Series B Preferred Stock, $0.01 par value; 14,000 shares authorized; 13,523 and 12,251 shares issued and outstanding at December 31, 2015 and 2014, respectively ($20,285 liquidation preference at December 31, 2015)
 
11,653
 
 
10,381
 
Series C Preferred Stock, $0.01 par value; 10,000 shares authorized; 5,491 and 4,975 shares issued and outstanding at December 31, 2015 and 2014, respectively ($8,237 liquidation preference at December 31, 2015)
 
6,069
 
 
5,553
 
Series D-1 Preferred Stock, $0.01 par value; 10,000 shares authorized; 8,077 and 5,800 shares issued and outstanding at December 31, 2015 and 2014, respectively ($8,077 liquidation preference at December 31, 2015)
 
6,866
 
 
5,139
 
Series D-2 Preferred Stock, $0.01 par value; 10,000 shares authorized; 6,321 and 5,720 shares issued and outstanding at December 31, 2015 and 2014, respectively ($6,321 liquidation preference at December 31, 2015)
 
5,272
 
 
4,671
 
Common stock, $0.01 par value; 2,000,000 shares authorized; 187 and 187 shares issued and outstanding at December 31, 2015 and 2014, respectively
 
2
 
 
2
 
Treasury shares, 5 at December 31, 2015 and December 31, 2014, respectively
 
(325
)
 
(325
)
Additional paid-in-capital
 
95,312
 
 
97,400
 
Accumulated deficit
 
(127,116
)
 
(123,199
)
Accumulated other comprehensive loss
 
(14
)
 
(14
)
Total iSign stockholders’ equity (deficit)
 
(1,334
)
 
483
 
Non-controlling interest
 
(536
)
 
(536
)
Total deficit
 
(1,870
)
 
(53
)
Total liabilities and deficit
$
1,976
 
$
1,950
 

 

 

December 31,

 

 

 

2007

 

2006

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

1,144

 

$

727

 

Accounts receivable, net of allowances of $117 and $397 at December 31, 2007 and 2006, respectively

 

452

 

487

 

Prepaid expenses and other current assets

 

135

 

105

 

Total current assets

 

1,731

 

1,319

 

Property and equipment, net

 

77

 

140

 

Patents

 

3,528

 

3,906

 

Capitalized software development costs

 

1,109

 

656

 

Deferred financing costs (Note 3)

 

 

75

 

Other assets

 

30

 

30

 

Total assets

 

$

6,475

 

$

6,126

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Convertible notes, net of unamortized fair value assigned to beneficial conversion feature and warrants of $228 at December 31, 2006 (Note 3)

 

$

 

$

1,154

 

Short-term debt –net of unamortized fair value assigned to warrants of $350 including related party debt of $1,170, net of $247 of unamortized fair value assigned to warrants (Note 4)

 

1,370

 

 

Accounts payable

 

135

 

72

 

Accrued compensation

 

364

 

236

 

Other accrued liabilities

 

298

 

269

 

Deferred revenue

 

431

 

404

 

Total current liabilities

 

2,598

 

2,135

 

Long-term debt –net of unamortized fair value assigned to warrants of $266, including related party debt of $450, net of $199 of unamortized fair value assigned to warrants (Note 4)

 

 

334

 

Long- term debt – other, net of unamortized fair value assigned to warrants of $21 at December 31, 2007 (Note 3)

 

96

 

 

 

Minority interest

 

 

73

 

Commitments and contingencies (Note 7)

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $.01 par value; 10,000 shares authorized; 0 outstanding at December 31, 2007 and 2006, respectively

 

 

 

Common stock, $.01 par value; 155,000 shares authorized; 129,057 and 107,557 shares issued and outstanding at December 31, 2007 and 2006, respectively

 

1,291

 

1,076

 

Additional paid-in capital

 

93,785

 

90,497

 

Accumulated deficit

 

(91,260

)

(87,861

)

Accumulated other comprehensive loss

 

(35

)

(128

)

Total stockholders’ equity

 

3,781

 

3,584

 

Total liabilities and stockholders’ equity

 

$

6,475

 

$

6,126

 

TheSee accompanying notes form an integral part ofto these Consolidated Financial Statements

F-3

F-17TABLE OF CONTENTS



Communication Intelligence CorporationiSign Solutions Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

 
Years Ended December 31,
 
2015
2014
Revenue:
 
 
 
 
 
 
Product
$
738
 
$
766
 
Maintenance
 
882
 
 
749
 
 
 
1,620
 
 
1,515
 
Operating costs and expenses:
 
 
 
 
 
 
Cost of sales:
 
 
 
 
 
 
Product
 
287
 
 
199
 
Maintenance
 
232
 
 
191
 
Research and development
 
1,771
 
 
1,931
 
Sales and marketing
 
980
 
 
1,264
 
General and administrative
 
2,175
 
 
1,743
 
 
 
5,445
 
 
5,328
 
Loss from operations
 
(3,825
)
 
(3,813
)
Other income (expense), net
 
(3
)
 
50
 
Interest expense:
 
 
 
 
 
 
Related party
 
(31
)
 
 
Other
 
(23
)
 
(259
)
Amortization of debt discount:
 
 
 
 
 
 
Related party
 
(11
)
 
 
Other
 
(42
)
 
 
Gain on derivative liability
 
18
 
 
7
 
Net loss
 
(3,917
)
 
(4,015
)
Preferred stock:
 
 
 
 
 
 
Accretion of beneficial conversion feature:
 
 
 
 
 
 
Related party
 
(457
)
 
(208
)
Other
 
(69
)
 
(444
)
Preferred stock dividends:
 
 
 
 
 
 
Related party
 
(1,576
)
 
(1,364
)
Other
 
(1,600
)
 
(1,348
)
Income tax expense
 
 
 
 
Net loss before non-controlling interest
 
(7,619
)
 
(7,379
)
Net loss attributable to non-controlling interest
 
 
 
 
Net loss attributable to common stockholders
$
(7,619
)
$
(7,379
)
Basic and diluted loss per common share
$
(41
)
$
(39
)
Weighted average common shares outstanding, basic and diluted
 
187
 
 
187
 

 

 

Years ended December 31,

 

 

 

2007

 

2006

 

Revenues:

 

 

 

 

 

Product

 

$

1,448

 

$

1,427

 

Maintenance

 

697

 

915

 

 

 

2,145

 

2,342

 

Operating costs and expenses:

 

 

 

 

 

Cost of sales:

 

 

 

 

 

Product

 

367

 

101

 

Maintenance

 

158

 

149

 

Research and development

 

476

 

817

 

Sales and marketing

 

1,276

 

1,658

 

General and administrative

 

2,061

 

2,174

 

 

 

4,338

 

4,899

 

 

 

 

 

 

 

Loss from operations

 

(2,193

)

(2,557

)

 

 

 

 

 

 

Interest income and other income (expense), net

 

(26

)

43

 

Interest expense:

 

 

 

 

 

Related party (Note 4)

 

(135

)

(11

)

Other (Note 3)

 

(149

)

(105

)

Amortization of loan discount and deferred financing cost:

 

 

 

 

 

Related party (Note 4)

 

(305

)

(70

)

Other (Note 3)

 

(664

)

(591

)

Minority interest

 

73

 

5

 

 

 

 

 

 

 

Net loss

 

$

(3,399

)

$

(3,286

)

 

 

 

 

 

 

Basic and diluted loss per share

 

$

(0.03

)

$

(0.03

)

 

 

 

 

 

 

Basic and diluted weighted average shares

 

113,960

 

107,374

 

TheSee accompanying notes form an integral part ofto these Consolidated Financial Statements

F-4

F-18TABLE OF CONTENTS



Communication Intelligence CorporationiSign Solutions Inc.

Consolidated Statements of Changes in Stockholders’ EquityComprehensive Loss

(In thousands, except per share amounts)

 
Years Ended December 31,
 
2015
2014
Net loss:
$
(3,917
)
$
(4,015
)
Other comprehensive income, net of tax
 
 
 
 
Foreign currency translation adjustment, net
 
 
 
 
Total comprehensive loss
$
(3,917
)
$
(4,015
)

 

 

Common
Shares

 

Common
Stock

 

Additional
Paid-In
Capital

 

Accumulated
Deficit

 

Accumulated
Other
Comprehensive
Loss

 

Total

 

Balances as of December 31, 2005

 

106,542

 

$

1,065

 

$

89,517

 

$

(84,575

)

$

(151

)

$

5,856

 

Shares of Common Stock issued on conversion of long-term notes

 

996

 

11

 

449

 

 

 

 

 

460

 

Shares issued for services

 

19

 

 

 

6

 

 

 

 

 

6

 

Stock based employee compensation

 

 

 

 

 

189

 

 

 

 

 

189

 

Fair value of warrants issued to the investors in connection with long –term debt, related party

 

 

 

 

 

336

 

 

 

 

 

336

 

Comprehensive (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

(3,286

)

 

 

(3,286

)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

23

 

23

 

Total comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(3,263

)

Balances as of December 31, 2006

 

107,557

 

1,076

 

90,497

 

(87,861

)

(128

)

3,584

 

Fair value of warrants issued in connection with short-term debt

 

 

 

 

 

546

 

 

 

 

 

546

 

Fair value of warrants issued in connection with long-term debt

 

 

 

 

 

23

 

 

 

 

 

23

 

Stock based employee compensation

 

 

 

 

 

130

 

 

 

 

 

130

 

Adjustment to the fair value of beneficial conversion feature associated with the convertible notes (Note 5)

 

 

 

 

 

202

 

 

 

 

 

202

 

Sale of common stock at approximately $0.14 per share net of related costs of $398

 

21,500

 

215

 

2,387

 

 

 

 

 

2,602

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

(3,399

)

 

 

(3,399

)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

93

 

93

 

Total comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(3,306

)

Balances as of December 31, 2007

 

129,057

 

$

1,291

 

$

93,785

 

$

(91,260

)

$

(35

)

$

3,781

 

TheSee accompanying notes form an integral part ofto these Consolidated Financial Statements

F-5

F-19TABLE OF CONTENTS


iSign Solutions Inc.
Consolidated Statement of Changes in Deficit
Year Ended December 31, 2015
(In thousands)

 
Series A-1
Preferred
Shares
Outstanding
Series A-1
Preferred
Shares
Amount
Series B
Preferred
Shares
Outstanding
Series B
Preferred
Shares
Amount
Series C
Preferred
Shares
Outstanding
Series C
Preferred
Shares
Amount
Series D-1
Preferred
Shares
Outstanding
Series D-1
Preferred
Shares
Amount
Series D-2
Preferred
Shares
Outstanding
Series D-2
Preferred
Shares
Amount
Common
Shares
Outstanding
Common
Stock
Amount
Treasury
Stock
Additional
Paid-In
Capital
Accumulated
Deficit
Non-
Controlling
Interest
Accumulated
Other
Comprehensive
Income (Loss)
Total
Balance as of December 31, 2013
 
1,031
 
$
1,031
 
 
11,102
 
$
9,232
 
 
4,508
 
$
5,086
 
 
3,415
 
$
3,345
 
 
4,783
 
$
4,002
 
 
186
 
$
2
 
$
(325
)
$
98,560
 
$
(119,184
)
$
(536
)
$
(14
)
$
1,199
 
Stock-based employee compensation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
298
 
 
 
 
 
 
 
 
 
 
 
298
 
Common shares issued in connection with the conversion of Series A-1 preferred shares
 
(238
)
 
(238
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
238
 
 
 
 
 
 
 
 
 
 
 
 
Common shares issued in connection with the conversion of Series C preferred shares
 
 
 
 
 
 
 
 
 
 
 
 
 
(1
)
 
(1
)
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 
 
 
 
 
 
 
 
1
 
 
 
 
 
 
 
 
 
 
 
 
Series D-1 preferred shares issued in a private placement for cash, net of offering expenses of $85
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,913
 
 
1,828
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,828
 
Series D-2 preferred shares issued in a private placement for cash, net of offering expenses of $16
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
397
 
 
381
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
381
 
Beneficial conversion feature on Series D-1 preferred shares issued in a private placement for cash
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(253
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
253
 
 
 
 
 
 
 
 
 
 
 
 
Accretion of beneficial conversion feature on Series D-1 preferred shares issued in a private placement for cash
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
253
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(253
)
 
 
 
 
 
 
 
 
 
 
 
Beneficial conversion feature on Series D-2 preferred shares issued in a private placement for cash
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(52
)
 
 
 
 
 
 
 
 
 
 
52
 
 
 
 
 
 
 
 
 
 
 
 
Accretion of beneficial conversion feature on Series D-2 preferred shares issued in a private placement for cash
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52
 
 
 
 
 
 
 
 
 
 
 
(52
)
 
 
 
 
 
 
 
 
 
 
 
Cost of warrants issued with Series D-1 preferred shares issued in a private placement for cash
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(506
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
506
 
 
 
 
 
 
 
 
 
 
 
 
Cost of warrants issued with Series D-2 preferred shares issued in a private placement for cash
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(253
)
 
 
 
 
 
 
 
 
 
 
253
 
 
 
 
 
 
 
 
 
 
 
 
Cost of warrants issued in connection with a line of credit
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
258
 
 
 
 
 
 
 
 
 
 
 
258
 
Preferred share dividends, paid in kind
 
82
 
 
82
 
 
1,149
 
 
1,149
 
 
468
 
 
468
 
 
472
 
 
472
 
 
540
 
 
541
 
 
 
 
 
 
 
 
 
 
 
(2,712
)
 
 
 
 
 
 
 
 
 
 
 
 
Beneficial conversion feature on preferred shares dividends issued in kind
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(152
)
 
 
 
 
(195
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
347
 
 
 
 
 
 
 
 
 
 
 
 
Accretion of beneficial conversion feature on preferred shares dividends issued in kind
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
152
 
 
 
 
 
195
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(347
)
 
 
 
 
 
 
 
 
 
 
 
Change in derivative value of expired warrants
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(2
)
 
 
 
 
 
 
 
 
 
 
(2
)
Net loss attributable to non-controlling interest
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4,015
)
 
 
 
 
 
 
 
(4,015
)
Foreign currency translation adjustment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2014
 
875
 
$
875
 
 
12,251
 
$
10,381
 
 
4,975
 
$
5,553
 
 
5,800
 
$
5,139
 
 
5,720
 
$
4,671
 
 
187
 
$
2
 
$
(325
)
$
97,400
 
$
(123,199
)
$
(536
)
$
(14
)
$
(53
)
Stock-based employee compensation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
575
 
 
 
 
 
 
 
 
 
 
 
575
 
Preferred share dividends, paid in kind
 
72
 
 
72
 
 
1,272
 
 
1,272
 
 
516
 
 
516
 
 
715
 
 
715
 
 
601
 
 
601
 
 
 
 
 
 
 
 
 
 
 
(3,176
)
 
 
 
 
 
 
 
 
 
 
 
Beneficial conversion feature on preferred shares dividends issued in kind
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(13
)
 
 
 
 
(15
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
28
 
 
 
 
 
 
 
 
 
 
 
 
Accretion of beneficial conversion feature on preferred shares dividends issued in kind
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13
 
 
 
 
 
15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(28
)
 
 
 
 
 
 
 
 
 
 
 
Series D-1 preferred shares issued in a private placement for cash, net of offering expenses of $37
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,562
 
 
1,525
 
 
 
 
 
 
 
 
 
 
 
 
 
��
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,525
 
Beneficial conversion feature on Series D-1 preferred shares issued in a private placement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(498
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
498
 
 
 
 
 
 
 
 
 
 
 
 
Accretion of beneficial conversion feature Series D-1 preferred shares issued in a private placement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
498
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(498
)
 
 
 
 
 
 
 
 
 
 
 
Cost of warrants issued with the Series D-1 private placement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(513
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
513
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to non-controlling interest
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(3,917
)
 
 
 
 
 
 
 
(3,917
)
Foreign currency translation adjustment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2015
 
947
 
$
947
 
 
13,523
 
$
11,653
 
 
5,491
 
$
6,069
 
 
8,077
 
$
6,866
 
 
6,321
 
$
5,272
 
 
187
 
$
2
 
$
(325
)
$
95,312
 
$
(127,116
)
$
(536
)
$
(14
)
$
(1,870
)


See accompanying notes to these Consolidated Financial Statements

F-6

TABLE OF CONTENTS

Communication Intelligence CorporationiSign Solutions Inc.

Consolidated Statements of Cash Flows

(In thousands)

 
December 31,
 
2015
2014
Cash flows from operating activities:
 
 
 
 
 
 
Net loss
$
(3,917
)
$
(4,015
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
 
Depreciation and amortization
 
357
 
 
367
 
Amortization of debt discount
 
53
 
 
 
Stock-based employee compensation
 
575
 
 
298
 
Warrants issued in connection with line of credit
 
 
 
258
 
Gain on derivative liability
 
(18
)
 
(7
)
Gain on sale of trademark
 
 
 
(50
)
Changes in operating assets and liabilities:
 
 
 
 
 
 
Accounts receivable, net
 
28
 
 
288
 
Prepaid expenses and other current assets
 
(292
)
 
(23
)
Accounts payable
 
459
 
 
1
 
Accrued compensation
 
(30
)
 
(22
)
Other accrued liabilities
 
229
 
 
87
 
Deferred revenue
 
(118
)
 
393
 
Net cash used in operating activities
 
(2,674
)
 
(2,425
)
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
Acquisition of property and equipment
 
(48
)
 
(4
)
Net cash used in investing activities
 
(48
)
 
(4
)
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
Proceeds from issuance of short-term debt
 
1,268
 
 
 
Net proceeds from issuance of Series D-1 preferred shares
 
1,525
 
 
1,828
 
Net proceeds from issuance of Series D-2 preferred shares
 
 
 
381
 
Proceeds from sale of trademark
 
 
 
50
 
Net cash provided by financing activities
 
2,793
 
 
2,259
 
 
 
 
 
 
 
 
Net increase (decrease) in cash and cash equivalents
 
71
 
 
(170
)
Cash and cash equivalents at beginning of period
 
775
 
 
945
 
Cash and cash equivalents at end of period
$
846
 
$
775
 

 

 

2007

 

2006

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

Net loss

 

$

(3,399

)

$

(3,286

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

Depreciation and amortization

 

857

 

623

 

Amortization of convertible note discount

 

589

 

445

 

Amortization of warrant costs on long-term debt - related party

 

305

 

70

 

Deferred financing costs

 

75

 

146

 

Loss on disposal of property and equipment

 

3

 

 

Provision for doubtful accounts

 

 

 

Stock issued for services

 

 

6

 

Stock based employee compensation

 

130

 

189

 

Minority interest

 

(73

)

(5

)

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

35

 

(4

)

Prepaid expenses and other current assets

 

(30

)

63

 

Accounts payable

 

63

 

(218

)

Accrued compensation

 

128

 

1

 

Other accrued liabilities

 

29

 

(18

)

Deferred revenue

 

27

 

(153

)

Net cash used in operating activities

 

(1,261

)

(2,141

)

Cash flows from investing activities:

 

 

 

 

 

Acquisition of property and equipment

 

(26

)

(93

)

Capitalization of software development costs

 

(788

)

(510

)

Net cash used in investing activities

 

(814

)

(603

)

Cash flows from financing activities:

 

 

 

 

 

Proceeds from issuance of long-term debt – related party

 

1,120

 

600

 

Proceeds from issuance of common stock net of related expenses

 

2,602

 

 

Principal payments on short-term debt

 

(1,265

)

 

Principal payments on long-term debt – related party

 

 

 

Principal payments on capital lease obligations

 

(5

)

(8

)

Proceeds from exercise of stock options

 

 

 

Net cash provided by (used in) financing activities

 

2,452

 

592

 

Effect of exchange rate changes on cash

 

40

 

30

 

Net increase (decrease) in cash and cash equivalents

 

417

 

(2,122

)

Cash and cash equivalents at beginning of year

 

727

 

2,849

 

Cash and cash equivalents at end of year

 

$

1,144

 

$

727

 

TheSee accompanying notes form an integral part ofto these Consolidated Financial Statements

F-7

F-20TABLE OF CONTENTS



Communication Intelligence CorporationiSign Solutions Inc.

Consolidated Statements of Cash Flows (continued)

(In thousands)

Supplemental disclosure of cash flow information:

 
December 31,
 
2015
2014
Supplementary disclosure of cash flow information
 
 
 
 
 
 
Interest paid
$
5
 
$
1
 
 
 
 
 
 
 
 
Non-cash financing and investing transactions
 
 
 
 
 
 
 
 
 
 
 
 
 
Dividends on preferred shares
$
3,176
 
$
2,712
 
Conversion of Series A-1 Preferred shares into Common Stock
$
 
$
238
 
Conversion of Series C Preferred Stock into Common Stock
$
 
$
1
 
Conversion of demand note into unsecured promissory note
$
250
 
$
 
Derivative liability related to convertible promissory notes
$
330
 
$
 
Accretion of beneficial conversion feature on Preferred Share dividends
 
 
 
 
 
 
Series C Preferred Stock
$
13
 
$
152
 
Series D-1 Preferred Stock
$
15
 
$
195
 
Accretion of beneficial conversion feature on Preferred Shares issued
 
 
 
 
 
 
Series D-1 Preferred Stock
$
498
 
$
253
 
Series D-2 Preferred Stock
$
 
$
52
 
 
 
 
 
 
 
 
Warrants issued in connection with Series D financing
$
513
 
$
759
 

 

 

December 31,

 

 

 

2007

 

2006

 

Interest paid

 

$

244

 

$

109

 

Schedule of non-cash transactions:

 

 

 

 

 

Fair value of warrants issued to the investors in connection with long –term debt

 

$

23

 

$

 

Fair value of warrants issued to the investors in connection with long –term debt

 

$

546

 

$

336

 

Fair value of the adjustment to the beneficial conversion feature associated with the convertible notes

 

$

202

 

$

 

Common stock issued upon the conversion of long-term debt, net

 

$

 

$

460

 

Issuance of common stock for services

 

$

 

$

6

 

TheSee accompanying notes form an integral part ofto these Consolidated Financial Statements

F-8

F-21TABLE OF CONTENTS



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1.   Nature of Business, Basis of Presentation and Summary of Significant Accounting PoliciesPolicies:

The Company:

On January 21, 2016, iSign Solutions Inc. (the “Company” or “iSign”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-1,250 reverse split of the Company’s outstanding shares of common stock. The reverse split became effective at 9:01 a.m. on January 22, 2016. The information with respect to common stock for the years ended December 31, 2015 and 2014 have been retroactively restated to give effect to the 1-for-1,250 reverse split.

The Company:

On November 30, 2015, the Company filed an Issuer Company-Related Action Notification Form with the Financial Industry Regulatory Authority, (“FINRA”), requesting that the name change to iSign Solutions, Inc. and a change to the trading symbol of its common stock from “CICI” to “ISGN” be approved. On December 11, 2015, the Company filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation with the Delaware Secretary of State to change its name from Communication Intelligence Corporation to iSign Solutions Inc. Pursuant to FINRA rules, the change in the Company’s name and its joint venture (the “Company” or “CIC”) develops and markets natural input and biometric electronic signature solutions aimedtrading symbol became effective at the emerging markets such as, e-commerce, wireless internet/information devices, and corporate security. These markets include all areasopen of personal computing, as well as electronic commerce and communications.

business on December 14, 2015.

The Company is a leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective management of document-based transactions. iSign’s solutions encompass a wide array of functionality and services, including electronic signatures, biometric authentication and simple-to-complex workflow management. These solutions are available across virtually all enterprise, desktop and mobile environments as a seamlessly integrated platform for both ad-hoc and fully automated transactions. The Company’s products and services result in legally binding transactions that are compliant with applicable laws and regulations and that can provide a higher level of security than paper-based processes. The Company has been a leading supplier of enterprise software solutions within the financial services and insurance industries and has delivered significant expense reduction by enabling complete document and workflow automation and the resulting reduction in mailing, scanning, filing and other costs related to the use of paper.

The Company's research and development activities have given rise to numerous technologies and products. The Company’sCompany's core DTM technologies are classified into two broad categories: “transactioninclude various forms of electronic signatures, such as handwritten biometric, click-to-sign and communication enabling technologies”others, as well as signature verification, cryptography and “natural input technologies”. CIC’s transactionthe logging of audit trails to show signers’ intent. These technologies can enable secure, legal and communication enabling technologies provide a means for protectingregulatory compliant electronic transactions that can enhance customer experience at a fraction of the time and documents. CIC has developed products for dynamic signature verification, electronic signatures and encryption and a suite of development tools and applications which the Company believes could increase the functionality of its core products and facilitate their integration into original equipment manufacturers’ (“OEM”) hardware products and computer systems and networks. CIC’s natural input technologies are designed to allow users to interact with a computer or handheld device through the use of an electronic pen or “stylus”.cost required by traditional, paper-based processes. The Company’s products include SignatureOne®, Sign-it®,SignatureOne® CeremonyServer, Sign-it® and iSign®, biometric and electronic signaturethe iSign® family of products and multi-lingual Jot® handwriting recognition system.services.

The Company’s 90% owned joint venture, Communication Intelligence Computer Corporation, in China (the “Joint Venture”), has licensed eCom Asia Pacific Pty Ltd (“eCom”) as its master reseller for CIC products to end usersGoing concern and resellers with the authority and responsibility to create optimal distribution channels within the People’s Republic of China.

Going concern:

management plans:

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. Except for 2004, the Company has incurred significant losses since its inception and, at December 31, 2007,2015, the Company’s accumulated deficit was approximately $91,300.$127,116. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of December 31, 2015, the Company’s cash balance was $846. These factors raise substantial doubt about the Company’s ability to continue as a going concern.  The Company has primarily funded these losses through the sale of debt and equity securities.

In November 2004, the Company consummated a financing in the form of convertible notes aggregating $3,885, net of expenses. In November 2006 and in March and June 2007, the Company consummated financings in the form of a notes and warrant purchase agreements aggregating $1,720. The funds were used for working capital purposes. In September 2007, the Company closed a Securities Purchase and Registration Rights Agreement aggregating $2,602, net of expenses, the proceeds of which were used for payment of outstanding indebtedness and working capital purposes. In 2007, prior to the convertible note maturity date of October 27, 2007, the Company offered the outstanding convertible note holders the option of being issued warrants to purchase two (2) shares of the Company’s common stock for each dollar of note principal outstanding in exchange for a two year extension of the note due date and termination of the conversion feature of the note. One note holder, with a principal balance of $117, accepted the offer and the remaining outstanding debt of $1,265 and accrued interest thereon was paid in October 2007 (See Note 4). The Company has experienced delays in closing several material orders in the last half of 2007, with negotiations still ongoing, and believes that the current pipeline and it’s growth rate has the sales potential for achieving and sustaining quarterly profitability.

There can be no assurance that the Company will havebe successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company’sCompany's business, results of operations and ability to operate as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

F-22



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Basis of consolidation:

The accompanying consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America, and include the accounts of Communication Intelligence CorporationiSign Solutions Inc. and its 90% owned-owned Joint Venture in the People’sPeople's Republic of China. All inter-company accounts and transactions have been eliminated. All amounts shown in the accompanying consolidated financial statements are in thousands of dollars except per share amounts.

F-9

TABLE OF CONTENTS

Segments1.   Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies: (continued)

The Company reports its financial results in one segment.  Prior to 2006, the Company reported in two segments. Due to the immateriality of the system integration segment the Company reclassified the operations into one segment.

Use of estimates:

The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the consolidated financial statements, as well as the reported amounts of revenuesrevenue and expenses during the reporting periods. Actual results could differ from these estimates.

Fair value measures:

Fair value is the price that would be received to sell an asset, or paid to transfer a liability, in the principal or most advantageous market for the asset or liability in an ordinary transaction between market participants on the measurement date. Our policy on fair value measures requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instruments:instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The policy prioritizes the inputs into three levels that may be used to measure fair value:

Level 1:Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
Level 2:Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
Level 3:Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company’s assets and liabilities measured at fair value, whether recurring or non-recurring, at December 31, 2015 and December 31, 2014, and the fair value calculation input hierarchy level that we have determined applies to each asset and liability category.

Fair Value of Financial Instruments:

The carrying amountsCompany carries financial instruments on the consolidated balance sheet at the fair value of the Company’s financial instruments including cashas of the consolidated balance sheet date. At the end of each period, management assesses the fair value of each instrument and cash equivalents,adjusts the carrying value to reflect its assessment. At December 31, 2015 and December 31, 2014, the carrying values of accounts receivable and accounts payable short-term debtapproximated their fair values.

Treasury Stock:

Shares of common stock returned to, or repurchased by, the Company are recorded at cost and long-term debt approximateare included as a separate component of stockholders’ equity (deficit).

Under the cost method, the gross cost of the shares reacquired is charged to a contra equity account titled treasury stock. The equity accounts that were credited for the original share issuance (common stock, additional paid-in capital, etc.) remain intact. When the treasury shares are reissued, proceeds in excess of cost are credited to additional paid-in capital. Any deficiency is charged to accumulated deficit (unless additional paid-in capital from previous treasury share transactions exists, in which case the deficiency is charged to that account, with any excess charged to accumulated deficit).

Derivatives:

The Company, from time to time, enters into transactions which contain conversion privileges, the settlement of which may entitle the holder or the Company to settle the obligation(s) by issuance of Company securities. The Company applies a two-step model in determining whether a financial instrument or an embedded feature is indexed to an issuer’s own stock and thus able to qualify for the scope exception. The fair value dueof each derivative is estimated each reporting period.

F-10

TABLE OF CONTENTS

1.   Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies: (continued)

The conversion option included within the unsecured convertible promissory notes is accounted for as a derivative liability at its estimated fair value. The derivative is subject to their relatively short maturities.remeasurement at the end of each reporting period, with changes in fair value recognized as a component of interest and other income, in the consolidated statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the conversion or maturity of the unsecured convertible promissory note purchase agreements.

Cash and cash equivalents:

The Company considers all highly liquid investments with maturities at the date of purchase of three months or less to be cash equivalents.

The Company’sCompany's cash and cash equivalents, at December 31, consisted of the following:

 
2015
2014
Cash in bank
$
846
 
$
775
 
Money market funds
 
 
 
 
Cash and cash equivalents
$
846
 
$
775
 

 

 

2007

 

2006

 

Cash in bank

 

$

89

 

$

533

 

Money market funds

 

1,055

 

194

 

Cash and cash equivalents

 

$

1,144

 

$

727

 

Concentrations of credit risk:

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company maintains its cash and cash equivalents with various financial institutions. This diversification of risk is consistent with Company policy to maintain liquidity, and mitigate risk of loss as to principal. At December 31, 2007, the Joint Venture had approximately $1 in cash accounts held by a financial institution in the People’s Republic of China.

To date, accounts receivable have been derived principally from revenuesrevenue earned from end users, manufacturers, retailers and distributors of computer products in North America and the Pacific Rim.America. The Company performs periodic credit evaluations of its customers, and does not require collateral. The Company maintains reserves for potential credit losses; historically, such losses have been within management’smanagement's expectations.

F-23



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Concentrations of credit risk (continued):

The allowance for doubtful accounts is based on the Company’s assessment of the collectibilitycollectability of specific customer accounts and an assessment of international, political and economic risk as well as the aging of the accounts receivable. If there is a change in actual defaults from the Company’s historical experience, the Company’s estimates of recoverability of amounts due could be affected and the Company will adjust the allowance accordingly (See Schedule II).accordingly.

Deferred financing costs:

Deferred financing costs include costs paid in cash, such as professional fees and commissions. The costs wereassociated with equity financings, such as in the sale Common or Preferred Stock, are netted against the proceeds of the offering. In the case of note financings, costs are amortized to interest expense over the life of the convertible notes or upon earlier conversionearly payment using the effective interest method. TheThere were no financing costs amortized to interest expense amounted to $75 and $146, for the years ended December 31, 20072015 and 20062014, respectively.

Property and equipment, net:

Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, ranging from three to five years. Leasehold improvements are amortized over their estimated useful lives, not to exceed the term of the related lease. The cost of additions and improvements is capitalized while maintenance and repairs are charged to expense as incurred. Depreciation expense was $78$15 and $100$10 for the years ended December 31, 20072015 and 2006 respectively. The Chinese Joint Venture disposed of certain assets at net book value of $3 in 2007.

Property and equipment, net at December 31, consists of the following:

 

 

2007

 

2006

 

Machinery and equipment

 

$

1,179

 

$

1,216

 

Office furniture and fixtures

 

435

 

483

 

Leasehold improvements

 

90

 

90

 

Purchased software

 

319

 

315

 

 

 

2,023

 

2,104

 

Less accumulated depreciation and amortization

 

(1,946

)

(1,964

)

 

 

$

77

 

$

140

 

Included in property and equipment, as of December 31, 2007 and 2006, are $42 and $82, respectively, of assets acquired under capital leases. Accumulated depreciation on such assets totaled $42 and $77 at December 31, 2007 and 2006,2014, respectively.

Intangible Assets:

Patents:

On October 6, 2000, the Company acquired certainIntangible assets of PenOp Limited (“PenOp”) and its subsidiary PenOp Inc. pursuant to an asset purchase agreement dated as of September 29, 2000.

The nature of the underlying technology of each material patent is as follows:

·                  Patent numbers 5544255, 5647017, 5818955 and 6064751 involve (a) the electronic capture of a handwritten signature utilizing an electronic tablet device on a standard computer system within an electronic document, (b) the verification of the identity of the person providing the electronic signature through comparison of stored signature measurements, and (c) a system to determine whether an electronic document has been modified after signature.

F-24



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Patents (continued):

·                  Patent number 6091835 involves all of the foregoing and the recording of the electronic execution of a document regardless of whether execution occurs through a handwritten signature, voice pattern, fingerprint or other identifiable means.

·                  Patent numbers 5933514, 6212295, 6381344, and 6487310 involve methods and processes related to handwriting recognition developed by the Company over the years.  Legal fees associated with these patents were immaterial and expensed as the fees were incurred.

Patents, net consists of the following at December 31:

 

 

Expiration

 

Estimated
Original
Life

 

2007

 

2006

 

Patent (Various)

 

Various

 

5

 

$

9

 

$

9

 

Patent (Various)

 

Various

 

7

 

476

 

476

 

5544255

 

2013

 

13

 

93

 

93

 

5647017

 

2014

 

14

 

187

 

187

 

5818955

 

2015

 

15

 

373

 

373

 

6064751

 

2017

 

17

 

1,213

 

1,213

 

6091835

 

2017

 

17

 

4,394

 

4,394

 

 

 

 

 

 

 

6,745

 

6,745

 

Less accumulated amortization

 

 

 

 

 

(3,217

)

(2,839

)

 

 

 

 

 

 

$

3,528

 

$

3,906

 

Patents are stated at cost less accumulated amortization that, in management’s opinion, does not exceed fair value.amortization. Amortization is computed using the straight-line method over the estimated lives of the related assets, ranging from five to seventeen years. Amortization expense was $378$342 and $379$357 for the years ended December 31, 20072015 and 2006,2014, respectively.  Amortization expense is estimated to be $379 for each of the five years through December 31, 2012. The estimated remaining weighted average useful lives of the patentsintangible assets are 9two years.  The patents identified, as “various” are technically narrow or dated patents that the Company believes the expiration of which will not be material to its operations.  At December 31, 2007, the net carrying value of those patents is $0.

The useful lives assigned to the patents are based upon the following assumptions and conclusions:

·                  The estimated cash flow from products based upon each patent are expected to exceed the value assigned to each patent;

·                  There are no legal, regulatory or contractual provisions known to the Company that limit the useful life of each patent to less than the assigned useful life;

·                  No additional material costs need to be incurred or modifications made in order for the Company to continue to be able to realize the protection afforded by the patents; and

·                  The Company, does not foresee any effects of obsolescence or significant competitive pressure on its current or future products, anticipates increasing demand for products utilizing the patented technology, and believes that the current markets for its products based on the patented technology will remain constant or will grow over the useful lives assigned to the patents because of a legal, regulatory and business environment encouraging the use of electronic signatures.

F-25



Communication Intelligence CorporationF-11

Notes to Consolidated Financial StatementsTABLE OF CONTENTS

(In thousands)

1.   Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies Policies: (continued)

Patents (continued):

The Company performsFuture intangible asset impairment analyses at least annually in accordance with the guidance in Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets” (“SFAS 142”) and Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long Lived Assets” (“SFAS 144”). The Company uses SFAS 144 in response to changes in industry and market conditions that affects its patents; the Company then determines if an impairment of its assets has occurred. The Company reassesses the lives of its patents and tests for impairment at least annually in order to determine whether the book value of each patent exceeds the fair value of each patent. Fair valueamortization is determined by estimating future cash flows from the products that are and will be protected by the patents and considering the additional factors listed in Critical Accounting Policies in Item 7 of this Form 10-K.as follows:

Year Ended December 31,
 
2016
$
322
 
2017
 
269
 
Total
$
591
 

Long-lived assets:

The Company evaluates the recoverability of its long-lived assets, including intangible assets at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in the event the net book value of such assets exceeded the future undiscounted cash flows attributable to such assets. No such impairment charges have been recorded induring the threetwo years ended December 31, 2007.2015 and 2014, respectively.

Share-based payment:

Software development costs:

Software development costs are accounted for in accordance with Statement of Financial Accounting Standards No. 86, “Accounting for the Costs of Computer Software to be Sold, Leased or Otherwise Marketed” (“SFAS 86”). Under SFAS 86, capitalization of software development costs begins upon the establishment of technological feasibility, subject to net realizable value considerations. The costs capitalized include the coding and testing of the product after the technological feasibility has been established and ends upon the release of the product. The annual amortizationShare-based compensation expense is the greater of (a) the straight-line amortization over the estimated useful life not to exceed three years or (b) the amount based on the ratio of current revenues to anticipated future revenues. The Company performs periodic impairment reviews to ensure that unamortized deferred development costs remain recoverable from the projected future net cash flows that they are expected to generate.

The capitalized costs are amortized to cost of sales. At December 31, 2007 and 2006 the Company had capitalized approximately $788 and $510 of software development costs, respectively. Amortization of capitalized software development costs for the years ended December 31, 2007 and 2006 was $335 and $149, respectively.

Other current liabilities:

The Company records liabilities based on reasonable estimates for expenses, or payables that are known but some amounts must be estimated such as deposits, taxes, rents and services.  The estimates are for current liabilities that should be extinguished within one year.

The Company had the following other accrued liabilities at December 31:

 

 

2007

 

2006

 

Accrued professional services

 

$

134

 

$

125

 

Refundable deposits

 

 

48

 

Rents

 

43

 

 

Interest

 

66

 

27

 

Other

 

55

 

69

 

Total

 

$

298

 

$

269

 

F-26



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Other current liabilities (continued):

Material commitments:

The Company had the following commitments at December 31, 2007:

 

 

Payments due by period

 

Contractual obligations

 

Total

 

2008

 

2009

 

2010

 

2011

 

2012

 

Thereafter

 

Short-term debt related party (1)

 

$

1,720

 

$

1,720

 

$

 

$

 

$

 

$

 

$

 

Long-term debt (2)

 

117

 

 

117

 

 

 

 

 

Operating lease commitments (3)

 

1,056

 

264

 

272

 

280

 

240

 

 

 

Total contractual cash obligations

 

$

2,893

 

$

1,984

 

$

389

 

$

280

 

$

240

 

$

 

$

 


(1)          Short-term debt reported on the balance sheet is net of approximately $350 in discounts representing the fair value of warrants issued in connection with the Company’s debt financings. Short-term debt includes $1,170 due to a related party.

(2)          Long-term debt reported on the balance sheet is net of approximately $21 in discounts representing the fair value of warrants issued to the investors.

(3)          The operating lease commenced on November 1, 2002. The lease was renegotiated in December 2005 and extended for an additional 60 months. The base rent will increase approximately 3% per annum over the term of the lease, which expires on October 31, 2011.

Stock-based compensation:

The Company has one stock option plan, the 1999 Option Plan, and also grants options to employees, directors and consultants outside of the 1999 Option Plan pursuant to Individual Plans.

On January 1, 2006, the Company adopted SFAS No. 123(R), “Share-Based Payment”, using the modified prospective transition method, which requires the application of the accounting standard as of January 1, 2006.  SFAS No. 123(R) establishes standards for the accounting of transactions in which an entity exchanges its equity instruments for goods or services, primarily focusing on accounting for transactions where an entity obtains employee services in share-based payment transactions.  SFAS No. 123(R) requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-dategrant date fair value of the award andportion of share-based payment awards that is ultimately expected to recognize it as compensation expense overvest during the period the employee is required to provide service in exchange for the award, usually the vesting period. In March 2005, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 107 (SAB 107) relating to SFAS No. 123(R). The Company has applied the provisions of SAB 107 in its adoption of SFAS No. 123(R).

The Company’s consolidated financial statements as of and for the years ended December 31, 2007 and 2006 reflect the impact of SFAS No. 123(R).

F-27



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Stock-based compensation (continued):

Prior to the Company adopting SFAS 123 (R), the Company accounted for stock-based compensation plans under Accounting Principles Board Opinion (“APB”) No. 25, “Accounting for Stock Issued to Employees”: (“APB 25”). Under APB 25, generally no compensation expense is recorded when the terms of the award are fixed an the exercise price of the employee stock option equals or exceeds thegrant date fair value of share-based awards to employees and directors is calculated using the underlying stock onBlack-Scholes-Merton valuation model. Forfeitures of share-based payment awards are estimated at the datetime of grant.grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates and it is assumed no dividends will be declared. The Company had previously adoptedestimated fair value of share-based compensation awards to employees is amortized over the disclosure-only provision of SFAS No. 123, “Accounting for Stock-Based Compensation” (“SFAS 123”).

These plans and related compensation expense prescribed by SFAS 123(R) are more fully described in Note 5 of these Notes to Consolidated Financial Statements.

Revenue recognition:

Revenue is recognized when earned in accordance with applicable accounting standards, including AICPA Statement of Position (“SOP”) No. 97-2, “Software Revenue Recognition”, as amended, Staff Accounting Bulletin 104, “Revenue Recognition” (“SAB 104”), and the interpretive guidance issued by the Securities and Exchange Commission and EITF issue number 00-21, “Accounting for Revenue Arrangements with Multiple Elements”,vesting period of the FASB’s Emerging Issues Task Force. options.

Revenue recognition:

The Company recognizes revenuesrevenue from sales of software products upon shipment, provided that persuasive evidence of an arrangement exists, collection is determined to be probable, all non-recurring engineering work necessary to enable the Company’sCompany's product to function within the customer’scustomer's application has been completed and the Company’sCompany's product has been delivered according to specifications. Revenue from service subscriptions is recognized as costs are incurred or over the service period, which-everwhichever is longer. Software license agreements may contain multiple elements, including upgrades and enhancements, products deliverable on a when and if available basis and postpost- contract support. Revenue from software license agreements is

F-28



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Revenue recognition (continued):

recognized upon delivery of the software, provided that persuasive evidence of an arrangement exists, collection is determined to be probable, all nonrecurring engineering work necessary to enable the Company’sCompany's products to function within the customer’scustomer's application has been completed, and the Company has delivered its product according to specifications.

For arrangements with multiple deliverables, the Company allocates consideration at the inception of an arrangement to all of its deliverables based on their relative selling prices which is determined using vendor specific objective evidence.

Maintenance revenue is recorded for post contractpost-contract support and upgrades or enhancements, which is paid for in addition to license fees, and is recognized as costs are incurred or over the support period whichever is longer. For undelivered elements where vendor specific objective and reliable evidence of fair value does not exist, revenue is deferred and subsequently recognized when delivery has occurred and when fair valuevendor specific evidence has been determined.

For the years ended December 31, 2007 and 2006, the Company’s sales in the United States as a percentage of total sales were 92% and  81%, respectively. For the years ended December 31, 2007 and 2006, the Company’s export sales as a percentage of total revenues were approximately 8% and 19%, respectively. Foreign sales are determined based on the countries to which the Company’s products are shipped.

Major customers:

For the year ended December 31, 2007, four customers accounted for 57% of total revenues in 2007. Access Systems Americas, Inc. (formerly PalmSource, Inc.) accounted for 24%, Tennessee Valley Authority accounted for 10%, World Financial Group accounted for 13% and Wells Fargo Bank, NA accounted for 10%. One customer, PalmSource, Inc., accounted for 27% of total revenues in 2006.

Four customers accounted for 92% of accounts receivable at December 31, 2007.  eCom Asia Pacific, Ltd accounted for 22%, Access Systems Americas, Inc, (formerly PalmSource) accounted for 28%, Sony Ericsson accounted for 10% and Tennessee Valley Authority accounted for 32%.  Four customers accounted for 69% of accounts receivable at December 31, 2006.  Prudential Insurance Co. of America accounted for 11%, eCom Asia Pacific Pty. Ltd. accounted for 14%, IA Systems Pty. Ltd. accounted for 17% and PalmSource, Inc. accounted for 27%.

Research and development:

Research and development costs are charged to expense as incurred.

Advertising:

Marketing:

The Company expenses advertising (marketing) costs as incurred. AdvertisingThese expenses are outbound marketing expenses associated with participation in industry events, related sales collateral and email campaigns aimed at generating customer participation in webinars. The expense for the years ended December 31, 20072015 and 20062014 was $100$8 and $177,$46, respectively.

F-12

TABLE OF CONTENTS

1.   Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies: (continued)

Net (loss) incomeloss per share:

The Company calculates net (loss) incomeloss per share under the provisions of Statement of Financial Accounting Standards No. 128, “Earnings Per Share” (“SFAS 128”). SFAS 128the relevant accounting guidance. That guidance requires the disclosure of both basic net income (loss)loss per share, which is based on the weighted average number of shares outstanding, and diluted income (loss)loss per share, which is based on the weighted average number of shares and dilutive potential shares outstanding.

For the year ended December 31, 2007, 6,036The number of shares of common stockCommon Stock subject to outstanding options, preferred shares on an as converted basis and 15,149 shares issuable upon exercise of the warrants were excluded from the calculation of dilutive earningsloss per share because the exercise of such options and warrantsas their inclusion would be anti-dilutive.anti-dilutive are as follows:

 
December 31,
2015
December 31,
2014
Common Stock subject to outstanding options
 
82
 
 
58
 
Series A-1 Preferred Stock
 
50
 
 
45
 
Series B Preferred Stock
 
1,044
 
 
945
 
Series C Preferred Stock
 
565
 
 
512
 
Series D-1 Preferred Stock
 
1,116
 
 
801
 
Series D-2 Preferred Stock
 
737
 
 
667
 
Warrants outstanding
 
206
 
 
171
 

F-29



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Net (loss) income per share(continued):

For the year ended December 31, 2006, 5,893 shares of common stock subject to outstanding options, 2,993 shares issuable upon the conversion of the convertible notes and 7,961 shares issuable upon exercise of the warrants were excluded from the calculation of dilutive earnings per share because the exercise or conversion of such options and warrants would be anti-dilutive.

Foreign currency translation:

The Company considers the functional currency of the Joint Venture, CICC, to be the local currency of China, which is the Renminbi (“RMB”) and, accordingly, gains and losses from the translation of the local foreign currency financial statements are included as a component of “accumulatedaccumulated other comprehensive loss”loss in the accompanying consolidated balance sheets. Foreign currency assets and liabilities are translated into U.S. dollars at the end-of-period exchange rates except for long-term assets and liabilities, which are translated at historical exchange rates. RevenuesRevenue and expenses are translated at the average exchange rates in effect during each period except for those expenses related to consolidated balance sheet amounts which are translated at historical exchange rates.

Net foreign currency transaction gains and losses are included in “Interest incomeinterest and other income, (expense), net”net in the accompanying consolidated statements of operations. Foreign currency transaction gains and losses in 20072015 and 20062014 were insignificant.

Comprehensive income:

In June 1997, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 130, “Reporting Comprehensive Income” (“SFAS 130”). The Company adopted SFAS 130 effective January 1, 1998.  SFAS 130 requires that all items recognized under accounting standards as components of comprehensive earnings be reported in an annual statement that is displayed with the same prominence as other annual financial statements. SFAS 130 also requires that an entity classify items as other comprehensive earnings by their nature in an annual financial statement.

Income taxes:

Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their financial statement reported amounts and for tax loss and credit carryforwards.carry-forwards. A valuation allowance is provided against deferred tax assets when it is determined to be more likely than not that the deferred tax asset will not be realized.

The Company adopted the provisions of Financial Standards Accounting Board Interpretation No. 48, “Accounting for Uncertainty in Income Taxes - an Interpretation of FASB Statement No. 109 (“FIN 48”), on January 1, 2007. There werehave been no unrecognized tax benefits and, accordingly, there has been no effect on the Company’sCompany's financial condition or results of operations as a result of implementing FIN 48.

operations.

The Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company is no longer subject to U.S. federal tax examinations for years before 2003,2006, and state tax examinations for years before 2002.2005. Management does not believe there will be any material changes in ourthe Company’s unrecognized tax positions over the next 12 months.

F-30



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

The Company’sCompany's policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of the date of adoption of FIN 48, there was no accrued interest

Recently issued accounting pronouncement:

Other accounting standards that have been issued or penalties associated with any unrecognized tax benefits, nor was any interest expense recognized during the twelve month period ended December 31, 2007.

Recent pronouncements:

In December 2007,proposed by the FASB issued Statement of Financial Accounting Standard No. 141 (R), Business Combinations (“SFAS 141 (R)”),which becomes effective for fiscal periods beginning after December 15, 2008. SFAS No. 141 (R) requires all business combinations completed after the effective date to be accounted for by applying the acquisition method (previously referred to as the purchase method). Companies applying this method will have to identify the acquirer, determine the acquisition date and purchase price and recognize at their acquisition date fair values of the identifiable assets acquired, liabilities assumed, and any non-controlling interests in the acquiree. In the case of a bargain purchase the acquirer is required to reevaluate the measurements of the recognized assets and liabilities at the acquisition date and recognize a gain on that date if an excess remains. The Company doesor other standards-setting bodies are not expect the adoption of this statementexpected to have a material impact on its consolidated financial statements.

In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements, an Amendment of ARB 51 (“SFAS 160”) which becomes effective for fiscal periods beginning after December 15, 2008. This statement amends ARB 51 to establish accounting and reporting standards for the non-controlling interest in a subsidiary and for the deconsolidation of a subsidiary. The statement requires ownership interests in subsidiaries held by parties other than the parent be clearly identified, labeled, and presented in the consolidated statement ofCompany’s financial position, within equity, but separate fromresults of operations or cash flows.

F-13

TABLE OF CONTENTS

2.   Concentrations:

The following table summarizes accounts receivable and revenue concentrations:

 
Accounts Receivable
As of December 31,
Total Revenue for the year
ended December 31,
 
2015
2014
2015
2014
Customer #1
 
 
 
44
%
 
13
%
 
 
Customer #2
 
20
%
 
19
%
 
10
%
 
12
%
Customer #3
 
 
 
 
 
 
 
12
%
Customer #4
 
 
 
 
 
24
%
 
11
%
Customer #5
 
18
%
 
10
%
 
 
 
 
Customer #6
 
20
%
 
 
 
 
 
 
Customer #7
 
39
%
 
 
 
 
 
 
Total concentration
 
97
%
 
73
%
 
47
%
 
35
%

The following table summarizes sales concentrations:

 
December 31,
2015
December 31,
2014
Sales within the United States
 
93
%
 
99
%
Sales outside of the United States
 
7
%
 
1
%
Total
 
100
%
 
100
%

3.   Property and equipment:

Property and equipment, net at December 31, consists of the parent’s equity. following:

 
2015
2014
Machinery and equipment
$
1,248
 
$
1,235
 
Office furniture and fixtures
 
435
 
 
435
 
Leasehold improvements
 
125
 
 
90
 
Purchased software
 
323
 
 
323
 
 
 
2,131
 
 
2,083
 
Less accumulated depreciation and amortization
 
(2,087
)
 
(2,072
)
 
$
44
 
$
11
 

4.   Intangible assets:

Intangible assets, net consists of the following at December 31:

 
Weighted Average
Amortization Period
(Years)
2015
2014
Technology
 
2
 
$
6,745
 
$
6,745
 
Less accumulated amortization
 
 
 
 
(6,154
)
 
(5,812
)
 
 
 
 
$
591
 
$
933
 

The statement also requires consolidated net incomenature of the underlying technology of our intangible assets can be referred to be reported at amounts that include the amounts attributableas “transaction-enabling,” “digital authentication” and “business process work flow.” This technology includes various forms of electronic signature methods, such as handwritten, biometric, click-to-sign and others, as well as technologies related to both the parentsignature verification, authentication, cryptography and the non-controlling interestlogging of audit trails to prove signers’ intent. Our technologies enable the appending of secure, legal and regulatory compliant electronic signatures coupled with disclosure on the facean enhanced user experience at a fraction of the consolidated statement of income, of the amounts of consolidated net income attributable to the parenttime and to the non-controlling interest. In addition this statement establishes a single method of accountingcost required by traditional, paper-based processes for changes in a parent’s ownership interest in a subsidiary that do not result in deconsolidation and requires that a parent recognize a gain or loss in net income when a subsidiary is deconsolidated.signature capture. The Company does not expect the adoptionforesee any effects of this statement to have a material impactobsolescence or significant competitive pressure on its consolidated financial statements.

In February 2007,current or future products, anticipates increasing demand for products utilizing its technology, and believes that the FASB issued Statement No. 159, “The Fair Value Optioncurrent markets for Financial Assets and Financial Liabilities — Including an amendmentits products based on technology will remain constant or will grow over the remaining useful lives assigned to FASB Statement No. 115”. This statement permits companies to choose to measure many financial instruments and other items at fair value. The objective is to improve financial reporting by providing entities with the opportunity to mitigate volatility in reported earnings caused by measuring relatedits intangible assets and liabilities differently without having to apply complex hedge accounting provisions.  This Statement is expected to expandbecause of business environments encouraging the use of fair value measurement of accounting for financial instruments.  This statement applies to all entities, including not for profit.electronic signatures.

F-14

TABLE OF CONTENTS

The fair value option established by this statement permits all entities to measure eligible items at fair value at specified election dates.  This statement is effective as of the beginning of an entity’s first fiscal year that begins after November 15, 2007.

The Company is currently assessing the impact adoption of SFAS No. 159 will have on its consolidated financial statements.

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurement”. This statement defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. This statement applies under other accounting pronouncements that require or permit fair value measurements. SFAS No. 157 is effective for fiscal years beginning after November 15,

F-31



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

1. Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

2007. The Company is currently assessing the impact of the adoption of SFAS No. 157 will have on its consolidated financial statements.

2.5.   Chinese Joint Venture:

Venture (Non-Controlling Interest):

The Company currently owns 90% of a joint venture (the “Joint Venture”) with the Jiangsu Hongtu Electronics Group, a provincial agency of the People’sPeople's Republic of China (the “Agency”). In June 1998, the registered capital of theChina. The Joint Venture's business license expires October 18, 2043. There were no significant operations in 2015 or 2014.

The Joint Venture was reduced from $10,000 to $2,550. As of December 31, 2007, the Company had contributed an aggregate of $1,800 in cash to the Joint Venture and provided it with non-exclusive licenses to technologies and certain distribution rights and the Agency had contributed certain land use rights. Following the reduction in registered capital of the Joint Venture, neither the Company nor the Agency is required to make further contributions to the Joint Venture. Prior to the reduction in the amount of registered capital, the Joint Venture was subject to the annual licensing requirements of the Chinese government. Concurrent with the reduction in registered capital, the Joint Venture’s business license has been renewed through October 18, 2043.

Revenues from the Joint Venture were $39 and $153,no revenue for the years ended December 31, 20072015 and 2006,2014, respectively. Long livedIt had no long-lived assets were $0 and $8 as of December 31, 2007,2015 and 2006, respectively.2014.

6.   Other accrued liabilities:

3. ConvertibleThe Company records liabilities based on reasonable estimates for expenses, or payables that are known or estimated including deposits, taxes, rents and services. The estimates are for current liabilities that should be extinguished within one year.

The Company had the following other accrued liabilities at December 31:

 
2015
2014
Accrued professional services
$
23
 
$
8
 
Rents
 
19
 
 
44
 
Management fees
 
503
 
 
280
 
Accrued interest
 
49
 
 
 
Other
 
21
 
 
6
 
Total
$
615
 
$
338
 

7.   Debt:

Short-term notes: payable:

In September 2015, the Company issued a demand note for an aggregate amount of $250 to an affiliate of the Company. This note bears interest at the rate of 10% per annum and both the principal and interest accrued are payable on demand.

In November 2004,and December 2015, the Company entered into an unsecured Noteconvertible promissory note purchase agreements with investors and Warrant Purchase Agreement (the “2004 Purchase Agreement”) and a Registration Rights Agreement (the “2004 Registration Rights Agreement, each dated asaffiliates of October 28, 2004). The Purchase Agreement did not require the Company to deliver registered shares upon exercise of the warrants. However, the Company was required to file a registration statement providing for the resale of the shares that were issuable upon the conversion of the notes and the exercise of the warrants.  The registration statement was filed on December 22, 2004 and was declared effective on January 26, 2005.

The conversion right and liquidated damage clause contained in the 2004 Purchase Agreement was analyzed under paragraphs 6 and 12 of SFAS 133, “Accounting for Derivative Instruments and Hedging Activities”, and EITF Issue 05-04 “The Effect of a Liquidated Damages Clause on a Freestanding Financial Instrument Subject to EITF 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock” to determine its proper classification in the Company’s balance sheet and to determine that no liquidated damages existed.

The 2004 financing discussed above, was a combination of debt and equity, closing November 2, 2004. The proceeds to the Company under the 2004 Purchase Agreement were approximately $3,885, net of $310 in commissions and legal expenses.  H.C. Wainwright & Co., Inc. (“Wainwright”) acted as placement agent.  As placement agent for the Company, at closing Wainwright received $731 in commissions, legal fees and warrants. The commissions of approximately $285 and legal fees of $25, were paidaggregating $1,018 in cash. The Company has used the proceeds of the financing for working capital. The Company issued warrants to Wainwright to acquire 1,218 shares of the Company’s common stock. Of the warrants issued, 870 are exercisable at $0.462 and 348 are exercisable at $0.508. The Company had ascribed the value of $421 to the Wainwright warrants, which was recorded as deferred financing costs in the balance sheet at December 31, 2004.

Under the terms of the 2004 Purchasenote purchase agreements, in November 2015, the Company issued, in exchange for a demand note, an unsecured convertible promissory note in the principal amount of $250 to an affiliate of the Company.

The principal amount of the unsecured convertible promissory notes issued in connection with the Company’s unsecured debt financing in November and December 2015 bear interest at a rate of 24% per year, are due on August 25, 2016 and are convertible into shares of our Common Stock at the holder’s option (i) prior to maturity, in the event the Company consummates an SEC registered public offering of shares of common stock, at a conversion price that is 30% less than the price to the public of the Common Stock in the public offering, or (ii) up to 60 days after maturity, at a conversion price based upon a Company pre-money valuation of $5,000,000, as determined by taking into account the outstanding shares of Common Stock and Preferred Stock, on an as-converted basis, on the maturity date of the note; provided, that following such conversion after the maturity date, each holder that converted such note will also receive cash payments, payable from 1.5% for each $100,000 of notes converted of the revenue received by the Company from its European customer to be paid quarterly on a pro rata basis, with any and all other holders who converted their notes; provided, further, however, that the total amount of cash payments that the holder will be entitled to receive will not exceed three times the aggregate principal amount of each holder’s note.

The conversion option included within the unsecured convertible promissory notes was deemed to be an embedded derivative, which required the Company to bifurcate and separately account for the embedded derivative as a separate liability on the consolidated balance sheets at the estimated fair value upon issuance. The Company estimated the fair value of the derivative liability to be $330 upon issuance of the notes. The amount of short-term debt recorded on the balance sheet is net of the amount of the derivative liability. The Company recorded $53 in debt discount amortization expense associated with the notes through December 31, 2015.

F-15

TABLE OF CONTENTS

7.   Debt:(continued)

Line of Credit:

On May 6, 2014, the Company entered into a Credit Agreement with Venture Champion Asia Limited, an affiliate of ICG Global Limited (the “Lender”). Under the terms of the Credit Agreement, for a period of 18 months, the Company was permitted to borrow up to $2,000 in unsecured indebtedness from the Lender. In connection with the Company’s entry into the Credit Agreement, the Company issued to certain accredited investors convertible promissory notesthe Lender warrants to purchase 9 shares of Common Stock and issued to a third party 1 warrant for assisting in the aggregate principal amount of $4,195 and warrants to acquire 3,632 sharesclosing of the Company’s common stock atCredit Agreement. The warrants had a three-year life and an exercise price of $0.508 per share.  The notes accrued interest at the rate of 7% per

F-32



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

3. Convertible notes (continued):

annum, payable semi-annually, and were convertible into shares of the Company’s common stock at the rate of $0.462$35 per share. The Company ascribed a value of $982 to the investor warrants whichof $258 using the Black Scholes Merton Pricing Model that was recorded ascharged to interest expense during the three-month period ended June 30, 2014. The Company concluded it did not have the intent nor the need to draw funds under the line during the term of the agreement.

On February 23, 2015, the Company and the Lender mutually agreed to terminate the Credit Agreement. At the time of the termination of the Credit Agreement, no amount was owed by the Company under the Credit Agreement, and contemporaneously with the termination of the Credit Agreement, the above mentioned warrants were likewise terminated.

8.   Derivative liability:

The Company has determined that a discount to notes payable incontract that would otherwise meet the balance sheet.  In 2007, duedefinition of a derivative but is both (a) indexed to the Company’s March/Aprilown stock and June 2007 debt financings,(b) classified in stockholders’ equity in the statement of financial position would not be considered a derivative financial instrument. The Company expensed $202 of additional discount dueapplies a two-step model in determining whether a financial instrument or an embedded feature is indexed to an issuer’s own stock and thus able to qualify for the note holders as the result of the issuance of newscope exception.

The Company issued certain warrants in a related party transaction andconnection with financing transactions from 2010 through 2012 that require liability classification because of certain provisions that may result in a private placement with an exercise price less than the note holders. The reduced exercise price of the new warrants resulting in the reduction of the conversion price of the note holder warrants from $0.46 to $0.41 per share.

The fair value ascribedadjustment to the Wainwrightnumber of shares issued upon settlement and investoran adjustment to their exercise price. The Company classifies these warrants was estimated on its balance sheet as a derivative liability which is fair valued at each reporting period subsequent to the commitment date usinginitial issuance.

The Company used a simulated probability valuation model to value these warrants. Determining the Black-Scholes pricingappropriate fair-value model with the following assumptions: risk-free interest rate of 3.21%; expected life of 3 years; expected volatility of 100%; and expected dividend yield of 0%.  In addition tocalculating the fair value ascribed toof the warrants the Company had ascribed $1,569 to the beneficial conversion featurerequires considerable judgment. The warrants expired in the convertible notes, which was recorded as a discount to notes payable in the balance sheet.  The values ascribed to the warrants and beneficial conversion feature followed the guidance of the EITF Issue No. 98-5, “Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratios”, and ETIF Issue No. 00-27, “Application of Issue No. 98-5 to Certain Convertible Instruments” of the FASB’s Emerging Issues Task Force.November 2015. The fair value of the warrants and beneficial conversion feature was amortized to expense over the life of the convertible notes or upon earlier conversion using the effective interest method.  During the year endedderivative liability at December 31, 2007, the Company had amortized to interest expense approximately $303, of the loan discount and deferred financing costs. There were no note conversions during the year ended December 31, 2007.

The Company offered the outstanding convertible note holders the option of being issued warrants to purchase two (2) shares of the Company’s common stock for each dollar of note principal outstanding in exchange for a two year extension of the note due date and termination of the conversion feature of the note.  The warrants would have a three year life from the date of issuance and an exercise price equal to the closing price of the Company’s common stock on the date the warrants were issued. The new warrants would have registration rights similar to those of the current warrants. In October 2007, one note holder, with a principal balance of $117, accepted the offer with a modification to the exercise price of the warrants revised to the average of the 20 day volume weighted average price of the Company’s commons stock ending on October 25, 2007. The Company issued 234 warrants to the investor on the terms discussed above. The relative fair value of $23 ascribed to the warrants2014 was estimated on the commitment date using the Black-Scholes pricing model with the following assumptions: risk-free interest rate of 4.90%; life of 3 years; expected volatility of 86%; and expected dividend yield of 0%. On October 26, 2007, the Company paid the remaining outstanding debt of $1,265 and accrued interest thereon.

The warrants issued under the 2004 Purchase Agreement expire on October 28, 2009. The Company may call the warrants if the Company’s common stock trades at $1.00 or above for 20 consecutive trading days after the date that is 20 days following the effectiveness of a registration statement providing for the resale of the shares issued upon the conversion of the notes and exercise of the warrants.  At December 31, 2007, there are warrants outstanding to purchase 4,903 shares of common stock at a weighted average exercise price of $0.44 per share, adjusted for the reduction in conversion price and sale of common stock in a private placement discussed above. The placement agent will be paid approximately $28 in the aggregate if all of the investor warrants are exercised.  The Company will receive additional proceeds of approximately $1,482, adjusted for the change in warrant exercise price, if all of the investor warrants are exercised.

Interest expense related to convertible debt for the years ended December 31, 2007 and 2006 was $584 and $694, respectively. Amortization of debt discount and deferred financing costs, including $202 related to the warrant re-pricing explained above, included in interest expense for the years ended December 31, 2007 and 2006 was $505 and $591, respectively.

F-33



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

4. Short-term debt:

$18.

In August 2006,November and December 2015, the Company entered into a Noteunsecured convertible promissory note purchase agreements with investors and Warrant Purchase Agreement (the “2006 Purchase Agreement”) and a Registration Rights Agreement (the “2006 Registration Rights Agreement”), each dated as of August 10, 2006.  The Company secured the right to borrow up to six hundred thousand dollars ($600).  On November 19, 2006 the Company borrowed the $600 available under the 2006 Purchase Agreement, of which $450 was borrowed from an approximate 7% shareholder (“Affiliated Shareholder”)affiliates of the CompanyCompany. The accounting for the unsecured convertible notes, which are convertible into shares of our common stock, requires us to bifurcate the conversion feature and the remaining $150 from an unrelated third party.  The Company used the proceeds of the financingaccount for additional working capital. In addition, the Company issued warrants to purchase 3,111 of the Company’s common stock.  The Company has ascribed a value of $336 to the warrants, which is recordedit as a discount to long-term debt, inderivative liability at the balance sheet and will be amortized to interest expense over the life of the loan.  The relativeestimated fair value ascribed to the warrants was estimated on the commitment date using the Black-Scholes pricing model with the following assumptions: risk-free interest rate of 4.68%; expected life of 3 years; expected volatility of 54%; and expected dividend yield of 0%.

The note is due May 17, 2008, bears interest at the rate of 15% per annum payable quarterly in cash. The warrants have a term of three years and an exercise price of $0.51. The warrants included piggyback registration rights for the underlying shares to participate in certain future registrations of the Company’s common stock.  The shares were registered with the Company’s Form S-1/A which was declared effective December 28, 2007.

In February 2007, the Company entered into a Note and Warrant Purchase Agreement (the “February 2007 Purchase Agreement”) and a Registration Rights Agreement (the “February 2007 Registration Rights Agreement”), each dated as of February 5, 2007, with the Affiliated Stockholder.  The Company secured the right to borrow up to $600. On March 15, 2007 the Company and the Affiliated Stockholder amended the February 2007 Purchase Agreement to increase the maximum amount of borrowing from $600, to $1,000. The terms of the February 2007 Purchase Agreement and 2006 Purchase Agreement are identical with the exception that the maximum number of warrants that may be issued under the February 2007 Purchase Agreement is 5,185 rather than 3,111. The warrants have a three year life, become exercisable on June 30, 2007, and have an exercise price of $0.51.  The warrants included piggyback registration rights for the underlying shares to participate in any future registrations of the Company’s common stock. The shares were registered with the Company’s Form S-1/A which was declared effective December 28, 2007.

On March 30, 2007, and April 1, 2007 the Company borrowed $670 and $50 under the February 2007 Purchase Agreement of which $320 was borrowed from the Affiliated Stockholder and the remaining $400 from unrelated third parties.  The proceeds were used for working capital purposes.  The Company has ascribed a value of $359 to the 3,733 warrants, issued as part of this borrowing, which is recorded as a discount to short-term debt in the balance sheet and will be amortized to interest expense over the life of the loan.  The relative fair value ascribed to the warrants was estimated on the commitment date using the Black-Scholes pricing model with the following assumptions: risk-free interest rate of 4.68%; life of 3 years; expected volatility of 45%; and expected dividend yield of 0%. The notes bear interest at the rate of fifteen percent (15%) per annum payable quarterly in cash and are due September 30, 2008.

On June 15, 2007, The Company entered into a Note and Warrant Purchase Agreement (the “June 2007 Purchase Agreement”) and a Registration Rights Agreement (the “June 2007 Registration Rights Agreement”), each dated as of June 15, 2007. The Company secured the right to borrow up to $1,000 from the Affiliated Stockholder. As of December 31, 2007, the Company had borrowed $400 under this facility and the option to borrow the remaining $600 lapsed as of that date. The Company used the proceeds of the financing for working capital purposes. The Note bears interest at the rate of fifteen percent (15%) per annum payable quarterly in cash. The Company was required to issue warrants to purchase shares of its common stock, the number to be determined by use of a formula known as the Cox-Rubenstein Model, which takes into account the volatility of the underlying stock, the risk free interest rate, dividend yield and exercise price. The exercise price of the warrants was determined by the volume weighted average price of the common stock for the thirty business days preceding the date of the draw. The warrants included piggyback registration rights for the underlying shares to participate in certain future registrations

F-34



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

4. Short-term debt (continued):

of the Company’s common stock.  The shares were registered with the Company’s Form S-1/A which was declared effective December 28, 2007.

The June 2007 Purchase Agreement required the Company to draw $400 of the funds upon signing.  Applying the formula described above, the Company issued warrants to purchase 3,168 shares of its common stock at an exercise price of $0.25.  The Company has ascribed a value of $187 to the warrants, issued as part of this borrowing, which is recorded as a discount to short-term debt in the balance sheet and will be amortized to interest expense over the life of the loan.  The relative fair value ascribed to the warrants was estimated on the commitment date using the

Black-Scholes pricing model with the following assumptions: risk-free interest rate of 4.90%; life of 3 years; expected volatility of 69%; and expected dividend yield of 0%. As described above, the $400 note bears interest at the rate of fifteen percent (15%) per annum payable quarterly in cash and is due December 30, 2008.

issuance. The Company used a volume weighted averageMonte Carlo simulation to value the conversion feature with the following assumptions:

As of
December 31,
2015
Common Stock price
$4.00
Convertible debt principal amount
$1,268,000
Term (years)
0.12 to 0.65
Expected volatility
100%
Convertible debt interest rate
24%
Trials (each trial equals 150,000 iterations)
10
Discount to IPO/next round
30%

The fair value of the common stock forderivative liability at December 31, 2015 was $330.

F-16

TABLE OF CONTENTS

8.   Derivative liability: (continued)

Changes in the thirty business days preceding the datefair value of the applicable draw to determine the $0.25 exercise price of the 3,168 warrants issued with the June 2007 Purchase Agreement. The calculation produces an exercise price less than the exercise price of the warrants associated with the convertible debt and less than the conversion price of such debt. This resulted in the Company having to reset both the conversion price of the convertible debt and the exercise price of the associated warrants.  The Company reduced the conversion price of the convertible debt from $0.46 to $0.45. The effect of this re-pricing resulted in the Company incurring $202 of additional interest expense during the period. The weighted average exercise price of the warrants associated with the convertible debt was reduced from $0.50 to $0.44, resulting in a reduction in gross proceeds if all of the warrants are exercised of $291.

Interest expense associated with short-term debtlevel 3 derivative liability for the year ended December 31, 2007 and 2006 was $666 and $81, respectively, of which $440 and $81 related to the Affiliated Shareholder, respectively. Amortization of debt discount included in interest expense for the year ended2015 are as follows:

 
Derivative
Liability
Balance at January 1, 2015
$
18
 
Issuance of new derivative liabilities related to the unsecured convertible promissory notes
 
330
 
Gain on derivative liability from expiration of warrants
 
(18
)
Balance at December 31, 2015
$
330
 

9.   Stockholders’ equity (deficit):

Common stock options:

At December 31, 2007 and 2006 was $463 and $70, respectively, of which $305 and $70 related to2015, the Affiliated Shareholder, respectively.

5. Stockholders’ equity:

Common stock options:

The Company has onetwo stock-based employee compensation plan, (the “1999 Option Plan”)plans, the 2009 Stock Compensation Plan, and the 2011 Stock Compensation Plan. The Company may also grantsgrant options to employees, directors and consultants outside of the 1999 Option Plan2009 and 2011 plans under Individual Plans.individual plans.

In June 1999,Information with respect to the Company adopted and the shareholders approved the 1999 Option Plan. Incentive and non-qualified options under the 1999 Option Plan may be granted to employees, officers, and consultants of the Company. There are 4,000 shares of Common Stock authorized for issuance under the 1999 Option Plan. The options have a seven year life and generally vest quarterly over three years. AtCompensation Plans at December 31, 2007, there were 72 shares available for future grants. As of December 31, 2007, 3,747 plan options were outstanding and 3,174 plan options were exercisable with a weighted average exercise price of $0.60 per share.

The Company has issued options under Individual Plans to its employees and directors. The Individual Plan options generally vest over four years or prorata quarterly over three years. Non-plan options are generally exercisable over a period not to exceed seven years. As of December 31, 2007, 2,289 non-plan options were outstanding and 2,189 non-plan options were exercisable with a weighted average exercise price of $0.65 per share.

Share-based payment:

On January 1, 2006, the Company adopted SFAS No. 123(R), “Share-Based Payment, using the modified prospective transition method, which requires the application of the accounting standard2015 is as of January 1, 2006.follows:

F-35

 
2009 Stock
Compensation Plan
2011 Stock
Compensation Plan
Shares authorized for issuance
7,000
150,000
Option vesting period
Quarterly over 3 years
Immediate/Quarterly over 3 years
Date adopted by shareholders
November 2011
Option term
7 Years
7 Years
Options outstanding
1
81
Options exercisable
1
56
Weighted average exercise price
$105
$45


Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

5. Stockholders’ equity (continued):

Share-based payment (continued):

SFAS No. 123(R) establishes standards for the accounting of transactions in which an entity exchanges its equity instruments for goods or services, primarily focusing on accounting for transactions where an entity obtains employee services in share-based payment transactions.  In March 2005, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 107 (SAB 107) relating to SFAS No. 123(R). The Company has applied the provisions of SAB 107 in its adoption of SFAS No. 123(R).

Share-based compensation expense is based on the estimated grant date fair value of the portion of share-based payment awards that are ultimately expected to vest during the period.  The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes option pricing model. SFAS No. 123(R) requires forfeitures of share-based payment awards to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.  The estimated average forfeiture rates for the year ended December 31, 2007, was approximately 27.90%.

For the years ended December 31, 2007 and 2006, stock-based compensation expense includes compensation expense for share-based payment awards granted prior to, but not yet vested as of December 31, 2005. Share based payment awards issued but not yet vested as of December 31, 2005 are valued in accordance with the pro forma provisions of section SFAS No. 123. Compensation expense for the share-based payment awards granted subsequent to December 31, 2005, are based on the grant date fair value estimated in accordance with the provisions of SFAS No. 123(R).

SFAS No. 123(R) requires the cash flows from tax benefits for deductions in excess of the compensation costs recognized for share-based payment awards to be classified as financing cash flows.  Due to the Company’s loss position, there was no such tax benefits during the year ended December 31, 2007.

Valuation and Expense Information under SFAS No. 123(R):Information:

The weighted-average fair value of stock-based compensation is based on the single optionBlack Scholes Merton valuation approach.  model.

Forfeitures are estimated and it is assumed no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized using the accrual method over the vesting period of the options. The fair value calculations are based on the following assumptions:

Year Ended
December 31, 2007

Year Ended
December 31, 2006

Risk free interest rate

3.32% - 5.11%

4.60% - 5.11%

Expected life (years)

3.21 – 6.83

3.46 -5.02

Expected volatility

80.96% - 104.57%

80.92% - 104.57%

Expected dividends

None

None

F-36

 
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Risk free interest rate
0.04% - 3.04%
0.04% - 3.73%
Expected life (years)
3.26 – 6.33
3.26 – 7.00
Expected volatility
120.74% - 198.90%
91.99% - 198.38%
Expected dividends
None
None
Estimated average forfeiture rate
7.9%
10%


Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

5. Stockholders’ equity (continued):

Share-based payment (continued):

The following table summarizes the allocation of stock-based compensation expense related to stock option grants under SFAS No. 123(R) for the years ended December 31, 20072015 and 2006.2014. During 2015, the Company granted 31 options at a weighted average grant date fair value of $25 per share. There were no stock option exercisesoptions exercised during the years ended December 31, 20072015 and 2006, except for 19 shares exercised in 2006 by a consultant that were issued for services.2014.

 
December 31, 2015
December 31, 2014
Research and development
$
174
 
$
77
 
Sales and marketing
 
132
 
 
72
 
General and administrative
 
226
 
 
134
 
Director options
 
43
 
 
15
 
Stock-based compensation expense included in operating expenses
$
575
 
$
298
 

 

 

Year Ended
December 31,
2007

 

Year Ended
December 31,
2006

 

Research and development

 

$

18

 

$

54

 

Sales and marketing

 

66

 

92

 

General and administrative

 

13

 

22

 

Director options

 

33

 

21

 

Stock-based compensation expense included in operating expenses

 

$

130

 

$

189

 

F-17

The summary activity under the Company’s 1999 Option Plan and Individual Plans is as follows:

 

 

December 31, 2007

 

December 31, 2006

 

 

 

Shares

 

Weighted
Average
Exercise
Price

 

Aggregate
Intrinsic
Value

 

Weighted
Average
Remaining
Contractual
Life

 

Shares

 

Weighted
Average
Exercise
Price

 

Aggregate
Intrinsic
Value

 

Weighted
Average
Remaining
Contractual
Life

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at beginning of period

 

5,893

 

$

0.69

 

 

 

 

 

8,591

 

$

0.75

 

 

 

 

 

Granted

 

870

 

$

0.21

 

 

 

 

 

1,764

 

$

0.44

 

 

 

 

 

Exercised

 

 

$

0.00

 

 

 

 

 

(19

)

$

0.42

 

 

 

 

 

Forfeited

 

(727

)

$

0.98

 

 

 

 

 

(4,443

)

$

0.72

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at period end

 

6,036

 

$

0.59

 

 

 

4.7

 

5,893

 

$

0.69

 

 

 

5.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options vested and exercisable at period end

 

5,364

 

$

0.62

 

 

 

4.5

 

5,066

 

$

0.74

 

 

 

5.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average grant-date fair value of options granted during the period

 

$

0.14

 

 

 

 

 

 

 

$

0.24

 

 

 

 

 

 

 

F-37TABLE OF CONTENTS



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

5.9.   Stockholders’ equity (deficit): (continued):

Share-based payment (continued):

The following table summarizes significant ranges of outstanding and exercisable options as of December 31, 2007:

 

 

Options Outstanding

 

Options Exercisable

 

Range of Exercise Prices

 

Options
Outstanding

 

Weighted
Average
Remaining
Contractual
Life(in years)

 

Weighted
Average
Exercise
Price

 

Number
Outstanding

 

Weighted
Average
Exercise
Price

 

$0.00 – $0.50

 

2,504

 

5.3

 

$

0.32

 

1,832

 

$

0.34

 

$0.51 – $1.00

 

3,341

 

4.3

 

$

0.73

 

3,341

 

$

0.73

 

$1.01 – $2.00

 

176

 

2.0

 

$

1.31

 

176

 

$

1.31

 

$2.01 – $2.99

 

 

0.0

 

$

0.00

 

 

$

0.00

 

$3.00 – $7.50

 

15

 

2.5

 

$

3.56

 

15

 

$

3.56

 

 

 

6,036

 

 

 

 

 

5,364

 

 

 

A summary of the status of the Company’s nonvested shares as of December 31, 2007 is as follows:

Nonvested Shares

 

Shares

 

Weighted
Average
Grant-Date
Fair Value

 

Nonvested at January 1, 2007

 

827

 

$

0.36

 

Granted

 

870

 

$

0.14

 

Forfeited

 

(727

)

$

0.29

 

Vested

 

(298

)

$

0.26

 

Nonvested

 

672

 

$

0.22

 

As of December 31, 2007,2015, there was $49$241 of total unrecognized compensation cost related to nonvestednon-vested share-based compensation arrangements. The unrecognized compensation cost is expected to be recognized over a weighted average period of 2.42.5 years.

The cash flows from tax benefits for deductions in excess of the compensation costs recognized for share-based payment awards would be classified as financing cash flows. Due to the Company’s loss position, there were no such tax benefits during the year ended December 31, 2015.

The summary activity for the Company’s 2009 and 2011 Stock Compensation Plans is as follows:

 
December 31, 2015
December 31, 2014
 
Shares
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
Weighted
Average
Remaining
Contractual
Life
Shares
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
Weighted
Average
Remaining
Contractual
Life
Outstanding at beginning of period
 
58
 
$
50
 
 
 
 
 
 
 
 
56
 
$
63
 
 
 
 
 
 
 
Granted
 
31
 
$
25
 
$
33,750
 
 
 
 
 
4
 
$
25
 
 
 
 
 
 
Forfeited/ Cancelled
 
(7
)
$
50
 
 
 
 
 
 
 
 
(2
)
$
138
 
 
 
 
 
 
 
Outstanding at period end
 
82
 
$
50
 
 
 
 
4.13
 
 
58
 
$
50
 
 
 
 
4.18
 
Options vested and exercisable at period end
 
57
 
$
50
 
$
8,750
 
 
3.86
 
 
46
 
$
63
 
 
 
 
3.86
 
Weighted average grant-date fair value of options granted during the period
$
25
 
 
 
 
 
 
 
 
 
 
$
50
 
 
 
 
 
 
 
 
 
 

The following table summarizes significant ranges of outstanding and exercisable options as of December 31, 2015:

 
Options Outstanding
Options Exercisable
Range of Exercise Prices
Options
Outstanding
Weighted Average
Remaining Contractual
Life (in years)
Weighted
Average
Exercise Price
Number
Outstanding
Weighted
Average
Exercise Price
$25 – $625
 
82
 
 
4.13
 
$
50
 
 
57
 
$
50
 

A summary of the status of the Company’s non-vested shares as of December 31, 2015 is as follows:

Non-vested Shares
Shares
Weighted Average
Grant-Date
Fair Value
Non-vested at January 1, 2014
 
12
 
$
47
 
Granted
 
31
 
$
24
 
Forfeited
 
(2
)
$
29
 
Vested
 
(16
)
$
49
 
Non-vested at December 31, 2015
 
25
 
$
27
 

An employee or consultant desiring to exercise or convert his or her stock options must provide a signed notice of exercise to the Chief Financial Officer. Once the exercise is approved an issue order is sent to the Company’s transfer agent and by certificate or through other means of conveyance, the shares are delivered to the employee or consultant, generally within three business days.

The Company expects to make additional option grants in future years. The options issued to employees and directors will be subject to the same provisions of FASB Statement 123(R),outlined above, which may have a material impact on the Company’s financial operations.statements.

F-18

TABLE OF CONTENTS

9.   Stockholders’ equity (deficit): (continued)

Treasury Stock:

The Company received 5 shares of its Common Stock having a fair value under the cost method of $325 in January 2012, in settlement of a 16b suit brought by a shareholder against Phoenix Venture Fund, LLC (“Phoenix”). At December 31, 2015, the total value of treasury stock was $325. The Company has no plans to repurchase shares of Common Stock in the future.

Preferred Shares:

The Company has five series of Preferred Stock: Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D-1 Preferred Stock and Series D-2 Preferred Stock. Generally, the Company’s Preferred Stock votes together on an as converted basis with the holders of Common Stock. In addition, the Company’s Preferred Stock enjoys certain protective provisions, a liquidation preference and anti-dilution protection that are similar to one another.

The Company has amended its Amended and Restated Certificate of Incorporation to increase the number of authorized shares of its Series D-1 and Series D-2 Preferred Stock. The Company solicited its stockholders and its stockholders approved an amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Series D-1 Preferred Stock from 6,000 to 10,000, and of Series D-2 Preferred Stock from 9,000 to 10,000 (the “Charter Amendment”). The Charter Amendment allows the Company to have additional shares of stock available for possible future capital raising activities as approved by the Board of Directors.

The Company has amended and restated the Certificates of Designation for the Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock to, among other things, subordinate the Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock, in terms of dividend rights, liquidation preferences and other rights, to the Series D Preferred Stock. Holders of at least a majority of the shares of the Company’s Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock have approved the amendment and restatement of the Certificate of Designation applicable to such holders.

Information with respect to the classes of Preferred Stock at December 31, 2015 is as follows:

Class of
Preferred Stock
Annual
Dividend
Annual
Dividend
Payable, in
Cash or
In Kind
Liquidation
Preference
Conversion
Price
Total
Preferred
Shares
Outstanding
Common
Shares to
be issued if
Fully
Converted
Series A-1
 
8
%
Quarterly in Arrears
$
1.00
 
$
0.0156
 
 
947
 
 
50
 
Series B
 
10
%
Quarterly in Arrears
$
1.50
 
$
0.0104
 
 
13,523
 
 
1,044
 
Series C
 
10
%
Quarterly in Arrears
$
1.50
 
$
0.0078
 
 
5,491
 
 
565
 
Series D-1
 
10
%
Quarterly in Arrears
$
1.00
 
$
0.0058
 
 
8,077
 
 
1,116
 
Series D-2
 
10
%
Quarterly in Arrears
$
1.00
 
$
0.0069
 
 
6,321
 
 
737
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3,512
 

Information with respect to dividends issued on the Company’s Preferred stock for the years ended December 31, 2015 and 2014 is as follows:

 
December 31,
December 31,
 
2015
2014
2015
2014
 
Dividends
Beneficial Conversion Feature Related to dividends
Series A-1
$
72
 
$
82
 
$
 
$
 
Series B
 
1,272
 
 
1,149
 
 
 
 
 
Series C
 
516
 
 
468
 
 
13
 
 
152
 
Series D-1
 
715
 
 
472
 
 
15
 
 
195
 
Series D-2
 
601
 
 
541
 
 
 
 
 
Total
$
3,176
 
$
2,712
 
$
28
 
$
347
 

F-19

TABLE OF CONTENTS

9.   Stockholders’ equity (deficit): (continued)

Series A-1 Preferred Stock

The shares of Series A-1 Preferred Stock are convertible any time and are subordinate to the Series B, Series C and Series D Preferred Stock.

In November 2014, a total of 238 shares of Series A-1 Preferred Stock was converted and the Company issued 2 shares of Common Stock.

Series B Preferred Stock

The shares of Series B Preferred Stock are convertible at any time and are subordinate to the Series C and Series D Preferred Stock.

Series C Preferred Stock

The shares of Series C Preferred Stock are convertible into Common Stock at any time and are subordinate to the Series D Preferred Stock.

In January 2012, the Company received 6 shares of Common Stock from Phoenix in settlement of a 16b claim brought by a Company stockholder against Phoenix, certain affiliates and the Company, as a nominal defendant. The Common Stock was valued at $325. In settlement of an indemnification claim brought by Phoenix in March 2012, resulting from the settlement of the 16b claim in January 2012, the Company issued to Phoenix 278 shares of Series C Preferred Stock valued at $417. The Company booked a $417 accretion amount for the beneficial conversion feature on the 278 shares of Series C Preferred Stock.

Series D Preferred Stock

The material terms of the Series D-1 and Series D-2 Preferred Stock, other than the initial conversion price, are essentially the same. The shares of Series D Preferred Stock are convertible at any time and rank senior to the Company’s outstanding shares of Series A-1, Series B and Series C Preferred Stock, and of Common Stock with respect to dividend rights and liquidation preferences.

On February 7, 2014, the Company sold for $733 in cash, net of a $47 administrative fee paid in cash to SG Phoenix and a nonrelated third party, 520 shares of Series D-1 preferred Stock and 260 shares of Series D-2 Preferred Stock. The investors received one hundred percent (100%) warrant coverage. These warrants are immediately exercisable at $35 per share and expire December 31, 2016. See the warrant table below for more detail. The warrants are exercisable in whole or in part into shares of the Company’s Common Stock and contain a cashless exercise provision.

On March 6, 2014, the Company sold for $406 in cash, net of a $4 in administrative fee paid in cash to an unrelated third party, 273 Shares of Series D-1 Preferred Stock and 137 shares of Series D-2 Preferred Stock. The investors received one hundred percent (100%) warrant coverage. These warrants are immediately exercisable at $35 per share and expire December 31, 2016. See the warrant table below for more detail. The warrants are exercisable in whole or in part into shares of the Company’s Common Stock and contain a cashless exercise provision.

On August 5, 2014, the Company sold for $1,070 in cash, net of $50 in administrative fees paid in cash to SG Phoenix, 1,120 Shares of Series D-1 Preferred Stock.

On March 24, 2015, the Company sold for $1,200 in cash, net of $33 in administrative fees paid in cash to SG Phoenix, 1,233 shares of Series D-1 Preferred Stock. Investors received warrants to purchase 22 shares of Common Stock, immediately exercisable at $29 per share. In October 2015 the investors received additional warrants to purchase 18 shares of Common Stock immediately exercisable at $16 per share, and the exercise price of the March 2015 warrants were reduced to $16 per share consistent with the terms of the July 2015 financing. The warrants expire March 23, 2018. The Company ascribed a value of $422 to the warrants using the Black-Scholes-Merton pricing model. The warrants are exercisable in whole or in part.

On July 23, 2015, the Company sold for $325 in cash, net of $4 in administrative fees paid in cash to SG Phoenix, 329 shares of Series D-1 Preferred Stock. The investors received warrants to purchase 11 shares of Common Stock, immediately exercisable at $16 per share. The warrants expire July 22, 2018. The Company ascribed a value of $91 to the warrants using the Black-Scholes-Merton pricing model. The warrants are exercisable in whole or in part.

F-20

TABLE OF CONTENTS

9.   Stockholders’ equity (deficit): (continued)

Preferred Stock Voting and Other Rights

Generally, the Company’s Preferred Stock votes together on an as converted basis with the holders of Common Stock. In addition, the Company’s Preferred Stock enjoys certain protective provisions, a liquidation preference and anti-dilution protection that are similar to one another.

Warrants:

There were no Warrant exercises in 2015 and 2014:

Summary of warrants issued in 2015 and 2014:

 
December 31, 2015
December 31, 2014
 
Related Party
Other
Total
Related Party
Other
Total
Warrants issued with purchase of Series D Preferred Stock
 
42
 
 
9
 
 
51
 
 
5
 
 
13
 
 
18
 
Warrants issued with line of credit
 
 
 
 
 
 
 
 
 
10
 
 
10
 
Contingent Warrants issued
 
 
 
 
 
 
 
28
 
 
70
 
 
98
 
Total
 
42
 
 
9
 
 
51
 
 
33
 
 
93
 
 
126
 

A summary of the outstanding warrants is as follows:

 
December 31, 2015
December 31, 2014
 
Warrants
Weighted Average
Exercise Price
Warrants
Weighted Average
Exercise Price
Outstanding at beginning of period
 
172
 
$
36
 
 
62
 
$
37
 
Issued
 
51
 
$
35
 
 
126
 
$
35
 
Exercised
 
 
$
 
 
 
$
 
Expired
 
(17
)
$
29
 
 
(16
)
$
29
 
Outstanding at end of period
 
206
 
$
33
 
 
172
 
$
36
 
Exercisable at end of period
 
206
 
$
33
 
 
172
 
$
36
 

A summary of the status of the warrants outstanding as of December 31, 2015 is as follows:

Number of Warrants
Outstanding and Exercisable
Weighted Average
Remaining Life
Weighted Average
Exercise Price per share
43
1.32
$29
14
0.90
$38
145
1.26
$35
4
2.83
$16
206
1.36
$33

As of December 31, 2007, 6,0362015, 3,800 shares of Common Stock were reserved for issuance upon exercise of outstanding options.

Warrants:

At December 31, 2007, 15,149 shares of Commoncommon stock were reserved for issuance upon exercise of 82 outstanding warrants.

Private placement of Common Stock

On August 24, 2007, the Company entered into a Securities Purchase and Registration Rights Agreement (the “August 2007 Purchase Agreement”) with Phoenix Venture Fund LLC (the “Purchaser”). On September 14, 2007,

F-38



Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

the transactions closedoptions, 206 outstanding warrants and the Company issued to the Purchaser 21,500conversion of 34,359 shares of the Company’s common stock (the “Shares”) at a price per share of approximately $0.14, for an aggregate purchase price of $3,000. An advisory fee of $250 was paid to the managing member of the Purchaser for services rendered in connection with the sale of the SharesPreferred Stock.

F-21

TABLE OF CONTENTS

10.   Commitments and $61 to the Purchaser’s legal counsel for services associated with the financing transactions.  In addition the Company paid $87 in professional fees associated with the sale of the shares.  The Company expects to use the proceeds of the sale of the Shares for payment of outstanding indebtedness and additional working capital. The Company was permitted under the terms of the Purchase Agreement to use up to $1,400 of the net proceeds to repay outstanding indebtedness. Under the August 2007 Purchase Agreement, so long as the Purchaser holds shares of common stock of the Company representing at least fifty-percent of the Shares purchased pursuant to the August 2007 Purchase Agreement and at least five-percent of the outstanding capital stock of the Company, the managing member of the Purchaser is entitled to a right of first offer to exclusively provide debt or equity financing to the Company prior to the Company’s pursuing debt or equity financing from another party, subject to certain conditions and exclusions. Additionally, provided the Purchaser meets the foregoing ownership requirements, the managing member of the Purchaser is permitted to designate up to two non-voting observers to attend meetings of the Company’s board of directors and, for a period of twenty-four months following the date a registration statement pertaining to the Shares is first declared effective by the Securities and Exchange Commission (the “Commission”), the Company is prohibited from selling or otherwise disposing of material properties, assets or rights of the Company without the consent of the managing member of the Purchaser.Contingencies:

The Company was obligated under the Purchase Agreement to use its best efforts to prepare and file with the Commission a registration statement covering the resale of the securities sold pursuant to the Purchase Agreement. The registration statement will provide for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”). The Company filed the registration statement on November 15, 2007, and the registration statement was declared effective on December 28, 2007. The Company must use its best efforts to keep the registration statement continuously effective under the Securities Act until the earlier of the date that all shares purchased under the Purchase Agreement have been sold or can be sold publicly under Rule 144(k). The Company was obligated to pay the costs and expenses of such registration, which was approximately $147.

The August 2007 Purchase Agreement provides for certain registration rights whereby the Company could be required to make liquidated damages payments if a registration statement is not filed or declared effective by the SEC within a specified timeframe and if after being declared effect the registration statement is not kept effective. The Company filed the registration statement within the required timeframe and it is currently effective.  Should the Company fail to keep the registration statement effective, it will upon that event and each thirty days thereafter until the registration statement is again effective, be subject to making payments to the Purchaser in an amount equal to one and a half percent (1.5%) of the greater of: (i) the weighted average market price of the Shares during such 30-day period, or (ii) the market price of the Shares five (5) days after the closing (the “Closing Market Price”), until the registration statement is again declared effective, or as to any Shares, until such Shares can be sold in a single transaction pursuant to SEC Rule144; provided, however, that the liquidated damages amount under this provision ten percent (10%) of the Closing Market Price. The Company has not recorded a liability in connection with the liquidated damages provisions of the August 2007 Purchase Agreement because it believes that it is not probable that an event will occur which will trigger a liquidated damages payment under the agreement.

6. Commitments:

Lease commitments:

The Company currently leases its principal facilities (the “Principal Offices) in Redwood Shores, California, pursuant to a sublease that expires in 2011. The Joint Venture leases space on a month to month basis in Nanjing, China.2016. In addition to monthly rent, the U.S. facilities are subject to additional rental payments for utilities and other costs above the base amount. Facilities rent expense was approximately $333$271 and $299$289 in 20072015 and 2006,2014, respectively. The Company has no future minimum payments required under capital leases.

F-39

Contractual obligations
Total
2016
Thereafter
Operating lease commitments(1)(2)
$
161
 
$
161
 
 
 


1.The Company extended the lease on its offices in April 2010. The base rent decreased by approximately 6% in November 2011 and will increase by approximately 3% per annum over the term of the new lease, which expires on October 31, 2016.
2.The Company sublet approximately 3,000 square feet of unutilized office space in August 2015. The sub-lease will expire on October 31, 2016. The operating lease commitments are net of the sub lease amounts of $97 through 2016.

Communication Intelligence Corporation

Notes to Consolidated Financial Statements

(In thousands)

7.11.   Income taxes:

As of December 31, 2007,2015, the Company had federal net operating loss carryforwardscarry-forwards available to reduce taxable income of approximately $72,469.$65,300. The net operating loss carryforwardscarry-forwards will begin to expire between 2008 and 2027.in 2017 if unused. The Company also had federal research and investment tax credit carryforwardshas state net operating loss carry-forwards available to reduce taxable income of approximately $315 that$35,422. The net state operating loss carry-forwards will begin to expire at various dates through 2012.

in 2015 if unused.

Deferred tax assets and liabilities at December 31 consist of the following:

 
2015
2014
Deferred tax assets:
 
 
 
 
 
 
Net operating loss carry-forwards
$
24,536
 
$
23,114
 
Accruals and reserves
 
97
 
 
141
 
Deferred revenue
 
334
 
 
382
 
Intangibles
��
923
 
 
273
 
Other, net
 
49
 
 
 
Fixed Assets
 
11
 
 
894
 
Gross tax assets
 
25,950
 
 
24,804
 
Valuation allowance
 
(25,950
)
 
(24,804
)
Net deferred tax assets
$
 
$
 

 

 

2007

 

2006

 

Deferred tax assets:

 

 

 

 

 

Net operating loss carryforwards

 

$

28,987

 

$

28,182

 

Credit carryforwards

 

315

 

315

 

Deferred income

 

172

 

162

 

Other, net

 

317

 

213

 

Total deferred tax assets

 

29,791

 

28,872

 

Valuation allowance

 

(29,791

)

(28,872

)

Net deferred tax assets

 

$

 

$

 

Income tax (benefit)The Company’s provision for income taxes differs from the expectedamount computed by applying the statutory U.S. federal income tax rate to loss before taxes as follows:follows for the years ended December 31, 2015 and December 31, 2014:

 

 

2007

 

2006

 

Expected income tax benefit

 

$

(1,157

)

$

(1,085

)

State income tax benefit

 

(204

)

(291

)

Expired net operating loss

 

1,512

 

1,471

 

Change in valuation allowance and other

 

(151

)

(95

)

Income tax expense (benefit)

 

$

 

$

 

 
2015
2014
Income tax benefit at the federal statutory rate
$
(1,264
)
$
(1,364
)
State income tax benefit
 
(216
)
 
(233
)
Credits
 
 
 
 
Prior year true up to return
 
128
 
 
5,758
 
Permanent items and other
 
206
 
 
81
 
Change in valuation allowance
 
1,146
 
 
(4,242
)
Income tax expense
$
 
$
 

A full valuation allowance has been established for the Company’sCompany's net deferred tax assets since the realization of such assets through the generation of future taxable income is uncertain.

Under the Tax Reform Act of 1986, the amounts of, and the benefit from, net operating losses and tax credit carryforwardscarry-forwards may be impaired or limited in certain circumstances. These circumstances include, but are not limited to, a cumulative stock ownership change of greater than 50%, as defined, over a three-year period. During 1997, the Company experienced stock ownership changes which could limit the utilization of its net operating loss and research

F-22

TABLE OF CONTENTS

11.   Income taxes: (continued)

and investment tax credit carryforwardscarry-forwards in future periods. In addition, a study of recent transactions has not been performed to determine whether any further limitations might apply.

12.   Subsequent events:

8. Employee benefit plans:

The Company sponsors a 401(k) defined contribution plan covering all employees meeting certain eligibility requirements. Contributions made byOn January 20, 2016, the Company are determined annually byheld its Special Meeting of Stockholders (the “Special Meeting”). At the BoardSpecial Meeting, the Company’s stockholders voted on (i) an amendment to our Amended and Restated Certificate of Directors. To date,Incorporation to effect a reverse stock split of our outstanding shares of common stock in a range of not less than 1-for-750 and not more than 1-for-1,250, (ii) amendments to each of the certificate of designation for each series of our preferred stock to, among other things, (a) automatically convert the respective series of our preferred stock into shares of common stock upon the closing of a firm-commitment underwritten public offering of shares our common stock at a price per share of not less than $4.00 which provides at least $8 million in gross proceeds to the Company has made no contributionsand (b) reduce the conversion price of the respective series of our preferred stock, and (iii) a Second Amended and Restated Certificate of Incorporation which will integrate the then-in-effect provisions of our Amended and Restated Certificate of Incorporation and further amend those provisions by, among other things, decreasing our authorized common stock and preferred stock. The voting results of the Special meeting are incorporated herein by reference to this plan.the Company’s Form 8-K dated January 22, 2016 filed with the Securities and Exchange Commission on January 22, 2016.

F-40



Communication Intelligence Corporation

NotesOn January 21, 2016, the Company filed a Certificate of Amendment to Consolidated Financial Statements

(In thousands)

9. Quarterlyits Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-1,250 reverse split of the Company’s outstanding shares of common stock. The reverse split became effective at 9:01 a.m. on January 22, 2016. The information (unaudited)

The unaudited summarized quarterly financial datawith respect to common stock for the years ended December 31, 20072015 and 2006, presented below, in2014 have been retroactively restated to give effect to the opinion1-for-1,250 reverse split.

The Company’s common stock began trading on the OTCQB on a post-reverse split basis on January 22, 2016. Immediately following the effectiveness of Management, reflects all adjustments which arethe reverse split of a normalthe Company’s outstanding shares of common stock, there were 187 shares of common stock issued and recurring nature necessary to present fairly the results of operationsoutstanding. The new CUSIP number for the periods presented.

 

 

First
Quarter

 

Second
Quarter

 

Third
Quarter

 

Fourth
Quarter

 

Total

 

2007 Unaudited

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

334

 

$

555

 

$

456

 

$

800

 

$

2,145

 

Gross profit

 

$

276

 

$

393

 

$

356

 

$

595

 

$

1,620

 

Loss before income taxes, and minority interest

 

$

(810

)

$

(845

)

$

(1,107

)

$

(710

)

$

(3,472

)

Net loss

 

$

(807

)

$

(843

)

$

(1,105

)

$

(644

)

$

(3,399

)

Basic and diluted loss per share

 

$

(0.01

)

$

(0.01

)

$

(0.01

)

$

(0.01

)

$

(0.03

)

 

 

 

 

 

 

 

 

 

 

 

 

2006 Unaudited

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

701

 

$

448

 

$

701

 

$

492

 

$

2,342

 

Gross profit

 

$

634

 

$

419

 

$

645

 

$

394

 

$

2,092

 

Loss before income taxes, and minority interest

 

$

(813

)

$

(928

)

$

(672

)

$

(878

)

$

(3,291

)

Net loss

 

$

(811

)

$

(925

)

$

(669

)

$

(881

)

$

(3,286

)

Basic and diluted loss per share

 

$

(0.01

)

$

(0.01

)

$

(0.01

)

$

(0.01

)

$

(0.03

)

F-41Company’s post reverse split common stock is 46436A203.



F-23

TABLE OF CONTENTS

   

Communication Intelligence Corporation

Notes Shares of Common Stock
Warrants to Consolidated Financial Statements

(In thousands)

Purchase  SCHEDULE II

Communication Intelligence Corporation

Valuation and Qualifying Accounts and Reserves

(In thousands)

Years Ended December 31, 2006 and 2007

 

 

Balance
At
Beginning
Of Period

 

Charged
to
Costs and
Expense

 

Deductions

 

Balance
At End
Of Period

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2006:

 

 

 

 

 

 

 

 

 

Accounts receivable reserves

 

$

387

 

$

10

 

$

 

$

397

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2007:

 

 

 

 

 

 

 

 

 

Accounts receivable reserves

 

$

397

 

$

123

 

$

(403

)

$

117

 

F-42



Through and including            , 2008 (the 25th day after this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.

PROSPECTUS

COMMUNICATION INTELLIGENCE CORPORATION

33,410,714Shares of Common Stock


PROSPECTUS

GRAPHICAxiom Capital Management, Inc.

COMMON STOCK

, 2008

2016



TABLE OF CONTENTS

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

ITEMItem 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

Other Expenses of Issuance and Distribution

The following table sets forth the costs and expenses, other than agent’sunderwriting discounts and commissions, payableto be paid by usthe Registrant in connection with the saleissuance and distribution of the common stock and warrants being registered. We will bear the expenses of registration of the shares of common stock being registered on account of the selling security holders. All amounts other than the SEC registration fees and FINRA fees are estimates except the Securitiesestimates.

SEC Registration Fees
$
344.74
 
FINRA Fees
 
3,680.00
 
Printing and Engraving Expenses
 
50,000.00
 
Legal Fees and Expenses
 
400,000.00
 
Accounting Fees and Expenses
 
40,000.00
 
Transfer Agent Fees
 
25,000.00
 
Miscellaneous
 
80,975.26
 
Total
$
600,000.00
 

Item 14. Indemnification of Directors and Exchange Commission filing fee.Officers

Securities and Exchange Commission filing fee

 

$

217

 

Legal fees and expenses*

 

$

65,000

 

Accounting fees and expenses*

 

$

6,000

 

Printing and engraving expenses*

 

$

8,000

 

Miscellaneous*

 

$

5,000

 

Total

 

$

84,217

 


* Estimated for the purpose of this filing.

ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

Section 102 ofOur officers and directors are indemnified as provided by the General Corporation Law of the State of Delaware allows a corporation to eliminate the personal liability(“DGCL”), our amended and restated certificate of directors of a corporation or its stockholders for monetary damages for a breach of a fiduciary duty as a director, except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase or redemption in violation of Delaware corporate law or obtained an improper personal benefit.

incorporation and our bylaws.

Section 145 of the Delaware General Corporation Law empowersDGCL authorizes a Delaware corporationcourt to award or a corporation’s board of directors to grant indemnification to directors and officers in terms that are sufficiently broad to permit indemnification under certain circumstances for liabilities (including reimbursement for expenses incurred) arising under the Securities Act. Our bylaws provide that we must indemnify anyand hold harmless each person who was or is made a party or is threatened to be made a party to any threatened, pending or completedis otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, (other than an action by or in the right of such corporation) by reason of the fact that suchhe or she or a person of whom he or she is the legal representative is or was a director or an officer employee or agent of such corporation,the Company or is or was serving at the request of such corporationthe Company as a director, officer, trustee, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise. The indemnity may include expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided that such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation and,enterprise, including service with respect to any criminal action or proceeding, had no reasonable causean employee benefit plan (which we refer to believe such person’s conduct was unlawful. A Delaware corporation may indemnify directors, officers, employees and other agentsas a covered person), whether the basis of such corporationproceeding is alleged action in an action by or in the right of a corporation under the same conditions against expenses (including attorneys’ fees) actually and reasonably incurred by the person in connection with the defense and settlement of such action or suit, except that no indemnification is permitted without judicial approval if the person to be indemnified has been adjudged to be liable to the corporation. Where a present or former director or officer of the corporation is successful on the merits or otherwise in the defense of any action, suit or proceeding referred to above or in defense of any claim, issue or matter therein, the corporation must indemnify such person against the expenses (including attorneys’ fees) which he or she actually and reasonably incurred in connection therewith.

Section 174 of the General Corporation Law of the State of Delaware provides, among other things, that a director who willfully or negligently approves of an unlawful payment of dividends or an unlawful stock purchase or redemption, may be held liable for such actions. A director who was either absent when the unlawful actions were approved or dissented at the time, may avoid liability by causing his or her dissent to such actions to be entered into the books containing the minutes of the meetings of the board of directors at the time such action occurred or immediately after such absent director receives notice of the unlawful acts.

II-1



Pursuant to the terms of our bylaws, we have agreed to indemnify, to the full extent permitted by the laws of the State of Delaware, any current or former directors and officers who are made, or threatened to be made, a party to an action or proceedings, whether criminal, civil, administrative or investigative, by reason of the fact that such person or such persons is or was a director or officer of the Company, or served any other enterpriseofficial capacity as a director, officer, trustee or employee or in any other capacity while serving as a director, officer, at the request of the Company. In addition, we may enter into agreements with our directors providing contractually for indemnification consistent with our certificate of incorporation and bylaws. Currently, we have no such agreements.

Pursuant to our certificate of incorporation,trustee, employee or agent, to the fullest extent permitted by Delaware law. In addition to such right of indemnification, our bylaws provide that we must advance all expenses incurred to any such covered person incurred in defending any such proceeding prior to the Delaware General Corporation Law,final disposition of the proceeding. If required by the DGCL, an advancement of expenses incurred by such covered person in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such covered person, including, without limitation, service to an employee benefit plan) will be made upon delivery to the Company of an undertaking by or on behalf of such director or officer to repay said amounts should it be ultimately determined that the person was not entitled to be indemnified under our bylaws or otherwise.

Our amended and restated certificate of incorporation also contains a provision eliminating the personal liability of our directors will not be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director. Our certificatedirector to the fullest extent permitted under Delaware law.

Item 15. Recent Sales of incorporation,Unregistered Securities

All sales of unregistered securities for the last three fiscal years were issued in a private placement exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended is included(“Securities Act”), and Regulation D promulgated under the Securities Act.

II-1

TABLE OF CONTENTS

Shares of Series D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock are convertible to common stock, as discussed in the exhibits to this Registration Statement.“Description of Capital Stock.”

2013

The Delaware General Corporation Law also authorizes us to purchase insurance for our directors and officers insuring them against risks as to which we may be unable lawfully to indemnify them. We have obtained limited insurance coverage for our officers and directors as well as insurance coverage to reimburse us for potential costs of our corporate indemnification of officers and directors.

ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES.

During the past three years, the Company has issued and sold unregistered securities as set forth below. We did not utilize an underwriter in any of these transactions.  The recipients of securities in each transaction represented their intention to acquire the securities without a view to the distribution thereof. All the issued securities were restricted securities under Rule 144 and appropriate restrictive legends were affixed to the securities in each transaction:

·In August 2006,On May 17, 2013, the Company entered into a Note and Warrant Purchase Agreementsubscription agreements with certain accredited investors. In November 2006,Under the terms of such subscription agreements, the investors purchased an aggregate of 230,000 units, each unit consisting of one share of Series D-1 Convertible Preferred Stock and four shares of Series D-2 Convertible Preferred Stock, at a purchase price of $5.00 per unit for an aggregate purchase price of $1,150,000.

On December 31, 2013, the Company received gross proceedsentered into subscription agreements with accredited investors. Under the terms of $600,000 undersuch subscription agreements, the agreementinvestors purchased an aggregate of 696,252 units, each unit consisting of two shares of the Company’s Series D-1 Convertible Preferred Stock and issued notes withone share of Series D-2 Convertible Preferred Stock, at a principal balancepurchase price of $600,000 and$3.00 per unit, for an aggregate purchase price of approximately $2,089,000, which amount included the exchange of $1,150,000 in existing indebtedness. The investors were also issued warrants to acquire 3,111,000purchase approximately 15,191 shares of common stock at closing. These warrants are exercisable for a period of three years and have an exercise price of $34.375 per share. In addition to the warrants issued at closing, the subscription agreements entitled the investors to receive warrants to purchase up to an additional 45,573 shares of common stock based on whether the Company attained certain revenue targets in 2014. Such revenue targets were not achieved and the additional warrants were fully issued and are exercisable until December 31, 2016 at an exercise price of $34.375 per share. All investors from the May 2013 financing agreed to exchange the securities issued to them in the prior financing for the same securities issued to investors in the financing closed on December 31, 2013, with the investors from the May 2013 financing receiving in such exchange an aggregate of 383,333 units and an initial warrant grant to purchase approximately 8,364 shares of common stock, with the ability to receive warrants to purchase up to an additional 25,090 shares of common stock promptly after each of the quarters ended March 31, 2014, June 30, 2014, and September 30, 2014, to the extent that the Company’s revenue for any such quarter did not exceed $750,000, $1,000,000 and $1,250,000, respectively.

2014

On February 7, 2014, the Company entered into subscription agreements with accredited investors. Under the terms of such subscription agreements, the investors purchased an aggregate of 259,996 units, each unit consisting of two shares of the Company’s Series D-1 Convertible Preferred Stock and one share of Series D-2 Convertible Preferred Stock, at a purchase price of $3.00 per unit, for an aggregate purchase price of approximately $780,000. The investors were also issued warrants to purchase approximately 5,673 shares of common stock at the time of the funding of their investment. These warrants are exercisable for a period of three years and have an exercise price of $34.375 per share. In addition to the warrants issued at closing, the subscription agreements entitled investors to receive warrants to purchase up to an additional 17,018 shares of common stock based on whether the Company attained certain revenue targets in 2014. Such revenue targets were not achieved and the additional warrants were fully issued and are exercisable until December 31, 2016 at an exercise price of $34.375 per share.

On March 6, 2014, the Company entered into subscription agreements with accredited investors. Under the terms of such subscription agreements, the investors purchased an aggregate of 136,665 units, each unit consisting of two shares of the Company’s Series D-1 Convertible Preferred Stock and one share of Series D-2 Convertible Preferred Stock, at a purchase price of $3.00 per unit, for an aggregate purchase price of approximately $410,000. The investors were also issued warrants to purchase approximately 2,960 shares of common stock at the time of the funding of their investment. These warrants are exercisable for a period of three years and have an exercise price of $34.375 per share. In addition to the warrants issued at closing, the subscription agreements entitled investors to receive warrants to purchase approximately up to an additional 8,800 shares of common stock based on whether the Company attained certain revenue targets in 2014. Such revenue targets were not achieved and the additional warrants were fully issued and are exercisable until December 31, 2016 at an exercise price of $34.375 per share.

On August 5, 2014, the Company entered into subscription agreements with accredited investors. Under the terms of such subscription agreements, the investors purchased an aggregate of 1,120,000 shares of Series D-1 Convertible Preferred Stock for an aggregate purchase price of $1,120,000.

II-2

TABLE OF CONTENTS

2015

On March 24, 2015, the Company entered into subscription agreements with accredited investors. Under the terms of such subscription agreements, the investors purchased an aggregate of 1,233,000 units, each unit consisting of one share of the Company’s Series D-1 Convertible Preferred Stock and one warrant to purchase 0.02 shares of the Company’s common stock, in connection with transactions under the agreement.at a purchase price of $1.00 per unit, for an aggregate purchase price of approximately $1,233,000. The warrants were originally exercisable at $0.51 per share. The notes and warrants, andissued to the investors entitle the investors to purchase up to an aggregate of approximately 21,920 shares of common stock to be issued uponstock. These warrants are exercisable for a period of three years and have an exercise price of the warrant, were and will be exempt from registration under Sections 4(2) and 4(6) of the Securities Act and Rule 506 of Regulation D promulgated thereunder.$28.125 per share.

·In February 2007,On July 23, 2015, the Company entered into a Note and Warrant Purchase Agreementsubscription agreements with certain accredited investors. In March 2007 and April 2007,Under the Company received gross proceedsterms of $720,000 and issued notes with a principal balancesuch subscription agreements, the investors purchased an aggregate of $720,000 and warrants to acquire 3,733,291 shares329,000 units, each unit consisting of our common stock. The warrants were originally exercisable at $0.51 per share. The notes and warrants, and the shares of common stock to be issued upon exerciseone share of the Company’s Series D-1 Convertible Preferred Stock and one warrant were and will be exempt from registration under Sections 4(2) and 4(6) of the Securities Act and Rule 506 of Regulation D promulgated thereunder.

·In June 2007, the Company entered into a Note and Warrant Purchase Agreement with certain accredited investors. In June 2007, the Company received gross proceeds of $400,000 and issued notes with a principal balance of $400,000 and warrants to acquire 3,167,898 shares of our common stock. The warrants were originally exercisable at $0.25 per share. The notes and warrants, and the shares of common stock to be issued upon exercise of the warrant, were and will be exempt from registration under Sections 4(2) and 4(6) of the Securities Act and Rule 506 of Regulation D promulgated thereunder.

·In August 2007, the Company entered into a Securities Purchase and Registration Rights Agreement with a single accredited investor, under which the Company issued 21,500,000purchase 0.03 shares of the Company’s common stock, at a purchase price of $1.00 per unit, for gross proceedsan aggregate purchase price of $3 million.approximately $329,000. The issuancewarrants issued to the investors entitle the investors to purchase up to an aggregate of approximately 10,560 shares of common stock. These warrants are exercisable for a period of three years and salehave an exercise price of such shares was effected without registration under the Securities Act in reliance on the exemption from registration$15.62 per share.

II-2



provided under Rule 506 of Regulation D promulgated under the Securities Act and under Sections 4(2) and 4(6) of the Securities Act.

·In October 2007,On November 25, 2015, the Company entered into a Debt Restructuring Agreement pursuantissued to which we converted a portion of theaccredited investors unsecured convertible promissory notes due October 28, 2007 in the aggregate principal amount of $117,000 into debt$1,000,000 in consideration of gross cash proceeds of $750,000 plus the exchange of a $250,000 demand note previously issued by the Company in an initial closing under the terms and warrantsconditions of a note purchase agreement dated as of November 25, 2015. On December 15, 2015, the Company issued unsecured convertible promissory notes in the aggregate principal amount of $268,000 to purchase shares of its common stock, with an exercise price of $0.29 per share. The Debt Restructuring Agreement entitledaccredited investors in a subsequent closing under the holder to warrants to purchase two shares of the Company’s common stock for each dollar of note principal outstanding, in exchange for a two year extension of the due dateterms and conditions of the note and terminationpurchase agreement. The principal amount of the conversion feature of the note. The Companyunsecured convertible promissory notes issued 234,000 warrants to the note holder. The issuance of the warrants was exempt from registration under Sections 4(2) and 4(6) of the Securities Act and Rule 506 of Regulation D promulgated thereunder.

·In June 2008, the Company executed documents and closed a financing transaction under which the Company raised capital through the issuance of secured indebtedness and equity and restructured a portion of the Company’s existing debt.  Inin connection with the transaction, we borrowed an aggregateCompany’s unsecured debt financing in November and December 2015 bear interest at a rate of $3,000,00024% per annum, are due on August 25, 2016 and refinanced $637,500 of existing indebtedness and accrued interest on that indebtedness. In partial consideration for the respective loans made as described above, we issued to each creditor a warrant to purchase up to the number ofare convertible into shares of our common stock obtainedat the holder’s option (i) prior to maturity, in the event the Company consummates an SEC registered public offering of shares of common stock, at a conversion price that is 30% less than the price to the public of the common stock in the public offering, or (ii) up to 60 days after maturity, at a conversion price based upon a Company pre-money valuation of $5,000,000, as determined by dividingtaking into account the outstanding shares of common stock and preferred stock, on an as-converted basis, on the maturity date of the note; provided, that following such conversion after the maturity date, each holder that converted such note will also receive cash payments, payable from 1.5% for each $100,000 of notes converted of the revenue received by the Company from Cegedim to be paid quarterly on a pro rata basis, with any and all other holders who converted their notes; provided, further, however, that the total amount of such creditor’s loan by 0.14.  A totalcash payments that the holder will be entitled to receive will not exceed three times the aggregate principal amount of 25,982,143 shareseach holder’s note. In April 2016, each holder of our common stock may be issued upon exercise of the warrants at an exercise price of $0.14 per share.  The issuance of the warrants was exempt from registration under Sections 4(2) and 4(6) of the Securities Act and Rule 506 of Regulation D promulgated thereunder.

·In June 2008, in connectionunsecured convertible promissory notes agreed with the closing of the financing transaction, we also entered into a Securities Purchase Agreement and a Registration Rights Agreement.  Under the Securities Purchase Agreement, in exchange for the cancellation of $995,000 in principal and $45,000 of interest accrued thereon of our existing debt and interest accrued thereon, we issuedCompany to the holders of such debt an aggregate of 1,040,000 shares of our Series A Cumulative Convertible Preferred Stock.  The preferred shares carry an 8% annual dividend, payable quarterly in arrears in cash or in additional preferred shares, have a liquidation preference over common stock of $1.00 per share and are convertibleconvert its note into shares of common stock at the conversionper share offering price of fourteen cents $0.14 per share.  Theand warrants to purchase shares of preferredcommon stock, are convertible at any time. The issuancein each case, upon consummation of the offering that is the subject of this registration statement.

Item 16. Exhibits and sale of such shares was effected without registration underFinancial Statement Schedules

(a) EXHIBITS

We have filed the Securities Act in relianceexhibits listed on the exemption fromaccompanying Exhibit Index of this registration provided under Rule 506 of Regulation D promulgated under the Securities Actstatement and under Sections 4(2) and 4(6) of the Securities Act.

II-3



ITEM 16.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

below in this Item 16:

Exhibit

Number

Description

Number

1.1 **

Document

Form of Underwriting Agreement.

3.1

Certificate of Incorporation of the Company, as amended, incorporated herein by reference to Exhibits 3.1, 3.2, 3.3 and 3.4 to the Company’s Registration Statement on Form 10
(File No. 000-19301).

3.1

3.2
Certificate of Amendment to the Company’s Certificate of Incorporation (authorizing the reclassification of the Class A Common Stock and Class B Common Stock into one class of Common Stock) filed with the Delaware Secretary of State on November 1, 1991, incorporated herein by reference to Exhibit 3 to Amendment 1 on Form 8 to the Company’s Form 8-A (File No. 000-19301).

II-3

TABLE OF CONTENTS

Exhibit
Number

Description
3.3
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State June 12, 1998, incorporated herein by reference to Exhibit 10.24 to the Company’s 1998 Form 10-K filed on April 6, 1999.
3.4
By-laws of the Company adopted on October 6, 1986, incorporated herein by reference to Exhibit 3.5 to the Company’s Registration Statement on Form 10 (File No. 0-19301)000-19301).

3.5

3.2

Amended and Restated Certificate of Incorporation dated May 10, 1995, as filed with the Delaware Secretary of State’s office on May 18, 1995, incorporated herein by reference to Exhibit 3.2 to the Company’s Form 10-Q, filed August 14, 2008 (File No. 0-19301).

3.3

Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated June 12, 1998, incorporated herein by reference to Exhibit 10.24 tofiled with the Company’s 1998 Form 10-K, filed April 6, 1999 (File No. 0-19301).

3.4

CertificateDelaware Secretary of Amendment to the Company’s Amended and Restated Certificate of Incorporation datedState January 24, 2001, incorporated herein by reference to Exhibit 3.5 to the Company’s Registration Statement on Form S-1/A filed on December 20, 2007.

3.6

3.5

Certificate of Elimination of the Company’s Certificate of Designation of the Series A Preferred Stock datedfiled with the Delaware Secretary of State August 17, 2001, incorporated herein by reference to Exhibit 3.6 to the Company’s Registration Statement on Form S-1/A filed on December 20, 2007.

3.7

3.6

Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation datedfiled with the Delaware Secretary of State August 17, 2007, incorporated herein by reference to Exhibit 3.7 to the Company’s Registration Statement on Form S-1/A,S/1 filed on December 20, 2007.

3.8

Amended and Restated Certificate of Incorporation of the Company filed with the Delaware Secretary of State on May 18, 1995, incorporated herein by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

3.7

3.9

Certificate of Designations, Powers, Preferences and Rights of the Series A Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on June 4, 2008, incorporated herein by reference to Exhibit 4.23 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.
3.10

Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation datedfiled with the Delaware Secretary of State on June 30, 2008, incorporated herein by reference to Exhibit 3.7 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008 (File No. 0-19301).

2008.

3.11

4.1

Form

Certificate of Designations, Powers, Preferences and Rights of the Series A-1 Cumulative Convertible Promissory Note issued byPreferred Stock filed with the Company,Delaware Secretary of State on October 30, 2008, incorporated herein by reference to Exhibit 10.33.11 to the Company’s Annual Report on Form 10-K filed on March 12, 2009.
3.12
Certificate of Elimination of the Company’s Series A Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on December 30, 2008, incorporated herein by reference to Exhibit 3.12 to the Company’s Annual Report on Form 10-K filed on March 12, 2009.
3.13
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on June 30, 2009, incorporated herein by reference to Exhibit 3.13 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.
3.14
Amendment No. 1 to By-laws dated June 17, 2010, incorporated herein by reference to Exhibit 3.14 to the Company’s Quarterly Report on Form 10-Q filed on August 16, 2010.
3.15
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.15 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
3.16
Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.16 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.

II-4

TABLE OF CONTENTS

Exhibit
Number
Description
3.17
Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.17 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
3.18
Certificate of Amendment to Amended And Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.18 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.19
Second Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.19 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.20
Amended and Restated Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.20 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.21
Certificate of Designation of Series C Participating Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.21 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.22
Amendment to the Amended And Restated Certificate of Designation of the Series B Participating Convertible Preferred Stock, incorporated herein by reference to Exhibit 10.59 to the Company’s Current Report on Form 8-K filed March 31, 2011.
3.23
Amendment to the Amended And Restated Certificate of Designation of the Series C Participating Convertible Preferred Stock, incorporated herein by reference to Exhibit 10.60 to the Company’s Current Report on Form 8-K filed March 31, 2011.
3.24
Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on October 22, 2012.
3.25
Third Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.25 to the Company’s Form 10-K filed March 31, 2014.
3.26
Second Amended and Restated Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.26 to the Company’s Form 10-K filed March 31, 2014.
3.27
Amended and Restated Certificate of Designation of Series C Participating Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, incorporated herein by reference to Exhibit 3.27 to the Company’s Form 10-K filed March 31, 2014.
3.28
Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.28 to the Company’s Form 10-K filed March 31, 2014.
3.29
Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 10, 2013, incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on November 1, 2013.

II-5

TABLE OF CONTENTS

Exhibit
Number
Description
3.30
Certificate of Amendment to Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2013, incorporated herein by reference to Exhibit 3.30 to the Company’s Form 10-K filed March 31, 2014.
3.31
Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 16, 2014, incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on October 17, 2014.
3.32
Certificate of Amendment to Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on March 24, 2015, incorporated herein by reference to Exhibit 3.32 to the Company’s Form 10-Q filed May 15, 2015.
3.33
Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 11, 2015, incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K filed November 4, 2004.

on December 14, 2015.

4.10†

1999 Stock Option Plan, as amended, incorporated herein by reference to Exhibit 4.2 to the Company’s Form S-8 filed on September 19, 2008.

4.2

4.12

Form of Warrant issued by the Company, incorporated herein by reference to Exhibit 10.4 to the Company’s Form 8-K filed on November 4,3, 2004.

4.16

4.3

Form of Promissory Note issued by the Company, incorporated herein by reference to Exhibit 10.36 to the Company’s Form 8-K, filed August 16, 2006.

4.4

Form of Warrant issued by the Company, incorporated herein by reference to Exhibit 10.37 to the Company’s Form 8-K filed August 16, 2006.

4.5

Form of Promissory Note issued by the Company, incorporated herein by reference to Exhibit 10.36 to the Company’s Form 8-K, filedon February 9, 2007.

4.18

4.6

Form of Warrant issued by the Company, incorporated herein by reference to Exhibit 10.37 to the Company’s Form 8-K, filed February 9, 2007.

4.7

Form of Promissory Note issued by the Company, incorporated herein by reference to Exhibit 10.36 to the Company’s Form 8-K, filed June 20, 2007.

4.8

Form of Warrant issued the Company, incorporated herein by reference to Exhibit 10.37 to the Company’s Form 8-K filed on June 20, 2007.

II-4



4.9

Certificate of Designations dated June 4, 2008 with respect to Series A Cumulative Convertible Preferred Stock, incorporated herein by reference to Exhibit 4.23 to the Company’s Form 10-Q, filed August 14, 2008.

4.19

4.10

Form of Common Stock Purchase Warrant issued by the Company, incorporated herein by reference to Exhibit 4.19 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

4.20

4.11

Form of Additional Common Stock Purchase Warrant, incorporated herein by reference to Exhibit 4.20 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.
4.26
Form of Common Stock Purchase Warrant issued by the Company, incorporated herein by reference to Exhibit 4.204.26 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

2009.

4.27

4.12

Form of Secured Promissory Note issued by the Company dated June 5, 2008,Additional Common Stock Purchase Warrant, incorporated herein by reference to Exhibit 4.214.27 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

2009.

4.28**

Form of Unsecured Convertible Promissory Note issued by the Company.

4.13

4.29**

Form of Additional Secured Promissory Note,Underwriter Warrant issued by the Company (included in Exhibit 1.1).
4.30**
Form of Warrant to Purchase Common Stock to be issued in this offering.
4.31**
Form of Warrant to Purchase Common Stock to be issued to the holders of unsecured convertible promissory notes.
4.32**
Form of Warrant to Purchase Common Stock to be issued to FirstGlobal Partners LLC and SG Phoenix LLC.
5.1*
Opinion of Pillsbury Winthrop Shaw Pittman LLP.
10.19
Software Development and License Agreement dated December 4, 1998 between Ericsson Mobile Communications AB and the Company incorporated herein by reference to Exhibit 4.22 to10.26 of the Company’s Form 10-Q, filed August 14, 2008.

*5.1

Opinion of Davis Wright Tremaine LLP.

10.2

Standby Stock Purchase Agreement between the Company and Philip Sassower dated October 3, 1994, incorporated herein by reference to Exhibit 10.13 to the Company’s 19941998 Form 10-K (File No. 0-19301).

II-6

TABLE OF CONTENTS

Exhibit
Number
Description

10.24

10.3

Form of SubscriptionNote and Warrant Purchase Agreement betweendated October 28, 2004, by and among the Company and the Purchasers dated November 28, 1995, incorporated herein by reference to Exhibit 1 to the Company’s Form 8-K, dated November 28, 1995(File No. 0-19301).

10.4

Form of Registration Rights Agreement between the Company and the Purchasers, dated November 28, 1995, incorporated herein by reference to Exhibit 1 to the Company’s Form 8-K, dated November 28, 1995(File No. 0-19301).

10.7

Form of Subscription Agreement between the Company and various investors, dated June 13, 1996, incorporated herein by reference to Exhibit 1 to the Company’s Form 8-K, filed June 27, 1996 (File No. 0-19301).

10.8

Form of Registration Rights Agreement between the Company and various investors, dated June 13, 1996, incorporated herein by reference to Exhibit 2 to the Company’s Form 8-K, filed June 27, 1996 (File No. 0-19301).

10.9

Form of Preferred Stock Investment Agreement, dated as of December 31, 1996, between the Company and the investors listed on Schedule 1 thereto, incorporated herein by reference to Exhibit 1 to the Company’s Form 8-K, filed January 7, 1997 (File No. 0-19301).

10.10

Form of Registration Rights Agreement between the Company and the Investors Listed on Schedule 1 thereto, incorporated herein by reference to Exhibit 2 to the Company’s Form 8-K, filed January 7, 1997 (File No. 0-19301).

10.13

Form of Subscription Agreement between the Company and each subscriber, dated as of November 25, 1997,identified therein, incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed December 8, 1997 (File No. 0-19301).

on November 3, 2004.

10.25

10.15

Form of Registration Rights Agreement dated October 28, 2004, by and among the Company and the signatories thereto, dated as of November 25, 1997,parties identified therein, incorporated herein by reference to Exhibit 10.310.2 to the Company’s Form 8-K filed December 8, 1997 (File No. 0-19301).

on November 3, 2004.

10.26

†10.19

Software Development and License Agreement dated December 4, 1998 between Ericsson Mobile

II-5



Communications AB and the Company incorporated herein by reference to Exhibit 10.26 to the Company’s 1998 Form 10-K, filed April 6, 1999 (File No. 0-19301).

10.26

Form of Note and Warrant Purchase Agreement dated August 10, 2006, among Communication Intelligence Corporationby and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.34 to the Company’s Form 8-K, filed August 16, 2006.

10.27

Form of Registration Rights Agreement dated August 10, 2006, among Communication Intelligence Corporation and the parties identified there in, incorporated herein by reference to Exhibit 10.35 to the Company’s Form 8-K, filed August 16, 2006.

†† 10.28

Amendment dated May 31, 2005 to the License Agreement dated December 22, 2000 between the Company and eCom Asia Pacific, Ltd., incorporated herein by reference to Exhibit 10.26 to the Company’s Form 10-K/A, filed September 15, 2005.

†† 10.29

License Agreement dated June 2, 2005 between the Company and SnapOn Credit LLC incorporated herein by reference to Exhibit 10.27 to the Company’s Form 10-K/A, filed September 15, 2005.

10.30

Amendment to employment agreement with Guido DiGregorio, incorporated herein by reference to the

Company’s Form 8-K dated September 21, 2005.

10.31

Amendment to employment agreement with Frank V. Dane, incorporated herein by reference to the Company’s Form 8-K dated September 21, 2005.

10.32

Form of stock option agreement dated August 31, 2005 with Russell L. Davis, incorporated by reference to Exhibit 10.30 to the Company’s Form 10-K/A, filed September 15, 2006.

10.33

Form of stock option agreement dated December 19, 2005 with Guido DiGregorio, incorporated by reference to Exhibit 10.30 to the Company’s Form 10-K/A, filed September 15, 2006.

10.34

Form of stock option agreement dated December 19, 2005 with Francis V. Dane, incorporated by reference to Exhibit 10.30 to the Company’s Form 10-K/A, filed September 15, 2006.

10.35

Form of stock option agreement dated December 31, 2005 with C. B. Sung, incorporated by reference to Exhibit 10.30 to the Company’s Form 10-K/A, filed September 15, 2006.

10.36

Form of Note and Warrant Purchase Agreement dated February 5, 2007, among the Company and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.34 to the Company’s Form 8-K filed February 9, 2007.

on August 12, 2006.

10.27

10.37

Form of Registration Rights Agreement dated February 5, 2007,August 10, 2006, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.35 to the Company’s Form 8-K filed February 9, 2007.

on August 12, 2006.

10.28

Amendment dated May 31, 2005 to the License agreement dated December 22, 2000 between the Company and eCom Asia Pacific, Ltd., incorporated by reference to Exhibit 10.26 of the Company’s Form 10-K/A filed on March 31, 2006.

10.38

10.29

License agreement dated June 2, 2005 between the Company and SnapOn Credit LLC, incorporated herein by reference to Exhibit 10.27 of the Company’s Form 10-K/A filed on March 31, 2006.
10.30

Amendment to employment agreement with Guido DiGregorio, incorporated herein by reference to the Company’s Form 8-K filed on September 21, 2005.
10.31
Amendment to employment agreement with Francis V. Dane, incorporated herein by reference to the Company’s Form 8-K filed on September 21, 2005.
10.32
Form of stock option agreement dated August 31, 2005 with Russell L. Davis, incorporated by reference to Exhibit 10.30 of the Company’s Form 10-K/A filed on September 15, 2006.
10.33
Form of stock option agreement dated December 19, 2005 with Guido DiGregorio, incorporated by reference to Exhibit 10.30 of the Company’s Form 10-K/A filed on September 15, 2006.
10.34
Form of stock option agreement dated August 31, 2005 with Francis V. Dane, incorporated by reference to Exhibit 10.30 of the Company’s Form 10-K/A filed on September 15, 2006.
10.35
Form of stock option agreement dated August 31, 2005 with C. B. Sung, incorporated by reference to Exhibit 10.30 of the Company’s Form 10-K/A filed on September 15, 2006.
10.36
Form of Note and Warrant Purchase Agreement dated February 5, 2007, among the companyby and the parties identified therein, incorporated herein by reference to Exhibit 99.1 to the Company’s Form 8-K, filed March 19, 2007.

10.39

Form of Note and Warrant Purchase Agreement dated June 15, 2007, among the Company and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.34 to the Company’s Form 8-K filed June 20,on February 5, 2007.

10.37

10.40

Form of Registration Rights Agreement dated June 15,February 5, 2007, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.35 to the Company’s Form 8-K filed June 20,on February 5, 2007.

10.38

Amendment to the Note and Warrant Purchase Agreement dated February 5, 2007, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 99.1 to the Company’s Form 8-K filed on March 15, 2007.

10.41

10.39
Form of Note and Warrant Purchase Agreement dated June 15, 2007, by and among the Company and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.34 to the Company’s Form 8-K filed on June 15, 2007.

II-7

TABLE OF CONTENTS

Exhibit
Number

Description
10.40
Form of Registration Rights Agreement dated June 15, 2007, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.35 to the Company’s Form 8-K filed on June 15, 2007.
10.41
Form of Securities Purchase and Registration Rights Agreement dated August 24, 2007, by and among Communication Intelligence Corporationthe Company and Phoenix Venture Fund LLC, incorporated herein by

II-6



reference to Exhibit 10.36 to the Company’s Form 8-K filed on August 27, 2007.

10.42

†††10.42

Consulting Agreement dated January 9, 2008 between the Company and GS Meyer & Associates LLC - Incorporated by reference to Exhibit 10.42 to the Company’s Annual Report on Form 10-K filed on March 12, 2007.
10.43
Credit Agreement dated June 5, 2008, by and among the Company and the Lenders Party hereto and SG Phoenix as Collateral Agent, incorporated herein by reference to Exhibit 10.41 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.
10.44
Pledge and Security Agreement dated June 5, 2008, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.42 to the Company’s Quarterly Report on Form 10-K,10-Q filed March 12,on August 14, 2008.

10.44

10. 43

Securities Purchase Agreement betweendated June 5, 2008, by and among the Company and the Investorsparties identified therein, dated June 5, 2008, incorporated herein by reference to Exhibit 10.43 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

10.45

10. 44

Registration Rights Agreement betweendated June 5, 2008, by and among the Company and the parties identified therein, dated June 5, 2008, incorporated herein by reference to Exhibit 10.44 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

10.46

Amendment No. 1 to Credit Agreement dated May 28, 2009, by and among the Company, the Lenders and Additional Lenders Parties thereto and SG Phoenix as Collateral Agent, incorporated herein by reference to Exhibit 10.46 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.

Xx10. 45

10.47

Amendment No. 1 to Registration Rights Agreement dated May 28, 2009, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.47 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.
10.48

Salary Reduction Plan for Executive Officers of the Company under Amendment No. 1 to Credit Agreement betweendated May 28, 2009, incorporated herein by reference to Exhibit 10.48 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.
10.53
Amendment No. 3 to Credit Agreement dated July 22, 2010, by and among the Company, the Lenders and Additional Lenders Parties hereto and SG Phoenix as Collateral Agent, incorporated herein by reference to Exhibit 10.53 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
10.54
Amendment No. 3 to Registration Rights Agreement dated July 22, 2010, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.54 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
10.55
Registration Rights Agreement dated August 5, 2010, by and among the Company and the Persons Executing the Agreement as Investors, incorporated herein by reference to Exhibit 10.55 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
10.56
Investor Rights Agreement dated August 5, 2010, by and among the Company and Phoenix Venture Fund LLC, SG Phoenix LLC, Michael Engmann, Ronald Goodman, Kendu Partners Company and MDNH Partners L.P., incorporated herein by reference to Exhibit 10.56 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.

II-8

TABLE OF CONTENTS

Exhibit
Number
Description
10.57
Securities Purchase Agreement dated December 9, 2010, by and among the Company, Phoenix Venture Fund LLC, Michael Engmann and Ronald Goodman dated June 5, 2008,the Investors signatory thereto, incorporated herein by reference to Exhibit 10.4110.57 to the Company’s Current Report on Form 8-K filed on December 9, 2010.
10.58
Registration Rights Agreement dated December 31, 2010, by and among the Company and the Persons Executing the Agreement as Investors, incorporated herein by reference to Exhibit 10.58 to the Company’s Current Report on Form 8-K filed on January 6, 2011.
10.59
Form of Subscription Agreement dated March 31, 2011, by and among the Company and the Person Executing the Agreement as Subscribers, incorporated herein by reference to Exhibit 10.61 to the Company’s Current Report on Form 8-K filed on April 4, 2011.
10.60
Amendment No. 1 to Registration Rights Agreement dated March 31, 2011, by and among the Company and the Persons Executing the Agreement as Required Holders, incorporated herein by reference to Exhibit 10.62 to the Company’s Current Report on Form 8-K filed on April 4, 2011.
10.61
Note and Warrant Purchase Agreement dated September 20, 2011, incorporated herein by reference to Exhibit 10.61 to the Company’s Quarterly Report on Form 10-Q filed on November 14, 2011.
10.62
Note and Warrant Purchase Agreement dated December 2, 2011, incorporated herein by reference to Exhibit 10.62 to the Company’s Annual Report on Form 10-K filed on March 30, 2012.
10.63
Note and Warrant Purchase Agreement dated April 23, 2012, incorporated herein by reference to Exhibit 10.63 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2012.
10.64
Form of Subscription Agreement dated September 14, 2012, incorporated herein by reference to Exhibit 10.64 to the Company’s Quarterly Report on Form 10-Q filed on November 14, 2012.
10.66
Form of Subscription Agreement dated May 17, 2013, incorporated herein by reference to Exhibit 10.66 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2013.
10.67
Form of Subscription Agreement dated December 16, 2013, incorporated herein by reference to Exhibit 10.67 to the Company’s Form 10-K filed March 31, 2014.
10.68
Credit Agreement with Venture Champion Asia Limited dated May 6, 2014, incorporated herein by reference to Exhibit 10.68 to the Company’s Form 10-Q filed August 14, 2008.

15, 2014.

10.69

10. 46

Pledge and Security

Form of Subscription Agreement between the Company and the parties identified therein, dated JuneAugust 5, 2008,2014, incorporated herein by reference to Exhibit 10.4210.69 to the Company’s Form 10-K filed March 31, 2015.
10.70
Form of Subscription Agreement dated as of February 27, 2015, incorporated herein by reference to Exhibit 10.70 to the Company’s Form 10-Q filed August 14, 2008.

May 15, 2015.

10.71

Form of Subscription Agreement dated July 23, 2015, incorporated herein by reference to Exhibit 10.71 to the Company Form 10-Q filed November 16, 2015.

21.1

10.72**

Note Purchase Agreement dated as of November 25, 2015.
10.73**

Schedule

Advisory Services Agreement with FirstGlobal Partners LLC dated August 12, 2011.
10.74**
Advisory Services Agreement with SG Phoenix LLC dated August 12, 2011.
10.75**
Letter Agreement with FirstGlobal Partners LLC dated December 3, 2015.
10.76**
Letter Agreement with SG Phoenix LLC dated December 3, 2015.
10.77**
Form of subsidiaries (incorporatedletter agreement with holders of unsecured convertible promissory notes.
10.78**
Letter Agreement with FirstGlobal Partners LLC dated April 11, 2016.
10.79**
Letter Agreement with SG Phoenix LLC dated April 11, 2016.

II-9

TABLE OF CONTENTS

Exhibit
Number
Description
21.1
Subsidiaries of the Company, incorporated herein by reference to Exhibit 21.1 to the Company’s Form 10-K filed March 12, 2008).

April 6, 2016.

23.1*

Consent of Armanino LLP, Independent Registered Public Accounting Firm.

23.2**23.1

Consent of Davis Wright TremainePillsbury Winthrop Shaw Pittman LLP (included as part ofin Exhibit 5.1).

24.1**

Power of Attorney (contained in the signature page of the Registration Statement).

*23.2

101.INS*

Consent of GHP Horwath, P.C.

XBRL Instance Document

101.SCH*

Taxonomy Extension Schema Document

*24.1

101.CAL*

Taxonomy Extension Calculation Linkbase Document
101.DEF*

Powers of Attorney (included on signature pages)

Taxonomy Extension Definition Linkbase Document
101.LAB*
Taxonomy Extension Labels Linkbase Document
101.PRE*
Taxonomy Extension Presentation Linkbase Document


*Filed herewith.
**Previously filed.
Indicates management contract or compensatory plan, contract or arrangement.

*Filed herewith.(b) Financial statement schedules.

Confidential treatment of certain portions of this exhibitAll schedules have been requested fromomitted because either they are not required, are not applicable or the SEC pursuant to a request for confidentiality dated March 30, 1999, filed pursuant toinformation is otherwise set forth in the Securitiesfinancial statements and Exchange Act of 1934.related notes thereto.

††Confidential treatment of certain portions of this exhibit have been requested from the SEC pursuant to a request for confidentiality dated March 30, 2006, filed pursuant to the Securities and Exchange Act of 1934.

†††Confidential treatment of certain portions of this exhibit have been requested from the SEC pursuant to a request for confidentiality dated March 10, 2008, filed pursuant to the Securities and Exchange Act of 1934.

XxConfidential treatment of certain portions of this exhibit have been requested from the SEC pursuant to a request for confidentiality dated August 14, 2008, filed pursuant to the Securities and Exchange Act of 1934.

ITEMItem 17. UNDERTAKINGS

Undertakings

The undersigned registrant hereby undertakes:

(1)To file, during For purposes of determining any period in which offers or sales are being made, a post-effective amendment to this registration statement:  (i) to include any prospectus required by section 10(a)(3) ofliability under the Securities Act, of 1933; (ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or

II-7



the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviationomitted from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed withas part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Commissionregistrant pursuant to Rule 424(b) if, in(I) or (4) or 497(h) under the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “CalculationSecurities Act shall be deemed to be part of Registration Fee” table in the effective registration statement; and (iii) to include any material information with respect to the plan of distribution not previously disclosed in thethis registration statement or any material change to such information inas of the registration statement;time it was declared effective; and

(2)That, for For the purpose of determining any liability under the Securities Act, of 1933, each such post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof;thereof.

(3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; and

(4)Insofar as indemnification by the registrant for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, referenced in Item 14 of this Registration Statement or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer, or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by asuch director, officer or controlling person in connection with the securities being registered, hereunder, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

II-8



II-10

TABLE OF CONTENTS

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrantRegistrant has duly caused this registration statementAmendment No. 4 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized at Redwood Shores, California,in the City of New York, State of New York, on August 18, 2008.

May 11, 2016.

COMMUNICATION INTELLIGENCE CORPORATION

ISIGN SOLUTIONS INC.

By:

/s/ Guido DiGregorio

Philip S. Sassower

Guido DiGregorio

CHAIRMAN, PRESIDENT AND CHIEF

EXECUTIVE OFFICER

Name: Philip S. Sassower
Title: Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this registration statementAmendment No. 4 to the Registration Statement has been signed by the following persons in the capacities indicatedand on August 18, 2008.

the dates indicated:

Signature

Title

TitleDate

/s/ Guido DiGregorio

Philip S. Sassower

Chairman and

Chief Executive Officer (Principal

and Director

Guido DiGregorio

Philip S. Sassower

(Principal Executive Officer)

May 11, 2016

/s/ Frank Dane

Andrea Goren

Chief Financial Officer (Principal Financial and

Director

Frank Dane

Andrea Goren

(Principal Accounting and Financial Officer)

Accounting Officer)

May 11, 2016

/s/ Louis P. Panetta

Director

Louis P. Panetta

*

Michael Engmann

Director

May 11, 2016

/s/ C.B. Sung

Director

C.B. Sung

*

/s/

Stanley Gilbert
Director
May 11, 2016
*
Jeffrey Holtmeier
Director
May 11, 2016
*
David E. Welch

Director

Director

May 11, 2016

David E. Welch

/s/ Garry S. Meyer

*

Director

Garry S. Meyer

Francis J. Elenio

Director

May 11, 2016
By:
/s/ Andrea Goren
Andrea Goren, as
Attorney-in-Fact pursuant to the
Power of Attorney previously provided

POWER

TABLE OF ATTORNEYCONTENTS

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Guido DiGregorio and Frank Dane as his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for him and in his name, place and stead, in any and all capacities to sign any and all amendments (including post-effective amendments) to this registration statement (and to any registration statement filed pursuant to Rule 462 under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or their substitutes, each acting alone, may lawfully do or cause to be done by virtue hereof.

EXHIBIT INDEX

SignatureExhibit

Number

Description

Title

1.1 **

Form of Underwriting Agreement.

/s/ Guido DiGregorio

3.1

Chairman

Certificate of Incorporation of the Company, as amended, incorporated herein by reference to Exhibits 3.1, 3.2, 3.3 and Chief Executive Officer (Principal

3.4 to the Company’s Registration Statement on Form 10 (File No. 000-19301).

Guido DiGregorio

3.2

Executive Officer)

Certificate of Amendment to the Company’s Certificate of Incorporation (authorizing the reclassification of the Class A Common Stock and Class B Common Stock into one class of Common Stock) filed with the Delaware Secretary of State on November 1, 1991, incorporated herein by reference to Exhibit 3 to Amendment 1 on Form 8 to the Company’s Form 8-A (File No. 000-19301).

3.3

Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State June 12, 1998, incorporated herein by reference to Exhibit 10.24 to the Company’s 1998 Form 10-K filed on April 6, 1999.

/s/ Frank Dane

3.4

Chief Financial Officer (Principal Financial and

Frank Dane

Accounting Officer)

/s/ Louis P. Panetta

Director

Louis P. Panetta

/s/ C.B. Sung

Director

C.B. Sung

/s/ David E. Welch

Director

David E. Welch

/s/ Garry S. Meyer

Director

Garry S. Meyer

II-9



Exhibit Index

Exhibit
Number

Document

3.1

By-laws of the Company adopted on October 6, 1986, incorporated herein by reference to Exhibit 3.5 to the Company’s Registration Statement on Form 10 (File No. 0-19301)000-19301).

3.5

3.2

Amended and Restated Certificate of Incorporation dated May 10, 1995, as filed with the Delaware Secretary of State’s office on May 18, 1995, incorporated herein by reference to Exhibit 3.2 to the Company’s Form 10-Q, filed August 14, 2008 (File No. 0-19301).

3.3

Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated June 12, 1998, incorporated herein by reference to Exhibit 10.24 tofiled with the Company’s 1998 Form 10-K, filed April 6, 1999 (File No. 0-19301).

3.4

CertificateDelaware Secretary of Amendment to the Company’s Amended and Restated Certificate of Incorporation datedState January 24, 2001, incorporated herein by reference to Exhibit 3.5 to the Company’s Registration Statement on Form S-1/A filed on December 20, 2007.

3.6

3.5

Certificate of Elimination of the Company’s Certificate of Designation of the Series A Preferred Stock datedfiled with the Delaware Secretary of State August 17, 2001, incorporated herein by reference to Exhibit 3.6 to the Company’s Registration Statement on Form S-1/A filed on December 20, 2007.

3.7

3.6

Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation datedfiled with the Delaware Secretary of State August 17, 2007, incorporated herein by reference to Exhibit 3.7 to the Company’s Registration Statement on Form S-1/A,S/1 filed on December 20, 2007.

3.8

Amended and Restated Certificate of Incorporation of the Company filed with the Delaware Secretary of State on May 18, 1995, incorporated herein by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

3.7

3.9

Certificate of Designations, Powers, Preferences and Rights of the Series A Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on June 4, 2008, incorporated herein by reference to Exhibit 4.23 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.
3.10

Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation datedfiled with the Delaware Secretary of State on June 30, 2008, incorporated herein by reference to Exhibit 3.7 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008 (File No. 0-19301).

2008.

3.11

4.1

Form

Certificate of Designations, Powers, Preferences and Rights of the Series A-1 Cumulative Convertible Promissory Note issued byPreferred Stock filed with the Company,Delaware Secretary of State on October 30, 2008, incorporated herein by reference to Exhibit 10.33.11 to the Company’s Annual Report on Form 10-K filed on March 12, 2009.
3.12
Certificate of Elimination of the Company’s Series A Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on December 30, 2008, incorporated herein by reference to Exhibit 3.12 to the Company’s Annual Report on Form 10-K filed on March 12, 2009.
3.13
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on June 30, 2009, incorporated herein by reference to Exhibit 3.13 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.

TABLE OF CONTENTS

Exhibit
Number
Description
3.14
Amendment No. 1 to By-laws dated June 17, 2010, incorporated herein by reference to Exhibit 3.14 to the Company’s Quarterly Report on Form 10-Q filed on August 16, 2010.
3.15
Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.15 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
3.16
Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.16 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
3.17
Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.17 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
3.18
Certificate of Amendment to Amended And Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.18 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.19
Second Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.19 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.20
Amended and Restated Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.20 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.21
Certificate of Designation of Series C Participating Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.21 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.22
Amendment to the Amended And Restated Certificate of Designation of the Series B Participating Convertible Preferred Stock, incorporated herein by reference to Exhibit 10.59 to the Company’s Current Report on Form 8-K filed March 31, 2011.
3.23
Amendment to the Amended And Restated Certificate of Designation of the Series C Participating Convertible Preferred Stock, incorporated herein by reference to Exhibit 10.60 to the Company’s Current Report on Form 8-K filed March 31, 2011.
3.24
Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on October 22, 2012.
3.25
Third Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.25 to the Company’s Form 10-K filed March 31, 2014.
3.26
Second Amended and Restated Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.26 to the Company’s Form 10-K filed March 31, 2014.
3.27
Amended and Restated Certificate of Designation of Series C Participating Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, incorporated herein by reference to Exhibit 3.27 to the Company’s Form 10-K filed March 31, 2014.

TABLE OF CONTENTS

Exhibit
Number
Description
3.28
Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.28 to the Company’s Form 10-K filed March 31, 2014.
3.29
Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 10, 2013, incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on November 1, 2013.
3.30
Certificate of Amendment to Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2013, incorporated herein by reference to Exhibit 3.30 to the Company’s Form 10-K filed March 31, 2014.
3.31
Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 16, 2014, incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on October 17, 2014.
3.32
Certificate of Amendment to Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on March 24, 2015, incorporated herein by reference to Exhibit 3.32 to the Company’s Form 10-Q filed May 15, 2015.
3.33
Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 11, 2015, incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K filed November 4, 2004.

on December 14, 2015.

4.10†

1999 Stock Option Plan, as amended, incorporated herein by reference to Exhibit 4.2 to the Company’s Form S-8 filed on September 19, 2008.

4.2

4.12

Form of Warrant issued by the Company, incorporated herein by reference to Exhibit 10.4 to the Company’s Form 8-K filed on November 4,3, 2004.

4.16

4.3

Form of Promissory Note issued by the Company, incorporated herein by reference to Exhibit 10.36 to the Company’s Form 8-K, filed August 16, 2006.

4.4

Form of Warrant issued by the Company, incorporated herein by reference to Exhibit 10.37 to the Company’s Form 8-K filed August 16, 2006.

4.5

Form of Promissory Note issued by the Company, incorporated herein by reference to Exhibit 10.36 to the Company’s Form 8-K, filedon February 9, 2007.

4.18

4.6

Form of Warrant issued by the Company, incorporated herein by reference to Exhibit 10.37 to the Company’s Form 8-K, filed February 9, 2007.

4.7

Form of Promissory Note issued by the Company, incorporated herein by reference to Exhibit 10.36 to the Company’s Form 8-K, filed June 20, 2007.

4.8

Form of Warrant issued the Company, incorporated herein by reference to Exhibit 10.37 to the Company’s Form 8-K filed on June 20, 2007.



4.9

Certificate of Designations dated June 4, 2008 with respect to Series A Cumulative Convertible Preferred Stock, incorporated herein by reference to Exhibit 4.23 to the Company’s Form 10-Q, filed August 14, 2008.

4.19

4.10

Form of Common Stock Purchase Warrant issued by the Company, incorporated herein by reference to Exhibit 4.19 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

4.20

4.11

Form of Additional Common Stock Purchase Warrant, incorporated herein by reference to Exhibit 4.20 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.
4.26
Form of Common Stock Purchase Warrant issued by the Company, incorporated herein by reference to Exhibit 4.204.26 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

2009.

4.27

4.12

Form of Secured Promissory Note issued by the Company dated June 5, 2008,Additional Common Stock Purchase Warrant, incorporated herein by reference to Exhibit 4.214.27 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

2009.

4.28**

Form of Unsecured Convertible Promissory Note issued by the Company.

4.13

4.29**

Form of Additional Secured Promissory Note, incorporated hereinUnderwriter Warrant issued by reference tothe Company (included in Exhibit 4.22 to the Company’s Form 10-Q, filed August 14, 2008.

1.1).

4.30**

Form of Warrant to Purchase Common Stock to be issued in this offering.

4.31**5.1

Form of Warrant to Purchase Common Stock to be issued to holders of unsecured convertible promissory notes.

TABLE OF CONTENTS

Exhibit
Number

Description
4.32**
Form of Warrant to Purchase Common Stock to be issued to FirstGlobal Partners LLC and SG Phoenix LLC.
5.1*
Opinion of Davis Wright TremainePillsbury Winthrop Shaw Pittman LLP.

10.19

10.2

Standby Stock Purchase Agreement between the Company and Philip Sassower dated October 3, 1994, incorporated herein by reference to Exhibit 10.13 to the Company’s 1994 Form 10-K (File No. 0-19301).

10.3

Form of Subscription Agreement between the Company and the Purchasers, dated November 28, 1995, incorporated herein by reference to Exhibit 1 to the Company’s Form 8-K, dated November 28, 1995 (File No. 0-19301).

10.4

Form of Registration Rights Agreement between the Company and the Purchasers, dated November 28, 1995, incorporated herein by reference to Exhibit 1 to the Company’s Form 8-K, dated November 28, 1995 (File No. 0-19301).

10.7

Form of Subscription Agreement between the Company and various investors, dated June 13, 1996, incorporated herein by reference to Exhibit 1 to the Company’s Form 8-K, filed June 27, 1996 (File No. 0-19301).

10.8

Form of Registration Rights Agreement between the Company and various investors, dated June 13, 1996, incorporated herein by reference to Exhibit 2 to the Company’s Form 8-K, filed June 27, 1996 (File No. 0-19301).

10.9

Form of Preferred Stock Investment Agreement, dated as of December 31, 1996, between the Company and the investors listed on Schedule 1 thereto, incorporated herein by reference to Exhibit 1 to the Company’s Form 8-K, filed January 7, 1997 (File No. 0-19301).

10.10

Form of Registration Rights Agreement between the Company and the Investors Listed on Schedule 1 thereto, incorporated herein by reference to Exhibit 2 to the Company’s Form 8-K, filed January 7, 1997 (File No. 0-19301).

10.13

Form of Subscription Agreement between the Company and each subscriber, dated as of November 25, 1997, incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K, filed December 8, 1997 (File No. 0-19301).

10.15

Form of Registration Rights Agreement, by and among the Company and the signatories thereto, dated as of November 25, 1997, incorporated herein by reference to Exhibit 10.3 to the Company’s Form 8-K, filed December 8, 1997 (File No. 0-19301).

†10.19

Software Development and License Agreement dated December 4, 1998 between Ericsson Mobile Communications AB and the Company incorporated herein by reference to Exhibit 10.26 toof the



Company’s 1998 Form 10-K filed April 6, 1999 (File No. 0-19301).

10.24

Form of Note and Warrant Purchase Agreement dated October 28, 2004, by and among the Company and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on November 3, 2004.

10.26

10.25

Form of Registration Rights Agreement dated October 28, 2004, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.2 to the Company’s Form 8-K filed on November 3, 2004.
10.26

Form of Note and Warrant Purchase Agreement dated August 10, 2006, among Communication Intelligence Corporationby and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.34 to the Company’s Form 8-K, filed August 16, 2006.

10.27

Form of Registration Rights Agreement dated August 10, 2006, among Communication Intelligence Corporation and the parties identified there in, incorporated herein by reference to Exhibit 10.35 to the Company’s Form 8-K, filed August 16, 2006.

†† 10.28

Amendment dated May 31, 2005 to the License Agreement dated December 22, 2000 between the Company and eCom Asia Pacific, Ltd., incorporated herein by reference to Exhibit 10.26 to the Company’s Form 10-K/A, filed September 15, 2005.

†† 10.29

License Agreement dated June 2, 2005 between the Company and SnapOn Credit LLC incorporated herein by reference to Exhibit 10.27 to the Company’s Form 10-K/A, filed September 15, 2005.

10.30

Amendment to employment agreement with Guido DiGregorio, incorporated herein by reference to the

Company’s Form 8-K dated September 21, 2005.

10.31

Amendment to employment agreement with Frank V. Dane, incorporated herein by reference to the Company’s Form 8-K dated September 21, 2005.

10.32

Form of stock option agreement dated August 31, 2005 with Russell L. Davis, incorporated by reference to Exhibit 10.30 to the Company’s Form 10-K/A, filed September 15, 2006.

10.33

Form of stock option agreement dated December 19, 2005 with Guido DiGregorio, incorporated by reference to Exhibit 10.30 to the Company’s Form 10-K/A, filed September 15, 2006.

10.34

Form of stock option agreement dated December 19, 2005 with Francis V. Dane, incorporated by reference to Exhibit 10.30 to the Company’s Form 10-K/A, filed September 15, 2006.

10.35

Form of stock option agreement dated December 31, 2005 with C. B. Sung, incorporated by reference to Exhibit 10.30 to the Company’s Form 10-K/A, filed September 15, 2006.

10.36

Form of Note and Warrant Purchase Agreement dated February 5, 2007, among the Company and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.34 to the Company’s Form 8-K filed February 9, 2007.

on August 12, 2006.

10.27

10.37

Form of Registration Rights Agreement dated February 5, 2007,August 10, 2006, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.35 to the Company’s Form 8-K filed February 9, 2007.

on August 12, 2006.

10.28

Amendment dated May 31, 2005 to the License agreement dated December 22, 2000 between the Company and eCom Asia Pacific, Ltd., incorporated by reference to Exhibit 10.26 of the Company’s Form 10-K/A filed on March 31, 2006.

10.38

10.29

License agreement dated June 2, 2005 between the Company and SnapOn Credit LLC, incorporated herein by reference to Exhibit 10.27 of the Company’s Form 10-K/A filed on March 31, 2006.
10.30

Amendment to employment agreement with Guido DiGregorio, incorporated herein by reference to the Company’s Form 8-K filed on September 21, 2005.
10.31
Amendment to employment agreement with Francis V. Dane, incorporated herein by reference to the Company’s Form 8-K filed on September 21, 2005.
10.32
Form of stock option agreement dated August 31, 2005 with Russell L. Davis, incorporated by reference to Exhibit 10.30 of the Company’s Form 10-K/A filed on September 15, 2006.
10.33
Form of stock option agreement dated December 19, 2005 with Guido DiGregorio, incorporated by reference to Exhibit 10.30 of the Company’s Form 10-K/A filed on September 15, 2006.
10.34
Form of stock option agreement dated August 31, 2005 with Francis V. Dane, incorporated by reference to Exhibit 10.30 of the Company’s Form 10-K/A filed on September 15, 2006.
10.35
Form of stock option agreement dated August 31, 2005 with C. B. Sung, incorporated by reference to Exhibit 10.30 of the Company’s Form 10-K/A filed on September 15, 2006.
10.36
Form of Note and Warrant Purchase Agreement dated February 5, 2007, among the companyby and the parties identified therein, incorporated herein by reference to Exhibit 99.1 to the Company’s Form 8-K, filed March 19, 2007.

10.39

Form of Note and Warrant Purchase Agreement dated June 15, 2007, among the Company and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.34 to the Company’s Form 8-K filed June 20,on February 5, 2007.

10.37

10.40

Form of Registration Rights Agreement dated June 15,February 5, 2007, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.35 to the Company’s Form 8-K filed June 20,on February 5, 2007.

TABLE OF CONTENTS

Exhibit
Number
Description

10.38

Amendment to the Note and Warrant Purchase Agreement dated February 5, 2007, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 99.1 to the Company’s Form 8-K filed on March 15, 2007.

10.41

10.39

Form of Note and Warrant Purchase Agreement dated June 15, 2007, by and among the Company and the Purchasers identified therein, incorporated herein by reference to Exhibit 10.34 to the Company’s Form 8-K filed on June 15, 2007.
10.40

Form of Registration Rights Agreement dated June 15, 2007, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.35 to the Company’s Form 8-K filed on June 15, 2007.
10.41
Form of Securities Purchase and Registration Rights Agreement dated August 24, 2007, by and among Communication Intelligence Corporationthe Company and Phoenix Venture Fund LLC, incorporated herein by reference to Exhibit 10.36 to the Company’s Form 8-K filed on August 27, 2007.



†††

10.42

Consulting Agreement dated January 9, 2008 between the Company and GS Meyer & Associates LLC - Incorporated by reference to Exhibit 10.42 to the Company’s Annual Report on Form 10-K filed on March 12, 2007.
10.43
Credit Agreement dated June 5, 2008, by and among the Company and the Lenders Party hereto and SG Phoenix as Collateral Agent, incorporated herein by reference to Exhibit 10.41 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.
10.44
Pledge and Security Agreement dated June 5, 2008, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.42 to the Company’s Quarterly Report on Form 10-K,10-Q filed March 12,on August 14, 2008.

10.44

10. 43

Securities Purchase Agreement betweendated June 5, 2008, by and among the Company and the Investorsparties identified therein, dated June 5, 2008, incorporated herein by reference to Exhibit 10.43 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

10.45

10. 44

Registration Rights Agreement betweendated June 5, 2008, by and among the Company and the parties identified therein, dated June 5, 2008, incorporated herein by reference to Exhibit 10.44 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

10.46

Amendment No. 1 to Credit Agreement dated May 28, 2009, by and among the Company, the Lenders and Additional Lenders Parties thereto and SG Phoenix as Collateral Agent, incorporated herein by reference to Exhibit 10.46 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.

Xx10. 45

10.47

Amendment No. 1 to Registration Rights Agreement dated May 28, 2009, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.47 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.
10.48

Salary Reduction Plan for Executive Officers of the Company under Amendment No. 1 to Credit Agreement betweendated May 28, 2009, incorporated herein by reference to Exhibit 10.48 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.
10.53
Amendment No. 3 to Credit Agreement dated July 22, 2010, by and among the Company, the Lenders and Additional Lenders Parties hereto and SG Phoenix as Collateral Agent, incorporated herein by reference to Exhibit 10.53 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
10.54
Amendment No. 3 to Registration Rights Agreement dated July 22, 2010, by and among the Company and the parties identified therein, incorporated herein by reference to Exhibit 10.54 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.

TABLE OF CONTENTS

Exhibit
Number
Description
10.55
Registration Rights Agreement dated August 5, 2010, by and among the Company and the Persons Executing the Agreement as Investors, incorporated herein by reference to Exhibit 10.55 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
10.56
Investor Rights Agreement dated August 5, 2010, by and among the Company and Phoenix Venture Fund LLC, SG Phoenix LLC, Michael Engmann, Ronald Goodman, Kendu Partners Company and MDNH Partners L.P., incorporated herein by reference to Exhibit 10.56 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
10.57
Securities Purchase Agreement dated December 9, 2010, by and among the Company, Phoenix Venture Fund LLC, Michael Engmann and Ronald Goodman dated June 5, 2008,the Investors signatory thereto, incorporated herein by reference to Exhibit 10.4110.57 to the Company’s Current Report on Form 8-K filed on December 9, 2010.
10.58
Registration Rights Agreement dated December 31, 2010, by and among the Company and the Persons Executing the Agreement as Investors, incorporated herein by reference to Exhibit 10.58 to the Company’s Current Report on Form 8-K filed on January 6, 2011.
10.59
Form of Subscription Agreement dated March 31, 2011, by and among the Company and the Person Executing the Agreement as Subscribers, incorporated herein by reference to Exhibit 10.61 to the Company’s Current Report on Form 8-K filed on April 4, 2011.
10.60
Amendment No. 1 to Registration Rights Agreement dated March 31, 2011, by and among the Company and the Persons Executing the Agreement as Required Holders, incorporated herein by reference to Exhibit 10.62 to the Company’s Current Report on Form 8-K filed on April 4, 2011.
10.61
Note and Warrant Purchase Agreement dated September 20, 2011, incorporated herein by reference to Exhibit 10.61 to the Company’s Quarterly Report on Form 10-Q filed on November 14, 2011.
10.62
Note and Warrant Purchase Agreement dated December 2, 2011, incorporated herein by reference to Exhibit 10.62 to the Company’s Annual Report on Form 10-K filed on March 30, 2012.
10.63
Note and Warrant Purchase Agreement dated April 23, 2012, incorporated herein by reference to Exhibit 10.63 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2012.
10.64
Form of Subscription Agreement dated September 14, 2012, incorporated herein by reference to Exhibit 10.64 to the Company’s Quarterly Report on Form 10-Q filed on November 14, 2012.
10.66
Form of Subscription Agreement dated May 17, 2013, incorporated herein by reference to Exhibit 10.66 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2013.
10.67
Form of Subscription Agreement dated December 16, 2013, incorporated herein by reference to Exhibit 10.67 to the Company’s Form 10-K filed March 31, 2014.
10.68
Credit Agreement with Venture Champion Asia Limited dated May 6, 2014, incorporated herein by reference to Exhibit 10.68 to the Company’s Form 10-Q filed August 14, 2008.

15, 2014.

10.69

10. 46

Pledge and Security

Form of Subscription Agreement between the Company and the parties identified therein, dated JuneAugust 5, 2008,2014, incorporated herein by reference to Exhibit 10.4210.69 to the Company’s Form 10-K filed March 31, 2015.
10.70
Form of Subscription Agreement dated as of February 27, 2015, incorporated herein by reference to Exhibit 10.70 to the Company’s Form 10-Q filed August 14, 2008.

May 15, 2015.

10.71

Form of Subscription Agreement dated July 23, 2015, incorporated herein by reference to Exhibit 10.71 to the Company Form 10-Q filed November 16, 2015.

21.1

10.72**

Note Purchase Agreement dated as of November 25, 2015.
10.73**

Schedule

Advisory Services Agreement with FirstGlobal Partners LLC dated August 12, 2011.
10.74**
Advisory Services Agreement with SG Phoenix LLC dated August 12, 2011.

TABLE OF CONTENTS

Exhibit
Number
Description
10.75**
Letter Agreement with FirstGlobal Partners LLC dated December 3, 2015.
10.76**
Letter Agreement with SG Phoenix LLC dated December 3, 2015.
10.77**
Form of subsidiaries (incorporatedletter agreement with holders of unsecured convertible promissory notes.
10.78**
Letter Agreement with FirstGlobal Partners LLC dated April 11, 2016.
10.79**
Letter Agreement with SG Phoenix LLC dated April 11, 2016.
21.1
Subsidiaries of the Company, incorporated herein by reference to Exhibit 21.1 to the Company’s Form 10-K filed March 12, 2008).

April 6, 2016.

23.1*

Consent of Armanino LLP, Independent Registered Public Accounting Firm.

23.2**23.1

Consent of Davis Wright TremainePillsbury Winthrop Shaw Pittman LLP (included as part ofin Exhibit 5.1).

24.1**

Power of Attorney (contained in the signature page of the Registration Statement).

*23.2

101.INS*

Consent of GHP Horwath, P.C.

XBRL Instance Document

101.SCH*

Taxonomy Extension Schema Document

*24.1

101.CAL*

Taxonomy Extension Calculation Linkbase Document
101.DEF*

Powers of Attorney (included on signature pages)

Taxonomy Extension Definition Linkbase Document
101.LAB*
Taxonomy Extension Labels Linkbase Document
101.PRE*
Taxonomy Extension Presentation Linkbase Document


*Filed herewith.

Confidential treatment of certain portions of this exhibit have been requested from the SEC pursuant to a request for confidentiality dated March 30, 1999, filed pursuant to the Securities and Exchange Act of 1934.

††Confidential treatment of certain portions of this exhibit have been requested from the SEC pursuant to a request for confidentiality dated March 30, 2006, filed pursuant to the Securities and Exchange Act of 1934.

†††Confidential treatment of certain portions of this exhibit have been requested from the SEC pursuant to a request for confidentiality dated March 10, 2008, filed pursuant to the Securities and Exchange Act of 1934.

XxConfidential treatment of certain portions of this exhibit have been requested from the SEC pursuant to a request for confidentiality dated August 14, 2008, filed pursuant to the Securities and Exchange Act of 1934.


*Filed herewith.
**Previously filed.
Indicates management contract or compensatory plan, contract or arrangement.